{"id": "22104738", "text": "<Variant>Novel compound heterozygous mutation of MLYCD in a Chinese patient with malonic aciduria.</Variant>", "label": []}
{"id": "22104738", "text": "<Variant>A 3-year-old Chinese boy presented with prominent clinical features of malonic aciduria, including developmental delay, short stature, brain abnormalities and massive excretion of malonic acid and methylmalonic acid.</Variant>", "label": []}
{"id": "22104738", "text": "<Variant>Molecular characterization by DNA sequencing analysis and multiplex ligation-dependent probe amplification of the MLYCD gene revealed a heterozygous mutation (c.920T>G, p.Leu307Arg) in the patient and his father and a heterozygous deletion comprising exon 1 in the patient and his mother.</Variant>", "label": [[168, 176, "Variant"], [178, 189, "Variant"]]}
{"id": "22104738", "text": "<Variant>The missense mutation (c.920T>G) was not found in 100 healthy controls and has not been reported previously.</Variant>", "label": [[32, 40, "Variant"]]}
{"id": "22104738", "text": "<Variant>Our findings expand the number of reported cases and add a novel entry to the repertoire of MLYCD mutations.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>BACKGROUND: Mutations in the neurofibromatosis type 2 (NF2) tumor-suppressor gene have been identified in not only NF2-related tumors but also sporadic vestibular schwannomas (VS).</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>This study investigated the genetic and epigenetic alterations in tumors and blood from 30 Korean patients with sporadic VS and correlated these alterations with tumor behavior.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>METHODOLOGY/PRINCIPAL FINDINGS:</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>NF2 gene mutations were detected using PCR and direct DNA sequencing and three highly polymorphic microsatellite DNA markers were used to assess the loss of heterozygosity (LOH) from chromosome 22.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>Aberrant hypermethylation of the CpG island of the NF2 gene was also analyzed.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>The tumor size, the clinical growth index, and the proliferative activity assessed using the Ki-67 labeling index were evaluated.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>We found 18 mutations in 16 cases of 30 schwannomas (53%).</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>The mutations included eight frameshift mutations, seven nonsense mutations, one in-frame deletion, one splicing donor site, and one missense mutation.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>Nine patients (30%) showed allelic loss.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>No patient had aberrant hypermethylation of the NF2 gene and correlation between NF2 genetic alterations and tumor behavior was not observed in this study.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>CONCLUSIONS/SIGNIFICANCE:</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>The molecular genetic changes in sporadic VS identified here included mutations and allelic loss, but no aberrant hypermethylation of the NF2 gene was detected.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>In addition, no clear genotype/phenotype correlation was identified.</Variant>", "label": []}
{"id": "22295085", "text": "<Variant>Therefore, it is likely that other factors contribute to tumor formation and growth.</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>RET mutational spectrum in Hirschsprung disease: evaluation of 601 Chinese patients.</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>Rare (RVs) and common variants of the RET gene contribute to Hirschsprung disease (HSCR; congenital aganglionosis).</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>While RET common variants are strongly associated with the commonest manifestation of the disease (males; short-segment aganglionosis; sporadic), rare coding sequence (CDS) variants are more frequently found in the lesser common and more severe forms of the disease (females; long/total colonic aganglionosis; familial).Here we present the screening for RVs in the RET CDS and intron/exon boundaries of 601 Chinese HSCR patients, the largest number of patients ever reported.</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>We identified 61 different heterozygous RVs (50 novel) distributed among 100 patients (16.64%).</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>Those include 14 silent, 29 missense, 5 nonsense, 4 frame-shifts, and one in-frame amino-acid deletion in the CDS, two splice-site deletions, 4 nucleotide substitutions and a 22-bp deletion in the intron/exon boundaries and 1 single-nucleotide substitution in the 5' untranslated region.</Variant>", "label": [[184, 198, "Variant"]]}
{"id": "22174939", "text": "<Variant>Exonic variants were mainly clustered in RET the extracellular domain.</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>RET RVs were more frequent among patients with the most severe phenotype (24% vs. 15% in short-HSCR).</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>Phasing RVs with the RET HSCR-associated haplotype suggests that RVs do not underlie the undisputable association of RET common variants with HSCR.</Variant>", "label": []}
{"id": "22174939", "text": "<Variant>None of the variants were found in 250 Chinese controls.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>A deletion of FGFR2 creating a chimeric IIIb/IIIc exon in a child with Apert syndrome.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>Signalling by fibroblast growth factor receptor type 2 (FGFR2) normally involves a tissue-specific alternative splice choice between two exons (IIIb and IIIc), which generates two receptor isoforms (FGFR2b and FGFR2c respectively) with differing repertoires of FGF-binding specificity.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>Here we describe a unique chimeric IIIb/c exon in a patient with Apert syndrome, generated by a non-allelic homologous recombination event.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>CASE PRESENTATION:</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>We present a child with Apert syndrome in whom routine genetic testing had excluded the FGFR2 missense mutations commonly associated with this disorder.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>The patient was found to harbour a heterozygous 1372 bp deletion between FGFR2 exons IIIb and IIIc, apparently originating from recombination between 13 bp of identical DNA sequence present in both exons.</Variant>", "label": [[57, 73, "Variant"]]}
{"id": "21943124", "text": "<Variant>The rearrangement was not present in the unaffected parents.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>Based on the known pathogenesis of Apert syndrome, the chimeric FGFR2 protein is predicted to act in a dominant gain-of-function manner.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>This is likely to result from its expression in mesenchymal tissues, where retention of most of the residues essential for FGFR2b binding activity would result in autocrine activation.</Variant>", "label": []}
{"id": "21943124", "text": "<Variant>This report adds to the repertoire of rare cases of Apert syndrome for which a pathogenesis based on atypical FGFR2 rearrangements can be demonstrated.</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>Detection of a-thalassemia-1 Southeast Asian and Thai type deletions and b-thalassemia 3.5-kb deletion by single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting analysis.</Variant>", "label": [[96, 111, "Variant"]]}
{"id": "21779184", "text": "<Variant>BACKGROUND: Prevention and control of thalassemia requires simple, rapid, and accurate screening tests for carrier couples who are at risk of conceiving fetuses with severe thalassemia.</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>Single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting (HRM) analysis were used for the identification of a-thalassemia-1 Southeast Asian (SEA) and Thai type deletions and b-thalassemia 3.5-kb gene deletion.</Variant>", "label": [[221, 241, "Variant"]]}
{"id": "21779184", "text": "<Variant>The results were compared with those obtained using conventional gap-PCR.</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>DNA samples were derived from 28 normal individuals, 11 individuals with a-thalassemia-1 SEA type deletion, 2 with a-thalassemia-1 Thai type deletion, and 2 with heterozygous b-thalassemia 3.5-kb gene deletion.</Variant>", "label": [[198, 218, "Variant"]]}
{"id": "21779184", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>HRM analysis indicated that the amplified fragments from a-thalassemia-1 SEA type deletion, a-thalassemia-1 Thai type deletion, b-thalassemia 3.5-kb gene deletion, and the wild-type b-globin gene had specific peak heights at mean melting temperature (T(m)) values of 86.89 , 85.66 , 77.24 , and 74.92 , respectively.</Variant>", "label": [[151, 171, "Variant"]]}
{"id": "21779184", "text": "<Variant>The results obtained using single-tube multiplex real-time PCR with SYBR Green1 and HRM analysis showed 100% consistency with those obtained using conventional gap-PCR.</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21779184", "text": "<Variant>Single-tube multiplex real-time PCR with SYBR Green1 and HRM analysis is a potential alternative for routine clinical screening of the common types of a- and b-thalassemia large gene deletions, since it is simple, cost-effective, and highly accurate.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>Xeroderma pigmentosum variant: complementary molecular approaches to detect a 13 base pair deletion in the DNA polymerase eta gene.</Variant>", "label": [[87, 108, "Variant"]]}
{"id": "21640722", "text": "<Variant>Deficiencies of DNA polymerase eta-an enzyme mediating replication past UV-induced DNA damage-predispose individuals to xeroderma pigmentosum variant (XPV) and result in a high incidence of skin cancers.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>We designed, developed and assessed several complementary molecular approaches to detect a genetically inherited deletion within DNA polymerase eta.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>RNA was reverse transcribed from XPV fibroblasts and from normal human cells, and standard polymerase chain reaction (PCR) was conducted on the cDNA targeting a region with a 13 base pair deletion within the polymerase eta gene.</Variant>", "label": [[184, 205, "Variant"]]}
{"id": "21640722", "text": "<Variant>PCR products were subjected to restriction fragment length polymorphism (RFLP) analysis and cycle DNA sequencing.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>The deletion was found to eliminate a BsrGI restriction site and affected the number of resultant fragments visualized after gel electrophoresis.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>Cycle sequencing of polymerase eta-specific amplicons from XPV and normal cells provided a second approach for detecting the mutation.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>Additionally, the use of a fluorescent nucleic acid dye-EvaGreen-in real-time PCR and melt curve analysis distinguished normal and XPV patient-derived amplicons as well as heteroduplexes that represent heterozygotic carriers without the need for high resolution melt analysis-compatible software.</Variant>", "label": []}
{"id": "21640722", "text": "<Variant>Our approaches are easily adaptable by diagnostic laboratories that screen for or verify genetically inherited disorders and identify carriers of a defective gene.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>In an earlier study we showed that C10ORF97 (chromosome-10, open reading frame-97) was expressed in almost all of the tissues and cell lines tested, and that it inhibited the growth of seven tumor cell lines, including two lung carcinoma cell lines (A549 and PG).</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>Here, we show that C10ORF97 is downregulated in non-small-cell lung cancer (NSCLC) tissue compared with normal lung tissue.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>Overexpression of C10ORF97 significantly suppressed human lung carcinoma A549 cell growth (proliferation and anchorage-independent growth in soft agar) and motility (migration and adhesion).</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>This tumor-suppressive function of C10ORF97 was also verified in vivo.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>We further found that C10ORF97 caused G(1) arrest of A549 cells and modulated the expression level of several cell-cycle regulators (such as CDK2, cyclin-E and p27).</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>These effects of C10ORF97 were mediated by physical association between C10ORF97 and Jun-activating domain-binding protein-1 (JAB1), and blocking of JAB1-mediated translocation of p27 from the nucleus to the cytoplasm.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>Together, these results indicated that C10ORF97 functions as a novel tumor suppressor by modulating several key G(1)/S-regulatory proteins by interacting with JAB1.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>These findings led us to hypothesize that a single-nucleotide polymorphism (SNP) in the C10ORF97 gene that affects its expression might be associated with susceptibility to NSCLC.</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>SNP216 C>T (rs2297882) in the C10ORF97 Kozak sequence was identified, and allele T of SNP216 suppressed C10ORF97 expression in vitro and in vivo.</Variant>", "label": [[16, 19, "Variant"], [21, 30, "Variant"]]}
{"id": "21499297", "text": "<Variant>Furthermore, the TT genotype of SNP216 was associated with an increased risk of NSCLC (adjusted odds ratio=1.73 (95% confidence interval: 1.33-2.25), P=4.6 10(-5)).</Variant>", "label": []}
{"id": "21499297", "text": "<Variant>These data indicated that C10ORF97 is a tumor suppressor of NSCLC progression and C10ORF97-SNP216 may serve as a predictor of NSCLC.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>MHC region and risk of systemic lupus erythematosus in African American women.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>The major histocompatibility complex (MHC) on chromosome 6p21 is a key contributor to the genetic basis of systemic lupus erythematosus (SLE).</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>Although SLE affects African Americans disproportionately compared to European Americans, there has been no comprehensive analysis of the MHC region in relationship to SLE in African Americans.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>We conducted a screening of the MHC region for 1,536 single nucleotide polymorphisms (SNPs) and the deletion of the C4A gene in a SLE case-control study (380 cases, 765 age-matched controls) nested within the prospective Black Women's Health Study.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>We also genotyped 1,509 ancestral informative markers throughout the genome to estimate European ancestry to control for population stratification due to population admixture.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>The most strongly associated SNP with SLE was the rs9271366 (odds ratio, OR = 1.70, p = 5.6 10(-5)) near the HLA-DRB1 gene.</Variant>", "label": [[59, 68, "Variant"]]}
{"id": "21695597", "text": "<Variant>Conditional haplotype analysis revealed three other SNPs, rs204890 (OR = 1.86, p = 1.2 10(-4)), rs2071349 (OR = 1.53, p = 1.0 10(-3)), and rs2844580 (OR = 1.43, p = 1.3 10(-3)), to be associated with SLE independent of the rs9271366 SNP.</Variant>", "label": [[67, 75, "Variant"], [105, 114, "Variant"], [148, 157, "Variant"], [232, 241, "Variant"]]}
{"id": "21695597", "text": "<Variant>In univariate analysis, the OR for the C4A deletion was 1.38, p = 0.075, but after simultaneous adjustment for the other four SNPs the odds ratio was 1.01, p = 0.98.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>A genotype score combining the four newly identified SNPs showed an additive risk according to the number of high-risk alleles (OR = 1.67 per high-risk allele, p < 0.0001).</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>Our strongest signal, the rs9271366 SNP, was also associated with higher risk of SLE in a previous Chinese genome-wide association study (GWAS).</Variant>", "label": [[35, 44, "Variant"]]}
{"id": "21695597", "text": "<Variant>In addition, two SNPs found in a GWAS of European ancestry women were confirmed in our study, indicating that African Americans share some genetic risk factors for SLE with European and Chinese subjects.</Variant>", "label": []}
{"id": "21695597", "text": "<Variant>In summary, we found four independent signals in the MHC region associated with risk of SLE in African American women.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>The genetic and clinical features of glioblastoma with an oligodendroglial component (GBMO), pathologically defined as anaplastic oligo-astrocytoma with necrosis, remain unclear.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>We investigated the correlation between genetic alterations and clinical outcomes in 19 GBMO patients we have encountered since 1997.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>Using single nucleotide polymorphism oligonucleotide genomic (SNP) microarrays, we analyzed gene amplification, loss of heterozygosity (LOH), and homozygous deletions in their whole genome.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>We also analyzed their overall survival (OS).</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>Pathological studies revealed the presence of calcification in 11 and of a cyst in 9 of the 19 patients.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>Whole-genome analysis using SNP microarrays revealed LOH of chromosome 10 in 11, EGFR amplification in 8, 9p21 (INK4 locus) deletion in 12, PDGFR amplification in 2, and LOH of 1p19q in 2 patients.</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>Median OS was 14 months (average 22.8 months).</Variant>", "label": []}
{"id": "21629979", "text": "<Variant>The pattern of genetic alterations was similar in GBMO and glioblastoma multiforme (GBM) patients, and the clinical outcomes were similar in GBMO and GBM patients.</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>Exploratory investigation on functional significance of ETS2 and SIM2 genes in Down syndrome.</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>Trisomy of the 21{st} chromosome leads to an over dosage of several regulatory genes in Down syndrome (DS).</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>Though allelic and genotypic combinations formed between genes are interesting, till date, this particular area has never been explored in DS.</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>In the present investigation four SNPs in two transcription factors, Single minded 2 (SIM2) and V-ets erythroblastosis virus E26 oncogene</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>homolog2 (ETS2), located in the 21{st} chromosome were genotyped to understand their role in DS.</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>Genomic DNA of eastern Indian probands with DS (N=132), their parents (N=209) and ethnically matched controls (N=149) was subjected to PCR-based analyses of functionally important SNPs followed by statistical analyses.</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>ETS2 rs461155 showed high heterozygosity in DS.</Variant>", "label": [[14, 22, "Variant"]]}
{"id": "22048266", "text": "<Variant>Significantly lower frequency of SIM2 C-G haplotype (rs2073601-rs2073416) was noticed in individuals with DS (P value =0.01669) and their fathers (P value=0.01185).</Variant>", "label": [[62, 71, "Variant"], [72, 81, "Variant"]]}
{"id": "22048266", "text": "<Variant>Significantly lower frequency of the A-C-C-G with higher frequency of A-C-A-G haplotypes was also noticed in subjects with DS (P value =0.02089 and 0.00588 respectively).</Variant>", "label": []}
{"id": "22048266", "text": "<Variant>Data obtained indicate that the rs2073601 'A' allele, responsible for nonsynonymous substitution of leucine to methionine, may have some role in DS in this population.</Variant>", "label": [[41, 50, "Variant"], [109, 130, "Variant"]]}
{"id": "21771880", "text": "<Variant>Resequencing of IRS2 reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Our objective was to resequence insulin receptor substrate 2 (IRS2) to identify variants associated with obesity- and diabetes-related traits in Hispanic children.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Exonic and intronic segments, 5' and 3' flanking regions of IRS2 ( 14.5 kb), were bidirectionally sequenced for single nucleotide polymorphism (SNP) discovery in 934 Hispanic children using 3730XL DNA Sequencers.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Additionally, 15 SNPs derived from Illumina HumanOmni1-Quad BeadChips were analyzed.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Measured genotype analysis tested associations between SNPs and obesity and diabetes-related traits.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Bayesian quantitative trait nucleotide analysis was used to statistically infer the most likely functional polymorphisms.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>A total of 140 SNPs were identified with minor allele frequencies (MAF) ranging from 0.001 to 0.47.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Forty-two of the 70 coding SNPs result in nonsynonymous amino acid substitutions relative to the consensus sequence; 28 SNPs were detected in the promoter, 12 in introns, 28 in the 3'-UTR, and 2 in the 5'-UTR.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Two insertion/deletions (indels) were detected.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Ten independent rare SNPs (MAF = 0.001-0.009) were associated with obesity-related traits (P = 0.01-0.00002).</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>SNP 10510452_139 in the promoter region was shown to have a high posterior probability (P = 0.77-0.86) of influencing BMI, fat mass, and waist circumference in Hispanic children.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>SNP 10510452_139 contributed between 2 and 4% of the population variance in body weight and composition.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>None of the SNPs or indels were associated with diabetes-related traits or accounted for a previously identified quantitative trait locus on chromosome 13 for fasting serum glucose.</Variant>", "label": []}
{"id": "21771880", "text": "<Variant>Rare but not common IRS2 variants may play a role in the regulation of body weight but not an essential role in fasting glucose homeostasis in Hispanic children.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>A large heterozygous deletion including the entire C1 inhibitor gene in a sporadic case of hereditary angio-oedema.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>C1 inhibitor (C1-INH) deficiency [hereditary or acquired angio-oedema (HAE or AAE)] is characterized by recurring episodes of subcutaneous or submucosal oedema.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>Many different mutations in the C1-INH gene have been identified as a cause of HAE.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>We investigated the molecular basis of the disease in a Japanese woman with sporadic HAE.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>Direct sequencing of genomic DNA revealed no point mutation in the C1-INH gene.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>Quantitative real-time PCR showed that the copy number of the C1-INH gene in the patient was half that of a healthy control.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>Furthermore, we identified a 650-kbp deletion on the chromosome, which included the C1-INH gene.</Variant>", "label": [[38, 54, "Variant"]]}
{"id": "21790735", "text": "<Variant>We evaluated the correlation between the patient's attacks and her coagulation activity.</Variant>", "label": []}
{"id": "21790735", "text": "<Variant>The levels of D-dimer were high during the angio-oedema attacks, and often exceeded the normal range even during remission, thus the level of D-dimer reflected the activity of HAE in this patient.</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow-up.</Variant>", "label": [[26, 46, "Variant"]]}
{"id": "21506149", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>We describe the four decades follow-up of 14 parkin patients belonging to two large eight-generation-long in-bred Muslim-Arab kindreds.</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>RESULTS: All patients had a single base-pair of adenine deletion at nucleotide 202 of exon 2 (202A) of the parkin gene (all homozygous, one heterozygous).</Variant>", "label": [[57, 91, "Variant"], [103, 107, "Variant"]]}
{"id": "21506149", "text": "<Variant>Parkinson's disease onset age was 17-68 years.</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>Special features were intractable axial symptoms (low back pain, scoliosis, camptocormia, antecollis), postural tremor, and preserved cognition.</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21506149", "text": "<Variant>The 202A deletion of the parkin gene causes early-onset Parkinson's disease with marked levodopa/STN-DBS-resistant axial features.</Variant>", "label": [[13, 17, "Variant"]]}
{"id": "21506149", "text": "<Variant>Postural tremor and preserved cognition, even after 40 years of disease, were also evident.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Two novel mutations of the PAX6 gene causing different phenotype in a cohort of Chinese patients.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Aniridia (AN) is a rare congenital panocular disorder caused by the mutations of the paired box homeotic gene 6(PAX6) gene.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>The PAX6gene is also involved in other anterior segment malformations including Peters anomaly.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>We studied the PAX6gene mutations in a cohort of affected individuals with different clinical phenotype including AN, coloboma of iris and choroid, or anterior segment malformations.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>PATIENTS AND METHODS: Six unrelated families and 10 sporadic patients were examined clinically.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>After informed consent was obtained, genomic DNA was extracted from the venous blood of all participants.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Mutation screening of all exons of the PAX6gene was performed by direct sequencing of PCR-amplified DNA fragments.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Multiplex ligation-dependent probe amplification (MLPA) was performed to detect large deletions.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>By clinical examination, the patients and the pedigrees were divided into the following three groups: AN, coloboma of iris and choroids, and the anterior segment malformations including peters anomaly.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Sequencing of the PAX6gene, three intragenic mutations including a novel heterozygous splicing-site mutations c.357-3C>G (p.Ser119fsX) were identified in the patients of the AN group.</Variant>", "label": [[119, 129, "Variant"], [131, 142, "Variant"]]}
{"id": "21904390", "text": "<Variant>A novel missense mutation c.643T>C (p.S216P) was detected in the anterior segment malformation group.</Variant>", "label": [[35, 43, "Variant"], [45, 52, "Variant"]]}
{"id": "21904390", "text": "<Variant>The mutation p.S216P located in the homeodomain region of the PAX6 caused the phenotype of Peters anomaly in family A6 with different expressing.</Variant>", "label": [[22, 29, "Variant"]]}
{"id": "21904390", "text": "<Variant>Through MLPA analysis, a large deletion including the whole PAX6gene and DKFZ p686k1684gene was detected in one sporadic patient from the AN group.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Neither intragenic mutation nor large deletion was identified in the group with coloboma of iris and choroid.</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21904390", "text": "<Variant>Our findings further confirmed that different kind of mutations might cause different ocular phenotype, and clearly clinical phenotype classification might increase the mutation detection rate of the PAX6gene.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>Screening and cell-based assessment of mutations in the Aristaless-related homeobox (ARX) gene.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>ARX mutations cause a diverse spectrum of human disorders, ranging from severe brain and genital malformations to non-syndromic intellectual disability (ID).</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>ARX is a transcription factor with multiple domains that include four polyalanine (pA) tracts, the first two of which are frequently expanded by mutations.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>We progressively screened DNA samples from 613 individuals with ID initially for the most frequent ARX mutations (c.304ins(GCG)(7)'expansion' of pA1 and c.429_452dup 'dup24bp' of pA2).</Variant>", "label": [[123, 139, "Variant"], [162, 174, "Variant"], [176, 183, "Variant"]]}
{"id": "21496008", "text": "<Variant>Five hundred samples without pA1 or pA2 mutations had the entire ARX ORF screened by single stranded polymorphism conformation (SSCP) and/or denaturing high pressure liquid chromatography (dHPLC) analysis.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>Overall, eight families with six mutations in ARX were identified (1.31%): five duplication mutations in pA2 (0.82%) with three new clinical reports of families with the dup24bp and two duplications larger than the dup24bp mutation discovered (dup27bp, dup33bp); and three point mutations (0.6%), including one novel mutation in the homeodomain (c.1074G>T).</Variant>", "label": [[179, 186, "Variant"], [224, 231, "Variant"], [253, 260, "Variant"], [262, 269, "Variant"], [355, 364, "Variant"]]}
{"id": "21496008", "text": "<Variant>Four ultraconserved regions distal to ARX (uc466-469) were also screened in a subset of 94 patients, with three unique nucleotide changes identified in two (uc466, uc467).</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>The subcellular localization of full length ARX proteins was assessed for 11 variants.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>Protein mislocalization increased as a function of pA2 tract length and phenotypic severity, as has been previously suggested for pA1.</Variant>", "label": []}
{"id": "21496008", "text": "<Variant>Similarly, protein mislocalization of the homeodomain mutations also correlated with clinical severity, suggesting an emerging genotype vs cellular phenotype correlation.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>Variation in genotype and higher virulence of a strain of Sporothrix schenckii causing disseminated cutaneous sporotrichosis.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>Sporotrichosis is usually a localized, lymphocutaneous disease, but its disseminated type was rarely reported.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>The main objective of this study was to identify specific DNA sequence variation and virulence of a strain of Sporothrix schenckii isolated from the lesion of disseminated cutaneous sporotrichosis.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>We confirmed this strain to be S. schenckii by( ) tubulin and chitin synthase gene sequence analysis in addition to the routine mycological and partial ITS and NTS sequencing.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>We found a 10-bp deletion in the ribosomal NTS region of this strain, in reference to the sequence of control strains isolated from fixed cutaneous sporotrichosis.</Variant>", "label": [[20, 34, "Variant"]]}
{"id": "21717135", "text": "<Variant>After inoculated into immunosuppressed mice, this strain caused more extensive system involvement and showed stronger virulence than the control strain isolated from a fixed cutaneous sporotrichosis.</Variant>", "label": []}
{"id": "21717135", "text": "<Variant>Our study thus suggests that different clinical manifestation of sporotrichosis may be associated with variation in genotype and virulence of the strain, independent of effects due to the immune status of the host.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>Identification of a novel FBN1 gene mutation in a Chinese family with Marfan syndrome.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>To identify the mutation in the fibrillin-1 gene (FBN1) in a Chinese family with Marfan syndrome (MFS).</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>Patients and family members were given complete physical, ophthalmic, and cardiovascular examinations.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>Genomic DNA was extracted from leukocytes of venous blood of six individuals in the family and 170 healthy Chinese individuals.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>All of the 65 coding exons and their flanking intronic boundaries of FBN1 were amplified in the proband by polymerase chain reaction and followed by direct sequencing.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>The mutation identified in the proband was screened in the other family members and the 170 healthy Chinese individuals by direct sequencing.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>Protein conservation analysis was performed in six species using an online ClustalW tool.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>Protein structure was modeled based on the Protein data bank and mutated in DeepView v4.0.1 to predict the functional consequences of the mutation.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>A novel heterozygous c.3703T>C change in exon 29 of FBN1 was detected in the proband, which resulted in the substitution of serine by proline at codon 1235 (p.S1235P).</Variant>", "label": [[30, 39, "Variant"], [133, 164, "Variant"], [166, 174, "Variant"]]}
{"id": "21976953", "text": "<Variant>This mutation was also present in two family members but absent in the other, unaffected family members and the 170 healthy Chinese individuals.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>The mutant residue located in the calcium binding epidermal growth factor-like#15 domain is highly conserved among mammalian species and could probably induce conformation change of the domain.</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21976953", "text": "<Variant>We indentified a novel p.S1235P mutation in FBN1, which is the causative mutation for MFS in this family.</Variant>", "label": [[32, 40, "Variant"]]}
{"id": "21976953", "text": "<Variant>Our result expands the mutation spectrum of FBN1 and contributes to the study of the molecular pathogenesis of Marfan syndrome.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>The 57 kb deletion in cystinosis patients extends into TRPV1 causing dysregulation of transcription in peripheral blood mononuclear cells.</Variant>", "label": [[13, 27, "Variant"]]}
{"id": "21546516", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>Cystinosis is an autosomal recessive disease characterised by the abnormal accumulation of lysosomal cystine.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>Mutations in the cystinosin gene (CTNS) represent known causes for the disease.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>The major cystinosis mutation is a 57 kb deletion on human chromosome 17p13 that removes the majority of CTNS and the entire adjacent gene, CARKL/SHPK.</Variant>", "label": [[44, 58, "Variant"]]}
{"id": "21546516", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>In order to identify other genes that may influence the cystinosis pathobiological pathway, peripheral blood mononuclear cells (PBMC) were collected from cystinosis family members, and DNA and RNA extracted. RESULTS: Using whole genome transcriptional profiling, transient receptor potential vanilloid 1 (TRPV1) was found to be differentially expressed in association with cystinosis.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>This was verified using TaqMan qRT-PCR.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>There was a 72% reduction in PBMC TRPV1 mRNA levels in cystinosis individuals homozygous for the 57 kb deletion (n=6) compared to unaffected individuals without the deletion (n=6) (p=0.002).</Variant>", "label": [[106, 120, "Variant"]]}
{"id": "21546516", "text": "<Variant>TRPV1 is a sensory receptor located on chromosome 17p13, adjacent to CARKL/SHPK.</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>It was ascertained that the 57 kb deletion extends from exon 10 of CTNS, upstream through CARKL/SHPK, to intron 2 of TRPV1, thus deleting the first two non-coding exons.</Variant>", "label": [[37, 51, "Variant"]]}
{"id": "21546516", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21546516", "text": "<Variant>This is the first study to report that the 57 kb deletion extends into the TRPV1 gene causing dysregulation of transcription in PBMC isolated from cystinosis patients.</Variant>", "label": [[52, 66, "Variant"]]}
{"id": "21976404", "text": "<Variant>Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>OBJECTIVES: To investigate the association of angiotensin-converting enzyme (ACE) gene polymorphism and serum ACE level among Egyptian SLE patients and its relation to disease activity parameters.</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>SUBJECTS AND METHODS:</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>We enrolled 50 Egyptian female systemic lupus erythematosus (SLE) patients and 29 healthy controls.</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Measurement of serum ACE level was done using ELISA, and the ACE genotype was determined by polymerase chain reaction using genomic DNA from peripheral blood.</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>A significant difference was found in ACE genotypes between SLE patients and controls ( (2 )= 7.84, p = 0.02).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>The frequency of ACE DD versus (DI and II) genotypes was significantly higher in SLE patients compared with controls ( (2 )= 5.57, p = 0.018 and OR for risk of SLE was 3.1 with 95% confidence interval: 1.198.06).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Mean serum ACE level was significantly higher in the SLE group compared with controls (p = 0.006).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Subjects with DD genotype had a significantly higher mean level than those with DI (p = 0.015) and II genotypes (p = 0.02).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Lupus nephritis patients had a significantly higher frequency of DD versus DI and II genotypes compared with lupus patients without nephritis (Fisher's exact test, p = 0.025) and controls ( (2) =8.74, p = 0.003).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>SLE patients with vasculopathy had a significantly higher frequency of DD versus DI/II genotypes compared with SLE patients without vasculopathy (Fisher's exact test, p = 0.04) and controls ( (2 )= 9.84 and p = 0.002).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Mean serum ACE level was significantly higher in the lupus nephritis and SLE patients with vasculopathy compared with controls (p = 0.008, p = 0.001, respectively).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Significant positive correlations were found between serum ACE level and serum creatinine and 24 h proteinuria (p = 0.03, 0.009, respectively).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>SLE patients with DD genotype had a statistically significant higher mean SLEDAI score than those with (DI/II) genotypes (p = 0.02).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Significant positive correlation was found between serum ACE levels and SLEDAI scores (p = 0.04).</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>CONCLUSION: ACE genotype and subsequently serum ACE level could be associated with the disease activity of Egyptian SLE patients; in addition, ACE deletion polymorphism might be used as one of the predictive factors for the activity of SLE.</Variant>", "label": []}
{"id": "21976404", "text": "<Variant>Further studies on a larger number of patients should be done to determine the exact prevalence of ACE gene polymorphism among Egyptian SLE patients.</Variant>", "label": []}
{"id": "21879313", "text": "<Variant>Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C.</Variant>", "label": [[18, 27, "Variant"]]}
{"id": "21879313", "text": "<Variant>The life cycle of the hepatitis C virus (HCV) is closely related to host lipoprotein metabolism.</Variant>", "label": []}
{"id": "21879313", "text": "<Variant>Serum levels of lipid are associated with the response to pegylated interferon plus ribavirin (PEG-IFN/RBV) therapy, while single nucleotide polymorphisms (SNPs) around the human interleukin 28B (IL28B) gene locus and amino acid substitutions in the core region of the HCV have been reported to affect the efficacy of PEG-IFN/RBV therapy in chronic hepatitis with HCV genotype 1b infection.</Variant>", "label": []}
{"id": "21879313", "text": "<Variant>The aim of this study was to elucidate the relationship between serum lipid and factors that are able to predict the efficacy of PEG-IFN/RB therapy, with specific focus on apolipoprotein B-100 (apoB-100) in 148 subjects with chronic HCV G1b infection.</Variant>", "label": []}
{"id": "21879313", "text": "<Variant>Our results demonstrated that both the aa 70 substitution in the core region of the HCV and the rs8099917 SNP located proximal to the IL28B were independent factors in determining serum apoB-100 and low-density lipoprotein (LDL) cholesterol levels.</Variant>", "label": [[105, 114, "Variant"]]}
{"id": "21879313", "text": "<Variant>A significant association was noted between higher levels of apoB-100 (P = 1.1 10(-3)) and LDL cholesterol (P = 0.02) and the subjects having Arg70.</Variant>", "label": [[151, 156, "Variant"]]}
{"id": "21879313", "text": "<Variant>A significant association was also observed between subjects carrying the rs8099917 TT responder genotype and higher levels of apoB-100 (P = 6.4 10(-3)) and LDL cholesterol (P = 4.2 10(-3)).</Variant>", "label": [[83, 92, "Variant"]]}
{"id": "21879313", "text": "<Variant>Our results suggest that apoB-100 and LDL cholesterol are markers of impaired cellular lipoprotein pathways and/or host endogenous interferon response to HCV in chronic HCV infection.</Variant>", "label": []}
{"id": "21879313", "text": "<Variant>In particular, serum apoB-100 concentration might be an informative marker for judging changes in HCV-associated intracellular lipoprotein metabolism in patients carrying the rs8099917 responder genotype.</Variant>", "label": [[184, 193, "Variant"]]}
{"id": "20728296", "text": "<Variant>Interstitial deletion of 13q14.13-q32.3 presenting with Arima syndrome and bilateral retinoblastoma.</Variant>", "label": []}
{"id": "20728296", "text": "<Variant>A patient with a large deletion of the distal part of the long arm of chromosome 13 showed severe psychomotor retardation, a characteristic face, nystagmus, retinopathy, cystic kidney disease, and brain malformation with molar tooth sign and cerebellar vermis hypoplasia, a phenotype typical of Arima syndrome.</Variant>", "label": []}
{"id": "20728296", "text": "<Variant>This patient also had bilateral retinoblastoma.</Variant>", "label": []}
{"id": "20728296", "text": "<Variant>Fluorescent in situ hybridization and single-nucleotide-polymorphism genotyping microarray demonstrated an interstitial deletion of 54 Mbp, ranging from 13q14.13 to 13q32.3 and involving the RB1 gene.</Variant>", "label": [[129, 147, "Variant"]]}
{"id": "20728296", "text": "<Variant>This patient is the first case of Arima syndrome, or a Joubert syndrome-related disorder, that showed linkage to chromosome 13q.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>Bikunin and a1-microglobulin/bikunin precursor (AMBP) gene mutational screening in patients with kidney stones: a case-control study.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>Bikunin is an inhibitor of kidney stone formation synthesized in the liver together with a(1)-microglobulin from the a(1)-microglobulin/bikunin precursor (AMBP) gene.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>The aim of this study was to investigate the possible association between bikunin/AMBP gene polymorphisms and urinary stone formation.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>MATERIAL AND METHODS: To analyse the DNA, blood samples were taken from 75 kidney stone formers who had a familial stone history, 35 sporadic stone formers and 101 healthy individuals.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>Four exons of bikunin gene and five parts of the promoter region of the AMBP gene were screened using single-strand conformation polymorphism and nucleotide sequence analysis.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>The Init-2 region of the promoter of AMBP gene had polymorphisms at positions -218 and -189 nt giving three different genotypes having 1,3, 2,4 and 1,2,3,4 alleles with frequencies of 17.06%, 60.19% and 22.75%, respectively, in all groups.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>Therefore, the Init-2 region appears to be polymorphic.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>As a result, the 1,3 allele has -218G and -189T complying with the reference database sequence, the 2,4 allele has -218G and T-189C substitution and the allele 1,2,3,4 genotype has substitutions at positions G-218C and T-189C. CONCLUSIONS:</Variant>", "label": [[41, 46, "Variant"], [51, 56, "Variant"], [124, 129, "Variant"], [134, 140, "Variant"], [217, 223, "Variant"], [228, 234, "Variant"]]}
{"id": "20602574", "text": "<Variant>There were no significant differences in allele distribution between patients and controls.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>These common alleles exist in the Turkish population independent of stone formation.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>These results are the first to demonstrate the existence of bikunin and AMBP promoter polymorphism.</Variant>", "label": []}
{"id": "20602574", "text": "<Variant>Although the Init-2 region of the AMBP gene is the binding site for various transcription factors, the results showed no association between these observed genotypes and stone-forming phenotypes.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>The GALT rush: high carrier frequency of an unusual deletion mutation of the GALT gene in the Ashkenazi population.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>Classic galactosemia is an autosomal recessive disorder of galactose metabolism manifesting in the first weeks of life following exposure to a milk-based diet.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>Despite the benefit of avoidance of lactose, many patients suffer from long-term complications including neurological deficits and ovarian failure.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>To date, over 230 mutations have been described in the GALT gene resulting in galactosemia.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>Recently, an unusual mutation was characterized causing a 5.5 kb deletion, with a relatively high carrier rate in subjects of Ashkenazi Jewish (AJ) descent.</Variant>", "label": [[67, 82, "Variant"]]}
{"id": "21059483", "text": "<Variant>The aim of this study was to estimate the carrier frequency of this mutation in the AJ population in Israel.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>For this purpose we developed a high-throughput methodology to genotype both normal and deleted alleles using a chip-based matrix-assisted laser desorption-time-of-flight (MALDI-TOF) mass spectrometer and Multiplex PCR.</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>DNA samples of 760 anonymous AJ subjects were submitted for analysis, subsequently detecting six individuals heterozygous for the GALT deletion mutation, giving a carrier frequency of 1 in 127 (0.79%).</Variant>", "label": []}
{"id": "21059483", "text": "<Variant>Based on these results, we suggest that the method described here provides a basis for genetic screening and prenatal counseling and can potentially reduce the morbidity and mortality associated with delayed diagnosis of galactosemia in this patient population.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>Characterisation of two novel large F8 deletions in patients with severe haemophilia A and factor VIII inhibitors.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been characterised precisely so far.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>In this study we characterised the deletion breakpoints of two patients with severe haemophilia A, large deletions and factor VIII (FVIII) inhibitors, and subsequently established deletion-specific assays for the identification of carriers.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>Patient 1 had a deletion of 37,410 bp comprising exon 1 and the F8 promoter region, and a 5 bp homology (GGGCC) is present at the chromosomal fusion site.</Variant>", "label": [[25, 46, "Variant"]]}
{"id": "21103668", "text": "<Variant>In patient 2, a deletion of 22,230 bp including parts of intron 25, exon 26 and 3'-UTR was identified.</Variant>", "label": [[25, 46, "Variant"]]}
{"id": "21103668", "text": "<Variant>No homologous repetitive elements were found at the breakpoints.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>However, both breakpoints were located within long terminal repeats of endogenous retroviruses and the DNA motif TTTAAA - known to be able to bend DNA molecules - was identified at the centromeric breakpoint.</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>By deletion-specific PCR experiments we were able to identify a heterozygous state in mother 2 (carrier) while mother 1 presented only with wild-type alleles (non-carrier).</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>Both deletions are most likely created by DNA double strand breaks and subsequent DNA repair by the non-homologous end joining DNA repair pathway (NHEJ).</Variant>", "label": []}
{"id": "21103668", "text": "<Variant>The exact identification of the deletion breakpoints provides a reliable diagnostic tool for carrier identification in affected families by means of a deletion-specific PCR.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>Lack of association of C-C chemokine receptor 5 DD32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.</Variant>", "label": [[57, 70, "Variant"]]}
{"id": "20682662", "text": "<Variant>OBJECTIVE: C-C chemokine receptor 5 (CCR5) plays an important role in inflammation.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>A 32 base-pair (DD32) deletion in the CCR5 gene leads to a nonfunctional receptor.</Variant>", "label": [[11, 39, "Variant"]]}
{"id": "20682662", "text": "<Variant>This deletion has been reported to have a protective effect on the development and progression of several autoimmune diseases.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>We investigated whether the DD32 deletion is associated with disease susceptibility in a population of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and lupus nephritis (LN); and whether it is associated with disease severity.</Variant>", "label": [[37, 50, "Variant"]]}
{"id": "20682662", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>DNA samples from 405 RA patients, 97 SLE patients, 113 LN patients, and 431 healthy controls were genotyped for the CCR5 DD32 deletion.</Variant>", "label": [[130, 143, "Variant"]]}
{"id": "20682662", "text": "<Variant>Differences in genotype frequencies were tested between patients and controls.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>Association of genotypes with disease severity was analyzed.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>RESULTS: Genotype frequencies of each group were in Hardy-Weinberg equilibrium.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>The genotype frequencies of patients did not differ significantly from controls (CCR5/DD32, DD32/DD32: RA 18.3% and 1.2%, respectively; SLE 17.5% and 2.1%; LN 13.3% and 1.8%; controls 20.0% and 2.8%).</Variant>", "label": [[95, 99, "Variant"], [101, 105, "Variant"], [106, 110, "Variant"]]}
{"id": "20682662", "text": "<Variant>However, there was a trend for lower DD32 deletion allele frequency in LN patients compared to controls (p = 0.08).</Variant>", "label": [[46, 59, "Variant"]]}
{"id": "20682662", "text": "<Variant>There was no significant association between the CCR5 status and disease severity in RA, SLE, or LN.</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20682662", "text": "<Variant>Although an association with LN cannot be excluded, the CCR5 DD32 deletion does not seem to be a disease susceptibility genotype for RA, SLE, or LN.</Variant>", "label": [[70, 83, "Variant"]]}
{"id": "20682662", "text": "<Variant>No significant effect of the DD32 deletion on disease severity was demonstrated.</Variant>", "label": [[38, 51, "Variant"]]}
{"id": "20806042", "text": "<Variant>A novel mutation in GJA8 causing congenital cataract-microcornea syndrome in a Chinese pedigree.</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>To identify the underlying genetic defect in a four-generation family of Chinese origin with autosomal dominant congenital cataract-microcornea syndrome (CCMC).</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>All individuals in the study underwent a full clinical examination and the details of history were collected .</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>Genomic DNA extracted from peripheral blood was amplified by polymerase chain reaction (PCR) method and the exons of all candidate genes were sequenced.</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>Direct sequencing of the encoding regions of the candidate genes revealed a heterozygous mutation c.592C-->T in exon 2 of the gap junction protein, alpha 8 (GJA8) gene.</Variant>", "label": [[107, 117, "Variant"]]}
{"id": "20806042", "text": "<Variant>This mutation was responsible for the familial disorder through the substitution of a highly conserved arginine to tryptophan at codon 198 (p.R198W).</Variant>", "label": [[112, 147, "Variant"], [149, 156, "Variant"]]}
{"id": "20806042", "text": "<Variant>This change co-segregated with all affected members of the family, but was not detected either in the non-carrier relatives or in the 100 normal controls.</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20806042", "text": "<Variant>This report is the first to relate p.R198W mutation in GJA8 with CCMC.</Variant>", "label": [[44, 51, "Variant"]]}
{"id": "20806042", "text": "<Variant>The result expands the mutation spectrum of GJA8 in associated with congenital cataract and microcornea, and implies that this gene has direct involvement with the development of the lens as well as the other anterior segment of the eye.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>Alpha2B-adrenergic receptor insertion/deletion polymorphism in women with spontaneous recurrent abortions.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>AIM:</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>The aim of our study was to investigate the relationship between the alpha2B-adrenoreceptor insertion/deletion (I/D) polymorphism and recurrent spontaneous abortions (RSA).</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>Genotyping was performed in 48 women with a history of at least three consecutive spontaneous abortions and 96 women with at least two live births and no history of pregnancy loss.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>Peripheral venous puncture, DNA extraction and PCR were used for the research of DD, ID and II genotype characters.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>The distribution of DD, ID and II genotypes of the alpha2B-adrenoreceptor gene was 2 (4.2%), 19 (39.6%) and 27 (56.2%) in the study group and 6 (6.5%), 28 (30.4%) and 58 (63%) in the control group, respectively.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>There was no significant difference between the groups.</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>The presence of the D allele was not associated with RSA (P = 0.78, odds ratio = 0.88, 95% CI = 0.47-1.65).</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21159032", "text": "<Variant>Our data fall short of showing any association between the presence of the alpha2B D allele and the occurrence of spontaneous abortions in the examined population.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>Lack of association between ADRA2B-4825 gene insertion/deletion polymorphism and migraine in Chinese Han population.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>The present study aimed to estimate the association between susceptibility to migraine and the 12-nucleotide insertion/deletion (indel) polymorphism in promoter region of alpha(2B)-adrenergic receptor gene (ADRA2B).</Variant>", "label": [[104, 144, "Variant"]]}
{"id": "20651814", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>A case-control study was carried out in Chinese Han population, including 368 cases of migraine and 517 controls.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>Genomic DNA was extracted from blood samples, and DNA fragments containing the site of polymorphism were amplified by PCR.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>Data were adjusted for sex, age, migraine history and family history, and analyzed using a logistic regression model.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>There was no association between indel polymorphism and migraine, at either the allele or the genotype level.</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20651814", "text": "<Variant>These findings do not support a functional significance of ADRA2B indel polymorphism at position -4825 relative to the start codon in the far upstream region of the promoter in the present migraine subjects.</Variant>", "label": [[75, 111, "Variant"]]}
{"id": "20534762", "text": "<Variant>Two novel mutations of the TSH-beta subunit gene underlying congenital central hypothyroidism undetectable in neonatal TSH screening.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>CONTEXT:</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>Patients with TSH-beta subunit defects and congenital hypothyroidism are missed by TSH-based neonatal screening.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>Our objective was to report the molecular consequences of a novel splice-junction mutation and a novel missense mutation in the TSH-beta subunit gene found in two patients with congenital central hypothyroidism and conventional treatment-resistant anemia.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>Patient 1 had a homozygous G to A nucleotide change at the 5' donor splice site of exon/intron 2.</Variant>", "label": [[36, 42, "Variant"]]}
{"id": "20534762", "text": "<Variant>This resulted in a silent change at codon 34 of the mature protein.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>In vitro splicing assays showed that the mutant minigene dramatically affected pre-mRNA processing, causing exon 2 to be completely skipped.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>The putative product from a new out-of-frame translational start point in exon 3 is expected to yield a nonsense 25-amino-acid peptide.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>In patient 2, sequence analysis revealed a compound heterozygosis for the already reported 313delT (C105Vfs114X) mutation and for a second novel mutation in exon 3, substituting G for A at cDNA nucleotide position 323, resulting in a C88Y change.</Variant>", "label": [[100, 107, "Variant"], [109, 120, "Variant"], [187, 226, "Variant"], [243, 247, "Variant"]]}
{"id": "20534762", "text": "<Variant>This cysteine residue is conserved among all dimeric pituitary and placental glycoprotein hormone-beta subunits.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>Data from in silico analysis confirmed that the C88Y mutation would affect subunit conformation.</Variant>", "label": [[57, 61, "Variant"]]}
{"id": "20534762", "text": "<Variant>Indeed, two different bioinformatics approaches, PolyPhen and SIFT analysis, predicted C88Y to be a damaging substitution.</Variant>", "label": [[96, 100, "Variant"]]}
{"id": "20534762", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>In isolated TSH deficiency, the exact molecular diagnosis is mandatory for diagnosis of isolated pituitary deficiency, delineation of prognosis, and genetic counseling.</Variant>", "label": []}
{"id": "20534762", "text": "<Variant>Moreover, diagnosis of central hypothyroidism should be considered in the face of severe infant anemia of uncertain etiology.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>Genes in the complement pathway, including complement factor H (CFH), C2/BF, and C3, have been reported to be associated with age-related macular degeneration (AMD).</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>Genetic variants, single-nucleotide polymorphisms (SNPs), in these genes were geno-typed for a case-control association study in a mainland Han Chinese population.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>METHODS: One hundred and fifty-eight patients with wet AMD, 80 patients with soft drusen, and 220 matched control subjects were recruited among Han Chinese in mainland China.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>Seven SNPs in CFH and two SNPs in C2, CFB', and C3 were genotyped using the ABI SNaPshot method.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>A deletion of 84,682 base pairs covering the CFHR1 and CFHR3 genes was detected by direct polymerase chain reaction and gel electrophoresis.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>RESULTS: Four SNPs, including rs3753394 (P = 0.0276), rs800292 (P = 0.0266), rs1061170 (P = 0.00514), and rs1329428 (P = 0.0089), in CFH showed a significant association with wet AMD in the cohort of this study.</Variant>", "label": [[39, 48, "Variant"], [63, 71, "Variant"], [86, 95, "Variant"], [115, 124, "Variant"]]}
{"id": "20523265", "text": "<Variant>A haplotype containing these four SNPs (CATA) significantly increased protection of wet AMD with a P value of 0.0005 and an odds ratio of 0.29 (95% confidence interval: 0.15-0.60).</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>Unlike in other populations, rs2274700 and rs1410996 did not show a significant association with AMD in the Chinese population of this study.</Variant>", "label": [[38, 47, "Variant"], [52, 61, "Variant"]]}
{"id": "20523265", "text": "<Variant>None of the SNPs in CFH showed a significant association with drusen, and none of the SNPs in CFH, C2, CFB, and C3 showed a significant association with either wet AMD or drusen in the cohort of this study.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>The CFHR1 and CFHR3 deletion was not polymorphic in the Chinese population and was not associated with wet AMD or drusen.</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20523265", "text": "<Variant>This study showed that SNPs rs3753394 (P = 0.0276), rs800292 (P = 0.0266), rs1061170 (P = 0.00514), and rs1329428 (P = 0.0089), but not rs7535263, rs1410996, or rs2274700, in CFH were significantly associated with wet AMD in a mainland Han Chinese population.</Variant>", "label": [[37, 46, "Variant"], [61, 69, "Variant"], [84, 93, "Variant"], [113, 122, "Variant"], [145, 154, "Variant"], [156, 165, "Variant"], [170, 179, "Variant"]]}
{"id": "20523265", "text": "<Variant>This study showed that CFH was more likely to be AMD susceptibility gene at Chr.1q31 based on the finding that the CFHR1 and CFHR3 deletion was not polymorphic in the cohort of this study, and none of the SNPs that were significantly associated with AMD in a white population in C2, CFB, and C3 genes showed a significant association with AMD.</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>We assessed the association between common variation at the SERPINE1 (PAI1) locus and myocardial infarction (MI).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>Haplotype-tagging polymorphisms, including the 4G/5G deletion/insertion polymorphism and seven single nucleotide polymorphisms, were analysed in a German sample containing 3,657 cases with MI and 1,211 controls.</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>The association between the 4G/5G polymorphism and MI was examined in a meta-analysis of data extracted from 32 studies (13,267 cases/14,716 controls).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>In addition, the relation between the 4G/5G polymorphism and coronary diseases, comprising MI, coronary artery disease, coronary heart disease, or the acute coronary syndrome, was assessed in a combined analysis enclosing 43 studies (17,278 cases/18,039 controls).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>None of the tagging polymorphisms was associated with MI in the present sample (p <or= 0.34).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>The adjusted odds ratio (OR) for 4G allele carriers was 1.02 (95% confidence interval</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>[CI] 0.87-1.19) compared to the 5G5G genotype.</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>None of 13 common (frequency >1.0%) 8-marker haplotypes was related to the risk of MI.</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>In a meta-analysis specifically addressing the association with MI, no elevated risk was found in the carriers of the 4G allele (OR 1.07, 95% CI 0.99-1.16; p = 0.11).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>A more general combined analysis of coronary diseases showed a marginally increased risk in 4G allele carriers (OR 1.08, 95% CI 1.00-1.16; p = 0.044).</Variant>", "label": []}
{"id": "20352162", "text": "<Variant>In essence, tagging polymorphisms, including the 4G/5G polymorphism, and common haplotypes of the SERPINE1 gene region were not associated with MI in a German sample, and no compelling evidence was obtained for a relationship of the 4G/5G polymorphism to MI and coronary atherosclerosis in a meta-analysis.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>SETTING:</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Multidrug-resistant tuberculosis (MDR-TB) is a serious health problem in Eastern European countries, including Latvia.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>OBJECTIVE: To investigate the proportion of tuberculosis, including MDR-TB cases, attributable to recent transmission and risk factors associated with clustering.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Retrospective nested case-control study.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>The data set incorporated a wide spectrum of social features, as well as genotypes of Mycobacterium tuberculosis isolates determined by insertion sequence 6110 restriction fragment length polymorphism analysis of PvuII cleaved genomic DNA and spoligotyping.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>In comparison with non-clustered M. tuberculosis, the Beijing genotype (OR 12.15) and multidrug resistance (OR 5.61, P < 0.01) were associated with clustering.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>In comparison with clustered drug-susceptible M. tuberculosis, clustering of MDR M. tuberculosis was associated with Beijing genotype (OR 41.67), previous hospitalisation (OR 18.33) and previous TB treatment (OR 17.68, P < 0.05).</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Direct epidemiological links in hospitals were found for almost one third (32%) of MDR Beijing cases.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>MDR cases were more likely to be found in clusters than drug-susceptible cases (74.0% vs. 33.6%).</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Recent nosocomial transmission of MDR-TB is an important risk factor for the spread of multiresistance, and is associated with the Beijing genotype.</Variant>", "label": []}
{"id": "20202300", "text": "<Variant>Special attention should be paid to infection control measures in hospitals and ambulatory treatment should be enforced.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>U87MG is a commonly studied grade IV glioma cell line that has been analyzed in at least 1,700 publications over four decades.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>In order to comprehensively characterize the genome of this cell line and to serve as a model of broad cancer genome sequencing, we have generated greater than 30x genomic sequence coverage using a novel 50-base mate paired strategy with a 1.4kb mean insert library.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>A total of 1,014,984,286 mate-end and 120,691,623 single-end two-base encoded reads were generated from five slides.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>All data were aligned using a custom designed tool called BFAST, allowing optimal color space read alignment and accurate identification of DNA variants.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>The aligned sequence reads and mate-pair information identified 35 interchromosomal translocation events, 1,315 structural variations (>100 bp), 191,743 small (<21 bp) insertions and deletions (indels), and 2,384,470 single nucleotide variations (SNVs).</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>Among these observations, the known homozygous mutation in PTEN was robustly identified, and genes involved in cell adhesion were overrepresented in the mutated gene list.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>Data were compared to 219,187 heterozygous single nucleotide polymorphisms assayed by Illumina 1M Duo genotyping array to assess accuracy: 93.83% of all SNPs were reliably detected at filtering thresholds that yield greater than 99.99% sequence accuracy.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>Protein coding sequences were disrupted predominantly in this cancer cell line due to small indels, large deletions, and translocations.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>In total, 512 genes were homozygously mutated, including 154 by SNVs, 178 by small indels, 145 by large microdeletions, and 35 by interchromosomal translocations to reveal a highly mutated cell line genome.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>Of the small homozygously mutated variants, 8 SNVs and 99 indels were novel events not present in dbSNP.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>These data demonstrate that routine generation of broad cancer genome sequence is possible outside of genome centers.</Variant>", "label": []}
{"id": "20126413", "text": "<Variant>The sequence analysis of U87MG provides an unparalleled level of mutational resolution compared to any cell line to date.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>Development and validation of a SYBR Green I-based real-time polymerase chain reaction method for detection of haptoglobin gene deletion in clinical materials.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>Anhaptoglobinemic patients run the risk of severe anaphylactic transfusion reaction because they produce serum haptoglobin (Hp) antibodies.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>Being homozygous for the Hp gene deletion (HP(del)) is the only known cause of congenital anhaptoglobinemia, and clinical diagnosis of HP(del) before transfusion is important to prevent anaphylactic shock.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>We recently developed a 5'-nuclease (TaqMan) real-time polymerase chain reaction (PCR) method.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>STUDY DESIGN AND METHODS:</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>A SYBR Green I-based duplex real-time PCR assay using two forward primers and a common reverse primer followed by melting curve analysis was developed to determine HP(del) zygosity in a single tube.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>In addition, to obviate initial DNA extraction, we examined serially diluted blood samples as PCR templates.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>Allelic discrimination of HP(del) yielded optimal results at blood sample dilutions of 1:64 to 1:1024.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>The results from 2231 blood samples were fully concordant with those obtained by the TaqMan-based real-time PCR method.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>The detection rate of the HP(del) allele by the SYBR Green I-based method is comparable with that using the TaqMan-based method.</Variant>", "label": []}
{"id": "20113448", "text": "<Variant>This method is readily applicable due to its low initial cost and analyzability using economical real-time PCR machines and is suitable for high-throughput analysis as an alternative method for allelic discrimination of HP(del).</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Investigation of SERPINE1 genetic polymorphism in Macedonian patients with occlusive artery disease and deep vein thrombosis.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Raised SERPINE1 plasma levels are related to a 1-bp guanine deletion/insertion (4G5G) polymorphism in the promoter of the SERPINE1 (plasminogen activator inhibitor 1 - PAI1) gene.</Variant>", "label": [[56, 87, "Variant"]]}
{"id": "20017074", "text": "<Variant>Evidence suggested that the plasma levels of SERPINE1 modulate the risk of coronary artery disease; furthermore, that the 4G5G polymorphism affects the expression of the SERPINE1 gene.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>AIM: To analyse association of SERPINE1 polymorphism with occlusive artery disease (OAD) and deep venous thrombosis (DVT) in Macedonians in order to investigate its role as a part of candidate genes in different vascular diseases in Macedonians.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Investigated groups consisted of 82 healthy patients, 75 with OAD, and 66 with DVT.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Blood samples were collected after written informed consent was obtained, and DNA was isolated from peripheral blood leukocytes.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Identification of SERPINE1 polymorphism was done with CVD StripAssay (ViennaLab, Labordiagnostica GmbH, Austria).</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>The population genetics analysis package, PyPop, was used for analysis of the SERPINE1 data.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Pearson's P-values, crude odds ratio and Wald's 95% CI were calculated with Bonferroni corrected p value.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>RESULTS: The frequency of 4G allele for SERPINE1 was 0.538 for DVT, 0.555 for healthy participants, and 0.607 for OAD.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>The frequency of 5G allele for SERPINE1 was the smallest in patients with OAD (0.393) and was higher in healthy participants (0.445), and patients with DVT (0.462).</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>Test of neutrality (Fnd) showed negative value, but was significantly different from 0 for SERPINE1 in healthy participants (p of F = 0.041) and in patients with DVT (p of F = 0.030).</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>SERPINE1 genotypes in healthy participants and patients with OAD were not in Hardy Weinberg proportions (p = 0.019 and 0.001, respectively).</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>No association between SERPINE1 polymorphisms and OAD or DVT was found.</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20017074", "text": "<Variant>There is no significant relationship between SERPINE1 polymorphisms and occlusive artery disease or deep venous thrombosis in Macedonian population.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>The interferon regulatory factor (IRF) family of DNA-binding proteins regulates expression of interferon-inducible genes with roles in the immune response and carcinogenesis.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>IRF4 is involved in the differentiation of B and T cells and is overexpressed in B-cell malignancies as a result of c-REL (NF-kappaB) hyperactivation.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>IRF4 polymorphisms are associated with susceptibility to chronic lymphoid leukemia (CLL) and non-Hodgkin lymphoma (NHL).</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>We examined 13 IRF4 SNPs in 114 cases of childhood acute lymphoblastic leukemia (ALL) and 388 newborn controls from Wales (U.K.) using TaqMan assays.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>IRF4 intron 4 SNP rs12203592 showed a male-specific risk association (OR=4.4, 95% CI=1.5 to 12.6, P=0.007).</Variant>", "label": [[27, 37, "Variant"]]}
{"id": "19897031", "text": "<Variant>Functional consequences of the C>T substitution at this SNP were assessed by cell-based reporter assays using three different cell lines.</Variant>", "label": [[40, 43, "Variant"]]}
{"id": "19897031", "text": "<Variant>We found a repressive effect of the rs12203592 wildtype allele C on IRF4 promoter activity (P<0.001) but no repression by the variant allele in any cell line tested.</Variant>", "label": [[45, 55, "Variant"]]}
{"id": "19897031", "text": "<Variant>Thus, homozygosity for the rs12203592 variant allele would result in increased IRF4 expression.</Variant>", "label": [[36, 46, "Variant"]]}
{"id": "19897031", "text": "<Variant>This increase would be compounded by high levels of NF-kappaB activity in males due to the absence of estrogen.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>IRF4 differs from other IRFs in its anti-interferon activity which interferes with immune surveillance.</Variant>", "label": []}
{"id": "19897031", "text": "<Variant>We propose that a detailed study of IRF4 can provide information on the mechanism of the sex effect and the role of immune surveillance in childhood ALL development.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>A novel insertion mutation in the SEDL gene results in X-linked spondyloepiphyseal dysplasia tarda in a large Chinese pedigree.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>Spondyloepiphyseal dysplasia tarda (SEDT) is an X-chromosome linked primary skeletal dysplasia characterized by a disproportionate short-trunked short stature, dysplasia of the large joints and flattened thoracic and lumber vertebral bodies.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>The objective of this study is to describe a large Chinese SEDT family with a milder phenotype and describe the molecular and clinical findings.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>METHODS: Eight affected males of the family were diagnosed with SEDT according to their clinical and radiological features.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>Direct DNA sequencing of the SEDL gene was performed.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>RT-PCR experiments on total RNA from blood lymphocytes were performed to confirm the defect on the SEDL gene.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>A short summary of all currently known SEDL gene mutations is presented.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>DNA sequencing revealed that all the affected males carried an insertion mutation (c.370-371insA) unreported previously, predicted to result in frameshifts and generate a premature stop codon (p.S124fsX127).</Variant>", "label": [[92, 105, "Variant"], [202, 214, "Variant"]]}
{"id": "19766614", "text": "<Variant>The identical mutation was also observed in a 10-year old presymptomatic boy of the family.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>Eight female carriers had the typical sequencing chromatograms of heterozygotes.</Variant>", "label": []}
{"id": "19766614", "text": "<Variant>CONCLUSIONS: Identification of the novel insertion mutation (c.370-371insA) in this SEDT family enables carrier detection and presymptomatic/prenatal diagnosis, but also the detailed molecular and clinical features will be useful for extending the evidence for genetic and phenotypic heterogeneity in SEDT.</Variant>", "label": [[70, 83, "Variant"]]}
{"id": "19730022", "text": "<Variant>Congestive heart failure with rhabdomyolysis and acute renal failure in a manifesting female carrier of Duchenne muscular dystrophy with duplication of dystrophin gene.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>We report a 69-year-old woman who presented with dyspnea, orthopnea, and acute renal failure.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>She also had proximal muscle weakness suggestive of muscle disease.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>Her symptoms were alleviated by induced dieresis, although there was high-serum creatine kinase.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>Investigations for any possible etiologies of rhabdomyolysis were all negative.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>An X-linked recessive muscle disease was highly suspicious in view of the fact that both of her sons had suffered from muscle disease and died of respiratory failure at the ages of 22 and 29, respectively.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>Her muscle biopsy showed mosaic pattern with dystrophin antibody against amino-terminal, carboxy-terminal, and rod domain.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>Her DNA study revealed heterozygous duplication at exon 1 to 6 of the dystrophin gene as well.</Variant>", "label": []}
{"id": "19730022", "text": "<Variant>Therefore, she is a manifesting carrier of dystrophinopathy who was first diagnosed in late adulthood with congestive heart failure, acute episode of spontaneous rhabdomyolysis, and acute renal failure.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>BACKGROUND: Dystrophic epidermolysis bullosa (DEB) is a severe genetic skin blistering disorder caused by mutations in the gene COL7A1, encoding collagen VII.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>Recently, the MMP1 promoter single nucleotide polymorphism (SNP) rs1799750, designated as 1G 2G, was shown to be involved in modulation of disease severity in patients with recessive DEB (RDEB), and was proposed as a genetic modifier.</Variant>", "label": [[74, 83, "Variant"]]}
{"id": "19681861", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>To identify the molecular basis of DEB in 103 individuals and to replicate the results of the MMP1 promoter SNP analysis in an independent patient group, as verification is necessary in such a rare and heterogeneous disorder.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>METHODS: To determine the molecular basis of the disease, we performed COL7A1 mutation screening, reverse transcription-polymerase chain reaction (PCR) and real-time quantitative PCR.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>The status of the MMP1 SNP was analysed by PCR and restriction enzyme digestion and verified by sequencing.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>We disclosed 42 novel COL7A1 mutations, including the first large genomic deletion of 4 kb affecting only the COL7A1 gene, and three apparently silent mutations affecting splicing.</Variant>", "label": [[83, 99, "Variant"]]}
{"id": "19681861", "text": "<Variant>Even though the frequency of the high-risk allele was increased in patients with RDEB, no statistically significant correlation between disease severity and genotype could be made.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>Also, no correlation was observed with development of squamous cell carcinoma, a severe complication of DEB.</Variant>", "label": []}
{"id": "19681861", "text": "<Variant>CONCLUSIONS: Taken together, the results suggest that the MMP1 SNP is not the sole disease modifier in different forms of DEB, and other genetic and environmental factors contribute to the clinical phenotype.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>We studied viral evolution in three HIV-1 ancestral patients from a group of LTNPs; although some minor sequences showing viral evolution were detected in all patients, the extremely low viral evolution of their viruses was shown by the phylogenetic analysis of the env sequences.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>Complete nucleotide sequencing of viral DNA showed the major presence of deletions.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>In two patients, deletions of 1088 and 228 nucleotides mapped to 5' LTR-gag region; in the other, a 247 nucleotide deletion was positioned in pol gene up to the vif ORF.</Variant>", "label": [[26, 51, "Variant"], [109, 132, "Variant"]]}
{"id": "19559455", "text": "<Variant>These deleted genomes became dominant during follow up.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>Patient's viruses displayed 13 common mutations in conserved residues, from the 5' LTR to the nef gene.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>These mutations provided evidence of a common origin.</Variant>", "label": []}
{"id": "19559455", "text": "<Variant>Regarding host characteristics, one patient had HLA B2705/B5801; another B1402/B5701; whereas a third showed B3901/B4402 and was Delta32-CCR5 heterozygous.</Variant>", "label": [[138, 145, "Variant"]]}
{"id": "19559455", "text": "<Variant>These HIV controllers presented a combination of deleted viral genomes and host protective factors.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Arthrogryposis multiplex congenita (AMC) is a group of disorders characterized by congenital joint contractures caused by reduced fetal movements.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>AMC has an incidence of 1 in 3000 newborns and is genetically heterogeneous.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>We describe an autosomal recessive form of myogenic AMC in a large consanguineous family.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>The disease is characterized by bilateral clubfoot, decreased fetal movements, delay in motor milestones, then progressive motor decline after the first decade.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Genome-wide linkage analysis revealed a single locus on chromosome 6q25 with Z(max) =</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>3.55 at theta = 0.0 and homozygosity of the polymorphic markers at this locus in patients.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Homozygous A to G nucleotide substitution of the conserved AG splice acceptor site at the junction of intron 136 and exon 137 of the SYNE-1 gene was found in patients.</Variant>", "label": [[20, 26, "Variant"]]}
{"id": "19542096", "text": "<Variant>This mutation results in an aberrant retention of intron 136 of SYNE-1 RNA leading to premature stop codons and the lack of the C-terminal transmembrane domain KASH of nesprin-1, the SYNE-1 gene product.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Mice lacking the KASH domain of nesprin-1 display a myopathic phenotype similar to that observed in patients.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Altogether, these data strongly suggest that the splice site mutation of SYNE-1 gene found in the family is responsible for AMC.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>Recent reports have shown that mutations of the SYNE-1 gene might be responsible for autosomal recessive adult onset cerebellar ataxia.</Variant>", "label": []}
{"id": "19542096", "text": "<Variant>These data indicate that mutations of nesprin-1 which interacts with lamin A/C may lead to at least two distinct human disease phenotypes, myopathic or neurological, a feature similar to that found in laminopathies.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Mantle cell lymphoma (MCL) is a lymphoma characterized by aberrant activation of CCND1/cyclin D1 followed by sequential genetic abnormalities.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Genomic abnormalities in MCL have been extensively examined by classical cytogenetics and microarray-based comparative genomic hybridization techniques, pointing out a number of alterations in genomic regions that correlate with the neoplastic phenotype and survival.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Recently, single nucleotide polymorphism genomic microarrays (SNP-chip) have been developed and used for analysis of cancer genomics.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>This technique allows detection of genomic changes with higher resolution, including loss of heterozygosity without changes of gene dosage, so-called acquired uniparental disomy (aUPD).</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>MATERIALS AND METHODS:</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>We have examined 33 samples of MCL (28 primary MCL and 5 cell lines) using the 250,000 SNP-chip from Affymetrix.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Known alterations were confirmed by SNP arrays, including deletion of INK4A/ARF, duplication/amplification of MYC, deletion of ATM, and deletion of TP53.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>We also identified a duplication/amplification that occurred at 13q involving oncogenic microRNA, miR17-92.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>We found other genomic abnormalities, including duplication/amplification of cyclin D1, del(1p), del(6q), dup(3q) and dup(18q).</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Our SNP-chip analysis detected these abnormalities at high resolution, allowing us to narrow the size of the commonly deleted regions, including 1p and 6q.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>Our SNP-chip analysis detected a number of aUPD sites, including whole chromosome 9 aUPD and 9p aUPD.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>We also found an MCL case with 19p, leading to homozygous deletion of TNFSF genes.</Variant>", "label": []}
{"id": "19477219", "text": "<Variant>CONCLUSION: SNP-chip analysis detected in MCL very small genomic gains/losses, as well as aUPDs, which could not be detected by more conventional methods.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>Deoxyguanosine kinase (dGK) deficiency is a frequent cause of mitochondrial DNA depletion associated with a hepatocerebral phenotype.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>In this study, we describe a new splice site mutation in the DGUOK gene and the clinical, radiologic, and genetic features of these DGUOK patients.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>This new DGUOK homozygous mutation (c.444-62C>A) was identified in three patients from two North-African consanguineous families with combined respiratory chain deficiencies and mitochondrial DNA depletion in the liver.</Variant>", "label": [[45, 56, "Variant"]]}
{"id": "19394258", "text": "<Variant>Brain MRIs are normal in DGUOK patients in the literature.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>Interestingly, we found subtentorial abnormal myelination and moderate hyperintensity in the bilateral pallidi in our patients.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>This new mutation creates a cryptic splice site in intron 3 (in position -62) and is predicted to result in a larger protein with an in-frame insertion of 20 amino acids.</Variant>", "label": [[151, 178, "Variant"]]}
{"id": "19394258", "text": "<Variant>In silico analysis of the putative impact of the insertion shows serious clashes in protein conformation: this insertion disrupts the alpha5 helix of the dGK kinase domain, rendering the protein unable to bind purine deoxyribonucleosides.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>In addition, a common haplotype that segregated with the disease in both families was detected by haplotype reconstruction with 10 markers (microsatellites and SNPs), which span 4.6 Mb of DNA covering the DGUOK locus.</Variant>", "label": []}
{"id": "19394258", "text": "<Variant>In conclusion, we report a new DGUOK splice site mutation that provide insight into a critical protein domain (dGK kinase domain) and the first founder mutation in a North-African population.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>To identify mutations in the carbohydrate sulfotransferase gene (CHST6) for a Chinese family with macular corneal dystrophy (MCD) and to investigate the histopathological changes in the affected cornea.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>METHODS: A corneal button of the proband was obtained by penetrating keratoplasty.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>The half button and ultrathin sections from the other half button were examined with special stains under a light microscope (LM) and an electron microscope (EM) separately.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>Genomic DNA was extracted from peripheral blood of 11 family members, and the coding region of CHST6 was amplified by the polymerase chain reaction (PCR) method.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>The PCR products were analyzed by direct sequencing and restriction enzyme digestion.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>The positive reaction to colloidal iron stain (extracellular blue accumulations in the stroma) was detected under light microscopy.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>Transmission electron microscopy revealed the enlargement of smooth endoplasmic reticulum and the presence of intracytoplasmic vacuoles.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>The compound heterozygous mutations, c.892C>T and c.1072T>C, were identified in exon 3 of CHST6 in three patients.</Variant>", "label": [[46, 54, "Variant"], [59, 68, "Variant"]]}
{"id": "19365571", "text": "<Variant>The two transversions resulted in the substitution of a stop codon for glutamine at codon 298 (p.Q298X) and a missense mutation at codon 358, tyrosine to histidine (p.Y358H).</Variant>", "label": [[65, 102, "Variant"], [104, 111, "Variant"], [140, 172, "Variant"], [174, 181, "Variant"]]}
{"id": "19365571", "text": "<Variant>The six unaffected family individuals carried alternative heterozygous mutations.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>These two mutations were not detected in any of the 100 control subjects.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>Those novel compound heterozygous mutations were thought to contribute to the loss of CHST6 function, which induced the abnormal metabolism of keratan sulfate (KS) that deposited in the corneal stroma.</Variant>", "label": []}
{"id": "19365571", "text": "<Variant>It could be proved by the observation of a positive stain reaction and the enlarged collagen fibers as well as hyperplastic fibroblasts under microscopes.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>Human pepsinogen C (PGC) is an aspartic protease produced specifically by the gastric mucosa, and is considered as a mature marker of gastric epithelium.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>This study examined the contributions of PGC polymorphisms and the Helicobacter pylori (H. pylori) infection to the risk of gastric cancer (GC), and its precancerous conditions in a Northeast Chinese population.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>The PGC insertion/deletion polymorphism was evaluated by polymerase chain reaction analysis, followed by direct DNA sequencing in 564 cases of GC, atrophic gastritis (AG), gastric ulcer (GU) and superficial gastritis (as control).</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>All cases were frequency-matched 1:1 by gender and age (+/-5).</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>H. pylori infection was identified by serum anti-H. pylori IgG measurement through enzyme-linked immunosorbent assay.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>Patients with a homozygous PGC allele 1 genotype had a significant risk of AG [adjusted odds ratio (OR) 3.11; 95% confidence interval (CI) 1.44-6.71] or of GC (OR 3.00; 95% CI 1.38-6.51), and a significantly elevated risk of intestinal metaplasia (OR 1.90, 95% CI 1.11-3.27).</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>The S value was 5.40, 6.48 and 4.34; and the AP value was 72.09, 7.00 and 69.69%, respectively.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>The PGC gene polymorphism increases an individual's susceptibility to GC and its precancerous conditions.</Variant>", "label": []}
{"id": "19132389", "text": "<Variant>Moreover, the PGC gene polymorphism shows a positive link to H. pylori infection in the development of GC.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>To date, four mutations in the IGFALS gene have been reported.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>We now describe two children of different ethnic background with total acid-labile subunit (ALS) and severe circulating IGF-I/IGFBP-3 deficiencies resulting from three novel mutations in the IGFALS gene.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>PATIENTS/METHODS:</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>Serum and DNA of patients were analyzed.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>Case 1 is a 12-year-old boy of Mayan origin.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>Case 2 is a 5-year-old girl of Jewish/Eastern European (Polish, Russian, Austrian-Hungarian)/Icelandic/European (French, English) ancestry.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>The reported cases had moderate short stature (-2.91 and -2.14 SDS, respectively), nondetectable serum ALS and extremely low serum concentrations of IGF-I and IGFBP-3.</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>Case 1 harbored a novel homozygous 1308_1316 dup9 mutation in a highly conserved leucine-rich repeat (LRR) 17 motif of exon 2, representing an in-frame insertion of 3 amino acids, LEL.</Variant>", "label": [[44, 58, "Variant"], [161, 187, "Variant"]]}
{"id": "19129715", "text": "<Variant>Case 2 harbored a novel heterozygous C60S/L244F mutation in exon 2, located within a highly conserved LRR 1 and LRR 9, respectively.</Variant>", "label": [[46, 50, "Variant"], [51, 56, "Variant"]]}
{"id": "19129715", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19129715", "text": "<Variant>The identification of additional novel IGFALS mutations, resulting in severe IGF-I/IGFBP-3 and ALS deficiencies, supports IGFALS as a candidate gene of the GH/IGF system, implicated in the pathogenesis of primary IGF deficiency, and represents an important part of its differential diagnosis.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>Study of a Taiwanese family with oculopharyngeal muscular dystrophy.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>Oculopharyngeal muscular dystrophy (OPMD) is a late onset autosomal dominant muscle disorder.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>OPMD is caused by a short trinucleotide repeat expansion encoding an expanded polyalanine tract in the polyadenylate binding-protein nuclear 1 (PABPN1) gene.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>We identified and characterized a PABPN1 mutation in a Taiwanese family with OPMD.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>The phenotypic and genotypic characteristics of all subjects were evaluated in a Taiwanese OPMD family.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>Genetic alterations in the PABPN1 gene were identified using PCR and DNA sequencing.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>RESULTS: Ten subjects with OPMD (6 symptomatic and 4 asymptomatic) within the Taiwanese family carried a novel mutation in the PABPN1 gene.</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>The normal (GCG)6(GCA)3GCG sequence was replaced by (GCG)6(GCA)(GCG)4(GCA)3GCG due to an insertion of (GCG)4GCA into the normal allele in the Taiwanese OPMD subjects.</Variant>", "label": [[20, 87, "Variant"], [98, 120, "Variant"]]}
{"id": "19101703", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19101703", "text": "<Variant>In contrast to a single GCG expansion in most of OPMD patients in the literature, an insertion of (GCG)4GCA in the PABPN1 gene was found in the Taiwanese OPMD subjects.</Variant>", "label": [[94, 116, "Variant"]]}
{"id": "19101703", "text": "<Variant>The identification of this mutation appears to support the molecular mechanism of unequal cross-over of two PABPN1 alleles.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>In the present study we explored the effect of three polymorphisms of the TS gene on overall and progression- free survival of colorectal cancer (CRC) patients subjected to 5FU chemotherapy.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>A 28 bp variable number of tandem repeats (VNTR), a G/C single nucleotide polymorphism (SNP), and a deletion of 6 bp at position 1494 were studied.</Variant>", "label": [[11, 50, "Variant"], [61, 64, "Variant"], [109, 142, "Variant"]]}
{"id": "19082493", "text": "<Variant>The possible combined effect of these DNA polymorphisms on the clinical outcome of patients was also evaluated.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>A retrospective study was carried out on paraffin-embedded sections from 113 patients diagnosed of advanced CRC.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>TS genotyping methods were polymerase chain reaction (PCR) for VNTR and PCR, followed by restriction length fragment polymorphism (PCR-RFLP) for SNP and ins/del 6 bp.</Variant>", "label": [[162, 174, "Variant"]]}
{"id": "19082493", "text": "<Variant>To study the combined effect of TS polymorphisms, four categories were defined accordingly to the level of expression attributed to SNP and ins/del 6 bp genotypes: C_allele</Variant>", "label": [[149, 161, "Variant"]]}
{"id": "19082493", "text": "<Variant>6-, C_6+/6+, G_allele6- and G_6+/6+. VNTR and ins/del 6 bp genotypes varied with tumour anatomical site: 2R/2R genotype was rare in left-sided tumours (7.0% vs. 26.3% of right-sided and 24.1% of rectal cancers; P<0.01), where the variant allele</Variant>", "label": [[55, 67, "Variant"]]}
{"id": "19082493", "text": "<Variant>6- was very frequent (69.0%).</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>Instead, most patients with right-sided tumours were wild-type homozygous 6+/6+ (63.9%) (P<0.01).</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>Heterozygous 6+/6- genotype was more frequent among tumours classified as C (50.0%) and D (76.5%) Dukes stages (P=0.05).</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>None of the studied polymorphisms alone affected overall or progression-free survival (PFS).</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>C_6+/6+ and G_6+/6+ combined genotypes were respectively associated to the best and worst PFS (P=0.03 when compared with each other), while combinations carrying the allele</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>6- determined an intermediate evolution that might be indicative of a variable response to chemotherapy.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>The rate of Dukes B stage tumours was unexpectedly high (59.1%) among patients with the unfavourable G_6+/6+ combination.</Variant>", "label": []}
{"id": "19082493", "text": "<Variant>In our study the combination of high TS expression genotypes G_6+/6+ identifies a group of high risk within CRC patients treated with 5FU.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>The importance of the BRCA gene products in maintaining genomic stability led us to hypothesize that BRCA-associated and sporadic ovarian cancers would have distinctive genetic profiles despite similarities in histologic appearance.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>EXPERIMENTAL DESIGN:</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>A whole-genome copy number analysis of fresh, frozen, papillary serous ovarian cancer DNA was done using the Affymetrix 50K Xba Mapping Array using each patient's normal genomic DNA as the matched control.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>Loss of heterozygosity and copy number abnormalities were summarized to define regions of amplification, deletion, or uniparental disomy (UPD), defined as loss of one allele and duplication of the remaining allele.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>Genomic abnormalities were compared between BRCA-associated and sporadic tumors.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>We compared 6 BRCA-associated with 14 sporadic papillary serous ovarian carcinomas.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>Genetic instability, measured by percentage of genome altered, was more pronounced in BRCA-associated tumors (median, 86.6%; range, 54-100%) than sporadic tumors (median, 43.6%; range, 2-83%; P = 0.009).</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>We used frequency plots to show the proportion of cases affected by each type abnormality at each genomic region.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>BRCA-associated tumors showed genome-wide loss of heterozygosity primarily due to the occurrence of UPD rather than deletion.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>UPD was found in 100% of the BRCA-associated and 50% of the sporadic tumors profiled.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>This study reports on a previously underappreciated genetic phenomenon of UPD, which occurs frequently in ovarian cancer DNA.</Variant>", "label": []}
{"id": "19047089", "text": "<Variant>We observed distinct genetic patterns between BRCA-associated and sporadic ovarian cancers, suggesting that these papillary serous tumors arise from different molecular pathways.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>Diffuse mesangial sclerosis occurs as an isolated abnormality or as a part of a syndrome.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>Recently, mutations in phospholipase C epsilon 1 (PLCE1) were found to cause a nonsyndromic, autosomal recessive form of this disease.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>Here we describe three children from one consanguineous kindred of Pakistani origin with diffuse mesangial sclerosis who presented with congenital or infantile nephrotic syndrome.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>Homozygous mutations in PLCE1 (also known as KIAA1516, PLCE, or NPHS3) were identified following genome-wide mapping of single-nucleotide polymorphisms.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>All affected children were homozygous for a four-basepair deletion in exon 3, which created a premature translational stop codon.</Variant>", "label": [[53, 75, "Variant"]]}
{"id": "19037252", "text": "<Variant>Analysis of the asymptomatic father of two of the children revealed that he was also homozygous for the same mutation.</Variant>", "label": []}
{"id": "19037252", "text": "<Variant>We conclude this nonpenetrance may be due to compensatory mutations at a second locus and that mutation within PLCE1 is not always sufficient to cause diffuse mesangial sclerosis.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Inactivation of the tumor suppressor gene, CDKN2A, can occur by deletion, methylation, or mutation.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>We assessed the principal mode of inactivation in childhood acute lymphoblastic leukemia (ALL) and frequency in biologically relevant subgroups.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Mutation or methylation was rare, whereas genomic deletion occurred in 21% of B-cell precursor ALL and 50% of T-ALL patients.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Single nucleotide polymorphism arrays revealed copy number neutral (CNN) loss of heterozygosity (LOH) in 8% of patients.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Array-based comparative genomic hybridization demonstrated that the mean size of deletions was 14.8 Mb and biallelic deletions composed a large and small deletion (mean sizes, 23.3 Mb and 1.4 Mb).</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Among 86 patients, only 2 small deletions were below the resolution of detection by fluorescence in situ hybridization.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>Patients with high hyperdiploidy, ETV6-RUNX1, or 11q23/MLL rearrangements had low rates of deletion (11%, 15%, 13%), whereas patients with t(9;22), t(1;19), TLX3, or TLX1 rearrangements had higher frequencies (61%, 42%, 78%, and 89%).</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>In conclusion, CDKN2A deletion is a significant secondary abnormality in childhood ALL strongly correlated with phenotype and genotype.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>The variation in the incidence of CDKN2A deletions by cytogenetic subgroup may explain its inconsistent association with outcome.</Variant>", "label": []}
{"id": "18838613", "text": "<Variant>CNN LOH without apparent CDKN2A inactivation suggests the presence of other relevant genes in this region.</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>CONTEXT:</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>Interindividual variations in glucocorticoid sensitivity have been associated with manifestations of cortisol excess or deficiency and may be partly explained by polymorphisms in the human glucocorticoid receptor (hGR) gene.</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>We studied a 43-yr-old female, who presented with manifestations consistent with tissue-selective glucocorticoid hypersensitivity.</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>We detected a novel, single, heterozygous nucleotide (G --> C) substitution at position 1201 (exon 2) of the hGR gene, which resulted in aspartic acid to histidine substitution at amino acid position 401 in the amino-terminal domain of the hGRalpha.</Variant>", "label": [[62, 101, "Variant"], [146, 212, "Variant"]]}
{"id": "18827003", "text": "<Variant>We investigated the molecular mechanisms of action of the natural mutant receptor hGRalphaD401H. METHODS-RESULTS:</Variant>", "label": [[99, 104, "Variant"]]}
{"id": "18827003", "text": "<Variant>Compared with the wild-type hGRalpha, the mutant receptor hGRalphaD401H demonstrated a 2.4-fold increase in its ability to transactivate the glucocorticoid-inducible mouse mammary tumor virus promoter in response to dexamethasone but had similar affinity for the ligand (dissociation constant = 6.2 +/- 0.6 vs. 6.1 +/- 0.6 nm) and time to nuclear translocation (14.75 +/- 0.25 vs. 14.25 +/- 1.13 min).</Variant>", "label": [[75, 80, "Variant"]]}
{"id": "18827003", "text": "<Variant>The mutant receptor hGRalphaD401H did not exert a dominant positive or negative effect upon the wild-type receptor, it preserved its ability to bind to glucocorticoid response elements, and displayed a normal interaction with the glucocorticoid receptor-interacting protein 1 coactivator.</Variant>", "label": [[37, 42, "Variant"]]}
{"id": "18827003", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18827003", "text": "<Variant>The mutant receptor hGRalphaD401H enhances the transcriptional activity of glucocorticoid-responsive genes.</Variant>", "label": [[37, 42, "Variant"]]}
{"id": "18827003", "text": "<Variant>The presence of the D401H mutation may predispose subjects to obesity, hypertension, and other manifestations of the metabolic syndrome.</Variant>", "label": [[29, 34, "Variant"]]}
{"id": "18813858", "text": "<Variant>Novel mutations in the IRF6 gene in Brazilian families with Van der Woude syndrome.</Variant>", "label": []}
{"id": "18813858", "text": "<Variant>Van der Woude Syndrome (VWS) is an autosomal craniofacial disorder characterized by lower lip pits and cleft lip and/or palate.</Variant>", "label": []}
{"id": "18813858", "text": "<Variant>Mutations in the interferon regulatory factor 6 (IRF6) gene have been identified in patients with VWS.</Variant>", "label": []}
{"id": "18813858", "text": "<Variant>To identify novel IRF6 mutations in patients affected by VWS, we screened 2 Brazilian families, sequencing the entire IRF6-coding region and flanking intronic boundaries.</Variant>", "label": []}
{"id": "18813858", "text": "<Variant>Two novel heterozygous mutations were identified: a frame shift mutation with deletion of G at the nucleotide position 520 in the exon 6 (520delG), and a missense single nucleotide substitution from T to A at nucleotide position 1135 in exon 8 (T1135A).</Variant>", "label": [[87, 131, "Variant"], [147, 154, "Variant"], [208, 242, "Variant"], [254, 260, "Variant"]]}
{"id": "18813858", "text": "<Variant>By using restriction enzyme analysis, we were able to demonstrate the lack of similar mutations in unrelated healthy individuals and non-syndromic cleft lip and palate patients.</Variant>", "label": []}
{"id": "18813858", "text": "<Variant>Our results further confirmed that haploinsufficiency of the IRF6 gene results in VWS.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>Genetic variation in an individual human exome.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>There is much interest in characterizing the variation in a human individual, because this may elucidate what contributes significantly to a person's phenotype, thereby enabling personalized genomics.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>We focus here on the variants in a person's 'exome,' which is the set of exons in a genome, because the exome is believed to harbor much of the functional variation.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>We provide an analysis of the approximately 12,500 variants that affect the protein coding portion of an individual's genome.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>We identified approximately 10,400 nonsynonymous single nucleotide polymorphisms (nsSNPs) in this individual, of which approximately 15-20% are rare in the human population.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>We predict approximately 1,500 nsSNPs affect protein function and these tend be heterozygous, rare, or novel.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>Of the approximately 700 coding indels, approximately half tend to have lengths that are a multiple of three, which causes insertions/deletions of amino acids in the corresponding protein, rather than introducing frameshifts.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>Coding indels also occur frequently at the termini of genes, so even if an indel causes a frameshift, an alternative start or stop site in the gene can still be used to make a functional protein.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>In summary, we reduced the set of approximately 12,500 nonsilent coding variants by approximately 8-fold to a set of variants that are most likely to have major effects on their proteins' functions.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>This is our first glimpse of an individual's exome and a snapshot of the current state of personalized genomics.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>The majority of coding variants in this individual are common and appear to be functionally neutral.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>Our results also indicate that some variants can be used to improve the current NCBI human reference genome.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>As more genomes are sequenced, many rare variants and non-SNP variants will be discovered.</Variant>", "label": []}
{"id": "18704161", "text": "<Variant>We present an approach to analyze the coding variation in humans by proposing multiple bioinformatic methods to hone in on possible functional variation.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>Breast carcinomas are characterized by DNA copy number alterations (CNAs) with biological and clinical significance.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>This explorative study integrated CNA, expression, and germline genotype data of 112 early-stage breast cancer patients.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>Recurrent CNAs differed substantially between tumor subtypes classified according to expression pattern.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>Deletion of 16q was overrepresented in Luminal A, and a predictor of good prognosis, both overall and for the nonluminal A subgroups.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>The deleted region most significantly associated with survival mapped to 16q22.2, harboring the genes TXNL4B and DXH38, whose expression was strongly correlated with the deletion.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>The area most frequently deleted resided on 16q23.1, 3.5 MB downstream of the area most significantly associated with survival, and included the tumor suppressor gene ADAMTS18 and the cell recognition gene CNTNAP4.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>Whole-genome association analysis identified germline single nucleotide polymorphisms (SNPs) and their corresponding haplotypes, residing on several different chromosomes, to be associated with deletion of 16q.</Variant>", "label": []}
{"id": "18398821", "text": "<Variant>The genes where these SNPs reside encode proteins involved in the extracellular matrix (CHST3 and SPOCK2), in regulation of the cell cycle (JMY, PTPRN2, and Cwf19L2) and chromosome stability (KPNB1).</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>TNFA -308G>A in two international population-based cohorts and risk of asthma.</Variant>", "label": [[14, 21, "Variant"]]}
{"id": "18385169", "text": "<Variant>Genetic association studies have related the tumour necrosis factor-alpha gene (TNFA) guanine to adenine substitution of nucleotide -308 (-308G>A) polymorphism to increased risk of asthma, but results are inconsistent.</Variant>", "label": [[95, 145, "Variant"], [147, 154, "Variant"]]}
{"id": "18385169", "text": "<Variant>The aim of the present study was to test whether two single-nucleotide polymorphisms, of TNFA and of the lymphotoxin-alpha gene (LTA), are associated with asthma, bronchial hyperresponsiveness and atopy in adults, by combining the results of two large population-based multicentric studies and conducting a meta-analysis of previously published studies.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>The European Community Respiratory Health Survey (ECRHS) and Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) used comparable protocols, including questionnaires for respiratory symptoms and measures of lung function and atopy.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>DNA samples from 11,136 participants were genotyped at TNFA -308 and LTA 252.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>Logistic regression employing fixed and random effects models and nonparametric techniques were used.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>The prevalence of asthma was 6%.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>The TNFA -308G>A polymorphism was associated with increased asthma prevalence and with bronchial hyperresponsiveness.</Variant>", "label": [[18, 25, "Variant"]]}
{"id": "18385169", "text": "<Variant>No consistent association was found for atopy.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>The LTA 252A>G polymorphism was not associated with any of the outcomes.</Variant>", "label": [[17, 23, "Variant"]]}
{"id": "18385169", "text": "<Variant>A meta-analysis of 17 studies showed an increased asthma risk for the TNFA -308 adenine allele.</Variant>", "label": [[84, 96, "Variant"]]}
{"id": "18385169", "text": "<Variant>The tumour necrosis factor-alpha gene nucleotide -308 polymorphism is associated with a moderately increased risk of asthma and bronchial hyperresponsiveness, but not with atopy.</Variant>", "label": []}
{"id": "18385169", "text": "<Variant>These results are supported by a meta-analysis of previously published studies.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>Mutations in the human ether-a-go-go-related gene (hERG) cause type 2 long QT syndrome.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>In this study, we investigated the pathogenic mechanism of the hERG splice site mutation 2398+1G>C and the genotype-phenotype relationship of mutation carriers in three unrelated kindreds with long QT syndrome.</Variant>", "label": [[98, 107, "Variant"]]}
{"id": "18272172", "text": "<Variant>The effect of 2398+1G>C on mRNA splicing was studied by analysis of RNA isolated from lymphocytes of index patients and using minigenes expressed in HEK293 cells and neonatal rat ventricular myocytes.</Variant>", "label": [[23, 32, "Variant"]]}
{"id": "18272172", "text": "<Variant>RT-PCR analysis revealed that the 2398+1G>C mutation disrupted the normal splicing and activated a cryptic splice donor site in intron 9, leading to the inclusion of 54 nt of the intron 9 sequence in hERG mRNA.</Variant>", "label": [[43, 52, "Variant"]]}
{"id": "18272172", "text": "<Variant>The cryptic splicing resulted in an in-frame insertion of 18 amino acids in the middle of the cyclic nucleotide binding domain.</Variant>", "label": [[54, 81, "Variant"]]}
{"id": "18272172", "text": "<Variant>In patch clamp experiments the splice mutant did not generate hERG current.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>Western blot and immunostaining studies showed that the mutant expressed an immature form of hERG protein that failed to reach the plasma membrane.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>Coexpression of the mutant and wild-type channels led to a dominant negative suppression of wild-type channel function by intracellular retention of heteromeric channels.</Variant>", "label": []}
{"id": "18272172", "text": "<Variant>Our results demonstrate that 2398+1G>C activates a cryptic site and generates a full-length hERG protein with an insertion of 18 amino acids, which leads to a trafficking defect of the mutant channel.</Variant>", "label": [[38, 47, "Variant"], [122, 149, "Variant"]]}
{"id": "18164595", "text": "<Variant>Mutations in the hairless gene underlie APL in three families of Pakistani origin.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>Atrichia with papular lesions (APL) (OMIM#209500) is a rare autosomal recessively inherited form of irreversible alopecia characterized by papular lesions of keratin-filled cysts on various regions of the body.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>Males and females are equally affected and present with a distinct pattern of total hair loss on scalp, axilla and body.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>It begins shortly after birth with the development of hair loss, and patients are normally devoid of eyelashes and eyebrows.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>Mutations in the hairless (HR) gene have been previously shown to be responsible for APL.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>In this study, we studied the molecular basis of APL in three unrelated families of Pakistani origin.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>METHOD:</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>Molecular analysis of the HR genes was performed on genomic DNA from probands and family members.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>RESULTS: DNA sequencing of the HR gene in family A revealed a novel homozygous 2bp deletion in exon 6 leading to a frameshift and a downstream premature termination codon in exon 8 (1782-83delAG).</Variant>", "label": [[88, 100, "Variant"], [191, 203, "Variant"]]}
{"id": "18164595", "text": "<Variant>In family B, we identified a novel homozygous deletion of a G nucleotide at the exon 15-intron 15 boundary, termed 3097delG. Family C carries a previously reported missense mutation consisting of an A-to-G transition at nucleotide 276 resulting in the mutation N970S in exon 14.</Variant>", "label": [[55, 81, "Variant"], [124, 132, "Variant"], [208, 243, "Variant"], [270, 275, "Variant"]]}
{"id": "18164595", "text": "<Variant>CONCLUSION: Two mutations identified in this study are novel mutations in the HR gene and extend the body of evidence implicating the hairless gene family in the pathogenesis of human skin disorders.</Variant>", "label": []}
{"id": "18164595", "text": "<Variant>The one previously reported mutation suggests it may represent a recurrent mutation, or alternatively, an allele that is widely dispersed around the world.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.</Variant>", "label": [[55, 75, "Variant"]]}
{"id": "18046082", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE).</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>This study investigated the association of a new variant of apoE with LPG in a Chinese family.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>The apoE gene in a family with 4 LPG patients was sequenced.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member.</Variant>", "label": [[50, 92, "Variant"]]}
{"id": "18046082", "text": "<Variant>This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. Those patients were all heterozygotes with apoE Guangzhou.</Variant>", "label": [[71, 123, "Variant"]]}
{"id": "18046082", "text": "<Variant>One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria.</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "18046082", "text": "<Variant>The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG.</Variant>", "label": [[54, 74, "Variant"]]}
{"id": "18046082", "text": "<Variant>This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Osteoporosis is defined as the loss of bone mineral density that leads to bone fragility with aging.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Population-based case-control studies have identified polymorphisms in many candidate genes that have been associated with bone mass maintenance or osteoporotic fracture.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>To investigate single nucleotide polymorphisms (SNPs) that are associated with osteoporosis, we examined the genetic variation among Koreans by analyzing 81 genes according to their function in bone formation and resorption during bone remodeling.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>We resequenced all the exons, splice junctions and promoter regions of candidate osteoporosis genes using 24 unrelated Korean individuals.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Using the common SNPs from our study and the HapMap database, a statistical analysis of deviation in heterozygosity depicted.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>We identified 942 variants, including 888 SNPs, 43 insertion/deletion polymorphisms, and 11 microsatellite markers.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Of the SNPs, 557 (63%) had been previously identified and 331 (37%) were newly discovered in the Korean population.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>When compared SNPs in the Korean population with those in HapMap database, 1% (or less) of SNPs in the Japanese and Chinese subpopulations and 20% of those in Caucasian and African subpopulations were significantly differentiated from the Hardy-Weinberg expectations.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>In addition, an analysis of the genetic diversity showed that there were no significant differences among Korean, Han Chinese and Japanese populations, but African and Caucasian populations were significantly differentiated in selected genes.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Nevertheless, in the detailed analysis of genetic properties, the LD and Haplotype block patterns among the five sub-populations were substantially different from one another.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Through the resequencing of 81 osteoporosis candidate genes, 118 unknown SNPs with a minor allele frequency (MAF) > 0.05 were discovered in the Korean population.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>In addition, using the common SNPs between our study and HapMap, an analysis of genetic diversity and deviation in heterozygosity was performed and the polymorphisms of the above genes among the five populations were substantially differentiated from one another.</Variant>", "label": []}
{"id": "18036257", "text": "<Variant>Further studies of osteoporosis could utilize the polymorphisms identified in our data since they may have important implications for the selection of highly informative SNPs for future association studies.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Novel TULP1 mutation causing leber congenital amaurosis or early onset retinal degeneration.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>To report a large, consanguineous Algerian family affected with Leber congenital amaurosis (LCA) or early-onset retinal degeneration (EORD).</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>All accessible family members underwent a complete ophthalmic examination, and blood was obtained for DNA extraction.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Homozygosity mapping was performed with markers flanking 12 loci associated with LCA.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>The 15 exons of TULP1 were sequenced.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>RESULTS: Seven of 30 examined family members were affected, including five with EORD and two with LCA.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>All patients had nystagmus, hemeralopia, mild myopia, and low visual acuity without photophobia.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Fundus features were variable among EORD patients: typical spicular retinitis pigmentosa or clumped pigmented retinopathy with age-dependent macular involvement.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>A salt-and-pepper retinopathy with midperipheral retinal pigment epithelium (RPE) atrophy was present in the older patients with LCA, whereas the retina appeared virtually normal in the younger ones.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Both scotopic and photopic electroretinograms were nondetectable.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Fundus imaging revealed a perifoveal ring of increased fundus autofluorescence (FAF) in the proband, and optical coherence tomography disclosed a thinned retina, mainly due to photoreceptor loss.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Linkage analysis identified a region of homozygosity on chromosome 6, region p21.3, and mutation screening revealed a novel 6-base in-frame duplication, in the TULP1 gene.</Variant>", "label": [[133, 160, "Variant"]]}
{"id": "17962469", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>Mutation in the TULP1 gene is a rare cause of LCA/EORD, with only 14 mutations reported so far.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>The observed intrafamilial phenotypic variability could be attributed to disease progression or possibly modifier alleles.</Variant>", "label": []}
{"id": "17962469", "text": "<Variant>This study provides the first description of FAF and quantitative reflectivity profiles in TULP1-related retinopathy.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>Focal dermal hypoplasia resulting from a new nonsense mutation, p.E300X, in the PORCN gene.</Variant>", "label": [[73, 80, "Variant"]]}
{"id": "17951029", "text": "<Variant>BACKGROUND: Focal dermal hypoplasia (FDH) (OMIM 305600) is an X-linked dominant disorder of ecto-mesodermal development.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>Also known as Goltz syndrome, FDH presents with characteristic linear streaks of hypoplastic dermis and variable abnormalities of bone, nails, hair, limbs, teeth and eyes.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>The molecular basis of FDH involves mutations in the PORCN gene, which encodes an enzyme that allows membrane targeting and secretion of several Wnt proteins critical for normal tissue development.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>To investigate the molecular basis of FDH in a 2-year-old Thai girl who presented at birth with depressed, pale linear scars on the trunk and limbs, sparse brittle hair, syndactyly of the right middle and ring fingers, dental caries and radiological features of osteopathia striata.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>Sequencing of genomic DNA from the affected individual and both parents to search for pathogenic mutations in PORCN gene.</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17951029", "text": "<Variant>DNA sequencing disclosed a heterozygous G>T substitution at nucleotide c.898 within exon 10 (NM_203475.1), converting a glutamic acid residue (GAA) to a premature termination codon (TAA).</Variant>", "label": [[49, 85, "Variant"], [129, 195, "Variant"]]}
{"id": "17951029", "text": "<Variant>This mutation, designated p.E300X, was not detected in DNA from either parent or in 100 control chromosomes.</Variant>", "label": [[35, 42, "Variant"]]}
{"id": "17951029", "text": "<Variant>CONCLUSION: Identification of this new de novo nonsense mutation confirms the diagnosis of FDH in this child and highlights the clinical importance of PORCN and Wnt signalling pathways in embryogenesis.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family.</Variant>", "label": [[33, 43, "Variant"]]}
{"id": "17868390", "text": "<Variant>We report here the clinical, genetic, and molecular characteristics of a large Chinese family exhibiting non-syndromic, late-onset autosomal dominant sensorineural hearing loss.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>Clinical evaluation revealed variable phenotypes of hearing loss in terms of severity and age-at-onset of disease in these subjects.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>Genome-wide linkage analysis mapped the disease gene to the DFNA5 locus with a maximum two-point log odds score of 5.39 at [theta] = 0 for marker D7S2457.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>DNA sequencing of DFNA5 revealed a novel heterozygous IVS8+4 A>G substitution in the splice donor site of intron 8.</Variant>", "label": [[63, 73, "Variant"]]}
{"id": "17868390", "text": "<Variant>Reverse transcriptase-polymerase chain reaction (RT-PCR) showed skipping of exon 8 in the mutant transcript.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>This mutation faithfully cosegregated with hearing loss in the family.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>In addition, the mutation was absent in 100 unrelated control DNA samples of Chinese origin.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>The IVS8+4 A>G mutation is predicted to create a shift in the reading frame and introduce a stop codon at position 372, thereby resulting in a prematurely truncated DFNA5 protein.</Variant>", "label": [[13, 23, "Variant"], [101, 127, "Variant"]]}
{"id": "17868390", "text": "<Variant>Up to date, a total of four mutations in DFNA5 have been reported to lead to hearing impairment, all of them result in skipping of exon 8 at the mRNA level.</Variant>", "label": []}
{"id": "17868390", "text": "<Variant>Our findings provide further support for the hypothesis that DFNA5-associated hearing loss is caused by a very specific gain-of-function mutation.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>The prognosis of breast cancer varies considerably among individuals, and inherited genetic factors may help explain this variability.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>Of particular interest are genes involved in defense against reactive oxygen species (ROS) because ROS are thought to cause DNA damage and contribute to the pathogenesis of cancer.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>PATIENTS AND METHODS:</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>We examined associations between 54 polymorphisms that tag the known common variants (minor allele frequency > 0.05) in 10 genes involved in oxidative damage repair (CAT, SOD1, SOD2, GPX1, GPX4, GSR, TXN, TXN2, TXNRD1, and TXNRD2) and survival in 4,470 women with breast cancer.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>Two single nucleotide polymorphisms (SNPs) in GPX4 (rs713041 and rs757229) were associated with all-cause mortality even after adjusting for multiple hypothesis testing (adjusted P = .0041 and P = .0035).</Variant>", "label": [[61, 69, "Variant"], [74, 82, "Variant"]]}
{"id": "17634480", "text": "<Variant>These SNPs are correlated with each other (r2 = 0.61).</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>GPX4 rs713041 is located near the selenocysteine insertion sequence element in the GPX4 3' untranslated region, and the rare allele of this SNP is associated with an increased risk of death, with a hazard ratio of 1.27 per rare allele carried (95% CI, 1.13 to 11.43).</Variant>", "label": [[14, 22, "Variant"]]}
{"id": "17634480", "text": "<Variant>This effect was not attenuated after adjusting for tumor stage, grade, or estrogen receptor status.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>We found that the common allele is preferentially expressed in normal lymphocytes, normal breast, and breast tumors compared with the rare allele, but there were no differences in total levels of GPX4 mRNA across genotypes.</Variant>", "label": []}
{"id": "17634480", "text": "<Variant>CONCLUSION: These data provide strong support for the hypothesis that common variation in GPX4 is associated with prognosis after a diagnosis of breast cancer.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Manganese superoxide dismutase (Mn-SOD) gene polymorphisms in urolithiasis.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Polymorphism in manganese superoxide dismutase gene (Mn-SOD) is a new approach to identify its probable association with urolithiasis.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Oxidative stress may be involved in the development of stone formation in the renal system.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>MnSOD is one of the primary enzymes that directly scavenges potential harmful oxidizing species.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>A valine (Val) to alanine (Ala) substitution at amino acid 16, occurring in the mitochondrial targeting sequence of the MnSOD gene, has been associated with an increase in urolithiasis risk.</Variant>", "label": [[11, 70, "Variant"]]}
{"id": "17628794", "text": "<Variant>This study was conducted to investigate the association of MnSOD gene polymorphism with the risk of urolithiasis.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>We investigated the MnSOD in 66 stone-forming adults and 72 healthy volunteers.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>DNA was isolated from peripheral blood and genotyping was performed with PCR-based methods.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Then PCR products were cut by BsaW1.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Products were run on 3% agarose gel, 246 bp regions were 1-Ala-9, 164 and 82 bp products were determined as 2 Val-9.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>Chi-square test was used for comparison between patients and controls.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>In the control group the homozygote Ala allele was significantly higher than in the patient group (P < 0.01).</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>The distribution of Ala/Val and homozygote Val alleles in the patient group was significantly higher than in the control group (P < 0.05).</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>MnSOD genotype determination may provide a tool to identify individuals who are at risk of urolithiasis.</Variant>", "label": []}
{"id": "17628794", "text": "<Variant>This experiment also provides data about antioxidant status and stone formation.</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study.</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>We recently showed that long-term weight reduction changes the gene expression profile of adipose tissue in overweight individuals with impaired glucose tolerance (IGT).</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>One of the responding genes was X-chromosomal tenomodulin (TNMD), a putative angiogenesis inhibitor.</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>Our aim was to study the associations of individual single nucleotide polymorphisms and haplotypes with adiposity, glucose metabolism, and the risk of type 2 diabetes (T2D).</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>Seven single nucleotide polymorphisms from two different haploblocks were genotyped from 507 participants of the Finnish Diabetes Prevention Study (DPS).</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>Sex-specific genotype effects were observed.</Variant>", "label": []}
{"id": "17495183", "text": "<Variant>Three markers of haploblock 1 were associated with features of adiposity in women (rs5966709, rs4828037) and men (rs11798018).</Variant>", "label": [[92, 101, "Variant"], [103, 112, "Variant"], [123, 133, "Variant"]]}
{"id": "17495183", "text": "<Variant>Markers rs2073163 and rs1155794 from haploblock 2 were associated with 2-hour plasma glucose levels in men during the 3-year follow-up.</Variant>", "label": [[17, 26, "Variant"], [31, 40, "Variant"]]}
{"id": "17495183", "text": "<Variant>The same two markers together with rs2073162 associated with the conversion of IGT to T2D in men.</Variant>", "label": [[44, 53, "Variant"]]}
{"id": "17495183", "text": "<Variant>The risk of developing T2D was approximately 2-fold in individuals with genotypes associated with higher 2-hour plasma glucose levels; the hazard ratios were 2.192 (p = 0.025) for rs2073162-A, 2.191 (p = 0.027) for rs2073163-C, and 1.998 (p = 0.054) for rs1155974-T. These results suggest that TNMD polymorphisms are associated with adiposity and also with glucose metabolism and conversion from IGT to T2D in men.</Variant>", "label": [[189, 198, "Variant"], [224, 233, "Variant"], [263, 272, "Variant"]]}
{"id": "17437275", "text": "<Variant>Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>We describe the search for mutations in six unrelated Czech and four unrelated British families with posterior polymorphous corneal dystrophy (PPCD); a relatively rare eye disorder.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>Coding exons and intron/exon boundaries of all three genes (VSX1, COL8A2, and ZEB1/TCF8) previously reported to be implicated in the pathogenesis of this disorder were screened by DNA sequencing.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>Four novel pathogenic mutations were identified in four families; two deletions, one nonsense, and one duplication within exon 7 in the ZEB1 gene located at 10p11.2.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>We also genotyped the Czech patients to test for a founder haplotype and lack of disease segregation with the 20p11.2 locus we previously described.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>Although a systematic clinical examination was not performed, our investigation does not support an association between ZEB1 changes and self reported non-ocular anomalies.</Variant>", "label": []}
{"id": "17437275", "text": "<Variant>In the remaining six families no disease causing mutations were identified thereby indicating that as yet unidentified gene(s) are likely to be responsible for PPCD.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>3' Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>Desmoid tumors may occur sporadically or as part of the extraintestinal manifestations of familial adenomatous polyposis.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>Different phenotypes have been described and some genotype-phenotype correlations have been raised, associated with different sites of germline mutations in the adenomatous polyposis coli (APC) gene.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>We report on a 42-year-old woman ascertained for a large desmoid tumor of the anterior chest wall with pleural involvement, which persistently recurred despite a decade of treatment including hormone therapy, chemotherapy, and surgery.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>Spontaneous disappearance of the tumor was later noted after 1 year without any treatment and confirmed after 4 years of regular follow-up.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>Repeated colonoscopies were normal in the proband and DNA sequencing showed a frameshift mutation due to a single adenosine deletion at position 5772 (codon 1924).</Variant>", "label": [[123, 158, "Variant"]]}
{"id": "17426470", "text": "<Variant>This mutation, located in the exon 15 at the 3' end of the APC gene, leads to an unusual and late onset phenotype.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>The pedigree revealed other isolated or familial adenomatous polyposis-associated cases of desmoid tumors.</Variant>", "label": []}
{"id": "17426470", "text": "<Variant>This family report shows that a molecular analysis of the APC gene should be performed in familial desmoid tumors for accurate genetic counseling and follow-up.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>Atypical Rothmund-Thomson syndrome in a patient with compound heterozygous mutations in RECQL4 gene and phenotypic features in RECQL4 syndromes.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>We describe the natural history of the RTSII phenotype in a 7-year-old boy who developed intrauterine and postnatal growth retardation, failure to thrive and persisting diarrhoea.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>The growth hormone stimulation test identified an isolated growth hormone deficiency.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>Since infancy, the patient manifested skin lesions characterized by a very mild poikilodermic-like appearance on the cheeks only, widespread caf -au-lait spots and the absence of eyebrows and eyelashes.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>There was no cataract.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>Orthopaedic and radiologic work-up identified the absence of thumb anomaly and radial head luxation and patellar hypoplasia.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>Neurologic, cognitive milestones and intelligence were normal.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>The cytogenetic work-up did not show any anomaly.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>Based on this clinical presentation, we carried out a sequencing analysis of the RECQL4 gene, which is responsible for Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes and found a splice site mutation (IVS10-1G>A) and a nucleotide substitution in exon 12 (L638P).</Variant>", "label": [[219, 229, "Variant"], [273, 278, "Variant"]]}
{"id": "17372760", "text": "<Variant>The mother was identified as a carrier for the substitution in exon 12 and the father for the splice site mutation, respectively.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>An analysis of the transcripts focused on the RECQL4 helicase domain: in the proband only those generated from the maternal L638 allele were present.</Variant>", "label": [[133, 137, "Variant"]]}
{"id": "17372760", "text": "<Variant>This case report emphasizes the clinical overlap between RAPADILINO and Rothmund-Thomson syndromes within a continuum phenotypic spectrum.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>The distinctive set of clinical signs displayed by the patient may be accounted for by his unique combination of two different RECQL4 mutations.</Variant>", "label": []}
{"id": "17372760", "text": "<Variant>The molecular findings provide information that enhances our comprehension of genotype-phenotype correlations in RECQL4 diseases, enables a more precise genetic counseling to the parents and facilitates a more appropriate long-term follow-up to the affected child.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Neuroblastomas are characterized by chromosomal alterations with biological and clinical significance.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>We analyzed paired blood and primary tumor samples from 22 children with high-risk neuroblastoma for loss of heterozygosity (LOH) and DNA copy number change using the Affymetrix 10K single nucleotide polymorphism (SNP) array.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>FINDINGS:</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Multiple areas of LOH and copy number gain were seen.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>The most commonly observed area of LOH was on chromosome arm 11q (15/22 samples; 68%).</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Chromosome 11q LOH was highly associated with occurrence of chromosome 3p LOH: 9 of the 15 samples with 11q LOH had concomitant 3p LOH (P = 0.016).</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Chromosome 1p LOH was seen in one-third of cases.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>LOH events on chromosomes 11q and 1p were generally accompanied by copy number loss, indicating hemizygous deletion within these regions.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>The one exception was on chromosome 11p, where LOH in all four cases was accompanied by normal copy number or diploidy, implying uniparental disomy.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Gain of copy number was most frequently observed on chromosome arm 17q (21/22 samples; 95%) and was associated with allelic imbalance in six samples.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>Amplification of MYCN was also noted, and also amplification of a second gene, ALK, in a single case.</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "17327916", "text": "<Variant>This analysis demonstrates the power of SNP arrays for high-resolution determination of LOH and DNA copy number change in neuroblastoma, a tumor in which specific allelic changes drive clinical outcome and selection of therapy.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>Two Epstein Barr virus (EBV) genotypes: EBV-1 and EBV-2 have been described.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>A 30-bp deletion in latent membrane protein-1 gene (del-LMP-1) has been identified in various pathologies.</Variant>", "label": [[11, 25, "Variant"]]}
{"id": "17311329", "text": "<Variant>The aim of this study was to determine EBV genotypes and 30-bp deletion frequency in HIV-infected patients from Argentina.</Variant>", "label": [[66, 80, "Variant"]]}
{"id": "17311329", "text": "<Variant>The study was performed on 258 individuals: Cases: 144 HIV-infected patients that included: (a) 7 AIDS patients with primary central nervous system lymphoma (PCNSL), (b) 62 AIDS patients, and (c) 75 asymptomatic HIV-infected patients.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>Controls: 114 HIV-negative individuals.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>EBV genotypes and variants in LMP-1 gene were detected by polymerase chain reaction (PCR)-Southern blot on DNA extracted from peripheral blood mononuclear cells and brain biopsies.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>In PCNSL, the presence of EBV was confirmed by EBER RNA in situ hybridization, and DNA sequencing of 3' end LMP-l gene of PCR products was performed.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>In HIV-infected patients, EBV-1 was detected in 48.6%, EBV-2 in 18.8%, and co-infection with both genotypes in 32.6%.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>In control group, EBV-1 was present in 74.3%, EBV-2 in 12.4%, and co-infection in 13.3%.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>Del-LMP-1 was found in 44.4% of HIV-infected patients samples (20.7% alone and 23.7% co-infection with non-deleted form) while it was found in 25.3% (6.3% alone and 19% with co-infection) in HIV-negative individuals.</Variant>", "label": []}
{"id": "17311329", "text": "<Variant>In HIV-infected patients EBV-2, co-infection and 30-bp deletion are more prevalent than in control group.</Variant>", "label": [[58, 72, "Variant"]]}
{"id": "17311329", "text": "<Variant>In all, PCNSL brain biopsies samples, del-LMP-1 always was detected with EBV-2, but more cases would have to be included to draw definitive conclusions.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>Retinoblastoma in India : microsatellite analysis and its application in genetic counseling.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>This study was conducted with two objectives.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>The first was to estimate the frequency of loss of heterozygosity (LOH) of the RB1 gene as a mechanism in disease causation in tumors of patients from India.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>The second objective was to employ RB1 molecular deletion and microsatellite-based linkage analysis as laboratory tools, while counseling families with a history of retinoblastoma (RB).</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>DNA was extracted from peripheral blood and tumors of 54 RB patients and their relatives.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>Eight fluorescent microsatellite markers, both intragenic and flanking the RB1 gene, were used.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>After PCR amplification, samples were run on an ABI PRISM 310 genetic analyzer for LOH, deletion detection, and haplotype generation.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>LOH was found in conjunction with tumor formation in 72.9% of RB patients (39/54 patients; p=0.001; 95% CI 0.6028, 0.8417); however, we could not associate various other clinical parameters of RB patients with the presence or absence of RB1 LOH.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>Seven germline deletions (13% of RB patients) were identified, and the maternal allele was more frequently lost (p=0.01).</Variant>", "label": [[9, 33, "Variant"]]}
{"id": "17286451", "text": "<Variant>A disease co-segregating haplotype was detected in two hereditary autosomal dominant cases.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>CONCLUSION: LOH of the RB1 gene could play an important role in tumor formation.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>Large deletions involving RB1 were observed, and a disease co-segregating haplotype was used for indirect genetic testing.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>This is the first report from India where molecular testing has been applied for RB families in conjunction with genetic counseling.</Variant>", "label": []}
{"id": "17286451", "text": "<Variant>In tertiary ophthalmic practice in India, there is an emerging trend towards the application of genetical knowledge in clinical practice.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Unusual forms of amyotrophic lateral sclerosis (ALS-G), Parkinsonism dementia complex (PDC-G) and Guam dementia (GD) are found in Chamorros, the indigenous people of Guam.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Neurofibrillary tangles composed of hyperphosphorylated tau are a neuropathologic feature of these closely related disorders.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>To determine if variation in the gene that encodes microtubule-associated protein tau gene (MAPT) contributes to risk for these disorders, we genotyped nine single nucleotide polymorphism (SNP) sites and one insertion/deletion in the 5' end of MAPT in 54 ALS-G, 135 PDC-G, 153 GD and 258 control subjects, all of whom are Chamorros.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Variation at three SNPs (sites 2, 6 and 9) influenced risk for ALS-G, PDC-G and GD.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>SNP2 acts through a dominant mechanism and is independent of the risk conferred by SNPs 6 and 9, the latter two acting by a recessive mechanism.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Persons with the high-risk SNP6 and SNP9 AC/AC diplotype had an increased risk of 3-fold [95% confidence interval (CI)=1.10-8.25] for GD, 4-fold (95% CI=1.40-11.64) for PDC-G and 6-fold (95% CI=1.44-32.14) for ALS-G, compared to persons with other diplotypes after adjusting for SNP2.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Carriers of the SNP2 G allele had an increased risk of 1.6-fold (95% CI=1.00-2.62) for GD, 2-fold (95% CI=1.28-3.66) for PDC-G, and 1.5-fold (95% CI=0.74-3.00) for ALS-G, compared to non-carriers after adjusting for SNPs 6 and 9.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>Others have shown that SNP6 is also associated with risk for progressive supranuclear palsy.</Variant>", "label": []}
{"id": "17185385", "text": "<Variant>These two independent cis-acting sites presumably influence risk for Guam neuro-degenerative disorders by regulating MAPT expression.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.</Variant>", "label": [[27, 32, "Variant"]]}
{"id": "17177139", "text": "<Variant>Resistance to thyroid hormone (RTH) is an inherited syndrome characterized by elevated serum thyroid hormones (TH), failure to suppress pituitary thyroid stimulating hormone (TSH) secretion, and variable peripheral tissue responsiveness to TH.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>The disorder is associated with diverse mutations in the thyroid hormone beta receptor (TRbeta).</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>Here, we report a novel natural RTH mutation (E333D) located in the large carboxy-terminal ligand binding domain of TRbeta.</Variant>", "label": [[55, 60, "Variant"]]}
{"id": "17177139", "text": "<Variant>The mutation was identified in a 22-year-old French woman coming to medical attention because of an increasing overweight.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>Biochemical tests showed elevated free thyroxine (T4: 20.8 pg/ml (normal, 8.5-18)) and triiodothyronine (T3: 5.7 pg/ml (normal, 1.4-4)) in the serum, together with an inappropriately nonsuppressed TSH level of 4.7 mU/ml (normal, 0.4-4).</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>Her father and her brother's serum tests also showed biochemical abnormalities consistent with RTH.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>Direct sequencing of the TRbeta gene revealed a heterozygous transition 1284A>C in exon 9 resulting in substitution of glutamic acid 333 by aspartic acid residue (E333D).</Variant>", "label": [[81, 88, "Variant"], [128, 162, "Variant"], [172, 177, "Variant"]]}
{"id": "17177139", "text": "<Variant>Further functional analyses of the novel TRbeta mutant were conducted.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>We found that the E333D mutation neither significantly affected the affinity of the receptor for T3 nor modified heterodimer formation with retinoid X receptor (RXR) when bound to DNA.</Variant>", "label": [[27, 32, "Variant"]]}
{"id": "17177139", "text": "<Variant>However, in transient transfection assays, the E333D TRbeta mutant exhibited impaired transcriptional regulation on two distinct positively regulated thyroid response elements (F2- and DR4-TREs) as well as on the negatively regulated human TSHalpha promoter.</Variant>", "label": [[56, 61, "Variant"]]}
{"id": "17177139", "text": "<Variant>Moreover, a dominant inhibition of the wild-type TRbeta counterpart transactivation function was observed on both a positive (F2-TRE) and a negative (TSHalpha) promoter.</Variant>", "label": []}
{"id": "17177139", "text": "<Variant>These results strongly suggest that the E333D TRbeta mutation is responsible for the RTH phenotype in the proposita's family.</Variant>", "label": [[49, 54, "Variant"]]}
{"id": "17065479", "text": "<Variant>Homozygous deletion related to Alu repeats in RLBP1 causes retinitis punctata albescens.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>Retinitis punctata albescens (RPA) is an infrequently occurring form of autosomal recessive (and rarely dominant) retinal dystrophy featuring early-onset severe night blindness and tiny, dotlike, white deposits in the fundus.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>RPA is associated mostly with mutations in RLBP1 and occasionally in RHO, RDS, and RDH5.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>In this study, mutations were sought in RLBP1, which encodes the retinol binding protein CRALBP in patients with typical RPA.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>Clinical investigation included funduscopy, visual field testing, electroretinogram recording, and adaptometry.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>The 7 coding exons (3-9) of RLBP1 and the 15th (last) exon of ABDH2 were PCR amplified and sequenced.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>Long-distance PCR and cloning of genomic DNA were performed to characterize the deletion.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>The study involved a 24-year-old Moroccan patient with typical RPA, born of first-cousin parents.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>He carried a 7.36-kb homozygous deletion encompassing the last 3 exons of RLBP1 (7, 8, and 9) and part of the intergenic region between RLBP1 and ABHD2, which lies downstream of RLBP1.</Variant>", "label": [[22, 49, "Variant"]]}
{"id": "17065479", "text": "<Variant>This deletion abolishes the retinal binding site of CRALBP.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>The telomeric breakpoint of the deletion (in RLBP1 intron 6) is embedded in an Alu element, whereas the centromeric breakpoint (in the intergenic region) lies between two Alu elements placed in the opposite orientation.</Variant>", "label": []}
{"id": "17065479", "text": "<Variant>CONCLUSIONS: Because of the high density of Alu elements in RLBP1, a systematic search should be made for deletions in this gene when one or both alleles lack point mutations, in the case of RPA or flecked retinal dystrophy.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>Evolvement and progression of cardiovascular diseases affecting the venous and arterial system are influenced by a multitude of environmental and hereditary factors.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>Many of these hereditary factors consist of defined gene polymorphisms, such as single nucleotide polymorphisms (SNPs) or insertion-deletion polymorphisms, which directly or indirectly affect the hemostatic system.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>The frequencies of individual hemostatic gene polymorphisms in different normal populations are well defined.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>However, descriptions of patterns of genetic variability of a larger extent of different factors of hereditary hypercoagulability in single populations are scarce.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>The aim of this study was i) to give a detailed description of the frequencies of factors of hereditary thrombophilia and their combinations in a German population (n = 282) and ii) to compare their distributions with those reported for other regions.</Variant>", "label": []}
{"id": "17003923", "text": "<Variant>Variants of coagulation factors [factor V 1691G></Variant>", "label": [[51, 58, "Variant"]]}
{"id": "17003923", "text": "<Variant>A (factor V Leiden), factor V 4070A>G (factor V HR2 haplotype), factor VII Arg353Gln, factor XIII Val34Leu, beta-fibrinogen -455G>A, prothrombin 20210G>A], coagulation inhibitors [tissue factor pathway inhibitor 536C>T, thrombomodulin 127G>A], fibrinolytic factors [angiotensin converting enzyme intron 16 insertion/deletion, factor VII-activating protease 1601G>A (FSAP Marburg I), plasminogen activator inhibitor 1-675 insertion/deletion (5G/4G), tissue plasminogen activator intron h deletion/insertion], and other factors implicated in influencing susceptibility to thromboembolic diseases [apolipoprotein E2/E3/E4,</Variant>", "label": [[38, 45, "Variant"], [83, 92, "Variant"], [106, 114, "Variant"], [132, 139, "Variant"], [153, 161, "Variant"], [220, 226, "Variant"], [243, 249, "Variant"], [365, 372, "Variant"], [425, 447, "Variant"]]}
{"id": "17003923", "text": "<Variant>glycoprotein Ia 807C>T, methylenetetrahydrofolate reductase 677C>T] were included.</Variant>", "label": [[24, 30, "Variant"], [68, 74, "Variant"]]}
{"id": "17003923", "text": "<Variant>The distribution of glycoprotein Ia 807C>T deviated significantly from the Hardy-Weinberg equilibrium, and a comparison with previously published data indicates marked region and ethnicity dependent differences in the genotype distributions of some other factors.</Variant>", "label": [[44, 50, "Variant"]]}
{"id": "17002658", "text": "<Variant>Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion.</Variant>", "label": [[71, 75, "Variant"]]}
{"id": "17002658", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>During infancy, a male patient experienced several life-threatening bleeding episodes.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>Standard coagulation tests revealed that the patient's plasma prothrombin activity was 8%, while his father's and mother's levels were 74% and 62%, respectively.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>A molecular genetic approach was used to determine the molecular basis of prothrombin deficiency within the family.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>PATIENT/METHODS:</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>Prothrombin genomic DNA fragments were amplified by using the polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>In addition, liver cDNA fragments were amplified from the patient by using reverse transcription (RT) and PCR.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>The nucleotide sequences of the DNA fragments were determined.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>RESULTS: A novel, heterozygous point mutation (g.1755 G > A, named prothrombin-Edmonton) was detected in the patient and his mother, resulting in the mutation of Arg-4 in the prothrombin propeptide to Gln (R-4Q).</Variant>", "label": [[56, 68, "Variant"], [171, 176, "Variant"], [215, 219, "Variant"]]}
{"id": "17002658", "text": "<Variant>RT-PCR analysis of the patient's liver sample demonstrated the presence of two mRNA transcripts that differed by the presence or absence of exon 11.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>Real-time PCR analysis on genomic DNA and cDNA confirmed a deletion (g.10435_10809del) in the paternal allele.</Variant>", "label": [[78, 94, "Variant"]]}
{"id": "17002658", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>The patient has a maternally-inherited point mutation (R-4Q) and a paternally-inherited deletion.</Variant>", "label": [[64, 68, "Variant"]]}
{"id": "17002658", "text": "<Variant>By analogy with the previously reported factor IX San Dimas, the R-4Q mutation probably causes under-carboxylation of prothrombin and poor cleavage of the propeptide in the hepatocyte.</Variant>", "label": [[74, 78, "Variant"]]}
{"id": "17002658", "text": "<Variant>The deletion probably results in a polypeptide that lacks 50 amino acids from the protease domain; this is likely to impair folding, secretion, stability and/or activity of the truncated prothrombin.</Variant>", "label": []}
{"id": "17002658", "text": "<Variant>The two mutations combine to give the prothrombin deficiency observed in the patient.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.</Variant>", "label": [[17, 26, "Variant"]]}
{"id": "16989765", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>To describe the phenotype and genotype of a family with suspected Sorsby fundus dystrophy (SFD).</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Case reports and results of deoxyribonucleic acid (DNA) analysis.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Clinical features were determined by complete ophthalmologic examination or by review of medical records.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Mutational analysis of the tissue inhibitor of metalloproteinase (TIMP)3 gene was performed by DNA resequencing.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Biochemical properties of the mutant TIMP3 protein were studied, and phylogenetic and molecular modeling analyses of TIMP proteins were performed.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Fundi of four affected family members demonstrated active or regressed bilateral choroidal neovascularization, whereas another affected individual displayed severe diffuse pigmentary degeneration associated with nyctalopia characteristic of SFD.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Onset of disease occurred in the fifth to seventh decades of life.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>A heterozygous His158Arg mutation was found in seven affected family members and was absent from an unaffected member and 98 unrelated controls.</Variant>", "label": [[24, 33, "Variant"]]}
{"id": "16989765", "text": "<Variant>Bioinformatic analyses indicate that histidine 158 is an evolutionarily conserved residue in most vertebrate TIMP homologs and predict that substitution by arginine disrupts TIMP3 function.</Variant>", "label": [[46, 59, "Variant"]]}
{"id": "16989765", "text": "<Variant>The mutant protein appears to be expressed by fibroblasts from an affected family member.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>Molecular modeling suggests that TIMP3 residue 158 may be part of a protein-protein interaction interface.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>CONCLUSION: A novel mutation in TIMP3 causes a late-onset form of SFD in this family.</Variant>", "label": []}
{"id": "16989765", "text": "<Variant>His158Arg is the first reported TIMP3 SFD coding sequence mutation that does not create an unpaired cysteine.</Variant>", "label": [[9, 18, "Variant"]]}
{"id": "16989765", "text": "<Variant>Further study of this unusual mutation may provide insight into the mechanism of SFD pathogenesis.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>Multiple endocrine neoplasia type 1 (MEN1) is characterized by parathyroid, enteropancreatic endocrine and pituitary adenomas as well as germline mutation of the MEN1 gene.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>We describe 2 families with MEN1 with novel mutations in the MEN1 gene.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>One family was of Turkish origin, and the index patient had primary hyperparathyroidism (PHPT) plus a prolactinoma; three relatives had PHPT only.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>The index patient in the second family was a 46-yr-old woman of Chinese origin living in Taiwan.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>This patient presented with a complaint of epigastric pain and watery diarrhea over the past 3 months, and had undergone subtotal parathyroidectomy and enucleation of pancreatic islet cell tumor about 10 yr before.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>There was also a prolactinoma.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>Sequence analysis of the MEN1 gene from leukocyte genomic DNA revealed heterozygous mutations in both probands.</Variant>", "label": []}
{"id": "16840830", "text": "<Variant>The Turkish patient and her affected relatives all had a heterozygous A to G transition at codon 557 (AAG-->GAG) of exon 10 of MEN1 that results in a replacement of lysine by glutamic acid.</Variant>", "label": [[79, 121, "Variant"], [174, 197, "Variant"]]}
{"id": "16840830", "text": "<Variant>The Chinese index patient and one of her siblings had a heterozygous mutation at codon 418 of exon 9 (GAC-->TAT) that results in a substitution of aspartic acid by tyrosine.</Variant>", "label": [[78, 121, "Variant"], [156, 181, "Variant"]]}
{"id": "16840830", "text": "<Variant>In conclusion, we have identified 2 novel missense mutations in the MEN1 gene.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>Hepatocyte nuclear factor 4alpha (HNF4alpha) is a transcription factor, which is necessary for normal function of human liver and pancreatic islets.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>We investigated whether single nucleotide polymorphisms (SNPs) of HNF4A, encoding HNF4alpha, influenced the conversion from impaired glucose tolerance (IGT) to type 2 diabetes mellitus in subjects of the STOP-NIDDM trial.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>This trial aimed at evaluating the effect of acarbose compared to placebo in the prevention of type 2 diabetes mellitus.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>Eight SNPs covering the intragenic and alternate P2 promoter regions of HNF4A were genotyped in study samples using the TaqMan Allelic Discrimination Assays.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>Three SNPs in the P2 promoter region (rs4810424, rs1884614, and rs2144908) were in almost complete association (D'>0.97, r (2)>0.95) and, therefore, only rs4810424 was included in further analyses.</Variant>", "label": [[47, 56, "Variant"], [58, 67, "Variant"], [73, 82, "Variant"], [163, 172, "Variant"]]}
{"id": "16838170", "text": "<Variant>Female carriers of the less frequent C allele of rs4810424 had a 1.7-fold elevated risk [95% confidence interval (CI) 1.09-2.66; P=0.020] for the conversion to diabetes compared to women with the common genotype after the adjustment for age, treatment group (placebo or acarbose), smoking, weight at baseline, and weight change.</Variant>", "label": [[58, 67, "Variant"]]}
{"id": "16838170", "text": "<Variant>No association was found in men.</Variant>", "label": []}
{"id": "16838170", "text": "<Variant>Haplotype analysis based on three SNPs (rs4810424, rs2071197, and rs3818247) representing the linkage disequilibrium blocks in our study population indicated that the conversion to type 2 diabetes mellitus was dependent on the number of risk alleles in different haplotypes in women.</Variant>", "label": [[49, 58, "Variant"], [60, 69, "Variant"], [75, 84, "Variant"]]}
{"id": "16838170", "text": "<Variant>Our results suggest that SNPs of HNF4A and their haplotypes predispose to type 2 diabetes mellitus in female subjects of the STOP-NIDDM study population.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>Genomic characterization of five deletions in the LDL receptor gene in Danish Familial Hypercholesterolemic subjects.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>BACKGROUND: Familial Hypercholesterolemia is a common autosomal dominantly inherited disease that is most frequently caused by mutations in the gene encoding the receptor for low density lipoproteins (LDLR).</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>Deletions and other major structural rearrangements of the LDLR gene account for approximately 5% of the mutations in many populations.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>METHODS: Five genomic deletions in the LDLR gene were characterized by amplification of mutated alleles and sequencing to identify genomic breakpoints.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>A diagnostic assay based on duplex PCR for the exon 7-8 deletion was developed to discriminate between heterozygotes and normals, and bioinformatic analyses were used to identify interspersed repeats flanking the deletions.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>In one case 15 bp had been inserted at the site of the deleted DNA, and, in all five cases, Alu elements flanked the sites where deletions had occurred.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>An assay developed to discriminate the wildtype and the deletion allele in a simple duplex PCR detected three FH patients as heterozygotes, and two individuals with normal lipid values were detected as normal homozygotes.</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16796766", "text": "<Variant>The identification of the breakpoints should make it possible to develop specific tests for these mutations, and the data provide further evidence for the role of Alu repeats in intragenic deletions.</Variant>", "label": []}
{"id": "16781314", "text": "<Variant>Ectodermal dysplasia-skin fragility syndrome resulting from a new homozygous mutation, 888delC, in the desmosomal protein plakophilin 1.</Variant>", "label": [[96, 103, "Variant"]]}
{"id": "16781314", "text": "<Variant>We report an unusual case of an inherited disorder of the desmosomal protein plakophilin 1, resulting in ectodermal dysplasia-skin fragility syndrome.</Variant>", "label": []}
{"id": "16781314", "text": "<Variant>The affected 6-year-old boy had red skin at birth and subsequently developed skin fragility, progressive plantar keratoderma, nail dystrophy, and alopecia.</Variant>", "label": []}
{"id": "16781314", "text": "<Variant>Skin biopsy revealed widening of intercellular spaces in the epidermis and a reduced number of small, poorly formed desmosomes.</Variant>", "label": []}
{"id": "16781314", "text": "<Variant>Mutation analysis of the plakophilin 1 gene PKP1 revealed a homozygous deletion of C at nucleotide 888 within exon 5.</Variant>", "label": [[80, 111, "Variant"]]}
{"id": "16781314", "text": "<Variant>This mutation differs from the PKP1 gene pathology reported in 8 previously published individuals with this rare genodermatosis.</Variant>", "label": []}
{"id": "16781314", "text": "<Variant>However, all cases show similar clinical features, highlighting the importance of functional plakophilin 1 in maintaining desmosomal adhesion in skin, as well as the role of this protein in aspects of ectodermal development.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>BACKGROUND: Accumulative evidence suggests that low folate intake is associated with increased risk of breast cancer.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>Polymorphisms in genes involved in folate metabolism may influence DNA methylation, nucleotide synthesis, and thus individual susceptibility to cancer.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>Thymidylate synthase (TYMS) is a key enzyme that participates in folate metabolism and catalyzes the conversion of dUMP to dTMP in the process of DNA synthesis.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>Two potentially functional polymorphisms [a 28-bp tandem repeat in the TYMS 5'-untranslated enhanced region (TSER) and a 6-bp deletion/insertion in the TYMS 3'-untranslated region (TS 3'-UTR)] were suggested to be correlated with alteration of thymidylate synthase expression and associated with cancer risk.</Variant>", "label": [[53, 72, "Variant"], [130, 153, "Variant"]]}
{"id": "16723031", "text": "<Variant>METHODS: To test the hypothesis that polymorphisms of the TYMS gene are associated with risk of breast cancer, we genotyped these two polymorphisms in a case-control study of 432 incident cases with invasive breast cancer and 473 cancer-free controls in a Chinese population.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>We found that the distribution of TS3'-UTR (1494del6) genotype frequencies were significantly different between the cases and controls (P = 0.026).</Variant>", "label": [[53, 61, "Variant"]]}
{"id": "16723031", "text": "<Variant>Compared with the TS3'-UTR del6/del6 wild-type genotype, a significantly reduced risk was associated with the ins6/ins6 homozygous variant genotype (adjusted OR = 0.58, 95% CI = 0.35-0.97) but not the del6/ins6 genotype (OR = 1.09, 95% CI = 0.82-1.46).</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>Furthermore, breast cancer risks associated with the TS3'-UTR del6/del6 genotype were more evident in older women, postmenopausal subjects, individuals with a younger age at first-live birth and individuals with an older age at menarche.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>However, there was no evidence for an association between the TSER polymorphism and breast cancer risks.</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16723031", "text": "<Variant>These findings suggest that the TS3'-UTR del6 polymorphism may play a role in the etiology of breast cancer.</Variant>", "label": [[50, 54, "Variant"]]}
{"id": "16723031", "text": "<Variant>Further larger population-based studies as well as functional evaluation of the variants are warranted to confirm our findings.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>Polymorphism of angiotensin converting enzyme (ACE) gene is reported to be associated with ischemic heart disease, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>In this study, we investigated the relationship between Kawasaki disease and insertion/deletion polymorphism of ACE gene.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>Fifty five Kawasaki disease patients and 43 healthy children were enrolled.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>ACE genotype was evaluated from each of the subjects' DNA fragments through polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>Frequencies of ACE genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD and high rate of ID genotype among Kawasaki patients (p<0.01).</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, p<0.05).</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>In Kawasaki group, both genotype and allelic frequencies were not statistically different between those with coronary dilatations and those without.</Variant>", "label": []}
{"id": "16614502", "text": "<Variant>ACE gene I/D polymorphism is thought to be associated with Kawasaki disease but not with the development of coronary dilatations.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.</Variant>", "label": [[36, 44, "Variant"]]}
{"id": "16575011", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>The purpose of this study was to analyze the value of germline and tumor thymidylate synthase (TS) genotyping as a prognostic marker in a series of colorectal cancer patients receiving adjuvant fluorouracil (FU) -based treatment.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>PATIENTS AND METHODS:</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>One hundred twenty-nine colorectal cancer patients homogeneously treated with FU plus levamisole or leucovorin in the adjuvant setting were included.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>TS enhancer region, 3R G > C single nucleotide polymorphism (SNP), and TS 1494del6 polymorphisms were assessed in both fresh-frozen normal mucosa and tumor.</Variant>", "label": [[32, 37, "Variant"], [83, 91, "Variant"]]}
{"id": "16575011", "text": "<Variant>Mutational analyses of TS and allelic imbalances were studied in all primary tumors and in 18 additional metachronic metastases.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>TS protein immunostaining was assessed in an expanded series of 214 tumors.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>Multivariate Cox models were adjusted for stage, differentiation, and location.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>Tumor genotyping (frequency of allelic loss, 26%) showed that the 3R/3R genotype was associated with a better outcome (hazard ratio [HR] = 0.38; 95% CI, 0.16 to 0.93; P = .020 for the recessive model).</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>3R G > C SNP genotyping did not add prognostic information.</Variant>", "label": [[12, 17, "Variant"]]}
{"id": "16575011", "text": "<Variant>Tumor TS 1494del6 allele (frequency of allelic loss, 36%) was protective (for each allele with the deletion, based on an additive model, HR = 0.42; 95% CI, 0.22 to 0.82; P = .0034).</Variant>", "label": [[18, 26, "Variant"]]}
{"id": "16575011", "text": "<Variant>Both polymorphisms were in strong linkage disequilibrium (D' = 0.71, P < .001), and the 3R/-6 base pair (bp) haplotype showed a significant overall survival benefit compared with the most prevalent haplotype 2R/+6bp (HR = 0.42; 95% CI, 0.20 to 0.85; P = .017).</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>No TS point mutation was detected in primary tumors or metastases.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>TS protein immunostaining was not associated with survival or any of the genotypes analyzed.</Variant>", "label": []}
{"id": "16575011", "text": "<Variant>CONCLUSION: Tumor TS 1494del6 genotype may be a prognostic factor in FU-based adjuvant treatment of colorectal cancer patients.</Variant>", "label": [[30, 38, "Variant"]]}
{"id": "16506214", "text": "<Variant>Genetic variation in the COX-2 gene and the association with prostate cancer risk.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>COX-2 is a key enzyme in the conversion of arachidonic acid to prostaglandins.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>The prostaglandins produced by COX-2 are involved in inflammation and pain response in different tissues in the body.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>Accumulating evidence from epidemiologic studies, chemical carcinogen-induced rodent models and clinical trials indicate that COX-2 plays a role in human carcinogenesis and is overexpressed in prostate cancer tissue.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>We examined whether sequence variants in the COX-2 gene are associated with prostate cancer risk.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>We analyzed a large population-based case-control study, cancer prostate in Sweden (CAPS) consisting of 1,378 cases and 782 controls.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>We evaluated 16 single nucleotide polymorphisms (SNPs) spanning the entire COX-2 gene in 94 subjects of the control group.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>Five SNPs had a minor allele frequency of more than 5% in our study population and these were genotyped in all case patients and control subjects and gene-specific haplotypes were constructed.</Variant>", "label": []}
{"id": "16506214", "text": "<Variant>A statistically significant difference in allele frequency between cases and controls was observed for 2 of the SNPs (+3100 T/G and +8365 C/T), with an odds ratio of 0.78 (95% CI=0.64-0.96) and 0.65 (95% CI=0.45-0.94) respectively.</Variant>", "label": [[127, 136, "Variant"], [141, 150, "Variant"]]}
{"id": "16506214", "text": "<Variant>In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046).</Variant>", "label": [[86, 95, "Variant"], [100, 109, "Variant"]]}
{"id": "16506214", "text": "<Variant>This study supports the hypothesis that inflammation is involved in prostate carcinogenesis and that sequence variation within the COX-2 gene influence the risk of prostate cancer.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>Genetic alterations in primary glioblastomas in Japan.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>Current knowledge of genetic alterations in glioblastomas is based largely on genetic analyses of tumors from mainly caucasian patients in the United States and Europe.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>In the present study, screening for several key genetic alterations was performed on 77 primary (de novo) glioblastomas in Japanese patients.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>SSCP followed by DNA sequencing revealed TP53 mutations in 16 of 73 (22%) glioblastomas and PTEN mutations in 13 of 63 (21%) cases analyzed.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>Polymerase chain reaction (PCR) showed EGFR amplification in 25 of 77 (32%) cases and p16 homozygous deletion in 32 of 77 (42%) cases.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>Quantitative microsatellite analysis revealed LOH 10q in 41 of 59 (69%) glioblastomas.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>The frequencies of these genetic alterations were similar to those reported for primary glioblastomas at the population level in Switzerland.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>As previously observed for glioblastomas in Europe, there was a positive association between EGFR amplification and p16 deletion (p=0.009), whereas there was an inverse association between TP53 mutations and p16 deletion (p=0.049) in glioblastomas in Japan.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>Multivariate analyses showed that radiotherapy was significantly predictive for longer survival of glioblastoma patients (p=0.002).</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>SSCP followed by DNA sequencing of the kinase domain (exons 18-21) of the EGFR gene revealed mutations in 2 ou of 69 (3%) glioblastomas in Japan and in 4 of 81 (5%) glioblastomas in Switzerland.</Variant>", "label": []}
{"id": "16410744", "text": "<Variant>The allele frequencies of polymorphisms at codon 787 CAG/CAA (Gln/Gln) in glioblastomas in Japan were G/G (82.4%), G/A (10.8%), A/A (6.8%), corresponding to G 0.878 versus A 0.122, significantly different from those in glioblastomas in Switzerland: G/G (27.2%), G/A (28.4%), A/A (44.4%), corresponding to G 0.414 versus A 0.586 (p < 0.0001).</Variant>", "label": [[52, 69, "Variant"], [71, 78, "Variant"]]}
{"id": "16410744", "text": "<Variant>These results suggest that primary glioblastomas in Japan show genetic alterations similar to those in Switzerland, suggesting a similar molecular basis in caucasians and Asians, despite different genetic backgrounds, including different status of a polymorphism in the EGFR gene.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>In this paper, we present whole-organ histologic and genetic mapping studies using hypervariable DNA markers on chromosome 13 and then integrate the recombination- and single-nucleotide polymorphic sites (SNPs)-based deletion maps with the annotated genome sequence.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Using bladders resected from patients with invasive urothelial carcinoma, we studied allelic patterns of 40 microsatellite markers mapping to all regions of chromosome 13 and 79 SNPs located within the 13q14 region containing the RB1 gene.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>A whole-organ histologic and genetic mapping strategy was used to identify the evolution of allelic losses on chromosome 13 during the progression of bladder neoplasia.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Markers mapping to chromosomal regions involved in clonal expansion of preneoplastic intraurothelial lesions were subsequently tested in 25 tumors and 21 voided urine samples of patients with bladder cancer.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Four clusters of allelic losses mapping to distinct regions of chromosome 13 were identified.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Markers mapping to the 13q14 region that is flanked by D13S263 and D13S276, which contains the RB1 gene, showed allelic losses associated with early clonal expansion of intraurothelial neoplasia.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Such losses could be identified in approximately 32% bladder tumor tissue samples and 38% of voided urines from patients with bladder cancer.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>The integration of distribution patterns of clonal allelic losses revealed by the microsatellite markers with those obtained by genotyping of SNPs disclosed that the loss within an approximately 4-Mb segment centered around RB1 may represent an incipient event in bladder neoplasia.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>However, the inactivation of RB1 occurred later and was associated with the onset of severe dysplasia/carcinoma in situ.</Variant>", "label": []}
{"id": "16402033", "text": "<Variant>Our studies provide evidence for the presence of critical alternative candidate genes mapping to the 13q14 region that are involved in clonal expansion of neoplasia within the bladder antecedent to the inactivation of the RB1 gene.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>Allele-specific amplification in cancer revealed by SNP array analysis.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>Amplification, deletion, and loss of heterozygosity of genomic DNA are hallmarks of cancer.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>In recent years a variety of studies have emerged measuring total chromosomal copy number at increasingly high resolution.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>Similarly, loss-of-heterozygosity events have been finely mapped using high-throughput genotyping technologies.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>We have developed a probe-level allele-specific quantitation procedure that extracts both copy number and allelotype information from single nucleotide polymorphism (SNP) array data to arrive at allele-specific copy number across the genome.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>Our approach applies an expectation-maximization algorithm to a model derived from a novel classification of SNP array probes.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>This method is the first to our knowledge that is able to (a) determine the generalized genotype of aberrant samples at each SNP site (e.g., CCCCT at an amplified site), and (b) infer the copy number of each parental chromosome across the genome.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>With this method, we are able to determine not just where amplifications and deletions occur, but also the haplotype of the region being amplified or deleted.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>The merit of our model and general approach is demonstrated by very precise genotyping of normal samples, and our allele-specific copy number inferences are validated using PCR experiments.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>Applying our method to a collection of lung cancer samples, we are able to conclude that amplification is essentially monoallelic, as would be expected under the mechanisms currently believed responsible for gene amplification.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>This suggests that a specific parental chromosome may be targeted for amplification, whether because of germ line or somatic variation.</Variant>", "label": []}
{"id": "16322765", "text": "<Variant>An R software package containing the methods described in this paper is freely available at http://genome.dfci.harvard.edu/~tlaframb/PLASQ.</Variant>", "label": []}
{"id": "16311014", "text": "<Variant>Tag/anti-tag liquid-phase primer extension array: a flexible and versatile genotyping platform.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>Nitric oxide has many beneficial functions in the human body at the right amounts, but it can also be hazardous if it is produced in amounts more than needed and has therefore been studied in relation to several neurological and non-neurological disorders.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>In vitro and in vivo studies demonstrate a connection between the inducible form of Nitric Oxide Synthase, iNOS, and the neuropathological disorder glaucoma, one of the major causes of blindness in the world.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>In this study, we sought to establish the genetic association between iNOS and primary open angle glaucoma, POAG, and to find the functional element(s) connected with the pathogenesis of the disease.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>METHODS: Two microsatellites, 1 insertion/deletion, and 8 single nucleotide polymorphisms (SNPs) in the regulatory region of iNOS were genotyped in 200 POAG patients and 200 age-matched controls.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>Also, the CCTTT-microsatellite was examined for its protein-binding capability in an electrophoretic mobility shift assay, EMSA.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>There was a significant difference in allele distribution of the CCTTT-microsatellite, between patients and controls.</Variant>", "label": []}
{"id": "16288199", "text": "<Variant>(CCTTT)14, which has been reported to have a higher activity in a reporter-construct, was significantly more abundant in POAG patients, while (CCTTT)10 and (CCTTT)13 were less common.</Variant>", "label": [[9, 18, "Variant"], [151, 160, "Variant"], [165, 174, "Variant"]]}
{"id": "16288199", "text": "<Variant>In EMSA, the (CCTTT)14 allele exhibited specific binding of nuclear proteins.</Variant>", "label": [[22, 31, "Variant"]]}
{"id": "16288199", "text": "<Variant>CONCLUSIONS: These results, together with other studies on this gene and the CCTTT-microsatellite, establish, for the first time, a genetic association of iNOS with POAG and suggest a regulatory function for the microsatellite.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>HPRTSardinia: a new point mutation causing HPRT deficiency without Lesch-Nyhan disease.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency always causing hyperuricemia presents various degrees of neurological manifestations, the most severe which is Lesch-Nyhan syndrome.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>The HPRT gene is situated in the region Xq26-q27.2 and consists of 9 exons.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>At least 300 different mutations at different sites in the HPRT coding region from exon 1 to exon 9 have been identified.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>A new mutation in the HPRT gene has been determined in one patient with complete deficiency of erythrocyte activity, with hyperuricemia and gout but without Lesch-Nyhan disease.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>Analysis of cultured fibroblasts revealed minimal residual HPRT activity mainly when guanine was the substrate.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>Genomic DNA sequencing demonstrated patient's mother heterozygosity for the mutation and no mutation in her brother.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>The mutation consists in a C-->T transversion at cDNA base 463 (C463T) in exon 6, resulting in proline to serine substitution at codon 155 (P155S).</Variant>", "label": [[36, 71, "Variant"], [73, 78, "Variant"], [104, 147, "Variant"], [149, 154, "Variant"]]}
{"id": "16216473", "text": "<Variant>This mutation had not been reported previously and has been designated HPRT(Sardinia).</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>The mutation identified in this patient allows some expression of functional enzyme in nucleated cells such as fibroblasts, indicating that such cell type may add further information to conventional blood analysis.</Variant>", "label": []}
{"id": "16216473", "text": "<Variant>A multicentre survey gathering patients with variant neurological forms could contribute to understand the pathophysiology of the neurobehavioral symptoms of HPRT deficiency.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chromosome 5 q 33.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>The T-cell immunoglobulin domain and mucin domain (TIM) gene family and the gene for IL-2-inducible T-cell kinase (ITK), located in chromosome 5 q 33 and potentially involved in the T-cell proliferation and differentiation, are good candidate genes for allergic diseases.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>We assessed the role of polymorphisms in the TIM family genes and ITK in atopy, eczema, and asthma.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>METHODS: Twenty-one polymorphisms in the TIM-ITK gene cluster were genotyped in 564 children enrolled in the Tucson Children's Respiratory Study.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>Skin prick tests to common allergens were performed at age 6.1 years (n=508), age 10.8 years (n=539), and age 16.6 years (n=424).</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>Asthma and eczema were assessed by questionnaire at these 3 points.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>Averaged relative risks were estimated.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>RESULTS: One 15-bp insertion/deletion in exon 4 of TIM 1 was significantly related to atopy and eczema (relative risk associated with carrying at least 1 rare allele=1.24</Variant>", "label": [[22, 46, "Variant"]]}
{"id": "16159638", "text": "<Variant>[1.07--1.45], P=.005; and 1.43 [1.01--2.01], P=.004, respectively).</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>The 3 tested single nucleotide polymorphisms (SNPs) in TIM 3 were significantly related to atopy and eczema.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>One of them, at position +4259 calculated from the translation start site, predicts a putative change in the amino acid sequence of the protein, and was the most strongly related to atopy (relative risk=1.28</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>[1.12--1.47]; P=.0003).</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>SNPs in the 5' genomic region in ITK, which show moderate linkage disequilibrium with those in TIM 3, had an independent effect on atopy.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>None of the polymorphisms studied was related to asthma.</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16159638", "text": "<Variant>Our findings support a potential role for SNPs in TIM 1, TIM 3, and ITK, independent of each other, in allergic diseases.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>In this study, we characterized five Ullrich scleroatonic muscular dystrophy patients (two Italians, one Belgian, and two Turks) with a clinical phenotype showing different degrees of severity, all carrying mutations localized in COL6A1.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>We sequenced the three entire COL6 complementary DNA.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>Three of five patients have recessive mutations: two patients (P1and P3) have homozygous single-nucleotide deletions, one in exon 9 and one in exon 22; one patient (P2) has a homozygous single-nucleotide substitution leading to a premature termination codon in exon 31.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>The nonsense mutation of P2 also causes a partial skipping of exon 31 with the formation of a premature termination codon in exon 32 in 15% of the total COL6A1 messenger RNA.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>The remaining two patients carry a heterozygous glycine substitution in exons 9 and 10 inside the triple-helix region; both are dominant mutations because the missense mutations are absent in the DNA of their respective parents.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>As for the three homozygous recessive mutations, the apparently healthy consanguineous parents all carry a heterozygous mutated allele.</Variant>", "label": []}
{"id": "16130093", "text": "<Variant>Here, for the first time, we report a genotype-phenotype correlation demonstrating that heterozygous glycine substitutions in the triple-helix domain of COL6A1 are dominant and responsible for a milder Ullrich scleroatonic muscular dystrophy phenotype, and that recessive mutations in COL6A1 correlate with more severe clinical and biochemical Ullrich scleroatonic muscular dystrophy phenotypes.</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>A single-nucleotide polymorphism in the 5'-untranslated region of the hPER2 gene is associated with diurnal preference.</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>The PERIOD2 (PER2) gene is a key component of the molecular mechanism that generates circadian rhythms in mammals.</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>A missense mutation in the human PER2 gene has previously been linked to advanced sleep phase syndrome (ASPS).</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>We have investigated three other single-nucleotide polymorphisms in the hPER2 gene, one downstream of the transcription start site (C-1228T), one in exon 2 in the 5'-untranslated region (5'-UTR) (C111G), and one missense mutation (G3853A) causing a glycine to glutamine substitution in the predicted protein.</Variant>", "label": [[141, 148, "Variant"], [205, 210, "Variant"], [240, 246, "Variant"], [258, 278, "Variant"]]}
{"id": "16120104", "text": "<Variant>Subjects selected from a group of 484 volunteers for extreme morning or evening preference, or intermediate diurnal preference were genotyped with regard to the three polymorphisms (n=35 for each group).</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>Whereas allele frequencies for the other two polymorphisms did not differ significantly between any of the groups, the 111G allele frequency was significantly higher in subjects with extreme morning preference (0.14) than in subjects with extreme evening preference (0.03)</Variant>", "label": [[128, 132, "Variant"]]}
{"id": "16120104", "text": "<Variant>(Fisher's exact test, two-sided P value=0.031, odds ratio=5.67).</Variant>", "label": []}
{"id": "16120104", "text": "<Variant>No significant difference in 111G allele frequency was observed between either of these groups and subjects with intermediate diurnal preference.</Variant>", "label": [[38, 42, "Variant"]]}
{"id": "16120104", "text": "<Variant>Computer prediction indicated that the C111G polymorphism, which occurs 12 bases upstream from the translation start codon, might alter the secondary structure of the transcript.</Variant>", "label": [[48, 53, "Variant"]]}
{"id": "16120104", "text": "<Variant>The PER2 111G allele associates with morning preference and is a potential candidate allele for ASPS.</Variant>", "label": [[18, 22, "Variant"]]}
{"id": "16005363", "text": "<Variant>Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome.</Variant>", "label": [[50, 63, "Variant"]]}
{"id": "16005363", "text": "<Variant>Wolfram syndrome (WFS) is an autosomal recessive disorder characterized by early onset diabetes mellitus, progressive optic atrophy, sensorineural deafness and diabetes insipidus.</Variant>", "label": []}
{"id": "16005363", "text": "<Variant>Affected individuals may also have renal tract abnormalities as well as neurogical and psychiatric syndromes.</Variant>", "label": []}
{"id": "16005363", "text": "<Variant>WFS1 encoding a transmembrane protein was identified as the gene responsible for WFS.</Variant>", "label": []}
{"id": "16005363", "text": "<Variant>We report herein a Japanese family, of which two members had this syndrome.</Variant>", "label": []}
{"id": "16005363", "text": "<Variant>In the WFS1 gene of these patients, we identified a novel mutation, a nine nucleotide insertion (AFF344-345ins).</Variant>", "label": [[79, 104, "Variant"], [106, 119, "Variant"]]}
{"id": "16005363", "text": "<Variant>In addition, one of these patients had preclinical hypopituitarism, which is an unusual feature of WFS.</Variant>", "label": []}
{"id": "16005363", "text": "<Variant>As only the two family members homozygous for the mutation showed WFS, these data support the notion that this mutation is the cause of WFS.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>Loss of heterozygosity (LOH) analysis was performed in epithelial ovarian cancers (EOC) to further characterize a previously identified candidate tumor suppressor gene (TSG) region encompassing D17S801 at chromosomal region 17q25.1.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>LOH of at least one informative marker was observed for 100 (71%) of 140 malignant EOC samples in an analysis of 6 polymorphic markers (cen-D17S1839-D17S785-D17S1817-D17S801-D17S751-D17S722-tel).</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>The combined LOH analysis revealed a 453 kilobase (Kb) minimal region of deletion (MRD) bounded by D17S1817 and D17S751.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>Human and mouse genome assemblies were used to resolve marker inconsistencies in the D17S1839-D17S722 interval and identify candidates.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>The region contains 32 known and strongly predicted genes, 9 of which overlap the MRD.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>The reference genomic sequences share nearly identical gene structures and the organization of the region is highly collinear.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>Although, the region does not show any large internal duplications, a 1.5 Kb inverted duplicated sequence of 87% nucleotide identity was observed in a 13 Kb region surrounding D17S801.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>Transcriptome analysis by Affymetrix GeneChip and reverse transcription (RT)-polymerase chain reaction (PCR) methods of 3 well characterized EOC cell lines and primary cultures of normal ovarian surface epithelial (NOSE) cells was performed with 32 candidates spanning D17S1839-D17S722 interval.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>RT-PCR analysis of 8 known or strongly predicted genes residing in the MRD in 10 EOC samples, that exhibited LOH of the MRD, identified FLJ22341 as a strong candidate TSG.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>The proximal repeat sequence of D17S801 occurs 8 Kb upstream of the putative promoter region of FLJ22341.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>RT-PCR analysis of the EOC samples and cell lines identified DKFZP434P0316 that maps proximal to the MRD, as a candidate.</Variant>", "label": []}
{"id": "15937959", "text": "<Variant>While Affymetrix technology was useful for initially eliminating less promising candidates, subsequent RT-PCR analysis of well-characterized EOC samples was essential to prioritize TSG candidates for further study.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>Autosomal dominant inheritance of Williams-Beuren syndrome in a father and son with haploinsufficiency for FKBP6.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>Williams-Beuren syndrome (WBS) is a neurodevelopmental microdeletion disorder that usually occurs sporadically due to its location within a highly repetitive genomic region that is unstable and prone to unequal cross-over during meiosis.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>The consequential loss of chromosomal material includes approximately 1.5 Mb of DNA at 7q11.23.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>Whilst cases of dominant inheritance have been described in the literature, there have been few reports of molecular confirmation and none have carried out detailed genotyping.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>We describe a Bulgarian father and son with WBS detected by fluorescent in situ hybridisation (with an elastin gene probe) and loss of heterozygosity mapping using microsatellite markers located in the critical region.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>These individuals appear to have a common WBS heterozygous deletion, confirming the expected dominant transmission and adding to the few familial cases reported.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>The deletion includes the gene FKBP6 which has recently been shown to play a role in homologous chromosome pairing in meiosis and male fertility in mouse models.</Variant>", "label": []}
{"id": "15770126", "text": "<Variant>Homozygous Fkbp6 -/- male mice are infertile and our data suggests that haploinsufficiency for FKBP6 does not appear to preclude male fertility in WBS, although male infertility involving this gene has the potential to follow the mouse model as a human autosomal recessive condition.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>Hb zoeterwoude [beta23(B5)Val-->Ala)]: a new beta-globin variant found in association with erythrocytosis.</Variant>", "label": [[35, 44, "Variant"]]}
{"id": "15768551", "text": "<Variant>We describe the characterization of a new hemoglobin (Hb) variant found in a 77-year-old Dutch woman, suspected of hypoxia-mediated erythrocytosis.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>The typical blood parameters (Hb 17.3 g/dL; PCV 0.525 L/L; RBC 5.82 x 10(12)/L) could not be explained by any of the pathological or physiological conditions causing erythrocytosis.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>The patient was preventively phlebotomized because of intermittent claudication and erythrocytosis.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>At the hematological and biochemical levels, no anemia or hemolysis were present and no abnormal Hb fractions were detectable on alkaline electrophoresis or high performance liquid chromatography (HPLC).</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>Molecular analysis revealed intact alpha-globin genes and a heterozygosity for a GTT-->GCT transition at codon 23 of the beta-globin gene, causing a Val-->Ala amino acid substitution.</Variant>", "label": [[90, 122, "Variant"], [158, 167, "Variant"]]}
{"id": "15768551", "text": "<Variant>The P50 measured in full blood indicated that this mutant has an elevated oxygen affinity.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>This is the fourth single nucleotide substitution at codon 23 of the beta gene and the second associated with erythrocytosis.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>Because the family was not available for investigation no information was obtained as to whether the mutation represents a de novo event or was inherited, and might be a more common cause of erythrocytosis in Dutch patients.</Variant>", "label": []}
{"id": "15768551", "text": "<Variant>Considering the relatively high frequency of beta-thalassemia (thal) in the large allochthonous population in The Netherlands, combinations of Hb Zoeterwoude and beta-thal traits may lead to hemizygosity, with severe hypoxia and erythrocytosis from a few months after birth.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>[Angiotensin converting enzyme gene polymorphisms and coronary risk in a Portuguese population].</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>BACKGROUND: A family history of coronary heart disease (CHD) is a strong risk marker for the disease, independently of classical risk factors.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>It could be decoded by recognizing the polymorphisms associated with increased risk.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>Renin-angiotensin system genes are candidate genes in CHD and the deletion allele of the angiotensin converting enzyme (ACE) has been reported as deleterious.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>However, there is disagreement as to the role of the insertion/deletion polymorphism of the ACE gene in coronary risk.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>AIM: To evaluate whether ACE gene polymorphisms constitute a CHD risk factor.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>We conducted a population-based case-control study of 301 subjects with a history of myocardial infarction or angiographic evidence of coronary heart disease and 510 age- and gender-matched controls, without CHD, living in a region with high CHD mortality rates.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>Blood samples were taken, DNA extracted and genotypes determined by the polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>Amplification products were identified by agarose gel electrophoresis.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>STATISTICAL ANALYSIS: The Data were evaluated by SPSS for Windows, using the Student's t test, the chi-square test, odds ratios and 95% confidence intervals.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>The prevalence of the DD, ID and II genotype was 41.2%, 46.3%, 12.5% in the cases and 28.1%, 55.2% and 16.7% in the control group.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>The frequency of the DD genotype was significantly higher in the cases than in the controls (41.2% vs. 28.1%, odds ratio 1.79, 95% CI 1.31 to 2.4, p < 0.0001).</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>By contrast, the ID and II genotypes' prevalence was higher in the control group (55.2% vs. 46.3%, p = 0.002 and 16.7 vs. 12.5%, p = NS, respectively) compared to the case group.</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15732660", "text": "<Variant>This study clearly shows that the ACE DD polymorphism is strongly linked to CHD, and if our data are confirmed in a larger population sample, more aggressive vascular prevention could be justified in patients carrying the DD genotype.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>Primary malignant lymphoma of the brain: frequent abnormalities and inactivation of p14 tumor suppressor gene.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>Ten primary central nervous system lymphomas (PCNSL, brain lymphomas) were examined for p14 gene exon 1beta deletion, mutation and methylation by Southern blot analysis, nucleotide analysis of polymerase chain reaction clones and Southern blot-based methylation assay.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>In Southern blot analysis, from the signal densities of the hybridized bands and their similarities to those of exons 2 and 3 in our previous quantitative study, we found that exon 1beta was homozygously deleted in four cases, hemizygously deleted in five cases and not deleted in one case.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>Thus, the same deletion patterns covered the entire p14 gene for all cases except for one case, which suggested the hemizygous deletion of exons 1beta and 2 and homozygous deletion of exon 3.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>In addition, although exon 1beta mutation is rare in various tumors, we detected a missense mutation (L50R) in one case with a hemizygous deletion.</Variant>", "label": [[111, 115, "Variant"]]}
{"id": "15649253", "text": "<Variant>Methylation of the 5'CpG island of the p14 gene was not suggested for any case without homozygous deletion.</Variant>", "label": []}
{"id": "15649253", "text": "<Variant>Our observation of frequent p14 gene abnormalities (90%) and inactivation (40-60%) was in striking contrast to the same pathological subtype of systemic lymphoma in which p14 gene abnormalities and inactivation were infrequent, suggesting a difference in carcinogenesis between PCNSL and systemic lymphoma.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>Leydig cell hypoplasia due to inactivation of luteinizing hormone receptor by a novel homozygous nonsense truncation mutation in the seventh transmembrane domain.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>Inactivating mutations in the LH receptor are the predominant cause for male pseudohermaphroditism in subjects with Leydig cell hypoplasia (LCH).</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>The severity of the mutations, correlates with residual receptor activities.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>Here, we detail the clinical presentation of one subject with complete male pseudohermaphroditism and LCH.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>We identify within the proband and her similarly afflicted sibling a homozygous T to G transversion at nucleotide 1836 in exon 11 of the LH/CGR gene.</Variant>", "label": [[89, 127, "Variant"]]}
{"id": "15607529", "text": "<Variant>This causes conversion of a tyrosine codon into a stop codon at codon 612 in the seventh transmembrane domain, resulting in a truncated receptor that lacks a cytoplasmic tail.</Variant>", "label": [[37, 82, "Variant"]]}
{"id": "15607529", "text": "<Variant>In vitro, in contrast to cells expressing a normal LHR, cells transfected with the mutant cDNA exhibit neither surface binding of radiolabeled hCG nor cAMP generation.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>In vitro expression under the control of the LHR signal peptide of either a wild type or mutant LHR-GFP fusion protein shows no differences in receptor cellular localization.</Variant>", "label": []}
{"id": "15607529", "text": "<Variant>In conclusion, the in vitro studies suggest that residues in the seventh transmembrane domain and cytoplasmic tail are important for receptor binding and activation without playing a major role in receptor cellular trafficking.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Recent data has suggested that polymorphisms in the prostate specific antigen (PSA) may increase prostate cancer (PC) risk.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>The PSA gene contains a G/A substitution in the androgen response element (ARE) 1 region.</Variant>", "label": [[33, 36, "Variant"]]}
{"id": "15599941", "text": "<Variant>The androgen receptor (AR) gene has polymorphic regions containing variable length glutamine and glycine repeats and these are believed to be associated with PC risk.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>The effect on PC risks from PSA polymorphisms alone and synergistically with the AR gene was examined in this report.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>METHODS: One hundred PC patients and an age matched cohort of 79 benign prostate hyperplasia and 67 population controls were entered in this study.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>DNA was extracted from blood and PSA/ARE promoter region amplified by PCR.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>PCR products were cut with Nhe 1 restriction enzyme to distinguish G/A alleles.</Variant>", "label": [[76, 79, "Variant"]]}
{"id": "15599941", "text": "<Variant>AR/CAG and GGC repeat length was detected by automated fluorescence from PCR products.</Variant>", "label": [[12, 30, "Variant"]]}
{"id": "15599941", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>We found a significantly higher PSA/GG distribution in PC (30%) than either benign prostatic hyperplasia (BPH) (18%) or population controls (16%) (P = 0.025).</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Furthermore the GG distribution within cases was even greater in younger men (< 65 years; 42%; P = 0.012).</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Additionally, when PSA genotype was cross classified with CAG repeat, significantly more cases than both BPH and population controls were observed to have a short (< 22) CAG/GG genotype (P = 0.006).</Variant>", "label": [[67, 77, "Variant"]]}
{"id": "15599941", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Our results indicate that the PSA/ARE GG genotype confers an increased risk of PC especially among younger men.</Variant>", "label": []}
{"id": "15599941", "text": "<Variant>Moreover, we confirm previous results that a short glutamine repeat in conjunction with GG genotype significantly increases the risk of malignant disease.</Variant>", "label": [[60, 76, "Variant"]]}
{"id": "15557460", "text": "<Variant>Genetic linkage of snowflake vitreoretinal degeneration to chromosome 2q36.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>To identify the chromosomal location of the gene causing snowflake vitreoretinal degeneration (SVD), an autosomal dominant retinal degeneration characterized by small yellow-white dots in the retina, fibrillar anomaly of the vitreous humor, and retinal detachment.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Clinical data were collected on 31 family members by history and examination.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Thirteen family members underwent prospective examination.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Genotyping was performed using microsatellite markers spaced at approximately 10 cM intervals.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Two-point and multipoint linkage analysis was performed (FASTLINK version of the MLINK program and the VITESSE algorithm, both available at http://linkage.rockefeller.edu/soft/list.html).</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Direct DNA sequencing of amplified genomic DNA and mRNA was performed for candidate gene analysis.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>The SVD locus was linked to markers in a region of chromosome 2q36 defined by D2S2158 and D2S2202, based on meiotic breakpoint mapping of affected individuals.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>A maximum two-point lod score of 5.5 was obtained with marker D2S172 at theta; = 0 within this region.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Direct DNA sequencing of all 52 exons of the COL4A3 gene revealed no potentially pathogenic coding sequence variation or evidence for deletion.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>The genetic locus for SVD lies in a 9 Mb region flanked by D2S2158 and D2S2202.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Localization of SVD to a genomic region distinct from both Wagner disease and the Stickler syndromes indicates that SVD is a distinct genetic entity.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>The absence of coding sequence variation in the only collagen gene within the disease-region, suggests a novel pathogenesis for vitreoretinal degeneration.</Variant>", "label": []}
{"id": "15557460", "text": "<Variant>Snowflake vitreoretinal degeneration should be considered in the differential diagnosis of families with fibrillar anomaly of the vitreous.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>Matrix metalloproteinases (MMPs) are proteolytic enzymes that regulate various cell behaviors in cancer biology, via their basic function of degradation of proteins.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>Genetic variations in several MMP promoters may influence transcription and expression of MMPs.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>The aim of this study is to assess the effects of the two single nucleotide polymorphisms (SNPs), the guanine insertion polymorphism in the MMP1 promoter and the adenosine insertion polymorphism in the MMP3 promoter, on risk of the development and lymphatic metastasis of non-small cell lung carcinoma (NSCLC).</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>The MMP1 and MMP3 SNPs were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 243 NSCLC patients and 350 control subjects in North China.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>The overall genotype and allelotype distribution of both the variants in cancer patients and controls was not significantly different (all P values are above 0.05).</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>However, stratification analysis showed that smoking individuals with the MMP3 5A allele had a >1.5-fold increased risk to develop NSCLC, compared with those harboring the 6A homozygous</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>[the age and gender adjusted odds ratio (OR) = 1.68, 95% confidence interval (CI) = 1.04-2.70].</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>In addition, the frequency of the MMP3 5A homozygote in NSCLC patients with lymphatic metastasis was significantly higher than that in lymph node negative ones (5.7 versus 0%, P = 0.04).</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>Moreover, the MMP 1G/5A haplotype significantly increased the risk of lymphatic metastasis (OR = 3.36, 95% CI = 1.42-7.94), compared with the 2G/6A haplotype.</Variant>", "label": []}
{"id": "15528217", "text": "<Variant>The present result suggested that the MMP3 promoter polymorphism may modify susceptibility to NSCLC, and the MMP 1G/5A haplotype may predicate the risk of lymphatic metastasis of this tumor.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Neuroblastoma, the most common extracranial tumor in childhood, has a wide spectrum of clinical and biological features.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>The loss of heterozygosity within the 9p21 region has been reported as a prognostic factor.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Two tumor suppressor genes located in this region, the CDKN2B/p15 and CDKN2A/p16 (cyclin-dependent kinase inhibitors 2B and 2A, respectively) genes, play a critical role in cell cycle progression and are considered to be targets for tumor inactivation.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>We analyzed CDKN2B/p15 and CDKN2A/p16 gene alterations in 11 patients, who ranged in age from 4 months to 13 years (male/female ratio was 1.2:1).</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>The most frequent stage of the tumor was stage IV (50%), followed by stages II and III (20%) and stage I (10%).</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>The samples were submitted to the multiplex PCR technique for homozygous deletion analysis and to single-strand conformation polymorphism and nucleotide sequencing for mutation analysis.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>All exons of both genes were analyzed, but no deletion was detected.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>One sample exhibited shift mobility specific for exon 2 in the CDKN2B/p15 gene, not confirmed by DNA sequencing.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Homozygous deletions and mutations are not involved in the inactivation mechanism of the CDKN2B/p15 and CDKN2A/p16 genes in neuroblastoma; however, these two abnormalities do not exclude other inactivation pathways.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Recent evidence has shown that the expression of these genes is altered in this disease.</Variant>", "label": []}
{"id": "15517085", "text": "<Variant>Therefore, other mechanisms of inactivation, such as methylation of promoter region and unproperly function of proteins, may be considered in order to estimate the real contribution of these genes to neuroblastoma genesis or disease progression.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>Fabry's disease is an X-linked inborn error of glycosphingolipid catabolism, resulting from a deficiency in alpha-galactosidase A (alpha-Gal A).</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>A 56-year-old Japanese woman was at first suspected of having hypertrophic cardiomyopathy.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>The patient and her son had alpha-Gal A activity in leukocytes that was remarkably below the limit of controls.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>DNA analysis of the alpha-Gal A gene revealed a novel missense mutation at codon 19 in exon 1, resulting in leucine-to-proline substitution.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>As a result she was confirmed as a classic Fabry heterozygote.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>Recent advances in enzyme replacement therapy can reverse the storage of glycosphingolipids in Fabry's disease.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>Thus, in patients with cardiac hypertrophy, it is important to differentiate Fabry's disease from other causes of hypertrophy.</Variant>", "label": []}
{"id": "15353880", "text": "<Variant>Therefore, it is necessary to measure alpha-Gal A activity in all suspected cases and to analyze genetic abnormalities in heterozygotes.</Variant>", "label": []}
{"id": "15205584", "text": "<Variant>Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency.</Variant>", "label": [[78, 83, "Variant"]]}
{"id": "15205584", "text": "<Variant>We analyzed the factor XII (FXII) gene of a patient with congenital FXII deficiency and identified a novel amino acid substitution (W486C) in the catalytic domain.</Variant>", "label": [[141, 146, "Variant"]]}
{"id": "15205584", "text": "<Variant>The proband was an asymptomatic 49-year-old Japanese female with abnormal coagulation test, discovered by chance.</Variant>", "label": []}
{"id": "15205584", "text": "<Variant>The FXII activity and antigen level were both under 10%, suggesting a cross-reacting material-negative FXII deficiency.</Variant>", "label": []}
{"id": "15205584", "text": "<Variant>Sequence analysis of the proband's FXII gene revealed a homozygous nucleotide substitution G --> C in exon 12, resulting in the amino acid substitution W486C in the catalytic domain.</Variant>", "label": [[100, 107, "Variant"], [161, 166, "Variant"]]}
{"id": "15205584", "text": "<Variant>We constructed the mutant FXII cDNA in an expression plasmid vector and transfected it into Chinese hamster ovary cells.</Variant>", "label": []}
{"id": "15205584", "text": "<Variant>The recombinant wild-type FXII antigen was detected in the culture medium by immunoprecipitation assay, but the mutant FXII (W486C) was not observed.</Variant>", "label": [[134, 139, "Variant"]]}
{"id": "15205584", "text": "<Variant>On the other hand, both the wild-type FXII and W486C cell lysates contained FXII antigen and FXII mRNA, as estimated by western blotting and quantitative reverse transcriptase-polymerase chain reaction.</Variant>", "label": [[56, 61, "Variant"]]}
{"id": "15205584", "text": "<Variant>These findings suggest that the W486C substitution of FXII impairs intracellular processing of the protein and/or transport system.</Variant>", "label": [[41, 46, "Variant"]]}
{"id": "15177686", "text": "<Variant>Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>DiGeorge and Velocardiofacial syndromes (DGS/VCFS) are endowed by a similar complex phenotype including cardiovascular, craniofacial, and thymic malformations, and are associated with heterozygous deletions of 22q11 chromosomal band.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>The Typically Deleted Region in the 22q11.21 subband (here called TDR22) is very gene-dense, and the extent of the deletion has been defined precisely in several studies.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>However, to date there is no evidence for a mechanism of haploinsufficiency that can fully explain the DGS/VCFS phenotype.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>In this study, we show that the candidate gene HIRA/Tuple1 mapping on the non-deleted TDR22, in DGS/VCFS subjects presents a delayed replication timing.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>Moreover, we observed an increase in the cell ratio showing the HIRA/Tuple1 locus localised toward the nuclear periphery.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>It is known that replication timing and nuclear location are generally correlated to the transcription activity of the relative DNA region.</Variant>", "label": []}
{"id": "15177686", "text": "<Variant>We propose that the alteration in the replication/nuclear location pattern of the non-deleted TDR22 indicates an altered gene regulation hence an altered transcritpion in DGS/VCFS.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>Desmin-related myopathies (DRMs) are a heterogeneous group of muscle disorders, morphologically defined by intrasarcoplasmic aggregates of desmin.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>Mutations in the desmin and the alpha-B crystallin genes account for approximately one third of the DRM cases.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>The genetic basis of the other forms remain unknown, including the early-onset, recessive form with Mallory body-like inclusions (MB-DRMs), first described in five related German patients.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>Recently, we identified the selenoprotein N gene (SEPN1) as responsible for SEPN-related myopathy (SEPN-RM), a unique early-onset myopathy formerly divided in two different nosological categories: rigid spine muscular dystrophy and the severe form of classical multiminicore disease.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>The finding of Mallory body-like inclusions in two cases of genetically documented SEPN-RM led us to suspect a relationship between MB-DRM and SEPN1.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>In the original MB-DRM German family, we demonstrated a linkage of the disease to the SEPN1 locus (1p36), and subsequently a homozygous SEPN1 deletion (del 92 nucleotide -19/+73) in the affected patients.</Variant>", "label": [[161, 186, "Variant"]]}
{"id": "15122708", "text": "<Variant>A comparative reevaluation showed that MB-DRM and SEPN-RM share identical clinical features.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>Therefore, we propose that MB-DRM should be categorized as SEPN-RM.</Variant>", "label": []}
{"id": "15122708", "text": "<Variant>These findings substantiate the molecular heterogeneity of DRM, expand the morphological spectrum of SEPN-RM, and implicate a necessary reassessment of the nosological boundaries in early-onset myopathies.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>CRYBA3/A1 gene mutation associated with suture-sparing autosomal dominant congenital nuclear cataract: a novel phenotype.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>To identify the genetic defect leading to the congenital nuclear cataract affecting a large five-generation Swiss family.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>METHODS: Family history and clinical data were recorded.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>The phenotype was documented by both slit lamp and Scheimpflug photography.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>One cortical lens was evaluated by electron microscopy after cataract extraction.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>Lenticular phenotyping and genotyping were performed independently with short tandem repeat polymorphism.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>Linkage analysis was performed, and candidate genes were PCR amplified and screened for mutations on both strands using direct sequencing.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>Affected individuals had a congenital nuclear lactescent cataract in both eyes.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>Linkage was observed on chromosome 17 for DNA marker D17S1857 (lod score: 3.44 at theta = 0).</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>Direct sequencing of CRYBA3/A1, which maps to the vicinity, revealed an in-frame 3-bp deletion in exon 4 (279delGAG).</Variant>", "label": [[90, 103, "Variant"], [115, 124, "Variant"]]}
{"id": "15111599", "text": "<Variant>This mutation involved a deletion of glycine-91, cosegregated in all affected individuals, and was not observed in unaffected individuals or in 250 normal control subjects from the same ethnic background.</Variant>", "label": [[34, 56, "Variant"]]}
{"id": "15111599", "text": "<Variant>Electron microscopy showed that cortical lens fiber morphology was normal.</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15111599", "text": "<Variant>The DeltaG91 mutation in CRYBA3/A1 is associated with an autosomal dominant congenital nuclear lactescent cataract.</Variant>", "label": [[13, 21, "Variant"]]}
{"id": "15111599", "text": "<Variant>A splice mutation (IVS3+1G/A) in this gene has been reported in a zonular cataract with sutural opacities.</Variant>", "label": [[28, 37, "Variant"]]}
{"id": "15111599", "text": "<Variant>These results indicate phenotypic heterogeneity related to mutations in this gene.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>BACKGROUND: Long-term anti-cytomegalovirus (CMV) treatments in immunocompromised patients are hampered by resistance to antiviral drugs.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>Longitudinal changes in the resistance genotype may depend on changes in selective pressure and the complexity of CMV isolates.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>OBJECTIVE: To evaluate longitudinal changes in the CMV resistance genotype and phenotype along with strain-specific variability in a patient with non-Hodgkin's lymphoma in whom successive anti-CMV treatments failed.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>STUDY DESIGN:</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>The resistance phenotype and genotype of seven CMV isolates collected from one patient during a 2-year follow-up period were retrospectively analysed.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>In parallel, we used glycoprotein B (gB) genotyping, and a- and UL10-13-sequence analysis to study CMV interstrain variability.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>The patient was infected by at least three CMV strains plus variants of the parental strains.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>Resistance to ganciclovir, cidofovir and foscarnet was successively detected during the follow-up period.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>UL97 protein kinase changes responsible for resistance to ganciclovir were initially detected at residues 591 and 592, and then at position 594.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>Decreased sensitivity to foscarnet coincided with the appearance of amino acid substitution N495K in DNA polymerase, whereas cross-resistance to ganciclovir and cidofovir was due to the L501I substitution.</Variant>", "label": [[101, 106, "Variant"], [195, 200, "Variant"]]}
{"id": "15018851", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>The CMV isolates obtained from our patient were complex mixtures of strains.</Variant>", "label": []}
{"id": "15018851", "text": "<Variant>Changes in resistance genotypes depended on resistance selective pressure and were not linked to interstrain variation.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>Familial HDL deficiency (FHD) is a rare autosomal dominant lipoprotein disorder.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>We describe a novel genetic variant of the apolipoprotein A-I (apoA-I) gene resulting in FHD.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>The proband is a 51-year-old woman who was hospitalized due to severe heart failure.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>Her plasma HDL-cholesterol (C) and apoA-I concentrations were 0.08mmol/l and 1mg/dl, respectively.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>She exhibited corneal opacities and planar xanthomas on eyelids and elbows.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>Coronary angiography demonstrated extensive obstructions in two major vessels.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>Genomic DNA sequencing of the patient's apoA-I gene revealed a homozygosity for a GC deletion between 5 GC repeats in exon 4, creating a frameshift and a stop codon at residue 178.</Variant>", "label": [[91, 102, "Variant"], [111, 123, "Variant"], [163, 188, "Variant"]]}
{"id": "14709355", "text": "<Variant>We designated this mutation as apoA-I Shinbashi.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>The proband's father, son, and daughter were found to be heterozygous for this mutation and their HDL-C and apoA-I levels were about half of normal levels, demonstrating a gene dosage effect.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>The father underwent coronary bypass surgery at age of 70 years.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>Lecithin-cholesterol acyltransferase (LCAT) activity was decreased by 63% in the homozygote and 31% in heterozygotes, respectively.</Variant>", "label": []}
{"id": "14709355", "text": "<Variant>This new case of apoA-I deficiency, apoA-I Shinbashi, is the first case involving a single gene defect of the apoA-I gene to develop all the characteristics for apoA-I deficiency, including premature coronary heart disease.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Gonadal mosaicism in severe Pallister-Hall syndrome.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Pallister-Hall syndrome (PHS, MIM #146510) is characterized by central and postaxial polydactyly, hypothalamic hamartoma (HH), bifid epiglottis, imperforate anus, renal abnormalities, and pulmonary segmentation anomalies.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>It is inherited in an autosomal dominant pattern.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Here, we describe a family with two affected children manifesting severe PHS with mental retardation, behavioral problems, and intractable seizures.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Both parents are healthy, with normal intelligence, and have no malformations on physical, laryngoscopic, and cranial MRI exam.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>The atypical presentation of these children and the absence of parental manifestations suggested an autosomal recessive mode of inheritance or gonadal mosaicism.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Sequencing of GLI3 revealed a two nucleotide deletion in exon 15 (c.3385_3386delTT) predicting a frameshift and premature stop at codon 1129 (p.F1129X) in the children while both parents have wild type alleles.</Variant>", "label": [[75, 91, "Variant"], [131, 149, "Variant"], [151, 159, "Variant"]]}
{"id": "14708104", "text": "<Variant>Genotyping with GLI3 intragenic markers revealed that both children inherited the abnormal allele from their mother thus supporting gonadal mosaicism as the underlying mechanism of inheritance (paternity was confirmed).</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>This is the first reported case of gonadal mosaicism in PHS.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>The severe CNS manifestations of these children are reminiscent of children with non-syndromic HH who often have progressive mental retardation with behavioral problems and intractable seizures.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>We conclude that the phenotypic spectrum of PHS can include severe CNS manifestations and that recurrence risks for PHS should include a proviso for gonadal mosaicism, though the frequency cannot be calculated from a single case report.</Variant>", "label": []}
{"id": "14708104", "text": "<Variant>Published 2003 Wiley-Liss, Inc.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Deletions found in several types of human tumor, including carcinomas of the colorectum, breast, and lung, suggest the presence of a potential tumor suppressor gene(s) on chromosome 15.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Common regions of deletion in these tumors are at 15q15 and 15q21.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Here, we have analyzed loss of heterozygosity (LOH) on chromosome 15 to ascertain its potential involvement in the development and progression of transitional cell carcinoma (TCC) of the bladder.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>A panel of 26 polymorphic markers, spanning 15q12-15q22, were used to map regions of LOH in 51 TCCs.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>LOH was found for at least one marker in the region 15q14-15q15.3 in 20 of 51 (39%) tumors.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Deletion mapping defined two minimum regions of deletion: a distal region between the markers D15S514 and D15S537 at 15q15.1-15q15.3 (estimated as 3 Mb) and a more proximal region between the markers D15S971 and D15S1042 at 15q14 (estimated as 1.1 Mb).</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Analysis of a panel of 33 bladder tumor cell lines revealed regions of contiguous homozygosity for markers in 15q15, indicating likely LOH.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Fluorescence in situ hybridization analysis demonstrated that mitotic recombination is the predicted mechanism of LOH in two of these.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>These regions of LOH on 15q may contain tumor suppressor genes the loss or inactivation of which is associated with TCC development.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>The DNA repair gene RAD51</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>at 15q15.1 represents a candidate 15q tumor suppressor gene.</Variant>", "label": []}
{"id": "14633686", "text": "<Variant>Expression analysis of rad51 protein in tumor cell lines revealed variable levels of expression but no significant loss of expression in cell lines with likely 15q LOH.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>To document 2 apparently incongruous clinical disorders occurring in the same infant: congenital myopathy with myophosphorylase deficiency (McArdle disease) and mitochondrial hepatopathy with liver failure and mitochondrial DNA depletion.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>An infant girl born to consanguineous Moroccan parents had severe congenital hypotonia and hepatomegaly, developed liver failure, and died at 5 months of age.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>We studied muscle and liver biopsy specimens histochemically and biochemically, and we sequenced the whole coding regions of the deoxyguanosine kinase (dGK) and myophosphorylase (PYGM) genes.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>Muscle biopsy specimens showed subsarcolemmal glycogen accumulation and negative histochemical reaction for phosphorylase.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>Liver biopsy specimens showed micronodular cirrhosis and massive mitochondrial proliferation.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>Biochemical analysis showed phosphorylase deficiency in muscle and cytochrome c oxidase deficiency in liver.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>We identified a novel homozygous missense G-to-A mutation at codon 456 in exon 11 of PYGM, as well as a homozygous 4-base pair GATT duplication (nucleotides 763-766) in exon 6 of dGK, which produces a frame shift and a premature TGA stop codon at nucleotides 766 to 768, resulting in a truncated 255-amino acid protein.</Variant>", "label": [[51, 79, "Variant"], [136, 174, "Variant"], [242, 278, "Variant"]]}
{"id": "14568816", "text": "<Variant>Both mutations were absent in 100 healthy individuals.</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "14568816", "text": "<Variant>Our data further expand the genetic heterogeneity in patients with McArdle disease; confirm the strong relationship between mitochondrial DNA depletion syndrome, liver involvement, and dGK mutations; and suggest that genetic \"double trouble\" should be considered in patients with unusual severe phenotypes.</Variant>", "label": []}
{"id": "12737948", "text": "<Variant>A \"null allele\" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.</Variant>", "label": []}
{"id": "12737948", "text": "<Variant>Mutations in the human ferrochelatase gene (FECH) are the primary cause of the inborn disorder erythropoietic protoporphyria (EPP).</Variant>", "label": []}
{"id": "12737948", "text": "<Variant>While the majority of the EPP patients exhibit only photosensitivity, a small percentage of patients (approximately 2%) develop liver complications in addition to the cutaneous symptoms.</Variant>", "label": []}
{"id": "12737948", "text": "<Variant>In this study, the FECH gene of an Israeli EPP patient who suffered from EPP-related liver complications was sequenced.</Variant>", "label": []}
{"id": "12737948", "text": "<Variant>A splicing defect IVS10+1, g-->t, which is known to cause the deletion of exon 10, was identified in the index patient as well as in his symptomatic older sister and his asymptomatic mother.</Variant>", "label": [[27, 41, "Variant"]]}
{"id": "12737948", "text": "<Variant>Like the other 12 known FECH mutations associated with liver complications, IVS10+1, g-->t is a \"null-allele\" mutation.</Variant>", "label": [[85, 99, "Variant"]]}
{"id": "12737948", "text": "<Variant>Although the two siblings with overt EPP share an identical genotype with respect to both the mutation on one FECH allele and three intragenic single nucleotide polymorphisms, -251G, IVS1-23T, and IVS3-48C on the other allele, the sister of the index patient has so far shown no signs of liver involvement, suggesting that additional factors might account for the liver disease in EPP.</Variant>", "label": [[185, 190, "Variant"], [192, 200, "Variant"], [206, 214, "Variant"]]}
{"id": "12701064", "text": "<Variant>A novel compound heterozygous mutation in the CYP17 (P450 17alpha-hydroxylase) gene leading to 17alpha-hydroxylase/17,20-lyase deficiency.</Variant>", "label": []}
{"id": "12701064", "text": "<Variant>Mutations in the CYP17 gene impair steroid biosynthesis in the adrenals and gonads and often cause 17alpha-hydroxylase/17,20-lyase deficiency, leading to amenorrhea, sexual infantilism, and hypokalemic low aldosterone hypertension.</Variant>", "label": []}
{"id": "12701064", "text": "<Variant>Several CYP17 mutations resulting in 17alpha-hydroxylase/17,20-lyase deficiency have been reported previously.</Variant>", "label": []}
{"id": "12701064", "text": "<Variant>In the present study, we found a novel CYP17 mutation from the molecular analysis of a Korean patient with primary amenorrhea with a 46,XX karyotype, and hypokalemic hypertension.</Variant>", "label": []}
{"id": "12701064", "text": "<Variant>We sequenced all 8 exons of the CYP17 gene that were amplified from patient's genomic DNA using polymerase chain reaction (PCR) and found a compound heterozygous mutation in the CYP17 structural gene; a 1-base deletion and a 1-base transversion (TAC-->AA) at codon 329, leading to the production of a truncated protein (1-417 amino acids), and a 3-base deletion (TCC, either 350-351 or 351-352 codon) in the other allele.</Variant>", "label": [[212, 227, "Variant"], [254, 277, "Variant"], [355, 409, "Variant"]]}
{"id": "12701064", "text": "<Variant>Restriction enzyme digestion analysis of patient's and parental DNA showed that the 1-base deletion and the 3-base deletion are inherited from mother and father, respectively.</Variant>", "label": [[93, 108, "Variant"], [117, 132, "Variant"]]}
{"id": "12701064", "text": "<Variant>Here we conclude that these novel compound heterozygous mutations might account for the patient's clinical manifestations of 17alpha-hydroxylase/17,20-lyase deficiency.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>We evaluated polymorphisms in the interleukin-1 alpha 3'-untranslated region (IL-1A 3'[UTR]) for association with type 2 diabetes-associated (DM) and nondiabetic-associated (non-DM) end-stage renal disease (ESRD) in two ethnic groups.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>METHODS: IL-1A 3'UTR polymorphisms were identified by alignment of overlapping human expressed sequence tags (ESTs).</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>Sequence ambiguities were experimentally confirmed and variants genotyped to test for association with ESRD in 75 unrelated Caucasians with DM ESRD, 95 unrelated Caucasian controls and, in a parallel study, 92 unrelated African Americans with type 2 DM ESRD, 95 unrelated African Americans with non-DM ESRD, and 86 unrelated African American controls.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>IL-1A 3' UTR genotype and lipopolysaccharide (LPS)-stimulated IL-1 alpha protein levels were measured in healthy Caucasians (N = 112) and African Americans (N = 101) to evaluate association between genotype and protein level.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>RESULTS: A polymorphism in the 3' UTR of the human IL-1A gene was associated with ESRD and IL-1 alpha protein expression.</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>The polymorphism consists of two single nucleotide polymorphisms (SNPs) and an insertion/deletion generating four different haplotypes: TN7TTCAA, AN7TTCAA, TN7TTCAG and an allele deleted for four internal bases, TN7(delTTCA)A. The 4 bp deletion allele, TN7(delTTCA)A, was significantly less common among Caucasian DM ESRD and African American non-DM ESRD patients (recessive model; P = 0.0364 and P = 0.0293, respectively).</Variant>", "label": [[225, 232, "Variant"], [266, 273, "Variant"]]}
{"id": "12631337", "text": "<Variant>In vitro, this polymorphism is associated with the amount of IL-1 alpha protein synthesized in LPS-stimulated lymphocytes from healthy subjects (P = 0.0013, additive model), with the TN7(delTTCA)A haplotype associated with higher levels of stimulated IL-1 alpha.</Variant>", "label": [[196, 203, "Variant"]]}
{"id": "12631337", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "12631337", "text": "<Variant>The association of the TN7(delTTCA)A haplotype with higher levels of IL-1 alpha expression and reduced risk for ESRD is consistent with involvement of cytokines in risk for developing nephropathy.</Variant>", "label": [[36, 43, "Variant"]]}
{"id": "21750150", "text": "<Variant>Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Loss or reduction in function of tumor suppressor genes contributes to tumorigenesis.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Here, by allelic DNA copy number analysis using single-nucleotide polymorphism genotyping array and mass spectrometry, we report homozygous deletion in glioblastoma multiformes at chromosome 13q21, where DACH1 gene is located.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>We found decreased cell proliferation of a series of glioma cell lines by forced expression of DACH1.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>We then generated U87TR-Da glioma cells, where DACH1 expression could be activated by exposure of the cells to doxycycline.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Both ex vivo cellular proliferation and in vivo growth of s.c. transplanted tumors in mice are reduced in U87TR-Da cells with DACH1 expression (U87-DACH1-high), compared with DACH1-nonexpressing U87TR-Da cells (U87-DACH1-low).</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>U87-DACH1-low cells form spheroids with CD133 and Nestin expression in serum-free medium but U87-DACH1-high cells do not.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Compared with spheroid-forming U87-DACH1-low cells, adherent U87-DACH1-high cells display lower tumorigenicity, indicating DACH1 decreases the number of tumor-initiating cells.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Gene expression analysis and chromatin immunoprecipitation assay reveal that fibroblast growth factor 2 (FGF2/bFGF) is transcriptionally repressed by DACH1, especially in cells cultured in serum-free medium.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>Exogenous bFGF rescues spheroid-forming activity and tumorigenicity of the U87-DACH1-high cells, suggesting that loss of DACH1 increases the number of tumor-initiating cells through transcriptional activation of bFGF.</Variant>", "label": []}
{"id": "21750150", "text": "<Variant>These results illustrate that DACH1 is a distinctive tumor suppressor, which does not only suppress growth of tumor cells but also regulates bFGF-mediated tumor-initiating activity of glioma cells.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>BACKGROUND: Basal cell carcinomas (BCCs) are the most frequent human cancer that results from malignant transformation of basal cells in the epidermis.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>Gorlin syndrome is a rare inherited autosomal dominant disease that predisposes with multiple BCCs and other birth defects.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>Both sporadic and inherited BCCs are associated with mutations in the tumor suppressor gene PTCH1, but there is still uncertainty on the role of its homolog PTCH2.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>To search for mutations and genomic instability in sporadic and inherited BCCs.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>DNA obtained from leukocytes and tumor cells was amplified by polymerase chain reaction regarding five exons of PTCH1 and PTCH2 and neighboring microsatellites.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>Exons were sequenced and compared with the GenBank database.</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>RESULTS: Only D9S180, of six microsatellites, showed loss of heterozygosity in three BCCs (two sporadic and one inherited).</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>One sporadic BCC presented the mutation g.2885G>C in exon 17 of PTCH1, which predicts the substitution p.R962T in an external domain of the protein.</Variant>", "label": [[49, 58, "Variant"], [112, 119, "Variant"]]}
{"id": "21699520", "text": "<Variant>In addition, the leukocytes and tumor cells of one patient with Gorlin syndrome showed the mutation g.2839T>G in the same exon and gene, which predicts a p.E947stop and truncated protein.</Variant>", "label": [[109, 118, "Variant"], [163, 173, "Variant"]]}
{"id": "21699520", "text": "<Variant>All control and tumor samples presented IVS9 + 217T in intron 9 of PTCH1.</Variant>", "label": [[49, 60, "Variant"]]}
{"id": "21699520", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21699520", "text": "<Variant>Mutations found in the PTCH1 gene and neighboring repetitive sequences may have contributed to the development of the studied BCCs.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Chasing the ubiquitous RET proto-oncogene in South African MEN2 families--implications for the surgeon.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>The RET proto-oncogene (REarranged during Transfection; RET) plays an important role in the causation of many thyroid tumours.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Germline RET proto-oncogene missense mutations have been clearly linked to medullary thyroid carcinoma (MTC) and the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN2A, MEN2B).</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>We investigated a cohort of MEN2-related patients referred to Tygerberg Hospital, W Cape (2003-2009).</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>The study cohort was divided into three groups based on pathology (viz. MEN/MTC, phaeochromocytoma, and a miscellaneous group of MEN pathologies).</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Families with identified high-risk factors were recalled.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Serum calcitonin levels were monitored where indicated.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>DNA was extracted from whole blood by standard techniques and polymerase chain reaction (PCR) products screened for RET gene variations by heteroduplex single-strand duplication techniques (heteroduplex single-strand conformation polymorphism analysis) being validated with automated sequencing techniques showing conformational variants in acrylamide gel.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>We screened 40 persons, male/female ratio 1:1.5.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Three ethnic groups were represented (white (12), black (11) and mixed race (17)).</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Nine were index MTC cases, 5 phaeochromocytoma, 3 Hirschsprung's disease-MEN associations and 2 miscellaneous (1 neuroblastoma, 1 intestinal neuronal dysplasia), while 1 fell into the MEN2B category.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>The remaining 19 were unaffected relatives screened for carrier status, among whom afamilial recurrence was observed in 7.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>On genetic testing, an RET point mutation at the high-risk 634 cysteine allele was identified in 11 cases.</Variant>", "label": [[68, 80, "Variant"]]}
{"id": "21542403", "text": "<Variant>A further cysteine radical mutation at the 620 position was related to MEN2 in 3 families plus 1 other family referred from elsewhere.</Variant>", "label": [[19, 64, "Variant"]]}
{"id": "21542403", "text": "<Variant>Other less-recognised gene variations were detected throughout the RET gene in 70% of cases and included the 691 position on codon 11 (11 cases); the 432 position (4 cases, 1 homozygous) intronic mutations on exon 4 (1 case); and an IVS19-37G/C and a D1017N variation in exon 19 in 2 MEN families.</Variant>", "label": [[242, 253, "Variant"], [260, 266, "Variant"]]}
{"id": "21542403", "text": "<Variant>Fifteen MTC patients have had thyroidectomies, of which 2 were prophylactic (C-cell hyperplasia; early occult MTC).</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>A further 3 are awaiting prophylactic surgery.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>CONCLUSION: RET gene mutation carries a risk of MEN2 and MTC in all ethnic groups in South Africa.</Variant>", "label": []}
{"id": "21542403", "text": "<Variant>Prophylactic surgery may prevent MTC, so genetic screening is important to identify and treat high-risk patients.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Homozygous or compound heterozygous mutations in renin (REN) cause renal tubular dysgenesis, which is characterized by death in utero due to kidney failure and pulmonary hypoplasia.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>The phenotype resembles the fetopathy caused by angiotensin-converting enzyme inhibitor or angiotensin receptor blocker intake during pregnancy.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Recently, heterozygous REN mutations were shown to result in early-onset hyperuricemia, anemia, and chronic kidney disease (CKD).</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>To date, only 3 different heterozygous REN mutations have been published.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>We report mutation analysis of the REN gene in 39 kindreds with hyperuricemia and CKD who previously tested negative for mutations in the UMOD (uromodulin) and HNF1B (hepatocyte nuclear factor 1b) genes.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>We identified one kindred with a novel thymidine to cytosine mutation at position 28 in the REN complementary DNA, corresponding to a tryptophan to arginine substitution at amino acid 10, which is found within the signal sequence (c.28T>C; p.W10R).</Variant>", "label": [[48, 93, "Variant"], [143, 195, "Variant"], [240, 247, "Variant"], [249, 255, "Variant"]]}
{"id": "21903317", "text": "<Variant>On this basis, we conclude that REN mutations are rare events in patients with CKD.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Within the kindred, we found affected individuals over 4 generations who carried the novel REN mutation and were characterized by significant anemia, hyperuricemia, and CKD.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Anemia was severe and disproportional to the degree of decreased kidney function.</Variant>", "label": []}
{"id": "21903317", "text": "<Variant>Because all heterozygous REN mutations that have been described are localized in the signal sequence, screening of the REN gene for patients with CKD with hyperuricemia and anemia may best be focused on sequencing of exon 1, which encodes the signal peptide.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>Detection of possible restriction sites for type II restriction enzymes in DNA sequences.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>In order to make a step forward in the knowledge of the mechanism operating in complex polygenic disorders such as diabetes and obesity, this paper proposes a new algorithm (PRSD -possible restriction site detection) and its implementation in Applied Genetics software.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>This software can be used for in silico detection of potential (hidden) recognition sites for endonucleases and for nucleotide repeats identification.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>The recognition sites for endonucleases may result from hidden sequences through deletion or insertion of a specific number of nucleotides.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>Tests were conducted on DNA sequences downloaded from NCBI servers using specific recognition sites for common type II restriction enzymes introduced in the software database (n = 126).</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>Each possible recognition site indicated by the PRSD algorithm implemented in Applied Genetics was checked and confirmed by NEBcutter V2.0 and Webcutter 2.0 software.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>In the sequence NG_008724.1</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>(which includes 63632 nucleotides) we found a high number of potential restriction sites for ECO R1 that may be produced by deletion (n = 43 sites) or insertion (n = 591 sites) of one nucleotide.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>The second module of Applied Genetics has been designed to find simple repeats sizes with a real future in understanding the role of SNPs (Single Nucleotide Polymorphisms) in the pathogenesis of the complex metabolic disorders.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>We have tested the presence of simple repetitive sequences in five DNA sequence.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>The software indicated exact position of each repeats detected in the tested sequences.</Variant>", "label": []}
{"id": "22303603", "text": "<Variant>Future development of Applied Genetics can provide an alternative for powerful tools used to search for restriction sites or repetitive sequences or to improve genotyping methods.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>Seven strains of Epstein-Barr virus (EBV) are defined based on C-terminal sequence variations of the latent membrane protein 1 (LMP1).</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>Some strains, especially those with a 30-bp deletion, are thought to be related to tumorigenic activity and geographical localization.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>The aims of the study were to determine the prevalence of different LMP1 strains and to investigate sequence variation in the C-terminal region of LMP1 in Serbian isolates.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>This study included 53 EBV-DNA-positive plasma and tissue block samples from patients with mononucleosis syndrome, renal transplantation, and tumors, mostly nasopharyngeal carcinoma.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>The sequence of the 506-bp fragment of LMP1 C terminus was used for phylogenetic analyses and identification of LMP1 strains, deletions, and mutations.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>The majority of isolates were non-deleted (66%), and the rest had 30-bp, rare 69-bp, or yet unknown 27-bp deletions, which were not related to malignant or non-malignant isolate origin.</Variant>", "label": [[109, 124, "Variant"]]}
{"id": "22337303", "text": "<Variant>However, the majority of 69-bp deletion isolates were derived from patients with nasopharyngeal carcinoma.</Variant>", "label": [[34, 48, "Variant"]]}
{"id": "22337303", "text": "<Variant>Less than five 33-bp repeats were found in the majority of non-deleted isolates (68.6%), whereas most 69-bp deletion isolates (75%) had five or six repeats.</Variant>", "label": [[19, 37, "Variant"], [111, 125, "Variant"]]}
{"id": "22337303", "text": "<Variant>Serbian isolates were assigned to four LMP1 strains: B95-8 (32.1%), China 1 (24.5%), North Carolina (NC; 18.9%), and Mediterranean (Med; 24.5%).</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>In NC isolates, three new mutations unique for this strain were identified.</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>EBV EBNA2 genotypes 1 and 2 were both found, with dominance of genotype 1 (90.7%).</Variant>", "label": []}
{"id": "22337303", "text": "<Variant>This study demonstrated noticeable geographical-associated characteristics in the LMP1 C terminus of investigated isolates.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>Large contiguous gene deletions in Sjogren-Larsson syndrome.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity and mutations in the ALDH3A2 gene for fatty aldehyde dehydrogenase, an enzyme that catalyzes the oxidation of fatty aldehyde to fatty acid.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>More than 70 mutations have been identified in SLS patients, including small deletions or insertions, missense mutations, splicing defects and complex nucleotide changes.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>We now describe 2 SLS patients whose disease is caused by large contiguous gene deletions of the ALDH3A2 locus on 17p11.2.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>The deletions were defined using long distance inverse PCR and microarray-based comparative genomic hybridization.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>A 24-year-old SLS female was homozygous for a 352-kb deletion involving ALDH3A2 and 4 contiguous genes including ALDH3A1, which codes for the major soluble protein in cornea.</Variant>", "label": [[55, 70, "Variant"]]}
{"id": "21684788", "text": "<Variant>Although lacking corneal disease, she showed severe symptoms of SLS with uncommon deterioration in oral motor function and loss of ambulation.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>The other 19-month-old female patient was a compound heterozygote for a 1.44-Mb contiguous gene deletion and a missense mutation (c.407C>T, P136L) in ALDH3A2.</Variant>", "label": [[81, 113, "Variant"], [139, 147, "Variant"], [149, 154, "Variant"]]}
{"id": "21684788", "text": "<Variant>These studies suggest that large gene deletions may account for up to 5% of the mutant alleles in SLS.</Variant>", "label": []}
{"id": "21684788", "text": "<Variant>Geneticists should consider the possibility of compound heterozygosity for large deletions in patients with SLS and other inborn errors of metabolism, which has implications for carrier testing and prenatal diagnosis.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>Metachondromatosis (MC) is a rare, autosomal dominant, incompletely penetrant combined exostosis and enchondromatosis tumor syndrome.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>MC is clinically distinct from other multiple exostosis or multiple enchondromatosis syndromes and is unlinked to EXT1 and EXT2, the genes responsible for autosomal dominant multiple osteochondromas (MO).</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>To identify a gene for MC, we performed linkage analysis with high-density SNP arrays in a single family, used a targeted array to capture exons and promoter sequences from the linked interval in 16 participants from 11 MC families, and sequenced the captured DNA using high-throughput parallel sequencing technologies.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>DNA capture and parallel sequencing identified heterozygous putative loss-of-function mutations in PTPN11 in 4 of the 11 families.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>Sanger sequence analysis of PTPN11 coding regions in a total of 17 MC families identified mutations in 10 of them (5 frameshift, 2 nonsense, and 3 splice-site mutations).</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>Copy number analysis of sequencing reads from a second targeted capture that included the entire PTPN11 gene identified an additional family with a 15 kb deletion spanning exon 7 of PTPN11.</Variant>", "label": [[157, 171, "Variant"]]}
{"id": "21533187", "text": "<Variant>Microdissected MC lesions from two patients with PTPN11 mutations demonstrated loss-of-heterozygosity for the wild-type allele.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>We next sequenced PTPN11 in DNA samples from 54 patients with the multiple enchondromatosis disorders Ollier disease or Maffucci syndrome, but found no coding sequence PTPN11 mutations.</Variant>", "label": []}
{"id": "21533187", "text": "<Variant>We conclude that heterozygous loss-of-function mutations in PTPN11 are a frequent cause of MC, that lesions in patients with MC appear to arise following a \"second hit,\" that MC may be locus heterogeneous since 1 familial and 5 sporadically occurring cases lacked obvious disease-causing PTPN11 mutations, and that PTPN11 mutations are not a common cause of Ollier disease or Maffucci syndrome.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>Primary glucocorticoid resistance (OMIM 138040) is a rare hereditary disease that causes a generalized partial insensitivity to glucocorticoid action, due to genetic alterations of the glucocorticoid receptor (GR).</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>Investigation of adrenal incidentalomas led to the discovery of a family (eight affected individuals spanning three generations), prone to cortisol resistance, bilateral adrenal hyperplasia, arterial hypertension and hypokalemia.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>This phenotype exacerbated over time, cosegregates with the first heterozygous nonsense mutation p.R469[R,X] reported to date for the GR, replacing an arginine (CGA) by a stop (TGA) at amino-acid 469 in the second zinc finger of the DNA-binding domain of the receptor.</Variant>", "label": [[106, 117, "Variant"], [160, 208, "Variant"]]}
{"id": "21042587", "text": "<Variant>In vitro, this mutation leads to a truncated 50-kDa GR lacking hormone and DNA binding capacity, devoid of hormone-dependent nuclear translocation and transactivation properties.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>In the proband's fibroblasts, we provided evidence for the lack of expression of the defective allele in vivo.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>The absence of detectable mutated GR mRNA was accompanied by a 50% reduction in wild type GR transcript and protein.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>This reduced GR expression leads to a significantly below-normal induction of glucocorticoid-induced target genes, FKBP5 in fibroblasts.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>We demonstrated that the molecular mechanisms of glucocorticoid signaling dysfunction involved GR haploinsufficiency due to the selective degradation of the mutated GR transcript through a nonsense-mediated mRNA Decay that was experimentally validated on emetine-treated propositus' fibroblasts.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>GR haploinsufficiency leads to hypertension due to illicit occupation of renal mineralocorticoid receptor by elevated cortisol rather than to increased mineralocorticoid production reported in primary glucocorticoid resistance.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>Indeed, apparent mineralocorticoid excess was demonstrated by a decrease in urinary tetrahydrocortisone-tetrahydrocortisol ratio in affected patients, revealing reduced glucocorticoid degradation by renal activity of the 11b-hydroxysteroid dehydrogenase type 2, a GR regulated gene.</Variant>", "label": []}
{"id": "21042587", "text": "<Variant>We propose thus that GR haploinsufficiency compromises glucocorticoid sensitivity and may represent a novel genetic cause of subclinical hypercortisolism, incidentally revealed bilateral adrenal hyperplasia and mineralocorticoid-independent hypertension.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>HCN channels activate the pacemaker current I(f), which is thought to contribute significantly to generation and regulation of heart rhythm.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>HCN4 represents the dominant isotype in the sinoatrial node and binding of cAMP was suggested to be necessary for autonomic heart rate regulation.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>METHODS AND RESULTS:</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>In a candidate gene approach, a heterozygous insertion of 13 nucleotides in exon 6 of the HCN4 gene leading to a truncated cyclic nucleotide-binding domain was identified in a 45-year-old woman with sinus bradycardia.</Variant>", "label": [[54, 81, "Variant"]]}
{"id": "20693575", "text": "<Variant>Biophysical properties determined by whole-cell patch-clamp recording of HEK293 cells demonstrated that mutant subunits (HCN4-695X) were insensitive to cAMP.</Variant>", "label": [[135, 139, "Variant"]]}
{"id": "20693575", "text": "<Variant>Heteromeric channels composed of wild-type and mutant subunits failed to respond to cAMP-like homomeric mutant channels, indicating a dominant-negative suppression of cAMP-induced channel activation by mutant subunits.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>Pedigree analysis identified 7 additional living carriers showing similar clinical phenotypes, that is, sinus node dysfunction with mean resting heart rate of 45.9 4.6 bpm (n=8) compared with 66.5 9.1 bpm of unaffected relatives (n=6; P<0.01).</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>Clinical evaluation revealed no ischemic or structural heart disease in any family member.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>Importantly, mutant carriers exhibited normal heart rate variance and full ability to accelerate heart rate under physical activity or pharmacological stimulation.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>Moreover, mutant carriers displayed distinctive sinus arrhythmias and premature beats linked to adrenergic stress.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>In humans, cAMP responsiveness of I(f) determines basal heart rate but is not critical for maximum heart rate, heart rate variability, or chronotropic competence.</Variant>", "label": []}
{"id": "20693575", "text": "<Variant>Furthermore, cAMP-activated I(f) may stabilize heart rhythm during chronotropic response.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>BACKGROUND: Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited blistering skin disorder caused by mutations in COL7A1 gene encoding type VII collagen, the major component of anchoring fibrils in the dermo-epidermal junction.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>The development of cutaneous squamous cell carcinoma (SCC) is one of the most serious complications of this disease.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>We report herein a Chinese patient with the severe generalized subtype of RDEB (RDEB-sev gen) complicated by SCC. METHODS:</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>Skin biopsies were examined for histology, basement membrane ultrastructure, and type VII collagen expression.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>Genomic DNA was extracted from the peripheral blood samples and subjected to polymerase chain reaction amplification and direct automated DNA sequencing.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>Histopathological examination of the patient's skin revealed an undetectable expression of type VII collagen polypeptides in the basement membrane zone.</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>Mutation analysis identified a novel splice site mutation in intron 64 (IVS64+5g->a) of COL7A1 gene, which resulted in an in-frame deletion of exon 64 in both alleles.</Variant>", "label": [[81, 92, "Variant"]]}
{"id": "21182502", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21182502", "text": "<Variant>This report contributes to the expanding database of COL7A1 mutations and emphasizes the need to elucidate the underlying genetic mechanisms associated with the increased incidence of SCC in RDEB patients.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>Ehlers-Danlos syndrome, vascular type (vEDS) (MIM #130050) is an autosomal dominant disorder caused by type III procollagen gene (COL3A1) mutations.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>Most COL3A1 mutations are detected by using total RNA from patient-derived fibroblasts, which requires an invasive skin biopsy.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>High-resolution melting curve analysis (hrMCA) has recently been developed as a post-PCR mutation scanning method which enables simple, rapid, cost-effective, and highly sensitive mutation screening of large genes.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>We established a hrMCA method to screen for COL3A1 mutations using genomic DNA.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>PCR primers pairs for COL3A1 (52 amplicons) were designed to cover all coding regions of the 52 exons, including the splicing sites.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>We used 15 DNA samples (8 validation samples and 7 samples of clinically suspected vEDS patients) in this study.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>The eight known COL3A1 mutations in validation samples were all successfully detected by the hrMCA.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>In addition, we identified five novel COL3A1 mutations, including one deletion (c.2187delA) and one nonsense mutation (c.2992C>T) that could not be determined by the conventional total RNA method.</Variant>", "label": [[89, 99, "Variant"], [128, 137, "Variant"]]}
{"id": "21219851", "text": "<Variant>Furthermore, we established a small amplicon genotyping (SAG) method for detecting three high frequency coding-region SNPs (rs1800255:G>A, rs1801184:T>C, and rs2271683:A>G) in COL3A1 to differentiate mutations before sequencing.</Variant>", "label": [[133, 142, "Variant"], [143, 146, "Variant"], [148, 157, "Variant"], [158, 161, "Variant"], [167, 176, "Variant"], [177, 180, "Variant"]]}
{"id": "21219851", "text": "<Variant>The use of hrMCA in combination with SAG from genomic DNA enables rapid detection of COL3A1 mutations with high efficiency and specificity.</Variant>", "label": []}
{"id": "21219851", "text": "<Variant>A better understanding of the genotype-phenotype correlation in COL3A1 using this method will lead to improve in diagnosis and treatment.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene.</Variant>", "label": [[88, 96, "Variant"]]}
{"id": "21126715", "text": "<Variant>Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disease that is characterized by a near-complete absence of adipose tissue from birth or early infancy.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>Mutations in the BSCL2 gene are known to result in CGL2, a more severe phenotype than CGL1, with earlier onset, more extensive fat loss and biochemical changes, more severe intellectual impairment, and more severe cardiomyopathy.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>We report a 3-month-old Taiwanese boy with initial presentation of a lack of subcutaneous fat, prominent musculature, generalized eruptive xanthomas, and extreme hypertriglyceridemia.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>Absence of mechanical adipose tissue in the orbits and scalp was revealed by head magnetic resonance imaging.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>Hepatomegaly was noticed, and histological examination of a liver biopsy specimen suggested severe hepatic steatosis and periportal necrosis.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>However, echocardiography indicated no sign of cardiomyopathy and he showed no distinct intellectual impairment that interfered with daily life.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>About 1 year later, abdominal computed tomography revealed enlargement of kidneys.</Variant>", "label": []}
{"id": "21126715", "text": "<Variant>He had a homozygous insertion of a nucleotide, 783insG (Ile262fs mutation), in exon 7 of the BSCL2 gene.</Variant>", "label": [[56, 63, "Variant"], [65, 73, "Variant"]]}
{"id": "21126715", "text": "<Variant>We reviewed the genotype of CGL cases from Japan, India, China and Taiwan, and found that BSCL2 is a major causative gene for CGL in Asian.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>8q24 allelic imbalance and MYC gene copy number in primary prostate cancer.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Four independent regions within 8q24 near the MYC gene are associated with risk for prostate cancer (Pca).</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Here, we investigated allelic imbalance (AI) at 8q24 risk variants and MYC gene DNA copy number (CN) in 27 primary Pcas.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Heterozygotes were observed in 24 of 27 patients at one or more 8q24 markers and 27% of the loci exhibited AI in tumor DNA.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>The 8q24 risk alleles were preferentially favored in the tumors.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Increased MYC gene CN was observed in 33% of tumors, and the co-existence of increased MYC gene CN with AI at risk loci was observed in 86% (P<0.004 exact binomial test) of the informative tumors.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>No AI was observed in tumors, which did not reveal increased MYC gene CN.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Higher Gleason score was associated with tumors exhibiting AI (P=0.04) and also with increased MYC gene CN (P=0.02).</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Our results suggest that AI at 8q24 and increased MYC gene CN may both be related to high Gleason score in Pca.</Variant>", "label": []}
{"id": "20634801", "text": "<Variant>Our findings also suggest that these two somatic alterations may be due to the same preferential chromosomal duplication event during prostate tumorigenesis.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>Lack of p16 gene mutations in gastric cancers in Kashmir.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>BACKGROUND AND AIM:</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>The focus of the study was to investigate the frequencies of homozygous deletions and mutations of p16 gene in gastric carcinomas in the Kashmiri population.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>A total of 84 gastric carcinoma patients were screened by the single strand conformation polymorphism (SSCP) technique and later by DNA sequencing to detect mutations of the p16 gene.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>Also PCR was applied further to further detect any homozygous deletions.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>RESULTS: SSCP and DNA sequencing performed encompassing all the three exons of p16 gene could not detect any mutations in any ofl 84 cases.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>Though we could observe mobility shifts in SSCP of two samples, subsequent DNA sequencing did not show any mutation.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>Further PCR could not detect any homozygous deletion in P16 in any case.</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>Though Kashmir is a high incidence area of gastric carcinomas, p16gene mutations /or</Variant>", "label": []}
{"id": "20843112", "text": "<Variant>deletions do not appear to be involved.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Clinical and genetic characterization of manifesting carriers of DMD mutations.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Manifesting carriers of DMD gene mutations may present diagnostic challenges, particularly in the absence of a family history of dystrophinopathy.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>We review the clinical and genetic features in 15 manifesting carriers identified among 860 subjects within the United Dystrophinopathy Project, a large clinical dystrophinopathy cohort whose members undergo comprehensive DMD mutation analysis.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>We defined manifesting carriers as females with significant weakness, excluding those with only myalgias/cramps.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>DNA extracted from peripheral blood was used to study X-chromosome inactivation patterns.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Among these manifesting carriers, age at symptom onset ranged from 2 to 47 years.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Seven had no family history and eight had male relatives with Duchenne muscular dystrophy (DMD).</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Clinical severity among the manifesting carriers varied from a DMD-like progression to a very mild Becker muscular dystrophy-like phenotype.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Eight had exonic deletions or duplications and six had point mutations.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>One patient had two mutations (an exonic deletion and a splice site mutation), consistent with a heterozygous compound state.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>The X-chromosome inactivation pattern was skewed toward non-random in four out of seven informative deletions or duplications but was random in all cases with nonsense mutations.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>We present the results of DMD mutation analysis in this manifesting carrier cohort, including the first example of a presumably compound heterozygous DMD mutation.</Variant>", "label": []}
{"id": "20630757", "text": "<Variant>Our results demonstrate that improved molecular diagnostic methods facilitate the identification of DMD mutations in manifesting carriers, and confirm the heterogeneity of mutational mechanisms as well as the wide spectrum of phenotypes.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>Recombinant phenotyping of cytomegalovirus sequence variants detected after 200 or 100 days of valganciclovir prophylaxis.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>In a phase III controlled trial IMproved Protection Against Cytomegalovirus in Transplantation (IMPACT) comparing 200 with 100 days of valganciclovir prophylaxis in 318 cytomegalovirus D+/R- kidney transplant recipients, an equal number of patients (n=3 per arm) had known ganciclovir resistance mutations detected during viral breakthrough.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>In addition, many other viral sequence variants were observed that were of unknown significance for ganciclovir resistance.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>Recombinant phenotyping was performed to determine whether the previously uncharacterized genotypic changes affected ganciclovir susceptibility, especially in those receiving the longer duration of prophylaxis.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>Sequences encoding individual amino acid substitutions in the UL97 kinase or UL54 DNA polymerase gene were transferred by recombination into a cloned cytomegalovirus laboratory strain, followed by reporter-based yield reduction phenotypic assay of the resulting virus for ganciclovir susceptibility.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>RESULTS: Twenty-six uncharacterized amino acid substitutions were detected, 2 in UL97 and 24 in UL54.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>All 10 substitutions in the 200-day arm and 9 of 17 substitutions in the 100-day arm (prioritized based on location and conservation) were selected for phenotyping; one substitution was detected in both subsets.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>Results were generated for nine of ten 200-day and eight of nine 100-day substitutions, with no substitution demonstrating a significant reduction in ganciclovir susceptibility.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>The two remaining amino acid substitutions, both in UL54, were not evaluated because of poor viral viability.</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21030903", "text": "<Variant>Phenotypic evaluation of previously uncharacterized viral genotypes in the 200-day valganciclovir prophylaxis group showed no evidence of an increased incidence of genotypic ganciclovir resistance when compared with those in the 100-day prophylaxis group.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>Monoallelic thyroid peroxidase gene mutation in a patient with congenital hypothyroidism with total iodide organification defect.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>The aim of this study was to identify the genetic defect of a patient with dyshormonogenetic congenital hypothyroidisms (CH) with total iodide organification defect (TIOD).</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>A male child diagnosed with CH during neonatal screening.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>Laboratory tests confirmed the permanent and severe CH with TIOD (99% perchlorate release).</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>The coding sequence of TPO, DUOX2, and DUOXA2 genes and 2957 base pairs (bp) of the TPO promoter were sequenced.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>Molecular analysis of patient's DNA identified the heterozygous duplication GGCC (c.1186_1187insGGCC) in exon 8 of the TPO gene.</Variant>", "label": [[73, 89, "Variant"], [91, 109, "Variant"]]}
{"id": "21340161", "text": "<Variant>No additional mutation was detected either in the TPO gene, TPO promoter, DUOX2 or DUOXA2 genes.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>We have described a patient with a clear TIOD causing severe goitrous CH due to a monoallelic TPO mutation.</Variant>", "label": []}
{"id": "21340161", "text": "<Variant>A plausible explanation for the association between an autosomal recessive disorder with a single TPO-mutated allele is the presence of monoallelic TPO expression.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>GH insensitivity and IGF deficiency may result from aberrations of the GH receptor (GHR).</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>We describe a 4-year-old child with modest growth failure and normal serum concentrations of GH-binding protein (GHBP), but clinical evidence of GH insensitivity.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>METHOD:</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>Serum and DNA samples from the proband and his parents were analyzed.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>The child had a height of -4 SD, elevated serum GH concentrations, abnormally low serum IGF-I and IGFBP-3 concentrations and normal GHBP concentrations.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>DNA analysis revealed compound heterozygosity for mutations of GHR, including a previously reported R211H mutation and a novel duplication of a nucleotide in exon 9 (899dupC), the latter resulting in a frameshift and a premature stop codon.</Variant>", "label": [[109, 114, "Variant"], [136, 173, "Variant"], [175, 182, "Variant"]]}
{"id": "20606392", "text": "<Variant>Treatment with recombinant DNA-derived IGF-I resulted in growth acceleration.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>Mutations affecting the intracellular domain of the GHR can result in GH insensitivity and IGF deficiency, despite normal serum concentrations of GHBP.</Variant>", "label": []}
{"id": "20606392", "text": "<Variant>The presence of clinical and biochemical evidence of GH resistance is sufficient to consider the possibility of aberrations of the GHR, even in the presence of normal serum GHBP concentrations.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>This study was designed to compare thymidylate synthase (TS) genotype, mRNA and protein levels in primary colorectal adenocarcinoma, and to examine the correlation between microsatellite instability (MSI) and TS expression.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>The TS genotype of 68 patients with colorectal cancer was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism analysis in peripheral blood mononuclear cells and tumour tissue.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>The TS mRNA levels in tumour tissue were measured by reverse-transcription PCR, and TS protein levels and MSI status were assessed using immunohistochemistry.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>Significantly higher mRNA and protein levels were observed in patients with the TS 3R/3R versus the 2R/2R and 2R/3R genotypes.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>There was no correlation between TS single nucleotide polymorphism and TS expression.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>Individuals homozygous for the six base-pair insertion in the 3'-untranslated region had significantly higher TS mRNA levels than heterozygous and homozygous wild type individuals.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>The TS mRNA and protein levels were significantly higher in microsatellite unstable tumours compared with microsatellite stable tumours.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>There was a significant association between the number of TS enhancer region repeats (in blood) and intratumoural TS mRNA and protein levels.</Variant>", "label": []}
{"id": "20515563", "text": "<Variant>A larger case series investigating the role of TS gene polymorphisms as predictors of sensitivity to 5-fluorouracil-based chemotherapy is required.</Variant>", "label": []}
{"id": "20143913", "text": "<Variant>Large deletion involving exon 5 of the arylsulfatase B gene caused apparent homozygosity in a mucopolysaccharidosis type VI patient.</Variant>", "label": []}
{"id": "20143913", "text": "<Variant>Apparent homozygosity for the mutation p.R315X</Variant>", "label": [[48, 55, "Variant"]]}
{"id": "20143913", "text": "<Variant>present on exon 5 of the arylsulfatase B (ARSB) gene in a mucopolysaccharidosis type VI patient was solved in this study by further testing for a second mutation.</Variant>", "label": []}
{"id": "20143913", "text": "<Variant>Patient cDNA analysis revealed that the entire exon 5 of the ARSB gene was lacking; this new mutation was identified as c.899-1142del.</Variant>", "label": [[129, 142, "Variant"]]}
{"id": "20143913", "text": "<Variant>As the genomic DNA sequencing excluded the presence of splicing mutations, polymerase chain reaction analysis was performed for polymorphisms listed in the NCBI SNP database for the ARSB gene.</Variant>", "label": []}
{"id": "20143913", "text": "<Variant>This allowed the mutation at the genomic DNA level to be identified as g.99367-102002del; this gross deletion, involving the entire exon 5 of the gene and parts of introns 4 and 5 led to a frameshift starting at amino acid 300 and resulting in a protein with 39% amino acids different from the normal enzyme.</Variant>", "label": [[80, 97, "Variant"]]}
{"id": "20143913", "text": "<Variant>We stress that extensive DNA analysis needs to be performed in case of apparent homozygosity to avoid potential errors in genetic counseling.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.</Variant>", "label": [[90, 96, "Variant"]]}
{"id": "20026870", "text": "<Variant>INTRODUCTION:</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Prostate cancer is one of the most common malignant neoplasias in developed countries.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>In 2003, 6,536 new cases and 4,602 related deaths were reported in Mexico.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>The renin-angiotensin system has been shown to play a role in prostate cancer pathology.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Two previous studies investigated the association of prostate cancer with the insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme (ACE) gene; both studies reported an association between prostate cancer and the DD genotype.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>The present study was aimed at searching for an association of prostate cancer and benign prostatic hyperplasia with the I/D polymorphism in the ACE gene and the A1166C polymorphism in the angiotensin type 1 receptor (AGT1R) gene and at comparing allele frequencies between both groups and the general population.</Variant>", "label": [[171, 177, "Variant"]]}
{"id": "20026870", "text": "<Variant>MATERIALS AND METHODS:</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>DNA was extracted from 20 samples from individuals with a prostate cancer diagnosis and from 20 samples from individuals with a benign prostatic hyperplasia diagnosis.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Genotyping was performed by PCR-RFLP analysis.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Polymorphism frequency results obtained for the test groups were compared with the frequencies in 66 individuals from the general population, which were previously obtained at the same molecular medicine laboratory in the context of other studies.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>The comparative analysis of the three groups revealed significant differences for allele frequencies in the two genes in patients groups (prostate cancer and benign prostatic hyperplasia) versus the general population.</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>The D allele in the ACE gene was closely associated with a significant higher risk of developing both benign prostatic hyperplasia (odds ratio [OR]=21.87; 95% confidence interval</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>[CI]=2.314-206.479) or prostate cancer (OR=31.66; 95% CI=0.091-1.272), and the AGT1R A1166 allele in the homozygote state was identified as a risk genotype for benign prostatic hyperplasia (OR=56.07).</Variant>", "label": [[94, 99, "Variant"]]}
{"id": "20026870", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20026870", "text": "<Variant>Genotypes in ACE and AGT1R polymorphisms could be considered as genetic risk markers for benign prostatic hyperplasia or prostate cancer.</Variant>", "label": []}
{"id": "19958188", "text": "<Variant>Molecular analysis of gamma-globin promoters, HS-111 and 3'HS1, in beta-thalassemia intermedia patients associated with high levels of Hb F.</Variant>", "label": []}
{"id": "19958188", "text": "<Variant>The nucleotide (nt) variations in the promoter region of the gamma-globin genes, HS-111 and 3'HS1 regions, were studied in Iranian patients with beta-thalassemia intermedia (beta-TI), beta-thalassemia major (beta-TM) and healthy individuals.</Variant>", "label": []}
{"id": "19958188", "text": "<Variant>Of the five nt variations at the 5' end of the (A)gamma-globin gene, -369 (C>G), -611 (-T)</Variant>", "label": [[78, 88, "Variant"], [90, 99, "Variant"]]}
{"id": "19958188", "text": "<Variant>and -603/604 (GA>AG) were found in all samples, whereas -588 (A>G) and -AAGC at -222 to -225 were found at different frequencies in the studied groups.</Variant>", "label": [[13, 29, "Variant"], [65, 75, "Variant"], [80, 101, "Variant"]]}
{"id": "19958188", "text": "<Variant>Therefore, the -369, -611 and -603/604 variations were considered common mutations in this population, and the difference with respect to the -AAGC deletion was not significant.</Variant>", "label": [[152, 165, "Variant"]]}
{"id": "19958188", "text": "<Variant>However, the A allele of the -588 variation and [+] allele of the XmnI polymorphism were more frequent in beta-TI patients, especially those who had the IVS-II-1(G>A)/IVS-II-1(G>A) genotype.</Variant>", "label": [[22, 42, "Variant"], [162, 175, "Variant"], [176, 189, "Variant"]]}
{"id": "19958188", "text": "<Variant>The + allele of XmnI also had complete correlation with the A allele of -588 variation.</Variant>", "label": [[69, 85, "Variant"]]}
{"id": "19958188", "text": "<Variant>The HS-111 (-21 A) variation also showed association with beta-TI patients who had high levels of Hb F. Bearing in mind that the -588 variation lies within the postulated adult-specific silencer region and that the majority of beta-TI patients had allele A, then it can be envisaged that this allele could have a role in altering the repressor function at this region.</Variant>", "label": [[21, 26, "Variant"]]}
{"id": "19958188", "text": "<Variant>Therefore, the A allele of -588, [+] allele of XmnI and HS-111 (-21 A) variation are useful genetic markers to differentiate between beta-TM and beta-TI patients.</Variant>", "label": [[24, 40, "Variant"], [73, 78, "Variant"]]}
{"id": "19958188", "text": "<Variant>However, these nt changes alone may not be the only elements raising the level of Hb F, other regulatory and modifying factors also play a role in Hb F production.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>Multiple trichoepitheliomas--a novel mutation in the CYLD gene.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>BACKGROUND: Trichoepitheliomas are benign neoplasms with follicular differentiation.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>They may present as a solitary lesion or as multiple lesions.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>Multiple trichoepitheliomas are inherited in an autosomal dominant pattern within families, with both variable penetrance and expressivity.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>Recent investigations support that mutations in CYLD, the gene affected in familial cylindromatosis as well as in Brooke-Spiegler syndrome, are also responsible for multiple trichoepitheliomas.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>The authors report the case of a 9-year-old African girl with multiple facial trichoepitheliomas in whom a mutation in the CYLD gene was hypothesised.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>MATERIALS AND METHODS:</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>After genomic DNA extraction from the peripheral blood, a molecular analysis of the CYLD gene was performed by PCR, DHPLC and automated sequencing.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>A novel heterozygous mutation in exon 18 of the CYLD gene (c.2449delT) was identified, with a deletion of one nucleotide resulting in a premature translational termination codon at amino acid position 831 on the affected allele (p.Cys817Valfs X15).</Variant>", "label": [[68, 78, "Variant"], [169, 213, "Variant"], [238, 255, "Variant"]]}
{"id": "19929939", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>The predominating tumours define the classification of these three entities.</Variant>", "label": []}
{"id": "19929939", "text": "<Variant>Nevertheless, studies suggest that they can simply represent phenotypic variations of the same disease spectrum, sharing common genetic mutations.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>However, information about FOXP3 gene in psoriasis is limited.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males).</Variant>", "label": [[54, 73, "Variant"], [75, 85, "Variant"], [87, 96, "Variant"], [98, 111, "Variant"]]}
{"id": "19880293", "text": "<Variant>The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype.</Variant>", "label": [[81, 89, "Variant"], [228, 236, "Variant"]]}
{"id": "19880293", "text": "<Variant>We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58).</Variant>", "label": [[89, 100, "Variant"]]}
{"id": "19880293", "text": "<Variant>However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype.</Variant>", "label": [[127, 138, "Variant"]]}
{"id": "19880293", "text": "<Variant>There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score >20; adjusted OR=1.97, 95% CI=1.41-2.75).</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).</Variant>", "label": [[30, 44, "Variant"]]}
{"id": "19880293", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population.</Variant>", "label": []}
{"id": "19880293", "text": "<Variant>Larger studies are needed to confirm these findings.</Variant>", "label": []}
{"id": "19804530", "text": "<Variant>A LDR-PCR approach for multiplex polymorphisms genotyping of severely degraded DNA with fragment sizes <100 bp.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>Children with 22q11.2 deletion syndrome (22q11.2DS) have a wide range of clinical features.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>TBX1 has been proposed as a candidate gene for some of the features in this condition.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>Polymorphisms in the nondeleted TBX1, which may affect the function of the sole TBX1 gene in individuals with the 22q11.2DS, may be a key to understanding the phenotypic variability among individuals with a shared deletion.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>Comprehensive single nucleotide polymorphism (SNP) discovery by resequencing candidate genes can identify genetic variants that influence a given phenotype.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>The purpose of this study was to further characterize the sequence variability in TBX1 by identifying all common SNPs in this gene.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>We resequenced TBX1 in 29 children with a documented 22q11.2 deletion and 95 nondeleted, healthy individuals.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>We estimated allele frequencies, performed tagSNP selection, and inferred haplotypes.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>We also compared SNP frequencies between 22q11.2DS and control samples.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>We identified 355 biallelic markers among the 190 chromosomes resequenced in the control panel.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>The vast majority of the markers identified were SNPs (n = 331), and the remainder indels (n = 24).</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>We did not identify SNPs or indels in the cis- regulatory element (FOX-binding site) upstream of TBX1.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>In children with 22q11.2DS we detected 187 biallelic markers, six of which were indels.</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>Four of the seven coding SNPs identified in the controls were identified in children with 22q11.2DS. CONCLUSIONS:</Variant>", "label": []}
{"id": "19645056", "text": "<Variant>This comprehensive SNP discovery data can be used to select SNPs to genotype for future association studies assessing the role of TBX1 and phenotypic variability in individuals with 22q11.2DS.</Variant>", "label": []}
{"id": "19592582", "text": "<Variant>Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.</Variant>", "label": []}
{"id": "19592582", "text": "<Variant>Mutations leading to abrogation of matriptase-2 proteolytic activity in humans are associated with an iron-refractory iron deficiency anemia (IRIDA) due to elevated hepcidin levels.</Variant>", "label": []}
{"id": "19592582", "text": "<Variant>Here we describe two novel heterozygous mutations within the matriptase-2 (TMPRSS6) gene of monozygotic twin girls exhibiting an IRIDA phenotype.</Variant>", "label": []}
{"id": "19592582", "text": "<Variant>The first is the frameshift mutation (P686fs) caused by the insertion of the four nucleotides CCCC in exon 16 (2172_2173insCCCC) that is predicted to terminate translation before the catalytic serine.</Variant>", "label": [[47, 53, "Variant"], [69, 107, "Variant"], [120, 136, "Variant"]]}
{"id": "19592582", "text": "<Variant>The second mutation is the di-nucleotide substitution c.467C>A and c.468C>T in exon 3 that causes the missense mutation A118D in the SEA domain of the extracellular stem region of matriptase-2.</Variant>", "label": [[63, 71, "Variant"], [76, 84, "Variant"], [129, 134, "Variant"]]}
{"id": "19592582", "text": "<Variant>Functional analysis of both variant matriptase-2 proteases has revealed that they lead to ineffective suppression of hepcidin transcription.</Variant>", "label": []}
{"id": "19592582", "text": "<Variant>We also demonstrate that the A118D SEA domain mutation causes an intra-molecular structural imbalance that impairs matriptase-2 activation.</Variant>", "label": [[38, 43, "Variant"]]}
{"id": "19592582", "text": "<Variant>Collectively, these results extend the pattern of TMPRSS6 mutations associated with IRIDA and functionally demonstrate that mutations affecting protease regions other than the catalytic domain may have a profound impact in the regulatory role of matriptase-2 during iron deficiency.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Asthma is a chronic inflammatory disease of the airways.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Several candidate genes have been identified with a potential role in the pathogenesis of asthma, including the angiotensin converting enzyme (ACE) gene.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>We aimed to investigate the frequency of an ACE gene polymorphism in Turkish asthmatic patients and to determine its impact on clinical parameters and disease severity.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Ninety-seven asthmatic patients (M/F 25/72, mean age 39 +/- 13 years) and 96 healthy subjects (M/F 26/70, mean age 38 +/- 12 years) were included.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>At baseline, all participants completed a questionnaire on demographics, symptoms, triggering factors, severity of asthma, and the presence of atopism.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Blood samples were obtained from all patients and genomic DNA was isolated.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>The frequency of the ACE genotypes (I = insertion and D = deletion) among asthmatics and controls were compared: asthmatics showed a 40.2% prevalence of the DD genotype (n = 39), ID was 45.4% (n = 44), and II was 14.4% (n = 14.4).</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>In the control subjects, the frequency of DD was 18.8% (n = 18), ID was 50% (n = 48) and II was 31.3% (n = 30).</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>The DD ACE genotype was significantly more frequent in asthmatics compared with controls (p < 0.001).</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Asthmatics with the ID ACE genotype showed a higher frequency of drug allergies, although this was not statistically significant (p = 0.08).</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Asthmatics with the DD genotype appeared to have a higher incidence of asthmatic episode exacerbations due to viral infections, but again this was not statistically significant (p = 0.08).</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>Patients with mild or moderate-severe asthma had similar frequencies of these mutations.</Variant>", "label": []}
{"id": "19484664", "text": "<Variant>We found a higher frequency of the ACE DD gene mutation in Turkish asthmatic patients compared with non-asthmatics, suggesting that this ACE gene polymorphism may be a risk factor for asthma but does not increase the severity of the disease.</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.</Variant>", "label": [[30, 37, "Variant"]]}
{"id": "19476483", "text": "<Variant>BACKGROUND: C-C chemokine receptor 5 (CCR5) is involved in the regulation of the inflammatory response.</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>Abdominal aortic aneurysms (AAA) may arise as the result of a chronic inflammatory process which is influenced by genetic predisposition.</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>The CCR5 gene is associated with a 32 base pair deletion (the Delta32 polymorphism).</Variant>", "label": [[44, 65, "Variant"], [71, 78, "Variant"]]}
{"id": "19476483", "text": "<Variant>The aim of this study was to investigate the role of the CCR5 Delta32 polymorphism in the development of AAA.</Variant>", "label": [[71, 78, "Variant"]]}
{"id": "19476483", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>A case-control study was conducted including 285 patients with AAA and 273 control subjects.</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>A blood sample was taken from each individual and DNA was extracted.</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>CCR5 genotype was determined using the polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>Flow cytometry was used to investigate the biological activity of the Delta32 polymorphism.</Variant>", "label": [[79, 86, "Variant"]]}
{"id": "19476483", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>There was no significant difference between the AAA and the control group in relation to the Delta32 allele frequency (AAA group 10%, control group = 12%, P = 0.82, chi-squared analysis).</Variant>", "label": [[102, 109, "Variant"]]}
{"id": "19476483", "text": "<Variant>Genotype analysis revealed no significant difference between the groups (AAA vs. controls, wild-type homozygotes = 82% vs. 77%, heterozygotes = 16% vs. 21%, vs. Delta32 homozygotes = 2% and 2%, respectively, P = 0.33, chi-squared analysis).</Variant>", "label": [[170, 177, "Variant"]]}
{"id": "19476483", "text": "<Variant>The polymorphism was shown to be biologically active with the number of Delta32 alleles correlating with cell expression of ccr5 as detected with flow cytometry (P < or = 0.05).</Variant>", "label": [[81, 88, "Variant"]]}
{"id": "19476483", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "19476483", "text": "<Variant>This study demonstrates that the ccr5 Delta32 is a biologically active genetic polymorphism; however, there is no association between this polymorphism and AAA.</Variant>", "label": [[47, 54, "Variant"]]}
{"id": "19473658", "text": "<Variant>Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).</Variant>", "label": [[87, 105, "Variant"]]}
{"id": "19473658", "text": "<Variant>We report a novel apolipoprotein A-I (apoA-I) mutation identified in a 64-year-old patient with marked plasma high density lipoprotein (HDL) cholesterol (4 mg/dl) and apoA-I (5mg/dl) deficiency, prior myocardial infarction, and moderate corneal opacities.</Variant>", "label": []}
{"id": "19473658", "text": "<Variant>Coronary angiography revealed extensive atherosclerosis in all three major vessels.</Variant>", "label": []}
{"id": "19473658", "text": "<Variant>Genomic DNA sequencing of the proband revealed a homozygous novel deletion of two successive adenine residues in codon 138 in the apoA-I gene, resulting in a frameshift mutation at amino acid residues 138-178, which we have designated as apoA-I Tomioka.</Variant>", "label": [[75, 131, "Variant"]]}
{"id": "19473658", "text": "<Variant>His elder brother was also homozygous for apoA-I Tomioka with marked HDL cholesterol and apoA-I deficiency, but had no clinical evidence of coronary heart disease.</Variant>", "label": []}
{"id": "19473658", "text": "<Variant>Other family members including three siblings and two sons were heterozygous for the mutation, and had approximately 50% of normal plasma HDL cholesterol, and apoA-I. Analysis of apoA-I-containing HDL particles by two-dimensional gel electrophoresis revealed undetectable apoA-I HDL particles in the homozygotes, while in heterozygotes, the mean concentrations of apoA-I in large alpha-1 and very small prebeta-1 HDL subpopulations were significantly decreased at about 35% of normal.</Variant>", "label": []}
{"id": "19473658", "text": "<Variant>Thus, apoA-I Tomioka, a novel deletion mutation in codon 138 of the apoA-I gene, is the causative defect in this case of HDL deficiency.</Variant>", "label": [[39, 69, "Variant"]]}
{"id": "19448408", "text": "<Variant>Correlation of polymorphism of the coding region of glutathione S- transferase M1 to susceptibility of nasopharyngeal carcinoma in South China population.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>BACKGROUND AND OBJECTIVE:</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>Glutathione S-transferase M1 (GSTM1) deficiency may increase the risk of nasopharyngeal carcinoma (NPC).</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>This study was to evaluate the correlation of the single nucleotide polymorphism (SNP) in the coding region of GSTM1 gene to NPC susceptibility in southern China population.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>In total 239 NPC patients and 286 age-matched healthy controls were entered into the study.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>Among them, 225 out of 239 NPC patients and 273 out of 286 controls were used for statistical analysis.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>SNP screening of all exons, relevant intron-exon boundaries, and the promoter region of GSTM1, in total 4739bp, was performed by PCR direct sequencing.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>The loci T1270533G and C1256088C were selected for the case-control study using the tetra-Primer ARMS-PCR, as well as the sequencing method.</Variant>", "label": [[18, 27, "Variant"], [32, 41, "Variant"]]}
{"id": "19448408", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>In total 29 SNPs of GSTM1 were identified by sequencing.</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>Missense mutation occurred in the polymorphic loci of T1270533G and C1256088C.</Variant>", "label": [[63, 72, "Variant"], [77, 86, "Variant"]]}
{"id": "19448408", "text": "<Variant>However, no evident relationships between the variants of T1270533G and clinical phenotypes of NPC were observed in the NPC group and healthy control group (OR = 0.170, 95%CI = 0.95-0.306 for homozygote TT).</Variant>", "label": [[67, 76, "Variant"]]}
{"id": "19448408", "text": "<Variant>The deletion frequency of C1256088C was 45% (45/100) for NPC patients and 42% (42/100) for controls.</Variant>", "label": [[35, 44, "Variant"]]}
{"id": "19448408", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19448408", "text": "<Variant>The polymorphism of T1270533G does not affect the detoxification function of GSTM1.</Variant>", "label": [[29, 38, "Variant"]]}
{"id": "19448408", "text": "<Variant>The T1270533G locus has no apparent association with genetic susceptibility to NPC in the southern China population.</Variant>", "label": [[13, 22, "Variant"]]}
{"id": "19448408", "text": "<Variant>The loss rate of C1256088C is high in this study.</Variant>", "label": [[26, 35, "Variant"]]}
{"id": "19435819", "text": "<Variant>High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Glioblastoma multiforme (GBM) is an extremely malignant brain tumor.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>To identify new genomic alterations in GBM, genomic DNA of tumor tissue/explants from 55 individuals and 6 GBM cell lines were examined using single nucleotide polymorphism DNA microarray (SNP-Chip).</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Further gene expression analysis relied on an additional 56 GBM samples.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>SNP-Chip results were validated using several techniques, including quantitative PCR (Q-PCR), nucleotide sequencing, and a combination of Q-PCR and detection of microsatellite markers for loss of heterozygosity with normal copy number [acquired uniparental disomy (AUPD)].</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Whole genomic DNA copy number in each GBM sample was profiled by SNP-Chip.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Several signaling pathways were frequently abnormal.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Either the p16(INK4A)/p15(INK4B)-CDK4/6-pRb or p14(ARF)-MDM2/4-p53 pathways were abnormal in 89% (49 of 55) of cases.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Simultaneous abnormalities of both pathways occurred in 84% (46 of 55) samples.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>The phosphoinositide 3-kinase pathway was altered in 71% (39 of 55) GBMs either by deletion of PTEN or amplification of epidermal growth factor receptor and/or vascular endothelial growth factor receptor/platelet-derived growth factor receptor alpha.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Deletion of chromosome 6q26-27 often occurred (16 of 55 samples).</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>The minimum common deleted region included PARK2, PACRG, QKI, and PDE10A genes.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Further reverse transcription Q-PCR studies showed that PARK2 expression was decreased in another collection of GBMs at a frequency of 61% (34 of 56) of samples.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>The 1p36.23 region was deleted in 35% (19 of 55) of samples.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Notably, three samples had homozygous deletion encompassing this site.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Also, a novel internal deletion of a putative tumor suppressor gene, LRP1B, was discovered causing an aberrant protein.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>AUPDs occurred in 58% (32 of 55) of the GBM samples and five of six GBM cell lines.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>A common AUPD was found at chromosome 17p13.3-12 (included p53 gene) in 13 of 61 samples and cell lines.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Single-strand conformational polymorphism and nucleotide sequencing showed that 9 of 13 of these samples had homozygous p53 mutations, suggesting that mitotic recombination duplicated the abnormal p53 gene, probably providing a growth advantage to these cells.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>A significantly shortened survival time was found in patients with 13q14 (RB) deletion or 17p13.1 (p53) deletion/AUPD.</Variant>", "label": []}
{"id": "19435819", "text": "<Variant>Taken together, these results suggest that this technique is a rapid, robust, and inexpensive method to profile genome-wide abnormalities in GBM.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Pure monosomy and pure trisomy of 13q21.2-31.1 consequent to a familial insertional translocation: exclusion of PCDH9 as the responsible gene for autosomal dominant auditory neuropathy (AUNA1).</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Insertional translocations (IT) are rare structural rearrangements.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Offspring of IT balanced carriers are at high risk to have either pure partial trisomy or monosomy for the inserted segment as manifested by \"pure\" phenotypes.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>We describe an IT between chromosomes 3 and 13 segregating in a three-generation pedigree.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Short tandem repeat (STR) segregation analysis and array-comparative genomic hybridization were used to define the IT as a 25.1 Mb segment spanning 13q21.2-q31.1.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>The phenotype of pure monosomy included deafness, duodenal stenosis, developmental and growth delay, vertebral anomalies, and facial dysmorphisms; the trisomy was manifested by only minor dysmorphisms.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>As the AUNA1 deafness locus on 13q14-21 overlaps the IT in the PCDH9 (protocadherin-9) gene region, PCDH9 was investigated as a candidate gene for deafness in both families.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Genotyping of STRs and single nucleotide polymorphisms defined the AUNA1 breakpoint as 35 kb 5' to PCDH9, with a 2.4 Mb area of overlap with the IT.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>DNA sequencing of coding regions in the AUNA1 family and in the retained homologue chromosome in the monosomic patient revealed no mutations.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>We conclude that AUNA1 deafness does not share a common etiology with deafness associated with monosomy 13q21.2-q31.3; deafness may result from monosomy of PCHD9 or another gene in the IT, as has been demonstrated in contiguous gene deletion syndromes.</Variant>", "label": []}
{"id": "19353688", "text": "<Variant>Precise characterization of the breakpoints of the translocated region is useful to identify which genes may be contributing to the phenotype, either through haploinsufficiency or extra dosage effects, in order to define genotype-phenotype correlations.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>Spinal muscular atrophy (SMA) is an autosomal recessive disease caused, in about 95% of SMA cases, by homozygous deletion of the survival motor neuron 1 (SMN1) gene or its conversion to the highly homologous SMN2 gene.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>The molecular diagnosis of SMA is usually carried out by a PCR-Restriction fragment length polymorphism (RFLP) approach.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>However, this approach is not useful for identification of healthy deletion carriers.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>TaqMan technology is one of the most reliable and widely adopted techniques for the SMN1 copy number evaluation.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>However, several limitations of this technique have been described.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>Particularly, DNA extraction methods and accurate template quantification have been shown to be critical for reliable results.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>In this work, we set up a reliable, highly reproducible, and easy-to-perform TaqMan technology-based protocol to obtain the SMN1 gene copy number assessment.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>We demonstrate that PCR amplification of both target gene and reference gene in the same reaction mix, instead of separated mixes, greatly reduces reported criticisms of simplex TaqMan technology.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>The multiplex real-time PCR we describe allows interlaboratory samples and data exchange, without the need to equalize the DNA isolation technique.</Variant>", "label": []}
{"id": "19309272", "text": "<Variant>Further, the protocol described below requires fewer replica tests than the simplex methodology does, leading to reduced overall cost for the diagnostic assay.</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>Identification of newly polymorphic intron 40 markers of the von Willebrand factor gene in a Japanese population.</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>We investigated a region of repetitive DNA located in intron 40 of the von Willebrand factor (vWF) gene (nucleotides [nt] 1639-2404; i.e., F8VWF).</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>We identified 13 alleles and 33 genotypes in 49 unrelated Japanese individuals.</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>The heterozygosity of the region was 0.897.</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>Direct sequence analyses revealed five single-base substitutions, one tetranucleotide (TTAT) insertion, and seven short tandem repeats (STRs) in the intron; four of the STRs and one single-base substitution had been reported previously.</Variant>", "label": [[95, 111, "Variant"]]}
{"id": "19144556", "text": "<Variant>The four new base substitutions we identified were 1849T>A, 2122C>T, 2180C>T, and 2192C></Variant>", "label": [[60, 67, "Variant"], [69, 76, "Variant"], [78, 85, "Variant"], [91, 98, "Variant"]]}
{"id": "19144556", "text": "<Variant>T.</Variant>", "label": []}
{"id": "19144556", "text": "<Variant>The novel TTAT tetranucleotide was inserted between nt 2057 and 2058.</Variant>", "label": [[18, 76, "Variant"]]}
{"id": "19144556", "text": "<Variant>The three newly identified STRs were 1978(TATC)(1-2), 2193(ATCT)(5-13), and 2234(TGTA)(5-7).</Variant>", "label": [[45, 60, "Variant"], [62, 78, "Variant"], [84, 99, "Variant"]]}
{"id": "19144556", "text": "<Variant>The five single-base substitutions and the TTAT insertion were identified only with 3' downstream of vWA allele 14.</Variant>", "label": [[51, 65, "Variant"]]}
{"id": "19048115", "text": "<Variant>Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Ovarian serous carcinoma (OSC) is the most common and lethal histologic type of ovarian epithelial malignancy.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Mutations of TP53 and dysfunction of the Brca1 and/or Brca2 tumor-suppressor proteins have been implicated in the molecular pathogenesis of a large fraction of OSCs, but frequent somatic mutations in other well-established tumor-suppressor genes have not been identified.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Using a genome-wide screen of DNA copy number alterations in 36 primary OSCs, we identified two tumors with apparent homozygous deletions of the NF1 gene.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Subsequently, 18 ovarian carcinoma-derived cell lines and 41 primary OSCs were evaluated for NF1 alterations.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Markedly reduced or absent expression of Nf1 protein was observed in 6 of the 18 cell lines, and using the protein truncation test and sequencing of cDNA and genomic DNA, NF1 mutations resulting in deletion of exons and/or aberrant splicing of NF1 transcripts were detected in 5 of the 6 cell lines with loss of NF1 expression.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>Similarly, NF1 alterations including homozygous deletions and splicing mutations were identified in 9 (22%) of 41 primary OSCs.</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>As expected, tumors and cell lines with NF1 defects lacked mutations in KRAS or BRAF but showed Ras pathway activation based on immunohistochemical detection of phosphorylated MAPK (primary tumors) or increased levels of GTP-bound Ras (cell lines).</Variant>", "label": []}
{"id": "19048115", "text": "<Variant>The TP53 tumor-suppressor gene was mutated in all OSCs with documented NF1 mutation, suggesting that the pathways regulated by these two tumor-suppressor proteins often cooperate in the development of ovarian carcinomas with serous differentiation.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>Interstitial collagenase-1 degrades a variety of extracellular matrix components.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>A single guanine insertion polymorphism in the promoter has been found that influences on the transcription and expression level of the gene.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>It is suggested that this polymorphism may enhance susceptibility to some types of cancer.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>Therefore, this case-control study evaluated the association of this genotype polymorphism with susceptibility to initiation and invasion of colorectal cancer.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>For this reason, whole blood samples were obtained from 150 CRC patients and 100 control subjects in Tehran.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>Genomic DNA was extracted and genotyped by PCR-RFLP method.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>We showed that 2G allele and 2G/2G genotype had higher frequencies in patients (60% and 39%, respectively) than in controls (47% and 23%, respectively).</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>The CRC patients were divided into two groups: with metastasis (M+) and without metastasis (M-) groups.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>The 2G allele was more frequent in M+ group compared with control group.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>However, no significantly difference was observed between M-group and control (chi(2) = 0.48, P = 0.78 for 2G/2G genotype).</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>Further stratification analyses showed that only gender (OR = 2.58, 95% CI = 0.89-7.52 for women and OR = 4.12, 95% CI = 1.62-10.42 for men) and smoking (OR = 3.03, 95% CI = 1.28-7.16 for non-smokers and OR = 4.09, 95% CI = 1.18-4.15 for smoker) may modify the risk of colorectal invasion related to 2G/2G genotype.</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>Furthermore, individual with 2G/2G genotype seems to spread metastasis, 3 years earlier than those who were 1G/1G and</Variant>", "label": []}
{"id": "18798060", "text": "<Variant>1G/2G. In conclusion, to our knowledge, the present epidemiological study for the first time indicates the relationship of 2G/2G genotype polymorphism with invasion risk of colorectal cancer in subgroups of gender and smoking, especially in smoker men.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding.</Variant>", "label": [[75, 90, "Variant"]]}
{"id": "18791947", "text": "<Variant>More than 20 DNA mutations with different inheritance pattern have been described in patients with Bernard-Soulier Syndrome (BSS), leading to abnormal or absent synthesis and/or expression of GPIbalpha.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>Clinical phenotype shows considerable variation between individuals, such as bleeding, platelet count and the percentage of large platelets.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>We describe in a BSS patient the first case of homozygous four bases deletion (TGAG) in the gpIbalpha gene coding sequence, leading to a premature stop codon.</Variant>", "label": [[78, 93, "Variant"]]}
{"id": "18791947", "text": "<Variant>In the propositus, blood smears revealed giant platelets (30 x 10(9) platelets/L), and platelet agglutination to ristocetin was absent.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>Propositus' parents are consanguineous.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>His father and paternal grandmother showed a mild thrombocytopenia (108 x 10(9)/L and 120 x 10(9)/L platelets respectively) while mothers and sister's referred normal platelet counts.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>The surface expression of GPIbalpha was practically undetectable by flow-cytometry and western blot in the patient and was reduced in the father.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>Proband's DNA analysis revealed a homozygous four-base-pair deletion (TGAG), starting from the last base of the codon for Ser39, leading to a coding frame shift with a new termination codon after 11 novel amino acids.</Variant>", "label": [[69, 84, "Variant"], [131, 136, "Variant"]]}
{"id": "18791947", "text": "<Variant>The same mutation was seen in heterozygosis in both parents.</Variant>", "label": []}
{"id": "18791947", "text": "<Variant>This is the first report of GPIbalpha TGAG deletion in homozygous state even if the defect has already been described in a case of compound heterozygosis.</Variant>", "label": [[47, 60, "Variant"]]}
{"id": "18791947", "text": "<Variant>Surprisingly, the propositus does not report any spontaneous bleeding tendency.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?</Variant>", "label": [[74, 81, "Variant"]]}
{"id": "18790087", "text": "<Variant>We studied the possible effects of the expansion of ancient Mediterranean civilizations during the five centuries before and after Christ on the European distribution of the mutant allele for the chemokine receptor gene CCR5 which has a 32-bp deletion (CCR5-Delta32).</Variant>", "label": [[246, 260, "Variant"], [267, 274, "Variant"]]}
{"id": "18790087", "text": "<Variant>There is a strong evidence for the unitary origin of the CCR5-Delta32 mutation, this it is found principally in Europe and Western Asia, with generally a north-south downhill cline frequency.</Variant>", "label": [[71, 78, "Variant"]]}
{"id": "18790087", "text": "<Variant>Homozygous carriers of this mutation show a resistance to HIV-1 infection and a slower progression towards AIDS.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>However, HIV has clearly emerged too recently to have been the selective force on CCR5.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>Our analyses showed strong negative correlations in Europe between the allele frequency and two historical parameters, i.e. the first colonization dates by the great ancient Mediterranean civilizations, and the distances from the Northern frontiers of the Roman Empire in its greatest expansion.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>Moreover, other studies have shown that the deletion frequencies in both German Bronze Age and Swedish Neolithic populations were similar to those found in the corresponding modern populations, and this deletion has been found in ancient DNA of around 7000 years ago, suggesting that in the past, the deletion frequency could have been relatively high in European populations.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>In addition, in West Nile virus pathogenesis, CCR5 plays an antimicrobial role showing that host genetic factors are highly pathogen-specific.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>Our results added to all these previous data suggest that the actual European allele frequency distribution might not be due to genes spreading, but to a negative selection resulting in the spread of pathogens principally during Roman expansion.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>Indeed, as gene flows from colonizers to European native populations were extremely low, the mutational changes might be associated with vulnerability to imported infections.</Variant>", "label": []}
{"id": "18790087", "text": "<Variant>To date, the nature of the parasites remains unknown; however, zoonoses could be incriminated.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>Identification of rifampin-resistant genotypes in Mycobacterium tuberculosis by PCR-reverse dot blot hybridization.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>A PCR-reverse dot blot hybridization (RDBH) assay was developed for rapid identification of rifampin (RFP)-resistant genotypes in Mycobacterium tuberculosis clinical isolates.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>The assay used the rpoB gene as target and was used to evaluate 148 clinical isolates (97 RFP-resistant isolates and 51 RFP-susceptible isolates).</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>At the same time, the isolates were subjected to DNA sequencing and conventional drug susceptibility test.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>One hundred and forty one (95.3%) and 136 (91.9%) of the 148 strains were correctly identified by DNA sequencing and RDBH assay, respectively.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>None of the 51 RFP-susceptible isolates examined had alterations in rpoB. The sensitivity and specificity of the DNA sequencing were 92.8% and 100%, and the positive predictive value (PPV) and negative predictive value (NPV) were 100% and 87.9%, respectively.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>The sensitivity and specificity of the RDBH assay were 87.6% and 100%, and the PPV and NPV were 100% and 81.0%, respectively.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>Codons 531 and 526 of the rpoB were found to be the most common sites of nucleotide substitutions.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>Mutations at codons 511, 513, 515, 516, 517, 518, and 533 were also found.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>There were two-codon mutations in four isolates.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>No deletion and insertion was found in the rpoB gene.</Variant>", "label": []}
{"id": "18600483", "text": "<Variant>These results indicate that the RDBH assay is a rapid, simple, and reliable method for routine identification of RFP resistance in M. tuberculosis.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>BACKGROUND: Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular matrix of the intervertebral disc.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>A SNP for guanine insertion/deletion (G/D), the -1607 promoter polymorphism, of the MMP1 gene was found significantly affecting promoter activity and corresponding transcription level.</Variant>", "label": [[19, 84, "Variant"]]}
{"id": "18439317", "text": "<Variant>Hence it is a good candidate for genetic studies in DDD.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>METHODS: Southern Chinese volunteers between 18 and 55 years were recruited from the population.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>DDD in the lumbar spine was defined by MRI using Schneiderman's classification.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Genomic DNA was isolated from the leukocytes and genotyping was performed using the Sequenom platform.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Association and Hardy-Weinberg equilibrium checking were assessed by Chi-square test and Mann-Whitney U test.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Our results showed substantial evidence of association between -1607 promoter polymorphism of MMP1 and DDD in the Southern Chinese subjects.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>D allelic was significantly associated with DDD (p value = 0.027, odds ratio = 1.41 with 95% CI = 1.04-1.90) while Genotypic association on the presence of D allele was also significantly associated with DDD (p value = 0.046, odds ratio = 1.50 with 95% CI = 1.01-2.24).</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Further age stratification showed significant genotypic as well as allelic association in the group of over 40 years (genotypic: p value = 0.035, odds ratio = 1.617 with 95% CI = 1.033-2.529; allelic: p value = 0.033, odds ratio = 1.445 with 95% CI = 1.029-2.029).</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Disc bulge, annular tears and the Schmorl's nodes were not associated with the D allele.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>We demonstrated that individuals with the presence of D allele for the -1607 promoter polymorphism of MMP1 are about 1.5 times more susceptible to develop DDD when compared with those having G allele only.</Variant>", "label": [[63, 85, "Variant"]]}
{"id": "18439317", "text": "<Variant>Further association was identified in individuals over 40 years of age.</Variant>", "label": []}
{"id": "18439317", "text": "<Variant>Disc bulge, annular tear as well as Schmorl's nodes were not associated with this polymorphism.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>Association between gynecomastia and aromatase (CYP19) polymorphisms.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>Aromatase cytochrome P45019 (CYP19) is a key enzyme in estrogen biosynthesis, and polymorphisms within its gene are associated with an increased risk of estrogen-dependent diseases.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>Enhanced estrogen stimulation of breast tissue in men may lead to gynecomastia.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>We assessed whether intron 4 (TTTA)n repeat and TCT deletion/insertion polymorphisms and an exon 10 (3'-UTR) C/T single nucleotide polymorphism of CYP19 are associated with gynecomastia.</Variant>", "label": [[36, 52, "Variant"], [57, 79, "Variant"], [118, 121, "Variant"]]}
{"id": "18426832", "text": "<Variant>DESIGN/METHODS:</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>We performed a genetic association study of 100 patients referred to the endocrinological outpatient clinic with breast glandular tissue enlargement confirmed by clinical and ultrasound examinations and 99 healthy volunteers without gynecomastia.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>Microsatellite (TTTA)n and insertion/deletion polymorphisms were studied using capillary electrophoresis, and the C/T polymorphism in the 3'-UTR was analyzed using the TaqMan assay.</Variant>", "label": [[24, 31, "Variant"], [123, 126, "Variant"]]}
{"id": "18426832", "text": "<Variant>RESULTS: Significantly increased risk of gynecomastia was found in subjects carrying a CYP19 exon 10 T allele that was previously related to the high aromatase activity.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>Frequency of the TT genotype was significantly higher in patients when compared with controls (40.6 vs 26.3%; TT versus CT and CC genotypes; P(c)<0.05).</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>We found strong linkage disequilibrium between the alleles of studied polymorphic loci.</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>T allele in the 3'-UTR was in linkage disequilibrium with the long alleles of the intron 4 polymorphism, mainly (TTTA)11.</Variant>", "label": [[121, 129, "Variant"]]}
{"id": "18426832", "text": "<Variant>However, our findings did not show significant correlation of alleles having more than nine TTTA repeats with gynecomastia.</Variant>", "label": [[101, 113, "Variant"]]}
{"id": "18426832", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18426832", "text": "<Variant>The CYP19 polymorphisms might contribute to the incidence of gynecomastia, but further studies in larger groups are needed to confirm these results.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>Interferon regulatory factor 5 (IRF5) is a member of the IRF family of transcription factors, which regulate the production of proinflammatory cytokines.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>Polymorphisms in the IRF5 gene have been associated with susceptibility to systemic lupus erythaematosus (SLE) in Caucasian and Asian populations, but their involvement in other autoimmune diseases is still uncertain.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>Here, we assessed the genetic role of IRF5 in susceptibility to rheumatoid arthritis (RA) in Japanese subjects.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>We selected 13 single nucleotide polymorphisms (SNPs) and a CGGGG insertion-deletion polymorphism in the IRF5 gene.</Variant>", "label": [[69, 93, "Variant"]]}
{"id": "18408250", "text": "<Variant>We performed 2 sets of case-control comparisons using Japanese subjects (first set: 830 patients with RA and 658 controls; second set: 1112 patients with RA and 940 controls), and then performed a stratified analysis using human leukocyte antigen (HLA)-DRB1 shared epitope (SE) status.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>We genotyped the SNPs using TaqMan assays.</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>A significant association of the rs729302</Variant>", "label": [[42, 50, "Variant"]]}
{"id": "18408250", "text": "<Variant>A allele with RA susceptibility was found in both sets (odds ratio (OR) 1.22, 95% CI 1.09 to 1.35, p<0.001 in the combined analysis).</Variant>", "label": []}
{"id": "18408250", "text": "<Variant>When the patients were stratified by the SE, the rs729302 A allele was found to confer increased risk to RA in patients that were SE negative (OR 1.50, 95% CI 1.17 to 1.92, p = 0.001) as compared with patients carrying the SE (OR 1.11, 95% CI 0.93 to 1.33, p = 0.24).</Variant>", "label": [[58, 66, "Variant"]]}
{"id": "18408250", "text": "<Variant>In both sets, no genotyped polymorphisms were significantly associated with RA susceptibility, but rs729302 was significantly associated.</Variant>", "label": [[108, 116, "Variant"]]}
{"id": "18408250", "text": "<Variant>CONCLUSIONS: These findings indicate that the promoter polymorphism of IRF5 is a genetic factor conferring predisposition to RA, and that it contributes considerably to disease pathogenesis in patients that were SE negative.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>For many years the precise genetic etiology of the majority of Wilms' tumors has remained unexplained.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Recently, the WTX gene, mapped to chromosome Xq11.1, has been reported to be lost or mutated in approximately one-third of Wilms' tumors.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Moreover, in female cases, the somatically inactivated alleles were found to invariantly derive from the active chromosome X. Consequently, WTX has been proposed as a 'one-hit' tumor suppressor gene.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>To provide further insights on the contribution of WTX to the development of the disease, we have examined 102 Wilms' tumors, obtained from 43 male and 57 female patients.</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Quantitative PCR analyses detected WTX deletions in 5 of 45 (11%) tumors from males, whereas loss of heterozygosity at WTX-linked microsatellites was observed in 9 tumors from 50 informative females (19%).</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>However, in the latter group, using a combination of HUMARA assay and bisulfite-modified DNA sequencing, we found that the deletion affected the active chromosome X only in two cases (4%).</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Sequence analyses detected an inactivating somatic mutation of WTX in a single tumor, in which a strongly reduced expression of the mutant allele respect to the wild-type allele was observed, a finding not consistent with its localization on the active chromosome X. Overall, a functional somatic nullizygosity of the WTX gene was ascertained only in seven of the Wilms' tumors included in the study (approximately 7%).</Variant>", "label": []}
{"id": "18391980", "text": "<Variant>Our findings indicate that previously reported estimates on the proportion of Wilms' tumors due to WTX alterations should be reconsidered.</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>Depressed calcium handling by the sarcoplasmic reticulum (SR) Ca-ATPase and its regulator phospholamban (PLN) is a key characteristic of human and experimental heart failure.</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>Accumulating evidence indicates that increases in the relative levels of PLN to Ca-ATPase in failing hearts and resulting inhibition of Ca sequestration during diastole, impairs contractility.</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>Here, we identified a genetic variant in the PLN promoter region, which increases its expression and may serve as a genetic modifier in dilated cardiomyopathy (DCM).</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>The variant AF177763.1:g.203A>C (at position -36 bp relative to the PLN transcriptional start site) was found only in the heterozygous form in 1 out of 296 normal subjects and in 22 out of 381 cardiomyopathy patients (heart failure at age of 18-44 years, ejection fraction=22+/-9%).</Variant>", "label": [[32, 40, "Variant"]]}
{"id": "18241046", "text": "<Variant>In vitro analysis, using luciferase as a reporter gene in rat neonatal cardiomyocytes, indicated that the PLN-variant increased activity by 24% compared to the wild type.</Variant>", "label": []}
{"id": "18241046", "text": "<Variant>Furthermore, the g.203A>C substitution altered the specific sequence of the steroid receptor for the glucocorticoid nuclear receptor (GR)/transcription factor in the PLN promoter, resulting in enhanced binding to the mutated DNA site.</Variant>", "label": [[26, 34, "Variant"]]}
{"id": "18241046", "text": "<Variant>These findings suggest that the g.203A>C genetic variant in the human PLN promoter may contribute to depressed contractility and accelerate functional deterioration in heart failure.</Variant>", "label": [[41, 49, "Variant"]]}
{"id": "18235024", "text": "<Variant>Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Cone dystrophy with supernormal rod response (CDSRR) is a retinal disorder characterized by reduced visual acuity, color vision defects, and specific alterations of ERG responses that feature elevated scotopic b-wave amplitudes at high luminance intensities.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Mutations in PDE6H and in KCNV2 have been described in CDSRR.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>A combined clinical and genetic study was conducted in a cohort of patients with CDSRR, to substantiate these prior RESULTS: Seventeen patients from 13 families underwent a detailed ophthalmic examination including color vision testing, Goldmann visual fields, fundus photography, Ganzfeld and multifocal ERGs, and optical coherence tomography.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>The coding sequences and flanking intron/UTR sequences of PDE6C and KCNV2 were screened for mutations by means of DHPLC and direct DNA sequencing of PCR-amplified genomic DNA.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>results.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Whereas no mutations were detected in the PDE6H gene, mutations in KCNV2 were identified in all patients, in either the homozygous or compound heterozygous state.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Ten of the 11 identified mutations were novel, including three missense and six truncating mutations and one gross deletion.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>The mutations concordantly segregate in all available families according a recessive mode of inheritance.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>The CDSRR phenotype was associated with reduced visual acuity of variable degree and color vision defects.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Macular defects ranging from mild pigmentary changes to distinct foveal atrophy were present in nine patients.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>Progression of the disease was observed in only three of seven patients with follow-up data.</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18235024", "text": "<Variant>The phenotype of cone dystrophy with supernormal rod response is tightly linked with mutations in KCNV2.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>Deletion of chromosome 6q14-q22 is common in multiple human cancers including prostate cancer, and chromosome 6 transferred into cancer cells induces senescence and reduces cell growth, tumorigenicity and metastasis, indicating the existence of one or more tumor-suppressor genes in 6q.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>To identify the 6q tumor-suppressor gene, we first narrowed the common region of deletion to a 2.5 Mb interval at 6q14-15.</Variant>", "label": [[90, 110, "Variant"]]}
{"id": "18202102", "text": "<Variant>Of the 11 genes located in this minimal deletion region and expressed in normal prostates, only snoRNA U50 was mutated, demonstrated transcriptional downregulation and inhibited colony formation in prostate cancer cells.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>The mutation, a homozygous 2 bp (TT) deletion, was found in two of 30 prostate cancer cell lines/xenografts and nine of 89 localized prostate cancers (eleven of 119 or 9% cancers).</Variant>", "label": [[41, 54, "Variant"]]}
{"id": "18202102", "text": "<Variant>Two of 89 (2%) patients with prostate cancer also showed the same mutation in their germline DNA, but none of 104 cancer-free control men did.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>The homozygous deletion abolished U50 function in a colony formation assay.</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>Analysis of 1371 prostate cancer cases and 1371 matched control men from a case-control study nested in a prospective cohort showed that, although a germline heterozygous genotype of the deletion was detected in both patients and controls at similar frequencies, the homozygosity of the deletion was significantly associated with clinically significant prostate cancer (odds ratio 2.9; 95% confidence interval 1.17-7.21).</Variant>", "label": []}
{"id": "18202102", "text": "<Variant>These findings establish snoRNA U50 as a reasonable candidate for the 6q tumor-suppressor gene in prostate cancer and likely in other types of cancers.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>Screening of Iranian thalassemic families for the most common deletions of the beta-globin gene cluster.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>Deltabeta-thalassemia (thal) is a disorder, characterized by increased levels of fetal hemoglobin (Hb F) in adult life.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>A considerable number of deletions of variable size and position in the beta-globin gene cluster are associated with the clinical manifestation of deltabeta-thal.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>In this study we have determined the presence of the eight most common deletions in Iranian patients.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>Thirty-two patients from 19 families were referred to the Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran (a private genetics center), within the past 3 years with elevated levels of Hb F and low mean corpuscular volume (MCV).</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>After obtaining their informed consent, DNA was extracted from whole blood by the salting-out method.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>Detection of eight deletions was performed using polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>These deletions included the hereditary persistence of fetal Hb (HPFH) 1 (Black) and 3 (Indian), Spanish (-114 kb), Sicilian (-13,377 bp), Chinese (G)gamma((A)gammadeltabeta)(0)-thal (-100 kb), Asian-Indian inversion-deletion (G)gamma((A)gammadeltabeta)(0)-thal, and the Turkish form of inversion-deletion (deltabeta)(0)-thal, as well as the Hbs Lepore, which are characterized by unequal crossovers between the delta- and beta-globin genes.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>We found the Sicilian (-13,377 bp) and Hb Lepore deletions as well as the Asian-Indian (G)gamma((A)gammadeltabeta)(0)-thal in 11 (57.89%), three (15.78%) and five (26.31%) families, respectively.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>None of the aforementioned deletions were found in one of the patients.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>This is the first study of the deletions involved in deltabeta-thal in Iranian patients.</Variant>", "label": []}
{"id": "17994380", "text": "<Variant>Our study highlights the importance of detecting these mutations for prenatal diagnosis carrier detection and genotype/phenotype prediction.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Clinical and molecular characterization of Italian patients affected by Cohen syndrome.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Cohen syndrome is an autosomal recessive disorder with variability in the clinical manifestations, characterized by developmental delay, visual disability, facial dysmorphisms and intermittent neutropenia.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>We described a cohort of 10 patients affected by Cohen syndrome from nine Italian families ranging from 5 to 52 years at assessment.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Characteristic age related facial changes were well documented.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Visual anomalies, namely retinopathy and myopia, were present in 9/10 patients (retinopathy in 9/10 and myopia in 8/10).</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Truncal obesity has been described in all patients older than 6 years (8/8).</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>DNA samples from all patients were analyzed for mutations in COH1 by DHPLC.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>We detected 15 COH1 alterations most of them were truncating mutations, only one being a missense change.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Partial gene deletions have been found in two families.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Most mutations were private.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>Two were already reported in the literature just once.</Variant>", "label": []}
{"id": "17990063", "text": "<Variant>A single base deletion leading to p.T3708fs3769, never reported before, was found in three apparently unrelated families deriving from a restricted area of the Veneto's lowland, between Padova town and Tagliamento river, in heterozygous state.</Variant>", "label": [[43, 56, "Variant"]]}
{"id": "17990063", "text": "<Variant>Given the geographical conformation of this region, which is neither geographically or culturally isolated, a recent origin of the mutation could be hypothesized.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>BACKGROUND AND OBJECTIVE:</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>Methylating agents are effective chemotherapy agents for Hodgkin lymphoma, but are associated with the development of second primary cancers.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>Cytotoxicity of methylating agents is mediated primarily by the DNA mismatch repair (MMR) system.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>Loss of MLH1, a major component of DNA MMR, results in tolerance to the cytotoxic effects of methylating agents and persistence of mutagenised cells at high risk of malignant transformation.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>We hypothesised that a common substitution in the basal promoter of MLH1 (position -93, rs1800734) modifies the risk of cancer after methylating chemotherapy.</Variant>", "label": [[97, 106, "Variant"]]}
{"id": "17959715", "text": "<Variant>METHODS: 133 patients who developed cancer following chemotherapy and/or radiotherapy (n = 133), 420 patients diagnosed with de novo myeloid leukaemia, 242 patients diagnosed with primary Hodgkin lymphoma, and 1177 healthy controls were genotyped for the MLH1 -93 polymorphism by allelic discrimination polymerase chain reaction (PCR) and restriction fragment length polymorphism assay.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>Odds ratios and 95% confidence intervals for cancer risk by MLH1 -93 polymorphism status, and stratified by previous exposure to methylating chemotherapy, were calculated using unconditional logistic regression.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>RESULTS: Carrier frequency of the MLH1 -93 variant was higher in patients who developed therapy related acute myeloid leukaemia (t-AML) (75.0%, n = 12) or breast cancer (53.3%.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>n = 15) after methylating chemotherapy for Hodgkin lymphoma compared to patients without previous methylating exposure (t-AML, 30.4%, n = 69; breast cancer patients, 27.2%, n = 22).</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>The MLH1 -93 variant allele was also over-represented in t-AML cases when compared to de novo AML cases (36.9%, n = 420) and healthy controls (36.3%, n = 952), and was associated with a significantly increased risk of developing t-AML (odds ratio 5.31, 95% confidence interval 1.40 to 20.15), but only in patients previously treated with a methylating agent.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>CONCLUSIONS: These data support the hypothesis that the common polymorphism at position -93 in the core promoter of MLH1 defines a risk allele for the development of cancer after methylating chemotherapy for Hodgkin lymphoma.</Variant>", "label": []}
{"id": "17959715", "text": "<Variant>However, replication of this finding in larger studies is suggested.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one.</Variant>", "label": [[131, 145, "Variant"], [158, 165, "Variant"]]}
{"id": "17876530", "text": "<Variant>The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>Fisher exact or chi (2) test was used for static analysis.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>There was no statistical significance in the differences in the distribution of DC-SIGN genotypes.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism.</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009).</Variant>", "label": []}
{"id": "17876530", "text": "<Variant>A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Association study between Gilles de la Tourette Syndrome and two genes in the Robo-Slit pathway located in the chromosome 11q24 linked/associated region.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Gilles de la Tourette Syndrome (GTS) is an inherited neuropsychiatric disorder characterized by the presence of motor and phonic tics.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Previous genetic studies have identified linkage and association between GTS and the 11q24 chromosomal region.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>We selected for study, within this region, two possible susceptibility genes for GTS, the ROBO3 and ROBO4 genes.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>These two genes were selected because of the recent identification of SLITRK1 as a potential susceptibility gene for GTS based on a translocation breakpoint and the further finding of two mutations in the SLITRK1 gene in three patients with GTS.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>While thus far, the SLITRK1 gene appears to account for only a few cases of GTS, these findings, if confirmed, point to other genes in these pathways that may contribute to GTS.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Based on this, we examined two genes in the Slit-Robo pathway involved in cell migration, axonal pathfinding, and/or neuronal differentiation because of their location in 11q24, a region previously identified as linked and associated with GTS.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>We selected six haplotype tagging single nucleotide polymorphisms (SNPs) for ROBO3 and four for ROBO4 and genotyped them in our sample of trios and sibpair families diagnosed with GTS.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Based on 155 nuclear families with 255 affected children, we did not find evidence for association between GTS and either the ROBO3 or ROBO4 genes.</Variant>", "label": []}
{"id": "17671968", "text": "<Variant>Thus, these two genes are unlikely to be the susceptibility genes contributing to GTS on 11q24.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>Inherited factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder mostly caused by point mutations.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>Large genomic re-arrangements at F7 locus could account for a fraction of mutant alleles that remain unidentified after DNA sequencing, because they escape conventional polymerase chain reaction (PCR)-based techniques.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>We report the first systematic screening of F7 for large re-arrangements, by semi-quantitative multiplex PCR of fluorescent fragments targeting the 9 exons and the promoter region.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>A well-characterised cohort of 43 unrelated patients either apparently homozygous for a F7 point mutation or carrying at least one unidentified F7 mutant allele participated in this study.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>Two large F7 re-arrangements were identified in two FVII-deficient pedigrees, including a discontinuous deletion involving two distinct portions of F7 whose proximal and distal end junctions were characterised.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>A simple and efficient method for the routine detection of gross alterations of F7, which accounted for 2.3% of mutant alleles in our sample, is now available in inherited FVII deficiency.</Variant>", "label": []}
{"id": "17614823", "text": "<Variant>This test should complement conventional PCR-based techniques not only in unsolved cases, but also where inheritance pattern analysis is not achievable.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>A novel IRF6 nonsense mutation (Y67X) in a German family with Van der Woude syndrome.</Variant>", "label": [[41, 45, "Variant"]]}
{"id": "17549393", "text": "<Variant>Van der Woude syndrome (VWS) is the most common type of syndromic orofacial cleft, which accounts for approximately 2% of all cleft lip and palate cases.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>It is characterised by variable association of lower lip pits, cleft lip and cleft palate, and hypodontia.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>VWS arises as the result of mutations in the gene encoding interferon regulatory factor 6 (IRF6).</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>The disorder is transmitted in an autosomal dominant manner, with high penetrance and variable expressivity.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>Very recently, mutations of the IRF6 gene in exons 2-9 have been found in VWS patients, suggesting that this gene plays an important role in orofacial development.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>We report a novel mutation of the IRF6 gene in a German family.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>Five out of the 12 persons affected were able to be investigated.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>The mutation produced a stop codon within exon 4 of the IRF6 gene.</Variant>", "label": []}
{"id": "17549393", "text": "<Variant>All 5 patients were heterozygous for a base substitution c.201C>A changing the tyrosine codon at amino acid position 67 into a stop codon (p.Y67X) in exon 4.</Variant>", "label": [[66, 74, "Variant"], [88, 140, "Variant"], [148, 154, "Variant"]]}
{"id": "17549393", "text": "<Variant>The premature stop codon was responsible for a truncated protein lacking parts of the DNA- binding domain and the complete Smad-interferon regulatory factor-binding domain probably essential for interactions with the Smad transcription factors.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>Subfertility in mice harboring a mutation in betaB2-crystallin.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>betaB2-crystallin is one of the most abundant proteins of the adult ocular lens of mammals although it is expressed at lower levels in several extralenticular locations.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>While mutations in betaB2-crystallin are known to result in lens opacities, alterations in tissues besides the lens have not been previously investigated in these mutants.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>Since we found mice harboring the Crybb2Phil mutation bred poorly, here we assess the contribution of betaB2-crystallin to mouse fertility and determine the expression pattern of betaB2-crystallin in the testis.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>The expression pattern of betaB2-crystallin in the testis was analyzed by rt-PCR, western blotting, and immunohistochemistry.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>The fecundity of wildtype and Crybb2Phil mice was analyzed by quantitative fertility testing.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>The morphology of testes and ovaries was assessed by hematoxylin and eosin staining.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>In the mouse testis, betaB2-crystallin mRNA is found at low levels at birth, but its expression upregulates in this tissue as the testis is primed to initiate spermatogenesis.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>Western blotting detected betaB2-crystallin protein in sperm obtained from mice, cattle, and humans while immunolocalization detected this protein in developing sperm from the spermatocyte stage onward.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>Male and female mice homozygous for a 12 nucleotide inframe deletion mutation in betaB2-crystallin are subfertile when analyzed on a Swiss Webster derived background due to defects in egg and sperm production.</Variant>", "label": [[47, 77, "Variant"]]}
{"id": "17392687", "text": "<Variant>However, mice harboring the same mutation on the C57Bl/6 genetic background did not exhibit any defects in reproductive function.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>CONCLUSIONS: betaB2-crystallin is expressed in developing and mature sperm and mice of both sexes harboring the Philly mutation in the betaB2-crystallin gene are subfertile when analyzed on a Swiss Webster genetic background.</Variant>", "label": []}
{"id": "17392687", "text": "<Variant>While these data are suggestive of a role for betaB2-crystallin in fertility, definitive determination of this will await the creation of a betaB2-crystallin null mouse.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>Monitoring the isochromosome i(7)(q10) in the bone marrow of patients with Shwachman syndrome by real-time quantitative PCR.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>Clonal chromosome anomalies may be found in the bone marrow (BM) of patients with Shwachman syndrome, who are at risk to develop myelodysplastic syndromes and/or acute myeloid leukemias.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>In particular, an isochromosome i(7)(q10) is frequent, and is usually monitored by chromosome analyses.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>We tested an approach by real-time quantitative polymerase chain reaction (RQ-PCR) on a chromosome 7 polymorphism.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>Five DNA samples of 2 Shwachman syndrome patients with clonal i(7)(q10) in the BM were used.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>Both were heterozygous for the diallelic indel polymorphism MID1064, which maps in 7q35.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>The percentage of i(7)(q10)-positive cells was extrapolated from the ratio of the 2 alleles measured by means of an allele-specific RQ-PCR assay.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>The results were compared with cytogenetic analyses on the same material used for RQ-PCR.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>In 1 patient, the RQ-PCR results matched well with those of chromosome analyses, whereas in the other one RQ-PCR showed that around 40% of the BM cells were abnormal, while they resulted to be nearly 80% with conventional monitoring assays.</Variant>", "label": []}
{"id": "17356395", "text": "<Variant>As the results obtained by RQ-PCR refer to the DNA of around 128,000 BM cells, our method proved to be feasible and more efficient in the quantitative evaluation of the i(7)(q10)-positive clone than conventional ones.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>We have previously defined a homozygously deleted region at chromosome 1p36.2-p36.3 in human neuroblastoma cell lines, NB-1 and NB-C201, and identified six genes including DFF45/ICAD within this region.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>In this study, we found that NB-C201 cells are much more resistant to various genotoxic stresses such as cisplatin (CDDP) than CHP134 and SH-SY5Y cells that do not have the homozygous deletion.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>To examine a role(s) of DFF45 in the regulation of apoptosis in response to CDDP, we have established stably DFF45-expressing NB-C201 cell clones (DFF45-1 and DFF45-3) and a control cell clone (NB-C201-C) using a retrovirus-mediated gene transfer.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>In contrast to NB-C201-C cells, DFF45-3 cells displayed apoptotic nuclear fragmentation in response to CDDP.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>Although CDDP-induced proteolytic cleavage of procaspase-3 and DFF45 in DFF45-3 cells, we could not detect a typical apoptotic DNA fragmentation.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>Additionally, deletion analysis revealed that C-terminal region of DFF45 is required for inducing nuclear fragmentation.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>Unexpectedly, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays demonstrated that DFF45 has undetectable effect on CDDP sensitivity of NB-C201 cells.</Variant>", "label": []}
{"id": "17353905", "text": "<Variant>Taken together, our present results suggest that DFF45/DFF40 system may be sufficient for CDDP-induced nuclear fragmentation but not DNA cleavage.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>A possible bichromatid mutation in a male gamete giving rise to a female mosaic for two different mutations in the X-linked gene WAS.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>In genetic disorders caused by point mutations or small frameshift mutations, affected members of the same family are expected to have the same mutation in the causative gene.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>We have recently evaluated a family in which this was not the case.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>Maternal cousins with Wiskott-Aldrich syndrome (WAS; MIM 301000) had two different but contiguous single base pair deletions in WAS.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>The proband had an A deletion in codon 242 in exon 7 of WAS; his two cousins had a C deletion in codon 241.</Variant>", "label": [[28, 51, "Variant"], [92, 115, "Variant"]]}
{"id": "17250667", "text": "<Variant>The mother of the proband was heterozygous for the A deletion allele, but her three sisters, including the mother of the affected cousins, were heterozygous for the C deletion.</Variant>", "label": [[60, 70, "Variant"], [174, 184, "Variant"]]}
{"id": "17250667", "text": "<Variant>Both deletions occurred on the haplotype from the unaffected maternal great-grandfather.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>The maternal grandmother, who was a carrier of WAS, based on a non-random pattern of X chromosome inactivation in T cells, was mosaic for both deletions.</Variant>", "label": []}
{"id": "17250667", "text": "<Variant>These findings are most consistent with the mutations originating in a male gamete with different mutations on the two strands of DNA, a bichromatid mutation.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>Multipoint interphase FISH in childhood T-acute lymphoblastic leukemia detects subpopulations that carry different chromosome 3 aberrations.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>We examined chromosome 3 in 32 childhood acute lymphoblastic leukemia (ALL) bone marrow samples.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>Using interphase multipoint FISH (mp-FISH), which was developed by our group, with 42 chromosome 3-specific probes, we detected clonal chromosome 3 aberrations in 4 T-cell ALL (T-ALL) cases.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>Four out of seven T-ALL cases carried 3q trisomies.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>One T-ALL case carried either trisomy 3 (in 15% of the cells) or a 23-megabase (Mb) 3p13 approximately p12 deletion in a different subpopulation of cells of 32%.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>Another T-ALL case had either 3q trisomy in 11% or a 12-Mb 3p12 approximately p13 deletion in 19% of the cells.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>The deletions were overlapping.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>In both cases, the majority of the bone marrow cells (47 and 70%, respectively) were normal chromosome 3 disomics.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>The interstitial deletions detected harbor a known homozygous deletion region between 72.6 and 78.8 Mb, which has been described in lung and breast tumors and contains the DUTT1/ROBO1 tumor suppressor gene.</Variant>", "label": []}
{"id": "17175380", "text": "<Variant>These deletions detected by mp-FISH would have remained unnoticed by conventional cytogenetics and multiplex FISH, as well as by current methods based on total tumor DNA analysis such as comparative genomic hybridization (CGH), array CGH, and loss of heterozygosity (LOH).</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>Single-base substitution at the last nucleotide of exon 6 (c.671G>A), resulting in the skipping of exon 6, and exons 6 and 7 in human succinyl-CoA:3-ketoacid CoA transferase (SCOT) gene.</Variant>", "label": [[68, 76, "Variant"]]}
{"id": "17169596", "text": "<Variant>Succinyl-CoA:3-ketoacid CoA transferase (SCOT, EC 2.8.3.5) is the key enzyme for ketone body utilization.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>Hereditary SCOT deficiency (MIM 245050) causes episodes of severe ketoacidosis.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>We identified a homozygous point mutation (c.671G>A) , which is a single-base substitution at the last nucleotide of exon 6, in a Turkish patient (GS12) with SCOT deficiency.</Variant>", "label": [[52, 60, "Variant"]]}
{"id": "17169596", "text": "<Variant>This point mutation resulted in the skipping of exon 6, and exons 6 and 7 in human SCOT genes.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>To understand why the c.671G>A causes exons 6 and 7 skipping, nuclear RNA was separated from cytoplasmic RNA and both were analyzed by RT-PCR.</Variant>", "label": [[31, 39, "Variant"]]}
{"id": "17169596", "text": "<Variant>In nuclear RNA, SCOT mRNA with exon 6 skipping was predominant and mRNA with exons 6 and 7 skipping was hardly detected, whereas the latter became one of major mRNA species in cytoplasmic RNA.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>This discrepancy was interpreted as follows: exon 6 skipping causes a frameshift and nonsense-mediated RNA decay in the cytosol, so mRNA with exon 6 skipping was unstable.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>On the other hand, SCOT mRNA with exons 6 and 7 is a minor transcript but it retains the reading-frame and is stable in cytosol.</Variant>", "label": []}
{"id": "17169596", "text": "<Variant>As a result, the latter mRNA is more abundant under steady-state conditions as compared to the former mRNA.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>BACKGROUND: Meningococcal disease occurs after colonization of the nasopharynx with Neisseria meningitidis.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>Surfactant protein (SP)-A and SP-D are pattern-recognition molecules of the respiratory tract that activate inflammatory and phagocytic defences after binding to microbial sugars.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>Variation in the genes of the surfactant proteins affects the expression and function of these molecules.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>METHODS: Allele frequencies of SP-A1, SP-A2, and SP-D were determined by polymerase chain reaction in 303 patients with microbiologically proven meningococcal disease, including 18 patients who died, and 222 healthy control subjects.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>RESULTS: Homozygosity of allele 1A1 of SP-A2 increased the risk of meningococcal disease (odds ratio [OR], 7.4; 95% confidence interval</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>[CI], 1.3-42.4); carriage of 1A5 reduced the risk (OR, 0.3; 95% CI, 0.1-0.97).</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>An analysis of the multiple single-nucleotide polymorphisms in SP-A demonstrated that homozygosity for alleles encoding lysine (in 1A1) rather than glutamine (in 1A5) at amino acid 223 in the carbohydrate recognition domain was associated with an increased risk of meningococcal disease (OR, 6.7; 95% CI, 1.4-31.5).</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>Carriage of alleles encoding lysine at residue 223 was found in 61% of patients who died, compared with 35% of those who survived (OR adjusted for age, 2.9; 95% CI, 1.1-7.7).</Variant>", "label": [[38, 59, "Variant"]]}
{"id": "17083016", "text": "<Variant>Genetic variation of SP-A1 and SP-D was not associated with meningococcal disease.</Variant>", "label": []}
{"id": "17083016", "text": "<Variant>CONCLUSIONS: Gene polymorphism resulting in the substitution of glutamine with lysine at residue 223 in the carbohydrate recognition domain of SP-A2 increases susceptibility to meningococcal disease, as well as the risk of death.</Variant>", "label": [[73, 109, "Variant"]]}
{"id": "17050029", "text": "<Variant>Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>The hepatitis B virus (HBV) genotype C is associated with the development of hepatocellular carcinoma (HCC).</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>In addition, the HBV X gene, which encodes the pleiotropic transactivator HBx, has also been associated with the development of HCC.</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>In this study, we investigated whether nucleotide changes in the X gene of genotype C are associated with the development of HCC. METHODS/RESULTS:</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>We sequenced the X gene in age- and sex-matched 39 HBV-infected patients with HCC and 36 HBV-infected patients without HCC.</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>A novel nucleotide change that resulted in a proline to serine substitution at codon 38 in HBx (codon-38 change) was preferentially found in patients with HCC.</Variant>", "label": [[54, 96, "Variant"]]}
{"id": "17050029", "text": "<Variant>Then, sera were collected from a new group of age- and sex-matched 52 patients with HCC and 51 patients without HCC.</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>In this cohort also, the codon-38 change was associated with HCC.</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>Multiple logistic regression analysis showed the prevalence of the codon-38 change was significantly associated with HCC in all patients (P=0.001, odds ratio: 4.89).</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "17050029", "text": "<Variant>The codon-38 change in genotype C is an independent risk factor for the development of HCC and may serve as a useful molecular marker for predicting the clinical outcomes in patients infected with HBV.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>BACKGROUND: To examine the contribution of mutations within the Norrie disease (NDP) gene to the clinically similar retinal diseases Norrie disease, X-linked familial exudative vitreoretinopathy (FEVR), Coat's disease and retinopathy of prematurity (ROP).</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>A dataset comprising 13 Norrie-FEVR, one Coat's disease, 31 ROP patients and 90 ex-premature babies of <32 weeks' gestation underwent an ophthalmologic examination and were screened for mutations within the NDP gene by direct DNA sequencing, denaturing high-performance liquid chromatography or gel electrophoresis.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>Controls were only screened using denaturing high-performance liquid chromatography and gel electrophoresis.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>Confirmation of mutations identified was obtained by DNA sequencing.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>RESULTS: Evidence for two novel mutations in the NDP gene was presented: Leu103Val in one FEVR patient and His43Arg in monozygotic twin Norrie disease patients.</Variant>", "label": [[82, 91, "Variant"], [116, 124, "Variant"]]}
{"id": "16970763", "text": "<Variant>Furthermore, a previously described 14-bp deletion located in the 5' unstranslated region of the NDP gene was detected in three cases of regressed ROP.</Variant>", "label": [[45, 59, "Variant"]]}
{"id": "16970763", "text": "<Variant>A second heterozygotic 14-bp deletion was detected in an unaffected ex-premature girl.</Variant>", "label": [[32, 46, "Variant"]]}
{"id": "16970763", "text": "<Variant>Only two of the 13 Norrie-FEVR index cases had the full features of Norrie disease with deafness and mental retardation.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>CONCLUSION: Two novel mutations within the coding region of the NDP gene were found, one associated with a severe disease phenotypes of Norrie disease and the other with FEVR.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>A deletion within the non-coding region was associated with only mild-regressed ROP, despite the presence of low birthweight, prematurity and exposure to oxygen.</Variant>", "label": []}
{"id": "16970763", "text": "<Variant>In full-term children with retinal detachment only 15% appear to have the full features of Norrie disease and this is important for counselling parents on the possible long-term outcome.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>CONTEXT: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare metabolic disorder, characterized by hypophosphatemia and rickets/osteomalacia with increased serum 1,25-dihydroxyvitamin D [1,25-(OH)(2)D] resulting in hypercalciuria.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Our objective was to determine whether mutations in the SLC34A3 gene, which encodes sodium-phosphate cotransporter type IIc, are responsible for the occurrence of HHRH.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>DESIGN AND SETTING:</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Mutation analysis of exons and adjacent introns in the SLC34A3 gene was conducted at an academic research laboratory and medical center.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>PATIENTS OR OTHER PARTICIPANTS:</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Members of two unrelated families with HHRH participated in the study.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>RESULTS: Two affected siblings in one family were homozygous for a 101-bp deletion in intron 9.</Variant>", "label": [[76, 91, "Variant"]]}
{"id": "16849419", "text": "<Variant>Haplotype analysis of the SLC34A3 locus in the family showed that the two deletions are on different haplotypes.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>An unrelated individual with HHRH was a compound heterozygote for an 85-bp deletion in intron 10 and a G-to-A substitution at the last nucleotide in exon 7.</Variant>", "label": [[78, 92, "Variant"], [112, 118, "Variant"]]}
{"id": "16849419", "text": "<Variant>The intron 9 deletion (and likely the other two mutations) identified in this study causes aberrant RNA splicing.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Sequence analysis of the deleted regions revealed the presence of direct repeats of homologous sequences.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>HHRH is caused by biallelic mutations in the SLC34A3 gene.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>Haplotype analysis suggests that the two intron 9 deletions arose independently.</Variant>", "label": []}
{"id": "16849419", "text": "<Variant>The identification of three independent deletions in introns 9 and 10 suggests that the SLC34A3 gene may be susceptible to unequal crossing over because of sequence misalignment during meiosis.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>Genotyping of five chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>CONTEXT: 17alpha-Hydroxylase deficiency is a rare form of congenital adrenal hyperplasia caused by CYP17 gene mutations.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>OBJECTIVE: Five Chinese patients with 17alpha-hydroxylase deficiency were genotyped.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>PATIENTS:</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>The five patients derived from four families living in Shandong Province, China.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>The diagnosis of 17alpha-hydroxylase deficiency was initially established through HPLC serum adrenal profiles in Qilu Hospital, China, from 1983-1993.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>RESULTS: Three CYP17 gene mutations were identified from these patients.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>Among them, V311fs and Y329fs are two novel frame-shifting mutations.</Variant>", "label": [[21, 27, "Variant"], [32, 38, "Variant"]]}
{"id": "16822828", "text": "<Variant>V311fs is an 8-bp nucleotide (TTAAATGG) deletion in exon 5.</Variant>", "label": [[9, 15, "Variant"], [22, 57, "Variant"]]}
{"id": "16822828", "text": "<Variant>Y329fs is a deletion-insertion combined mutation (TAC-->AA) at codon 329 in exon 6.</Variant>", "label": [[9, 15, "Variant"], [58, 81, "Variant"]]}
{"id": "16822828", "text": "<Variant>Two homozygotes for Y329fs and one compound heterozygote for Y329fs and V311fs were identified from three different families.</Variant>", "label": [[29, 35, "Variant"], [70, 76, "Variant"], [81, 87, "Variant"]]}
{"id": "16822828", "text": "<Variant>Two homozygous sisters for the D487_S488_F489 deletion were identified.</Variant>", "label": [[40, 63, "Variant"]]}
{"id": "16822828", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>The results confirmed the diagnostic value of the HPLC serum adrenal profile for 17alpha-hydroxylase deficiency.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>The D487_S488_F489 deletion had been identified in two previously genotyped Chinese families.</Variant>", "label": [[13, 36, "Variant"]]}
{"id": "16822828", "text": "<Variant>In our present study, a third Chinese family with this mutation was identified, suggesting that this mutation is a prevalent CYP17 mutation in the Chinese population.</Variant>", "label": []}
{"id": "16822828", "text": "<Variant>The identification of Y329fs mutation in addition to three previously identified mutations at codon 329 suggests that codon 329 is an unstable point of the CYP17 gene.</Variant>", "label": [[31, 37, "Variant"]]}
{"id": "16822828", "text": "<Variant>The mutations identified from our five patients appear to be random, but the recurrence of the Y329fs mutation may be attributed to a founder effect.</Variant>", "label": [[104, 110, "Variant"]]}
{"id": "16822828", "text": "<Variant>Our studies suggest that 17alpha-hydroxylase deficiency may not be rare in the Chinese population.</Variant>", "label": []}
{"id": "16628674", "text": "<Variant>A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus.</Variant>", "label": []}
{"id": "16628674", "text": "<Variant>A single nucleotide polymorphism characterized by the substitution of valine for glutamate (V1188E) in exon 25 of the multidrug resistance protein 2 gene was found in a group of patients with primary biliary cirrhosis.</Variant>", "label": [[79, 99, "Variant"], [101, 107, "Variant"]]}
{"id": "16628674", "text": "<Variant>This heterozygous mutation was significantly associated with the presence of pruritus.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>Migraine is a common debilitating primary headache disorder with significant mental, physical and social health implications.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>The brain neurotransmitter 5-hydroxytryptamine (5-HT; serotonin) is involved in nociceptive pathways and has been implicated in the pathophysiology of migraine.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>With few genetic studies investigating biosynthetic and metabolic enzymes governing the rate of 5-HT activity and their relationship to migraine, it was the objective of this study to assess genetic variants within the human tryptophan hydroxylase (TPH), amino acid decarboxylase (AADC) and monoamine oxidase</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>A (MAOA) genes in migraine susceptibility.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>This objective was undertaken using a high-throughput DNA pooling experimental design, which proved to be a very accurate, sensitive and specific method of estimating allele frequencies for single nucleotide polymorphism, insertion deletion and variable number tandem repeat loci.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>Application of DNA pooling to a wide array of genetic loci provides greater scope in the assessment of population-based genetic association study designs.</Variant>", "label": []}
{"id": "16200390", "text": "<Variant>Despite the application of this high-throughput genotyping method, negative results from the two-stage DNA pooling design used to screen loci within the TPH, AADC and MAOA genes did not support their role in migraine susceptibility.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>Two novel mutations in SRY gene form Chinese sex reversal XY females.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>The SRY gene (sex determining region on Y chromosome) acts as TDF and is required for regulating male sex determination.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>SRY represents a transcription factor belonging to the superfamily of genes sharing the HMG-box motif (high-mobility group-box), which acts as DNA binding region.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>Deletion and inactivating mutations of SRY are among the known causes of XY sex reversal.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>Here, we described the screening of 10 patients who presented with 46,XY sex reversal for mutations in open reading frame (ORF) of SRY gene.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>DNA was isolated from blood samples using standard techniques.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>A 609 bp fragment from the central portion of the SRY gene was amplified, using primers XES-2 and XES-7.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>The amplified PCR fragments were cloned into the pUCm-T vectors, and direct sequencing were carried out on an ABI 377-3 automated DNA sequencer to detect the mutation.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>PCR-restriction enzyme digestion was applied to detect the results of DNA sequencing.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>In two patients,de novo mutations led to an amino acid substitution.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>An A was replaced by a G in codon 38 upstream of the 5' border outside the HMG box of the SRY gene, resulting in the replacement of the amino acid glutamate by glycine.</Variant>", "label": [[12, 45, "Variant"], [156, 176, "Variant"]]}
{"id": "16018252", "text": "<Variant>Another heterozygous T to A transition at the nucleotide position +387 which encodes for a Tyrosine (Tyr) instead of a Term, whereas her father was proven to have the wild-type sequence.</Variant>", "label": [[30, 79, "Variant"], [100, 132, "Variant"]]}
{"id": "16018252", "text": "<Variant>These point mutations have been confirmed with PCR-restrict enzyme method.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>As demonstrated by the Human Gene Mutation Database analysis,homology search, and review of the literature, these two mutations were not described previously and brought the total number of SRY gene nucleotide substitutions (missense/nonsense) to 45.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>These findings indicated that these amino acid substitutions may be responsible for the sex reversal,not only inside the HMG-box but also outside the HMG-box.</Variant>", "label": []}
{"id": "16018252", "text": "<Variant>The two novel mutations in SRY gene provided valuable information for understanding the molecular mechanism of the patient with 46,XY female sex reversal.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>A 38-year-old woman was admitted with superior mesenteric vein (SMV) thrombosis, which was refractory to anticoagulation therapy.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>The plasma antithrombin activity was decreased and hardly compensated by concentrated antithrombin preparation due to high consumption rate.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>However, successful anticoagulation was achieved by administration of direct thrombin inhibitor, argatroban.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>Family studies of antithrombin activity revealed that she had type I congenital antithrombin deficiency.</Variant>", "label": []}
{"id": "16000134", "text": "<Variant>A novel heterozygous mutation in the gene for antithrombin (single nucleotide T insertion at 7916 and 7917, Glu 272 to stop in exon 4) was identified.</Variant>", "label": [[87, 115, "Variant"], [117, 132, "Variant"]]}
{"id": "16000134", "text": "<Variant>Argatroban administration would be effective in the treatment of congenital antithrombin deficiency with SMV thrombosis.</Variant>", "label": []}
{"id": "15837627", "text": "<Variant>Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.</Variant>", "label": []}
{"id": "15837627", "text": "<Variant>Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors.</Variant>", "label": []}
{"id": "15837627", "text": "<Variant>An internet-based protocol was used to collect clinical information and biological specimens from patients with these diseases.</Variant>", "label": []}
{"id": "15837627", "text": "<Variant>High-throughput DNA resequencing identified a recurrent somatic missense mutation JAK2V617F in granulocyte DNA samples of 121 of 164 PV patients, of which 41 had homozygous and 80 had heterozygous mutations.</Variant>", "label": [[95, 100, "Variant"]]}
{"id": "15837627", "text": "<Variant>Molecular and cytogenetic analyses demonstrated that homozygous mutations were due to duplication of the mutant allele.</Variant>", "label": []}
{"id": "15837627", "text": "<Variant>JAK2V617F was also identified in granulocyte DNA samples from 37 of 115 ET and 16 of 46 MMM patients, but was not observed in 269 normal individuals.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "15837627", "text": "<Variant>In vitro analysis demonstrated that JAK2V617F is a constitutively active tyrosine kinase.</Variant>", "label": [[49, 54, "Variant"]]}
{"id": "15827093", "text": "<Variant>Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>CONTEXT:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>The central clinical feature of GH insensitivity (GHI) is severe growth failure associated with elevated serum concentrations of GH and abnormally low serum levels of IGF-I. GHI can be the result of an abnormality in the GH receptor or aberrancies downstream of the GH receptor.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>We investigated the GH-IGF-I axis in a young female GHI subject who presented with a height of 114 cm (-7.8 sd score) at age 16.4 yr.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>PATIENT:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>The subject, from a consanguineous pedigree, had circulating levels of GH and GH-binding protein that were normal to elevated, whereas IGF-I (7.2 ng/ml; normal, 242-600), IGF-binding protein-3 (543 ng/ml; normal, 2500-4800), and acid-labile subunit (1.22 microg/ml; normal, 5.6-16) levels were abnormally low and failed to increase during an IGF-I generation test.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>Dermal fibroblast cultures were established with the consent of the patient and family.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>Immunoblot analysis of cell lysates and DNA sequencing of her signal transducer and activator of transcription 5b (STAT5b), a critical intermediate of the GH-IGF-I axis, were performed.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>Sequencing of the STAT5b gene revealed a novel homozygous insertion of a single nucleotide in exon 10.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>The insertion resulted in a frame shift, leading to early protein termination and consequent lack of immunodetectable STAT5b protein.</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "15827093", "text": "<Variant>The identification of a second case of severe growth failure associated with STAT5b mutation implicates a unique and critical role for STAT5b in GH stimulation of IGF-I gene expression and statural growth.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.</Variant>", "label": [[58, 76, "Variant"]]}
{"id": "15818664", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>Certain mutations in ANKH, which encodes a multiple-pass transmembrane protein that regulates inorganic pyrophosphate (PPi) transport, are linked to autosomal-dominant familial chondrocalcinosis.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>This study investigated the potential for ANKH sequence variants to promote sporadic chondrocalcinosis.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>ANKH variants identified by genomic sequencing were screened for association with chondrocalcinosis in 128 patients with severe sporadic chondrocalcinosis or pseudogout and in ethnically matched healthy controls.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>The effects of specific variants on expression of common markers were evaluated by in vitro transcription/translation.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>The function of these variants was studied in transfected human immortalized CH-8 articular chondrocytes.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>Sporadic chondrocalcinosis was associated with a G-to-A transition in the ANKH 5'-untranslated region (5'-UTR) at 4 bp upstream of the start codon (in homozygotes of the minor allele, genotype relative risk 6.0, P = 0.0006; overall genotype association P = 0.02).</Variant>", "label": [[58, 64, "Variant"]]}
{"id": "15818664", "text": "<Variant>This -4-bp transition, as well as 2 mutations previously linked with familial and sporadic chondrocalcinosis (+14 bp C-to-T and C-terminal GAG deletion, respectively), but not the French familial chondrocalcinosis kindred 143-bp T-to-C mutation, increased reticulocyte ANKH transcription/ANKH translation in vitro.</Variant>", "label": [[119, 132, "Variant"], [148, 160, "Variant"], [231, 244, "Variant"]]}
{"id": "15818664", "text": "<Variant>Transfection of complementary DNA for both the wild-type ANKH and the -4-bp ANKH protein variant promoted increased extracellular PPi in CH-8 cells, but unexpectedly, these ANKH mutants had divergent effects on the expression of extracellular PPi and the chondrocyte hypertrophy marker, type X collagen.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>A subset of sporadic chondrocalcinosis appears to be heritable via a -4-bp G-to-A ANKH</Variant>", "label": [[78, 90, "Variant"]]}
{"id": "15818664", "text": "<Variant>5'-UTR transition that up-regulates expression of ANKH and extracellular PPi in chondrocyte cells.</Variant>", "label": []}
{"id": "15818664", "text": "<Variant>Distinct ANKH mutations associated with heritable chondrocalcinosis may promote disease by divergent effects on extracellular PPi and chondrocyte hypertrophy, which is likely to mediate differences in the clinical phenotypes and severity of the disease.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>In the present study, we aimed to substantiate the putative significance of angiotensin I-converting enzyme (ACE) on gastric cancer biology by investigating the influence of its gene polymorphism on gastric cancer progression.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>EXPERIMENTAL DESIGN:</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>Genomic DNA was purified from peripheral blood mononuclear cells or tissue specimens.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>Amplified ACE gene fragments were separated on agarose gels.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>D or I alleles were identified by the presence of 190- or 490-bp fragments, respectively.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>Local expression of ACE was investigated by immunohistochemistry.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>RESULTS: Twenty-four of 113 (21%) gastric cancer patients had the II, 57 (51%) the ID, and 32 (28%) the DD genotype.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>The distribution of the ACE genotypes did not differ significantly from the control group of 189 patients without gastric cancer.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>However, the ACE genotypes correlated with the number of lymph node metastases and the Unio Internationale Contra Cancrum (UICC) tumor stage.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>Patients with the II genotype had a highly significantly smaller number of lymph node metastases (P < 0.001) and a significantly lower UICC tumor stage (P = 0.01) than patients with the DD genotype.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>No correlation was found between tumor type, tumor location, local tumor growth, distant metastases, and the ACE genotype.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>The expression of ACE in gastric cancer was investigated by immunohistochemistry in 100 of 113 patients.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>ACE was expressed by endothelial cells in all (100%) specimens and by tumor cells in 56 (56%) specimens.</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15814629", "text": "<Variant>Our study shows that ACE is expressed locally in gastric cancer and that the gene polymorphism influences metastatic behavior.</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>Identification of novel type VII collagen gene mutations resulting in severe recessive dystrophic epidermolysis bullosa.</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>In this work, we studied the proband in a small nuclear family of Chinese and Dutch/German descent and identified two novel mutations in the type VII collagen gene leading to recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens variant (HS-RDEB).</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>The maternal mutation is a single base pair deletion of a cytosine nucleotide in exon 26, designated 3472delC, resulting in a frameshift and a premature termination codon (PTC) within the same exon, 7 bp downstream of the site of the mutation.</Variant>", "label": [[36, 86, "Variant"], [110, 118, "Variant"]]}
{"id": "15807692", "text": "<Variant>The paternal mutation is a G-->A transition located at the 5' donor splice site within intron 51, designated IVS51 +</Variant>", "label": [[36, 41, "Variant"], [118, 132, "Variant"]]}
{"id": "15807692", "text": "<Variant>1G-->A.</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>This mutation leads to the activation of a cryptic splice site, 32 bp downstream of the mutation site and to subsequent aberrant out-of-frame splicing, resulting in two alternative mRNA transcripts and a downstream PTC.</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>To our knowledge, these two mutations have not been previously reported.</Variant>", "label": []}
{"id": "15807692", "text": "<Variant>These findings extend the body of evidence for compound heterozygous mutations leading to HS-RDEB and provide the basis for prenatal diagnosis in this family.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>BACKGROUND: Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by the deficiency of arylsulfatase A (ARSA).</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Clinically, the disease is heterogeneous with respect to the age of onset, affection of peripheral and central nervous systems, and progression.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>To analyze mutations in the ARSA gene of a patient with adult-onset MLD with no signs of peripheral polyneuropathy and to emphasize the clinical, neuroradiologic, neuropathologic, and genetic features of the disease.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Case study of a patient clinically presenting with rapidly progressive dementia and behavioral abnormalities.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>We report the findings of clinical evaluation and neurophysiologic and neuropathologic studies of peripheral nerves; we also performed DNA sequence analysis, transfections, metabolic labeling, and immunoprecipitation of mutant ARSA polypeptides.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>SETTING:</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Genetic research and clinical unit, university hospital.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Genetic analysis revealed homozygosity for a novel mutation in exon 3 of ARSA (F219V).</Variant>", "label": [[88, 93, "Variant"]]}
{"id": "15710861", "text": "<Variant>This substitution leads to a misfolded unstable enzyme with a specific activity less than 1% of normal.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>There were no clinical or neurophysiologic signs of peripheral nervous system dysfunction.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>Typical neuropathologic signs for MLD were absent from nerve biopsy specimens.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>This novel mutation is associated with progressive psychocognitive impairment without clinical or electrophysiologic signs and only minor morphologic signs of peripheral nerve affection.</Variant>", "label": []}
{"id": "15710861", "text": "<Variant>The F219V substitution causes reduction in enzyme activity to an extent unexpected for an adult patient with MLD.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "15481887", "text": "<Variant>Two new beta-chain variants: Hb Tripoli [beta26(B8)Glu-->Ala] and Hb Tizi-Ouzou [beta29(B11)Gly-->Ser].</Variant>", "label": [[60, 69, "Variant"], [101, 110, "Variant"]]}
{"id": "15481887", "text": "<Variant>Two new beta-globin chain variants: Hb Tripoli: codon 26, GAG-->GCG [beta26(B8)Glu-->Ala] and Hb Tizi-Ouzou: codon 29, GGC-->AGC</Variant>", "label": [[57, 76, "Variant"], [88, 97, "Variant"], [118, 137, "Variant"]]}
{"id": "15481887", "text": "<Variant>[beta29(B11)Gly-->Ser] are described on the first exon of the beta-globin gene.</Variant>", "label": [[21, 30, "Variant"]]}
{"id": "15481887", "text": "<Variant>The two variants are characterized by DNA sequencing and mass spectrometry (MS).</Variant>", "label": []}
{"id": "15481887", "text": "<Variant>Hematological abnormalities were found in the two carriers.</Variant>", "label": []}
{"id": "15481887", "text": "<Variant>The presence of microcytosis and hypochromia is explained by an additional homozygous 3.7 kb alpha(+)</Variant>", "label": []}
{"id": "15481887", "text": "<Variant>thalassemic deletion for the carrier of Hb Tizi-Ouzou.</Variant>", "label": []}
{"id": "15481887", "text": "<Variant>Hb Tizi-Ouzou showed a slight instability in vitro.</Variant>", "label": []}
{"id": "15481887", "text": "<Variant>The same hematological abnormalities associated with anemia are difficult to explain for Hb Tripoli's carrier in the absence of an alpha-globin genes abnormality and could suggest a possible abnormal splicing.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>BACKGROUND: Mutations in COL17A1, coding for type XVII collagen, cause junctional epidermolysis bullosa with an ultrastructural plane of cleavage through the lamina lucida of the epidermal basement membrane.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>To identify the COL17A1 mutations in a child with reduced type XVII collagen expression and intraepidermal blister formation.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>PATIENT AND METHODS:</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>Protein expression and level of tissue separation were studied by immunofluorescence and electron microscopy.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>The mutations were identified by analysing the patient's DNA and mRNA.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>Immunofluorescence microscopy performed on nonlesional skin demonstrated absence of the type XVII collagen endodomain and presence, although reduced, of the shed ectodomain.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>Electron microscopy showed that the plane of cleavage was through the basal cells, not through the lamina lucida.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>Two heterozygous mutations were identified in COL17A1: a new 3'-acceptor splice-site mutation in intron 21 (1877-2A-->C), and a deletion in exon 48 (3432delT).</Variant>", "label": [[117, 128, "Variant"], [158, 166, "Variant"]]}
{"id": "15377356", "text": "<Variant>The splice-site mutation in intron 21 results in alternative transcripts of which two are in-frame, with deletions of the first nine codons of exon 22 and the entire exon 22, respectively.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>By Western blot analysis, a type XVII collagen molecule was detected that was slightly smaller than normal.</Variant>", "label": []}
{"id": "15377356", "text": "<Variant>CONCLUSIONS: Occasionally mutations in the COL17A1 gene may result in split levels suggesting epidermolysis bullosa simplex rather than junctional epidermolysis bullosa.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>The fission yeast Schizosaccharomyces pombe rad9 gene promotes cell survival through activation of cell cycle checkpoints induced by DNA damage.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Mouse embryonic stem cells with a targeted deletion of Mrad9, the mouse ortholog of this gene, were created to evaluate its function in mammals.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Mrad9(-/-) cells demonstrated a marked increase in spontaneous chromosome aberrations and HPRT mutations, indicating a role in the maintenance of genomic integrity.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>These cells were also extremely sensitive to UV light, gamma rays, and hydroxyurea, and heterozygotes were somewhat sensitive to the last two agents relative to Mrad9(+/+) controls.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Mrad9(-/-) cells could initiate but not maintain gamma-ray-induced G(2) delay and retained the ability to delay DNA synthesis rapidly after UV irradiation, suggesting that checkpoint abnormalities contribute little to the radiosensitivity observed.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Ectopic expression of Mrad9 or human HRAD9 complemented Mrad9(-/-) cell defects, indicating that the gene has radioresponse and genomic maintenance functions that are evolutionarily conserved.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Mrad9(+/-) mice were generated, but heterozygous intercrosses failed to yield Mrad9(-/-) pups, since embryos died at midgestation.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>Furthermore, Mrad9(-/-) mouse embryo fibroblasts were not viable.</Variant>", "label": []}
{"id": "15282322", "text": "<Variant>These investigations establish Mrad9 as a key mammalian genetic element of pathways that regulate the cellular response to DNA damage, maintenance of genomic integrity, and proper embryonic development.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Endometriosis is a steroid-dependent disease with a particular genetic background, but the locations of possible genomic aberrations are still poorly clarified.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>We have investigated the potential association between endometriosis and the PROGINS 306 base pair insertion polymorphism in intron G of the progesterone receptor (PR) gene, which has been reported previously to segregate with this disease.</Variant>", "label": [[94, 117, "Variant"]]}
{"id": "15272913", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>In a case-control study, we examined the PROGINS polymorphism of the progesterone receptor gene in 131 Italian women affected by endometriosis diagnosed according to published criteria for the definition of the definite disease.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Control subjects were represented by 127 Italian women without laparoscopic evidence of the disease.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>MEASUREMENTS:</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Peripheral blood samples, DNA extraction and polymerase chain reaction (PCR) were used to genotype women for the presence of the PROGINS polymorphism.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>We found a statistically significant difference in the distribution of PROGINS genotypes between patients with and without endometriosis.</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>The frequency of the PROGINS allele T2 was 17.2% and 11%, respectively, in affected women and in controls [odds ratio (OR) = 1.7, 95% confidence interval (CI) 1.0-2.8].</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>This association was stronger in patients with more severe forms of endometriosis, such as an infiltrating disease or a disease characterized by severe pelvic adhesions (OR 2.4, 95% CI 1.2-4.8; and OR 2.7, 95% CI 1.4-5.3, respectively).</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Combination of the results from an earlier study and the current data indicates that carrying the allele variant T2 is associated with a twofold increase in the risk of developing endometriosis (OR 2.0, 95% CI 1.3-2.9).</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15272913", "text": "<Variant>Our results further support the idea that the PROGINS polymorphism of the progesterone receptor may be associated with an increased risk of endometriosis.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Mre11 deficiency in Arabidopsis is associated with chromosomal instability in somatic cells and Spo11-dependent genome fragmentation during meiosis.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>The Mre11/Rad50/Nbs1 complex is involved in many aspects of chromosome metabolism.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Aberrant function of the complex is associated with defects in the DNA checkpoint, double-strand break repair, meiosis, and telomere maintenance.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>In this article, we report the consequences of Mre11 dysfunction for the stability of mitotic and meiotic chromosomes in Arabidopsis thaliana.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Although plants homozygous for a T-DNA insertion in a conserved region of the MRE11 gene are viable, they exhibit growth defects and are infertile.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Analysis of mitotic chromosomes prepared from the mutant plants revealed abundant dicentric chromosomes and chromosomal fragments.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Fluorescence in situ hybridization showed that anaphase bridges are often formed by homologous chromosome arms.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>The frequency of chromosome fusions was not reduced in mre11 ku70 double mutants, suggesting that plants possess DNA end-joining activities independent of the Ku70/80 and Mre11 complexes.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>Cytogenetic examination of pollen mother cells revealed massive chromosome fragmentation and the absence of synapsis in the initial stages of meiosis.</Variant>", "label": []}
{"id": "15258261", "text": "<Variant>The fragmentation was substantially suppressed in mre11 spo11-1 double mutants, indicating that Mre11 is required for repair but not for the induction of Spo11-dependent meiotic DNA breaks in Arabidopsis.</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene.</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>Resistance to thyroid hormone syndrome (RTH) is a rare disorder, usually inherited as an autosomal dominant trait.</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>Patients with RTH are usually euthyroid but can occasionally present with signs and symptoms of thyrotoxicosis or rarely with hypothyroidism.</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>Affected individuals are usually heterozygous for mutations in the thyroid hormone receptor beta gene (TR-beta).</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>We present a patient with RTH found to be homo-/hemizygous for a mutation in the TR-beta gene.</Variant>", "label": []}
{"id": "15191352", "text": "<Variant>The single nucleotide substitution I280S (1123T-->G) was present either on both alleles or in a hemizygous form with complete deletion of the second allele.</Variant>", "label": [[44, 49, "Variant"], [51, 60, "Variant"]]}
{"id": "15191352", "text": "<Variant>The I280S mutation was recently reported in a heterozygous patient.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "15191352", "text": "<Variant>The severe phenotype with seriously impaired intellectual development, hyperkinetic behaviour, tachycardia, hearing and visual impairment is probably due to the dominant negative effect of the I280S mutant protein and the absence of any functional TR-beta.</Variant>", "label": [[202, 207, "Variant"]]}
{"id": "15184540", "text": "<Variant>Microevolution between paired antral and paired antrum and corpus Helicobacter pylori isolates recovered from individual patients.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>Sequence variations located at the signal sequence and mid-region within the vacA gene, the 3'-end of the cagA gene, the indel motifs at the 3'-end of the cag pathogenicity island and the regions upstream of the vacA and ribA genes were determined by PCR in 19 paired antral or antrum and corpus Helicobacter pylori isolates obtained at the same endoscopic session, and three antral pairs taken sequentially.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>Random amplification of polymorphic DNA (RAPD)-PCR and fluorescent amplified fragment length polymorphism (FAFLP)-PCR fingerprinting were applied to these paired clinical isolates.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>The FAFLP-PCR profiles generated were phylogenetically analysed.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>For the 22 paired isolates there were no differences within pairs at five of the genetic loci studied.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>However, six pairs of isolates (27%), of which four were antrum and corpus pairs, showed differences in the numbers of repeats located at the 3'-end of the cagA gene.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>RAPD-PCR fingerprinting showed that 16 (73%) pairs, nine of which were antrum and corpus pairs, possessed identical profiles, while six (27%) displayed distinctly different profiles, indicating mixed infections.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>Three of the six pairs showing differences at the 3'-end of the cagA gene yielded identical RAPD-PCR fingerprints.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>FAFLP-PCR fingerprinting and phylogenetic analysis revealed that all 16 pairs that displayed identical RAPD-PCR profiles had highly similar, but not identical, fingerprints, demonstrating that these pairs were ancestrally related but had undergone minor genomic alterations.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>Two antrum and corpus pairs of isolates, within the latter group, were isolates obtained from two siblings from the same family.</Variant>", "label": []}
{"id": "15184540", "text": "<Variant>This analysis demonstrated that each sibling was colonized by ancestrally related strains that exhibited differences in vacA genotype characteristics.</Variant>", "label": []}
{"id": "15135245", "text": "<Variant>A new but frequent mutation of apoB-100-apoB His3543Tyr.</Variant>", "label": [[54, 64, "Variant"]]}
{"id": "15135245", "text": "<Variant>ApolipoproteinB 100 (apoB-100) is an important component of atherogenic lipoproteins such as LDL and serves as a ligand for the LDL-receptor.</Variant>", "label": []}
{"id": "15135245", "text": "<Variant>Familial defective apolipoproteinB 100 (FDB) is caused by a R3500Q mutation of the apoB gene and results in decreased binding of LDL to the LDL-receptor.</Variant>", "label": [[69, 75, "Variant"]]}
{"id": "15135245", "text": "<Variant>So far FDB is the most frequent and best studied alteration of apoB-100.</Variant>", "label": []}
{"id": "15135245", "text": "<Variant>Apart from this, three other apoB mutations, R3500W, R3531C and R3480W, affecting binding to the LDL-receptor are known to date.</Variant>", "label": [[54, 60, "Variant"], [62, 68, "Variant"], [73, 79, "Variant"]]}
{"id": "15135245", "text": "<Variant>We screened the apoB gene segment of codons 3448-3561 by denaturing gradient gel electrophoresis (DGGE) analysis in a total of 853 consecutively sampled German patients undergoing diagnostic coronary angiography for suspected CAD.</Variant>", "label": []}
{"id": "15135245", "text": "<Variant>By this, a new single base mutation was detected and confirmed by DNA sequencing.</Variant>", "label": []}
{"id": "15135245", "text": "<Variant>The mutation, CAC(3543)TAC results in a His3543Tyr substitution in apoB-100 (H3543Y).</Variant>", "label": [[23, 35, "Variant"], [49, 59, "Variant"], [86, 92, "Variant"]]}
{"id": "15135245", "text": "<Variant>The prevalence of heterozygotes for H3543Y in the study population was 0.47% compared to 0.12% for the known Arg 3500 Gln (R3500Q) mutation.</Variant>", "label": [[45, 51, "Variant"], [118, 130, "Variant"], [132, 138, "Variant"]]}
{"id": "15135245", "text": "<Variant>In conclusion, the new mutation is four times more frequent than \"classical\" FDB and thus appears to be the most common apoB mutation in Germany.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>Identification of three F5 gene mutations associated with inherited coagulation factor V deficiency in two Chinese pedigrees.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>To investigate the molecular defects in two Chinese pedigrees with inherited factor V (FV) deficiency.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>A 37-year-old male (proband 1) and an 18-month-old boy (proband 2) were diagnosed as inherited coagulation FV deficiency by severely reduced plasma levels of FV activity and antigen.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>All 25 exons and their flanking sequence of F5 gene were amplified by polymerase chain reaction (PCR) for both probands and the PCR products were directly sequenced.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>Total RNA was extracted from the peripheral lymphocytes of proband 1 for detecting the changes at mRNA level.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>The homozygous deletion IVS8 -2A>G was identified in the F5 gene of proband 1 and complementary DNA (cDNA) analysis revealed the abolishment of the canonical splicing site by the mutation and the activation of the cryptic acceptor site 24 bp upstream instead.</Variant>", "label": [[33, 43, "Variant"]]}
{"id": "15086325", "text": "<Variant>The insertion introduced eight additional amino acids (AA) into the FV protein.</Variant>", "label": [[13, 62, "Variant"]]}
{"id": "15086325", "text": "<Variant>Two heterozygous mutations of F5 gene were discovered in proband 2.</Variant>", "label": []}
{"id": "15086325", "text": "<Variant>The 2238-9del AG in exon 13 introduced a premature termination code at 689 AA and the substitution of G6410 by T in exon 23 lead to the missense mutation Gly2079Val.</Variant>", "label": [[13, 25, "Variant"], [111, 121, "Variant"], [163, 173, "Variant"]]}
{"id": "15086325", "text": "<Variant>Three F5 gene mutations, IVS8 -2A>G, 2238-9del AG and G6410T, have been identified in two Chinese pedigree with congenital FV deficiency, respectively.</Variant>", "label": [[34, 44, "Variant"], [46, 58, "Variant"], [63, 69, "Variant"]]}
{"id": "14999772", "text": "<Variant>Expression mapping at 12p12-13 in advanced prostate carcinoma.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>We have previously mapped a putative prostate cancer tumor-suppressor gene to a 1-2 Mb region of 12p12-13.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>Initial work to identify the tumor suppressor at this locus focused on candidates previously implicated in malignancy; however, mutational and methylation analyses failed to identify significant genomic events.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>An alternative approach is to use expression analysis to prioritize the genes within the region of interest.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>This experimental design is based on the hypothesis that tumor-suppressor genes demonstrate decreased expression in tumors compared to normals.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>Herein, we narrow the region of interest using deletion mapping data and employ expression analysis to prioritize the genes in the minimal deleted region.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>Highly informative polymorphic markers spanning our region were used to assess for loss of heterozygosity in 99 tumor and normal DNA pairs.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>The minimal region of deletion was determined to be approximately 500 kb bounded by D12S391 and A002Q26.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>Publically available databases place 7 genes within this minimal deletion region.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>An additional 3 genes lie just outside this minimal deletion region and could possibly be inactivated by deletion of promoter, 3'-untranslated region sequences or alternative splice variants.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>Relative levels of expression of these 10 candidate genes were determined in 6 normal prostates, 5 local prostate tumors, 9 prostate lymph node metastases, 6 prostate cancer cell lines and 12 prostate cancer xenografts using quantitative RT-PCR.</Variant>", "label": []}
{"id": "14999772", "text": "<Variant>DUSP16, FLJ10298 and BCLG were significantly downregulated in both clinical tumors and cultured prostate cancer tissue, indicating that one or all may be critical to initiation or progression of prostate carcinoma.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Studies on nontumorigenic and tumorigenic human cell hybrids derived from the fusion of HeLa (a cervical cancer cell line) with GM00077 (a normal skin fibroblast cell line) have demonstrated \"functional\" tumor-suppressor activity on chromosome 11.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>It has been shown that several of the neoplastically transformed radiation-induced hybrid cells called GIMs (gamma ray induced mutants), isolated from the nontumorigenic CGL1 cells, have lost one copy of the fibroblast chromosome 11.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>We hypothesized, therefore, that the remaining copy of the gene might be mutated in the cytogenetically intact copy of fibroblast chromosome 11.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Because a cervical cancer tumor suppressor locus has been localized to chromosome band 11q13, we performed deletion-mapping analysis of eight different GIMs using a total of 32 different polymorphic and microsatellite markers on the long arm (q arm) of chromosome 11.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Four irradiated, nontumorigenic hybrid cell lines, called CONs, were also analyzed.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Allelic deletion was ascertained by the loss of a fibroblast allele in the hybrid cell lines.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>The analysis confirmed the loss of a fibroblast chromosome 11 in five of the GIMs.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Further, homozygous deletion (complete loss) of chromosome band 11q13 band sequences, including that of D11S913, was observed in two of the GIMs.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Detailed mapping with genomic sequences localized the homozygous deletion to a 5.7-kb interval between EST AW167735 and EST F05086.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Southern blot hybridization using genomic DNA probes from the D11S913 locus confirmed the existence of homozygous deletion in the two GIM cell lines.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Additionally, PCR analysis showed a reduction in signal intensity for a marker mapped 31 kb centromeric of D11S913 in four other GIMs.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Finally, Northern blot hybridization with the genomic probes revealed the presence of a novel >15-kb transcript in six of the GIMs.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>These transcripts were not observed in the nontumorigenic hybrid cell lines.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>Because the chromosome 11q13 band deletions in the tumorigenic hybrid cell lines overlapped with the minimal deletion in cervical cancer, the data suggest that the same gene may be involved in the development of cervical cancer and in radiation-induced carcinogenesis.</Variant>", "label": []}
{"id": "14978789", "text": "<Variant>We propose that a gene localized in proximity to the homozygous deletion is the candidate tumor-suppressor gene.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>Germline deletions of EXO1 do not cause colorectal tumors and lesions which are null for EXO1 do not have microsatellite instability.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>Exonuclease 1 (EXO1) is a candidate gene for colorectal tumor susceptibility because it is believed to play a role in mismatch repair.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>There have been several studies investigating the role of EXO1 in mismatch repair but few investigating its role in causing clinical disease.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>In one recent study, germline variants of EXO1 were reported to be associated with predisposition to colorectal cancer in families with phenotypes similar to hereditary nonpolyposis colon cancer (HNPCC).</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>We recently identified nine individuals from two British families with multiple cutaneous and uterine leiomyomatosis with independently arising heterozygous germline deletions of 1q42.3 approximately q43 encompassing not only FH, the multiple leiomyomatosis-associated gene, but also several flanking genes, including EXO1.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>We investigated these families for any indication of predisposition to colorectal cancer or other HNPCC spectrum cancers by means of detailed questionnaires, interviews, and examination of EXO1-null skin leiomyomata for microsatellite instability (MSI).</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>No individual in these families had developed colorectal cancer or known colorectal adenomas, and none had any symptoms warranting gastrointestinal or other investigation.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>EXO1-null tumors showed no evidence of MSI.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>This study questions the functional significance of previously reported variants of EXO1 reported in HNPCC-like families and suggests that in humans there may be other as yet undiscovered proteins that have exonuclease function overlapping with that of EXO1 in DNA mismatch repair.</Variant>", "label": []}
{"id": "14623461", "text": "<Variant>Also of interest is the absence of phenotypic abnormality apart from multiple leiomyomatosis in any deletion carrier even though the adjacent genes RGS7, KMO, CHML, and OPN3 were also deleted.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>Beta-thalassemia in association with a new delta-chain hemoglobin variant [delta116(g18)Arg-->Leu]: implications for carrier screening and prenatal diagnosis.</Variant>", "label": [[97, 106, "Variant"]]}
{"id": "14587045", "text": "<Variant>We describe a complicated genetic counseling and prenatal diagnostic case involving an East Indian couple that had lost two consecutive pregnancies.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>Hemoglobinopathy screening was conducted to investigate the possibility of Hb Bart's hydrops fetalis or Hb H hydrops fetalis.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>The initial work-up indicated that alpha-thalassemia was not a contributing factor, with both parents being carriers of single gene deletions (-alpha(3.7)/alphaalpha).</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>However, the Hb electrophoresis results indicated that the couple might be at risk for having children with Hb E/Hb Lepore disease.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>Subsequent DNA testing demonstrated that the father carried the Hb E mutation, but failed to confirm that the mother carries the Hb Lepore deletion.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>Sequence analysis revealed that the mother was heterozygous for a common East Indian beta(0)-thalassemia mutation, yet had a normal level of Hb A(2).</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>The mother also carried a previously unreported missense mutation of the delta-globin gene, in cis with the beta(0)-thalassemia mutation, which gave rise to the minor Hb variant originally misidentified as Hb Lepore.</Variant>", "label": []}
{"id": "14587045", "text": "<Variant>This case illustrates the importance of comprehensive molecular analyses for accurate assessment of genetic risks for hemoglobinopathy syndromes.</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>Novel polypyrimidine variation (IVS46: del T -39...-46) in ABCA1 causes exon skipping and contributes to HDL cholesterol deficiency in a family with premature coronary disease.</Variant>", "label": [[41, 63, "Variant"]]}
{"id": "14576201", "text": "<Variant>Recent studies have implicated mutations in the ATP-binding cassette transporter A1, ABCA1, as a cause of Tangier disease (TD) and familial hypoalphalipoproteinemia (FHA).</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>We investigated a proband with very low levels of high-density lipoprotein cholesterol (HDL-C, 6 mg/dL) and a history of premature coronary heart disease (CHD).</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>Sequencing of the ABCA1 gene revealed 2 distinct variants.</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>The first mutation was a G5947A substitution (R1851Q).</Variant>", "label": [[34, 40, "Variant"], [55, 61, "Variant"]]}
{"id": "14576201", "text": "<Variant>The second mutation was a single-nucleotide deletion of thymidine in a polypyrimidine tract located 33 to 46 bps upstream to the start of exon 47.</Variant>", "label": [[53, 121, "Variant"]]}
{"id": "14576201", "text": "<Variant>This mutation does not involve the 3' acceptor splice site and is outside the lariat branchpoint sequence (IVS46: del T -39...-46).</Variant>", "label": [[116, 138, "Variant"]]}
{"id": "14576201", "text": "<Variant>Amplification of cDNA obtained in cultured fibroblasts of the proband and affected family member revealed an abnormally spliced cDNA sequence with skipping of exon 47.</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>These variants were not identified in over 400 chromosomes of healthy whites.</Variant>", "label": []}
{"id": "14576201", "text": "<Variant>Compound heterozygotes (n=4) exhibited the lowest HDL-C (11+/-5 mg/dL) and ApoA-I (35+/-15 mg/dL) compared with wild-type (n=25) (HDL-C 51+/-14 mg/dL; ApoA-I 133+/-21 mg/dL) (P<0.0005) or subjects affected with either R1851Q (n=6) (HDL-C 36+/-8; ApoA-I 117+/-19) or IVS46: del T -39...-46 (n=5) (HDL-C 31+9; ApoA-I 115+28 (P<0.01).</Variant>", "label": [[227, 233, "Variant"], [275, 297, "Variant"]]}
{"id": "14576201", "text": "<Variant>These data suggest that polypyrimidine tract variation may represent a novel mechanism for altered splicing and exon skipping that is independent of traditional intronic variants as previously identified in acceptor/donor splice regions or the lariat branchpoint domain.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>Entry of human immunodeficiency type 1 virus (HIV-1) into target cells requires both CD(4)and one of the chemokine receptors.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>Viruses predominantly use one, or occasionally both, of the major co-receptors CCR5 and CXCR4, although other receptors, including CCR2B and CCR3, function as minor co-receptors.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>A 32-nucleotide deletion (D32) within the b-chemokine receptor 5 gene (CCR5) has been described in subjects who remain uninfected despite extensive exposition to HIV-1.</Variant>", "label": [[11, 33, "Variant"], [35, 38, "Variant"]]}
{"id": "14533983", "text": "<Variant>The heterozygous genotype delays disease progression.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>This allele is common among Caucasians, but has not been found in people of African or Asian ancestry.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>A more common transition involving a valine to isoleucine switch in transmembrane domain I of CCR2B (64I), with unknown functional consequences, was found to delay disease progression but not to reduce infection risk.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>As the Brazilian population consists of a mixture of several ethnic groups, we decided to examine the genotype frequency of these polymorphisms in this country.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>There were 11.5% CCR5 heterozygotes among the HIV-1 infected population and 12.5% among uninfected individuals, similar to data from North America and Western Europe.</Variant>", "label": []}
{"id": "14533983", "text": "<Variant>The prevalence of CCR2-64I homozygotes and heterozygotes was 0.06 and 15.2%, respectively, also similar to what is known for North America and Western Europe.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Familial autosomal dominant neurohypophyseal diabetes insipidus (FNDI) is a rare form of central diabetes insipidus (DI), which is caused by mutations in the vasopressin-neurophysin II (AVP-NPII) gene.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>The present study evaluated the AVP secretion over time and analysed the structure of the AVP-NPII gene in a Brazilian family with FNDI.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>SUBJECTS AND DESIGN:</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Four affected members and one nonaffected member from one Brazilian family with FNDI were studied.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>The diagnosis of central DI was established by fluid deprivation test and hypertonic saline infusion.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Two affected members were assessed twice within a 6-year interval.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>For molecular analysis, genomic DNA was extracted and the AVP-NPII gene was amplified by polymerase chain reaction.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>The functional assessment of patients with FNDI over time confirmed a progressive loss in AVP secretion.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Two patients were first diagnosed as partial central DI and, several years later, they developed severe central DI.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Sequencing analysis revealed a heterozygous new point mutation in the nucleotide 1892 in the coding sequence for neurophysin-II of the AVP-NPII gene (1892G>C) predicting an amino acid substitution (A68P) in all affected members.</Variant>", "label": [[159, 166, "Variant"], [207, 211, "Variant"]]}
{"id": "14510916", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>Our data demonstrate a gradual vasopressinergic deficiency due to a novel mutation in the AVP-NPII gene in a Brazilian family with FNDI.</Variant>", "label": []}
{"id": "14510916", "text": "<Variant>The accumulation of A68P mutated precursor might have a cytotoxicity effect, leading to a gradual death of magnocellular neurones, and a progressive decline in AVP secretion.</Variant>", "label": [[29, 33, "Variant"]]}
{"id": "14510914", "text": "<Variant>Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>Iodide transport defect (ITD) is a rare disorder characterised by an inability of the thyroid to maintain an iodide gradient across the basolateral membrane of thyroid follicular cells, that often results in congenital hypothyroidism.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>When present the defect is also found in the salivary glands and gastric mucosa and it has been shown to arise from abnormalities of the sodium/iodide symporter (NIS).</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>PATIENT:</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>We describe a woman with hypothyroidism identified at the 3rd month of life.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>The diagnosis of ITD was suspected because of nodular goitre, and little if any iodide uptake by the thyroid and salivary glands.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>Treatment with iodide partially corrected the hypothyroidism; however, long-term substitution therapy with L-thyroxine was started.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>MEASUREMENTS:</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>Thyroid radioiodide uptake was only 1.4% and 0.3% at 1 and 24 h after the administration of recombinant human TSH.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>The saliva to plasma</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>I- ratio was 1.1 indicating that the inability of the thyroid gland to concentrate I- was also present in the salivary glands.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>Analysis of the patient's NIS gene revealed a 15 nucleotide (nt) deletion of the coding sequence (nt 1314 through nt 1328) and the insertion of 15 nt duplicating the first 15 nt of the adjacent intron.</Variant>", "label": [[74, 131, "Variant"], [153, 170, "Variant"]]}
{"id": "14510914", "text": "<Variant>The patient was homozygous for this insertion/deletion, while both consanguineous parents were heterozygous.</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>This deletion predicts the production of a protein lacking the five terminal amino acids of exon XI (439-443) which are located in the 6th intracellular loop.</Variant>", "label": [[60, 118, "Variant"]]}
{"id": "14510914", "text": "<Variant>COS-7 cells transfected with a vector expressing the mutant del-(439-443) NIS failed to concentrate iodide, suggesting that the mutation was the direct cause of the ITD in this patient.</Variant>", "label": [[69, 82, "Variant"]]}
{"id": "14510914", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "14510914", "text": "<Variant>In conclusion we describe the first Italian case of congenital hypothyroidism due to a new deletion in the NIS gene.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>A Cdx-2 binding site polymorphism (G to A) in the promoter region of the human vitamin D receptor gene was reported.</Variant>", "label": [[44, 50, "Variant"]]}
{"id": "12968672", "text": "<Variant>In an ecological study in eight ethnic groups and an association study in 2848 elderly whites, we found the A-allele to be associated with decreased fracture risk.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>Our findings expand previous similar findings in a Japanese study to whites and show a relationship with fracture risk of this functional polymorphism.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>INTRODUCTION:</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>A single nucleotide polymorphism (SNP) within a binding site of the intestinal-specific transcription factor Cdx-2 in the promoter region of the human vitamin D receptor (VDR) gene was previously reported.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>It was found to modulate the transcription of the hVDR gene and to be associated with decreased bone mineral density in a small group of postmenopausal Japanese women.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>In this study, we investigated the relationship between the VDR Cdx-2 genotype and risk of fracture.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>We first determined the location of this SNP in the VDR gene by sequencing analysis, and we developed an allele-specific multiplex polymerase chain reaction test to determine the Cdx-2 genotype.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>We then performed an ecological study in eight ethnic groups and an association analysis in a large epidemiological cohort of 2848 Dutch white men and women, > or = 55 years old.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>RESULTS AND CONCLUSIONS:</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>The location of the G to A substitution was found in the promoter region of exon le (le-G-1739A) of the VDR gene.</Variant>", "label": [[29, 35, "Variant"], [97, 104, "Variant"]]}
{"id": "12968672", "text": "<Variant>By comparing the frequency of the A-allele in eight different ethnic groups, we observed a negative correlation between prevalence of the A-allele and published hip fracture incidence rates in these ethnic groups (p = 0.006 for men and p = 0.02 for women), suggesting a protective effect of this allele on fracture risk.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>Subsequently, in the association study, the A-allele (population frequency 19%) was observed to have a protective effect on occurrence of osteoporotic fractures, especially for nonvertebral fracture in women (relative risk of AA versus GG genotype is 0.2; 95% CI, 0.05-0.8).</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>This effect remained after adjustment for age, weight, and bone mineral density.</Variant>", "label": []}
{"id": "12968672", "text": "<Variant>We conclude that the A-allele of the VDR Cdx-2 polymorphism is present in whites, albeit at low frequency, and show a protective effect of this allele on risk of fracture.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>Genes of the renin-angiotensin system (RAS) are involved in the progression of renal failure.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>Among them, the angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) genes are of particular interest.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>We examined polymorphisms of these three genes for association with the development of interstitial nephritis and progression to end-stage renal failure.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>The allele frequency and genotype distribution were compared in 90 patients with interstitial nephritis and 200 healthy controls.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>DNA samples were genotyped by polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>We did not find statistically significant differences between groups in the insertion/deletion polymorphism of the ACE gene.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>An involvement of M235T polymorphism of the AGT gene in renal disease was observed in our study.</Variant>", "label": [[27, 32, "Variant"]]}
{"id": "12898858", "text": "<Variant>The frequency of the T allele was higher in patients than in controls (32% vs. 24%).</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>In the A1166C AT1R polymorphism the homozygous CC genotype was also more frequent in interstitial nephritis patients (7% vs. 3.5%).</Variant>", "label": [[16, 22, "Variant"]]}
{"id": "12898858", "text": "<Variant>In patients carrying the C allele, an average time to ESRD was significantly shorter than in subjects with the AA genotype.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>Our study shows the association of the AGT and AT1R gene polymorphisms with the development and progression of interstitial nephritis.</Variant>", "label": []}
{"id": "12898858", "text": "<Variant>The C allele of the A1166C polymorphism appears to be a risk factor for faster disease progression.</Variant>", "label": [[29, 35, "Variant"]]}
{"id": "12832681", "text": "<Variant>Epidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>In recent years several population based studies using restriction fragment length polymorphism (RFLP) analysis have shown a higher rate of recent transmission of tuberculosis than previously thought.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>This study was undertaken to determine the transmission patterns of tuberculosis and the potential causes of recent transmission on the island of Gran Canaria (Spain).</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>The strains of all patients diagnosed with tuberculosis confirmed by culture between 1 January 1993 and 31 December 1996 were typed by RFLP using the insertion sequence IS6110.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>A cluster was defined as two or more isolates with an identical RFLP pattern.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>Epidemiological linkage through contact tracing was investigated.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>RESULTS: Of the total of 719 patients, 153 (21.3%) were excluded because there was inadequate bacterial DNA for genotyping (n=129) or the isolates of Mycobacterium tuberculosis had less than five copies of IS6110 (n=24).</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>The isolates from 409 patients (72.3%) were grouped into 78 different clusters with an estimated 58.5% of the cases being due to recent transmission.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>Young age was the only significant predictor of clustering.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>Only in 147 (35.9%) of the 409 patients belonging to a cluster could an epidemiological link be found.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>111 patients (19.6%) were identified as having had previous contact with a tuberculosis patient and 81 of them (72.9%) belonged to a cluster.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>The three largest clusters included 75, 49 and 20 patients, respectively.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>Recent transmission is frequent among patients with tuberculosis on Gran Canaria and could be associated with certain aspects of control measures.</Variant>", "label": []}
{"id": "12832681", "text": "<Variant>Some of the clusters described in the study could be due to the prevalence of particular strains of M tuberculosis on the island.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>The molecular basis for the thalassaemias in Sri Lanka.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>The beta-globin gene mutations and the alpha-globin genes of 620 patients with the phenotype of severe to moderate thalassaemia from seven centres in Sri Lanka were analysed.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>Twenty-four beta-globin gene mutations were identified, three accounting for 84.5% of the 1240 alleles studied: IVSI-5 (G-->C) 56.2%; IVSI-1 (G-->A) 15.2%; and haemoglobin E (codon (CD)26 GAG-->GAA) 13.1%.</Variant>", "label": [[121, 135, "Variant"], [143, 157, "Variant"], [184, 206, "Variant"]]}
{"id": "12752111", "text": "<Variant>Three new mutations were found; a 13-bp deletion removing the last nucleotide in CD6 to CD10 inclusively, IVSI-129 (A-->C) in the consensus splice site, and a frame shift, CD55 (-A).</Variant>", "label": [[43, 57, "Variant"], [115, 131, "Variant"]]}
{"id": "12752111", "text": "<Variant>The allele frequency of alpha+ thalassaemia was 6.5% and 1.1% for -alpha3.7 and -alpha4.2 deletions respectively.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>Non-deletion alpha-thalassaemia was not observed.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>Triplicate or quadruplicate alpha-globin genes were unusually common.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>In 1.5% of cases it was impossible to identify beta-thalassaemia alleles, but in Kurunegala detailed family studies led to an explanation for the severe thalassaemia phenotype in every case, including a previously unreported instance of homozygosity for a quadruplicated alpha-globin gene together with beta-thalassaemia trait.</Variant>", "label": []}
{"id": "12752111", "text": "<Variant>These findings have implications for the control of thalassaemia in high-frequency populations with complex ethnic histories.</Variant>", "label": []}
{"id": "12750403", "text": "<Variant>Pacemaker channel dysfunction in a patient with sinus node disease.</Variant>", "label": []}
{"id": "12750403", "text": "<Variant>The cardiac pacemaker current I(f) is a major determinant of diastolic depolarization in sinus nodal cells and has a key role in heartbeat generation.</Variant>", "label": []}
{"id": "12750403", "text": "<Variant>Therefore, we hypothesized that some forms of \"idiopathic\" sinus node dysfunction (SND) are related to inherited dysfunctions of cardiac pacemaker ion channels.</Variant>", "label": []}
{"id": "12750403", "text": "<Variant>In a candidate gene approach, a heterozygous 1-bp deletion (1631delC) in exon 5 of the human HCN4 gene was detected in a patient with idiopathic SND.</Variant>", "label": [[54, 67, "Variant"], [69, 77, "Variant"]]}
{"id": "12750403", "text": "<Variant>The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and lacked the cyclic nucleotide-binding domain.</Variant>", "label": [[39, 43, "Variant"]]}
{"id": "12750403", "text": "<Variant>COS-7 cells transiently transfected with HCN4-573X cDNA indicated normal intracellular trafficking and membrane integration of HCN4-573X subunits.</Variant>", "label": [[55, 59, "Variant"], [141, 145, "Variant"]]}
{"id": "12750403", "text": "<Variant>Patch-clamp experiments showed that HCN4-573X channels mediated I(f)-like currents that were insensitive to increased cellular cAMP levels.</Variant>", "label": [[50, 54, "Variant"]]}
{"id": "12750403", "text": "<Variant>Coexpression experiments showed a dominant-negative effect of HCN4-573X subunits on wild-type subunits.</Variant>", "label": [[76, 80, "Variant"]]}
{"id": "12750403", "text": "<Variant>These data indicate that the cardiac I(f) channels are functionally expressed but with altered biophysical properties.</Variant>", "label": []}
{"id": "12750403", "text": "<Variant>Taken together, the clinical, genetic, and in vitro data provide a likely explanation for the patient's sinus bradycardia and the chronotropic incompetence.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>It was reported that 60-70% of hepatitis B virus (HBV)-negative hepatocellular carcinoma (HCC) had loss of heterozygosity (LOH) at the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) locus and this gene was mutated in 55% of these patients with LOH.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>In this study, genomic DNA from 29 pairs of HBV-positive HCC and corresponding non-tumor tissues was used to analyze LOH at the M6P/IGF2R locus and single deoxyguanosine deletion in this gene by PCR.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>Total RNA from 19 of the 29 patients was utilized to determine a 192 bp insert in the M6P/IGF2R mRNA and expression of this gene by RT-PCR.</Variant>", "label": [[74, 87, "Variant"]]}
{"id": "12736721", "text": "<Variant>Twenty-eight of 29 (97%) HBV-positive HCC were found to be informative at the M6P/IGF2R locus but LOH at this region was only detected in 4/28 (14%) informative patients.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>Neither single deoxyguanosine deletion in this gene nor 192 bp insert in its mRNA occurred in these patients.</Variant>", "label": [[65, 78, "Variant"]]}
{"id": "12736721", "text": "<Variant>Compared with corresponding non-tumor tissues, expression of the M6P/IGF2R mRNA was decreased in 13/19 (68%) HBV-positive HCC tissues, suggesting that M6P/IGF2R may be involved in HBV-associated hepatocarcinogenesis by the regulation of its expression level.</Variant>", "label": []}
{"id": "12736721", "text": "<Variant>In the development of HBV-associated HCC, M6P/IGF2R mutation may not be a major agent.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>A novel CACNA1F mutation in a french family with the incomplete type of X-linked congenital stationary night blindness.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>To describe a French family with the incomplete type of X-linked congenital stationary night blindness (CSNB2) associated with a novel mutation in the retina-specific calcium channel alpha(1) subunit gene (CACNA1F).</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>Interventional case report.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>METHODS: Two family members with a history of nonprogressive night blindness and subnormal visual acuity were clinically examined and the genotype determined by molecular genetic analysis.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>RESULT:</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>Both patients had clinical manifestations characteristic of CSNB2.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>Electrophysiologically, we found a predominant reduction of the ERG B-wave in the maximal response.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>Both rod and cone function were subnormal, with the latter tending to be more attenuated.</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>We identified a C deletion at nucleotide position 4548, resulting in a frameshift with a predicted premature termination at codon 1524.</Variant>", "label": [[25, 63, "Variant"], [118, 143, "Variant"]]}
{"id": "12719097", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "12719097", "text": "<Variant>The clinical and genetic study of a novel mutation in the CACNA1F gene adds further support to the contention that CSNB2 represents a genetically distinct retinal disorder of a calcium channel.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>DMBT1 has been implicated as a candidate tumor suppressor gene on chromosome 10q for brain, gastrointestinal and lung cancer.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Homozygous deletion and lack of expression are 2 known mechanisms for inactivating DMBT1.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>We evaluated whether somatic mutation, which represents a major inactivation mechanism for most tumor suppressor genes, occurs in the DMBT1 gene.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>A total of 102 primary brain tumors, consisting of 25 glioblastoma multiforme, 24 medulloblastoma and 53 oligodendroglial tumors, were analyzed by conformation-sensitive gel electrophoresis in all 54 coding exons of DMBT1.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Twelve different base substitutions were detected in 26 (25%) tumors.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Eight base substitutions resulted in amino acid changes and 4 were silent.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>These base changes were also detected in tumor-matched blood samples, however, indicating that the base variations represent genetic polymorphisms.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>We also assessed homozygous deletions of the DMBT1 gene in the series and found that 16 of 95 (5 glioblastomas, 5 medulloblastomas, 6 oligodendroglial tumors; total 17%) tumors harbor such alteration.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>High-quality blood DNA samples were available in 5 tumors carrying homozygous deletion and, using long-range PCR, 3 of these blood samples showed germline hemizygous deletions in a region between introns 10 and 26 of DMBT1.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Our results showed that mutation does not play a role in inactivation of DMBT1 in brain tumors.</Variant>", "label": []}
{"id": "12672033", "text": "<Variant>Intragenic homozygous deletion of DMBT1 is common in brain tumors and is likely a result of a germline deletion of 1 allele followed by loss of the second allele during tumor development.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>OBJECTIVE: Studies have shown that genetic factors are significant in predisposing individuals to shyness and social phobia.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>Toward further elucidating the genetic structure of shyness, the authors examined four functional polymorphisms that make biological sense for contributing to the development of this phenotype: serotonin transporter promoter region 44 base pair insertion/deletion (5-HTTLPR), dopamine D(4) receptor exon III repeat (DRD4), catechol O-methyltransferase (COMT), and monoamine oxidase</Variant>", "label": [[241, 272, "Variant"]]}
{"id": "12668354", "text": "<Variant>A promoter region repeat (MAO(A)).</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>METHOD:</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>The authors assessed shyness after recruitment of a nonclinical sample (N=118, unscreened second-grade children) using a composite scale derived from questionnaires administered to the children, parents, and teachers.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>DNA from buccal smears successfully obtained from 98 children was genotyped by polymerase chain reaction methods for the 5-HTTLPR, DRD4, COMT, and MAO(A) polymorphisms.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>Significant correlations were observed for parents', teachers', and children's ratings of shyness, and Cronbach's alpha reliability was high for all three scales.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>A significant association was observed between the long 5-HTTLPR polymorphism and shyness, both by the functional classification of Lesch as well as by consideration of all three genotypes.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>No significant association was observed for the DRD4, COMT, or MAO(A) polymorphisms.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>This study provisionally identifies a common genetic polymorphism, 5-HTTLPR, that modestly (effect size=7%) contributed to greater shyness scores in a nonclinical group of second-grade students.</Variant>", "label": []}
{"id": "12668354", "text": "<Variant>These first findings may be relevant to previous reports that have shown an association between the 5-HTTLPR long form and obsessive-compulsive disorder and autism.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>Restricted genetic defects underlie human complement C6 deficiency.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>Complement C6 homozygous deficiency (C6D) has been rarely observed in Caucasians but was reported at higher prevalence among African-Americans.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>We report on the molecular basis of C6D in seven unrelated black individuals of North or Central Africa descent who live in France.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>These patients have presented Neisseria meningitidis infection (four cases), focal and segmental glomerulosclerosis with hyalinosis (one case), systemic lupus erythematosus (one case) or Still's disease (one case).</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>All patients exhibited undetectable antigenic C6 by using a sensitive ELISA assay.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>An additional four cases of complete C6 deficiency with no associated disease have been characterized after family studies.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>Exons 6, 7 and 12 have been described recently as the location of molecular defects on the C6 gene in randomly chosen black Americans.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>Genomic DNA from the seven patients were subjected to direct polymerase chain reaction amplification of these three exons.</Variant>", "label": []}
{"id": "12653841", "text": "<Variant>Nucleotide sequencing analysis of the amplified DNA fragments revealed a homozygous single-base deletion (1936delG) in exon 12 in three cases and four compound heterozygous deletions for a single base in exon 7 (1195delC) or in exon 6 (878delA) associated with the same deletion in exon 12 (1936delG).</Variant>", "label": [[93, 113, "Variant"], [115, 123, "Variant"], [221, 229, "Variant"], [245, 252, "Variant"], [300, 308, "Variant"]]}
{"id": "12653841", "text": "<Variant>Our observations further establish the restricted pattern of genetic defects associated with homozygous C6 complement deficiency in individuals of African descent.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>To identify the genetic defect of a consanguineous Portuguese family with rod-cone dystrophy and varying degrees of decreased audition.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>A detailed ophthalmic and auditory examination was performed on a Portuguese patient with severe autosomal recessive rod-cone dystrophy.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>Known genetic defects were excluded by performing autosomal recessive retinitis pigmentosa (arRP) genotyping microarray analysis and by Sanger sequencing of the coding exons and flanking intronic regions of eyes shut homolog-drosophila (EYS) and chromosome 2 open reading frame 71 (C2orf71).</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>Subsequently, genome-wide homozygosity mapping was performed in DNA samples from available family members using a 700K single nucleotide polymorphism (SNP) microarray.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>Candidate genes present in the significantly large homozygous regions were screened for mutations using Sanger sequencing.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>The largest homozygous region (~11 Mb) in the affected family members was mapped to chromosome 9, which harbors deafness, autosomal recessive 31 (DFNB31; a gene previously associated with Usher syndrome).</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>Mutation analysis of DFNB31 in the index patient identified a novel one-base-pair deletion (c.737delC), which is predicted to lead to a truncated protein (p.Pro246HisfsX13) and co-segregated with the disease in the family.</Variant>", "label": [[77, 99, "Variant"], [101, 110, "Variant"], [164, 180, "Variant"]]}
{"id": "21738389", "text": "<Variant>Ophthalmic examination of the index patient and the affected siblings showed severe rod-cone dystrophy.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>Pure tone audiometry revealed a moderate hearing loss in the index patient, whereas the affected siblings were reported with more profound and early onset hearing impairment.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>We report a novel truncating mutation in DFNB31 associated with severe rod-cone dystrophy and varying degrees of hearing impairment in a consanguineous family of Portuguese origin.</Variant>", "label": []}
{"id": "21738389", "text": "<Variant>This is the second report of DFNB31 implication in Usher type 2.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>The genotype B of hepatitis B virus (HBV) was reported to associate with fulminant hepatitis (FH).</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>We aimed to clarify the characteristics of HBV obtained from FH patients in an area of Japan where genotype B HBV is prevalent.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>Using serum samples of 16 HBV-associated FH patients, partial HBV sequences were determined.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>The effects of HBV mutation/insertion/deletion were evaluated using an in vitro HBV replication system.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>RESULTS: Of the 16 HBV isolates, 31% belonged to subgenotype B1/Bj, 38% were subgenotype B2/Ba, and 31% were subgenotype C2/Ce.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>Notably, the single nucleotide insertion/deletion that resulted in a frameshift of the precore protein was found exclusively in 60% of B1/Bj strains.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>An in vitro study showed that all of the frameshift mutants had significantly higher amounts of HBV DNA than did the wild type.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>One of the isolates had a novel insertion of A between nucleotides 1900 and 1901, which resulted in a 3-nucleotide change within the Kozak sequence of the core protein and enhanced the core protein expression in vitro.</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21881116", "text": "<Variant>The frameshift insertion/deletion in the precore region enhanced HBV replication and might be associated with the development of FH by the subgenotype B1/Bj HBV.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>We describe a single consanguineous family with three affected children exhibiting knee and/or hip pain associated with swelling.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>Detailed clinical evaluation demonstrated diffuse joint involvement with an unusual proliferative synovitis on MRI.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>Synovial biopsies were notable for an infiltration of macrophages with abundant cytoplasm filled with faintly basophilic vacuoles.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>We used homozygosity mapping with a panel of 262,000 single nucleotide polymorphism markers to identify a homozygous stretch of 40.52 Mb on chromosome 3p22.3 - 3p13 that segregated with the arthropathy in the family.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>Of the 378 genes in the interval, the three hyaluronoglucosaminidase genes were considered good candidates based on the phenotype.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>Dideoxy sequencing identified a homozygous deletion in HYAL1, c.104delT, resulting in a premature termination codon, p.Val35AlafsX25, found in all three affected children.</Variant>", "label": [[71, 80, "Variant"], [126, 141, "Variant"]]}
{"id": "21559944", "text": "<Variant>Enzymatic analysis confirmed total HYAL1 deficiency in the three affected children.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>This confirms the diagnosis of Mucopolysaccharidosis IX (MPS IX) which has only been described in a single patient to date.</Variant>", "label": []}
{"id": "21559944", "text": "<Variant>In contrast to the previously described MPS IX patient, our three patients display a phenotype limited to the joints, suggesting that this is the primary manifestation of HYAL1 deficiency.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>Genomic alterations of the Wilms' Tumor 1 (WT1) gene have been reported to occur in patients with acute myeloid leukemia (AML).</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>No data presently exists regarding the frequency of WT1 mutations in the Southeast Asian AML population.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>This study focused on WT1 exons 7-10 mutations and their correlation with other molecular markers and patients' characteristics.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>The zinc finger domain of WT1 gene covering exons 7-10 was directly sequenced.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>Six types of mutations were identified among 49 cases (12.24%); 4 localized on exon 7 and 2 on exon 9.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>Two novel mutations were identified including the insertion within codon 313 and codon 314.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>Patients harboring WT1 mutations seemed to have a younger age (29.5 vs 45.4 years), a higher white blood cell count (120.3 vs 19.8 10(9)/L), and a lower platelet count (54.2 vs 104.3 10(9)/L) as compared to those without the mutations although statistical differences could not be demonstrated.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>All exon 7 mutations were frameshift mutations and had NRAS mutation while exon 9 mutations were base substitutions and had FLT3-ITD mutation.</Variant>", "label": []}
{"id": "21798259", "text": "<Variant>Interestingly, the major allele for rs16754 single nucleotide polymorphism was G (25-homozygous and 6-heterozygous) which was in contrast to A in the Western reports.</Variant>", "label": [[45, 52, "Variant"]]}
{"id": "21798259", "text": "<Variant>The frequency of WT1 mutation in the Southeast Asian AML was thus comparable to the figures reported from the West although the designated major allele for rs16754 polymorphism was different.</Variant>", "label": [[165, 172, "Variant"]]}
{"id": "21897748", "text": "<Variant>A recurrent missense mutation in GJA3 associated with autosomal dominant cataract linked to chromosome 13q.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>To map and identify the genetic defect underlying autosomal dominant cataract segregating in a 5-generation Caucasian American family.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Genomic DNA was prepared from blood leukocytes, genotyping was performed using microsatellite markers, and logarithm of the odds (LOD) scores were calculated using the LINKAGE programs.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Mutation profiling was performed using direct exon cycle-sequencing and restriction fragment analysis.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Protein function effects were evaluated using in silico prediction algorithms.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Significant evidence of linkage was obtained at marker D13S175 (maximum LOD score [Z(max)]=3.67; maximum recombination fraction [ (max)]=0.04) and D13S1316 (Z(max)=2.80, (max)=0.0).</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Haplotyping indicated that the disease lay in the ~170</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Kb physical interval between D13S1316 and D13S175, which contained the gene for gap-junction protein alpha-3 (GJA3) or connexin-46.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>Sequencing of GJA3 detected a heterozygous transition (c.130G>A) in exon-2 that resulted in gain of an Hsp92 II restriction site.</Variant>", "label": [[64, 72, "Variant"]]}
{"id": "21897748", "text": "<Variant>Allele-specific PCR amplification and restriction analysis confirmed that the novel Hsp92 II site co-segregated with cataract in the family but was not detected in 192 normal unrelated individuals.</Variant>", "label": []}
{"id": "21897748", "text": "<Variant>The c.130G>A transition was predicted to result in a non-conservative substitution of valine-to-methionine at codon 44 (p.V44M) with damaging effects on protein function.</Variant>", "label": [[13, 21, "Variant"], [95, 127, "Variant"], [129, 135, "Variant"]]}
{"id": "21897748", "text": "<Variant>CONCLUSIONS: These data confirm GJA3 as one of the most frequently mutated genes that underlie autosomal dominant cataract in humans, and further emphasize the importance of connexin function in maintaining lens transparency.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>The plasminogen activator inhibitor type-1 (PAI-1) has been implicated in the regulation of fibrinolysis and extracellular matrix components.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>The single base pair guanine insertion/deletion polymorphism (4G/5G) within the promoter region of the PAI-1 gene influences PAI-1 synthesis and may modulate hepatic fibrogenesis.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>AIM: To evaluate the influence of PAI-1 serum levels and 4G/5G polymorphism on the risk of liver fibrosis associated to non-alcoholic fatty liver disease (NAFLD) in morbidly obese patients.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>MATERIAL AND METHODS:</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>Case-control study of 50 obese patients undergoing bariatric surgery and 71 non-obese subjects matched by age and sex.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>Anthropometric and biochemical measurements were performed, including PAI-1 serum levels.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>Genomic DNA was obtained to assess the presence of 4G/5G polymorphism.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>RESULTS: BMI, insulinemia, triglycerides, HOMA-IR, hypertension and diabetes were significantly higher in obese patients compared to control subjects.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>PAI-1 serum levels observed in obese patients were significantly lower (10.63 4.82) compared to controls (14.26 11.4; p < 0.05).</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>No differences were observed in the PAI-1 4G/5G promoter genotypes frequencies (p = 0.12).</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>No differences were observed in PAI-1 plasma levels among obese patients with liver fibrosis (10.64 4.35) compared to patients without liver fibrosis (10.61 5.2; p = 0.985).</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>PAI-1 4G/5G promoter genotypes frequencies were similar in patients with or without liver fibrosis associated to NASH (p = 0.6).</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>CONCLUSIONS: Morbidly obese patients had significantly lower PAI-1 serum levels with similar PAI-1 4G/5G genotypes frequencies compared to non-obese subjects.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>The frequency of 4G/5G genotypes in Chilean Hispanic healthy subjects was similar to that described in other populations.</Variant>", "label": []}
{"id": "21911891", "text": "<Variant>No association was found between PAI-1 serum levels or 4G/5G genotype with liver fibrosis in obese patients.</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>A 13-bp deletion in the 3' untranslated region of the b-globin gene causes b-thalassemia major in compound heterozygosity with IVSII-1 mutation.</Variant>", "label": [[11, 25, "Variant"]]}
{"id": "21757944", "text": "<Variant>OBJECTIVE: To describe hematological and molecular features of a 13-bp deletion in the 3' untranslated region(3' UTR) of the b-globin gene in carrier individuals and a compound heterozygous patient.</Variant>", "label": [[74, 88, "Variant"]]}
{"id": "21757944", "text": "<Variant>SUBJECTS AND METHODS: Five members of an Iranian family of Persian ethnic origin were studied.</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>Red blood cell indices and hemoglobin analysis were carried out according to standard methods.</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>Genomic DNA was obtained from peripheral blood cells by salting-out procedures.</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>b-Globin gene amplification and DNA sequencing were performed.</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>RESULTS: One patient had a 13-bp deletion in the 3' UTR of the b-globin gene that causes the b-thalassemia phenotype in combination with the IVSII-1 (G > A) mutation.</Variant>", "label": [[36, 50, "Variant"], [150, 165, "Variant"]]}
{"id": "21757944", "text": "<Variant>The patient had inherited the IVSII-1 (G > A) mutation from his mother, while the second b-globin gene (inherited paternally) had a 13-bp deletion at nucleotide 90 downstream of the termination codon (CD +90 del 13 bp).The patient's father and paternal grandmother, who are carriers of this deletion, had no hematological abnormalities.</Variant>", "label": [[39, 54, "Variant"], [141, 208, "Variant"], [210, 226, "Variant"]]}
{"id": "21757944", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21757944", "text": "<Variant>This case showed a patient with a 13-bp deletion in the 3' UTR of b-globin gene that could cause a slight decrease in the stability of the mRNA, but did not have a hematological effect in the heterozygotes.</Variant>", "label": [[43, 57, "Variant"]]}
{"id": "21757944", "text": "<Variant>The 13-bp deletion could be clinically important only in situations where b-chain synthesis in trans is compromised.</Variant>", "label": [[13, 27, "Variant"]]}
{"id": "22129472", "text": "<Variant>The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder caused by defects in LDLR.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>Few reports describe FH mutations among Arabs.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>We describe a mutation in LDLR of two unrelated Arab families.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>We investigated 19 patients using DNA sequencing, RFLP, and real-time (RT) PCR.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>DNA sequencing showed a base pair substitution (c.1706-2 A>T) in the splice acceptor site of LDLR intron 11.</Variant>", "label": [[57, 69, "Variant"]]}
{"id": "22129472", "text": "<Variant>Our results were confirmed by RFLP on 2% agarose gel.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>In silico analysis predicted a new cryptic splice site downstream of the original position generating a 10-base deletion from the beginning of exon 12; (c.1706-1715del.ATCTCCTCAG).</Variant>", "label": [[113, 129, "Variant"], [162, 187, "Variant"]]}
{"id": "22129472", "text": "<Variant>cDNA</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>sequencing of exon 12 confirmed the computational analysis.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>The deletion was visualized on 4% agarose gel.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>The deletion generates a frameshift and a premature termination codon (c.1991-1993; p.(Asp569Valfs*93).</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>RT-PCR revealed that LDLR mRNA is 9.3% 6.5 and 17.9% 8.0 for FH homozygote and heterozygote individuals respectively, compared to a healthy family control.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>We predict a class II LDLR mutation that leads to a truncated receptor missing exons 14-18.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>We called this mutation \"the Arabic allele\".</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>We expect a significant contribution of this mutation to the prevalence of FH among Arabs.</Variant>", "label": []}
{"id": "22129472", "text": "<Variant>Also, we propose that the severe down regulation of LDLR mRNA expression is due to nonsense-mediated-decay.</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.</Variant>", "label": [[15, 24, "Variant"]]}
{"id": "21682595", "text": "<Variant>It has been shown that DNA repair is reduced in patients with systemic lupus erythematosus (SLE) and that the X-ray repair cross-complementing (XRCC1)</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>Arg399Gln (rs25487) polymorphism may contribute to DNA repair.</Variant>", "label": [[9, 18, "Variant"], [20, 27, "Variant"]]}
{"id": "21682595", "text": "<Variant>We evaluated the frequency of the XRCC1 Arg399Gln substitution in patients with SLE (n=265) and controls (n=360) in a sample of the Polish population.</Variant>", "label": [[49, 58, "Variant"]]}
{"id": "21682595", "text": "<Variant>The odds ratio (OR) for SLE patients with the Gln/Gln versus Gln/Arg or Arg/Arg genotypes was 1.553 (95% confidence interval</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>[CI]=0.9573-2.520; p=0.0729).</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>OR for the Gln/Gln or Gln/Arg versus Arg/Arg genotype was 1.551 (95% CI=1.122-2.144, p=0.0077).</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>The OR for the 399 Gln allele in patients with SLE was 1.406 (95% CI=1.111-1.779, p=0.0045).</Variant>", "label": [[24, 31, "Variant"]]}
{"id": "21682595", "text": "<Variant>There was also a statistically significant p-value of the (2) test for the trend observed in the XRCC1 Arg399Gln polymorphism (ptrend=0.0048).</Variant>", "label": [[112, 121, "Variant"]]}
{"id": "21682595", "text": "<Variant>We also found a significant contribution of the Gln/Gln or Arg/Gln versus Arg/Arg genotype to the presence of either the malar rash or photosensitivity manifestations of SLE OR=2.241 (1.328-3.781, p=0.0023, pcorr=0.0414).</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>Moreover, the meta-analysis of Taiwanese Han Chinese, Brazilian, and Polish populations showed that the Gln/Gln or Gln/Arg genotype and Gln allele were associated with SLE incidence.</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>OR for the Gln/Gln or Gln/Arg versus Arg/Arg genotype was 1.440 (95% CI=1.15-1.80, p=0.0019) and OR for the Gln allele was 1.27 (95% CI=1.08-1.51, p=0.0051).</Variant>", "label": []}
{"id": "21682595", "text": "<Variant>Our studies may confirm that the XRCC1 Arg399Gln polymorphism may increase the risk of incidence of SLE and the occurrence of some SLE manifestations.</Variant>", "label": [[48, 57, "Variant"]]}
{"id": "21054465", "text": "<Variant>Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>WHAT IS KNOWN AND OBJECTIVE: CYP2C8 is involved in the cytochrome P450 (CYP) epoxygenase pathway.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>Arachidonic acid metabolites such as epoxyeicosatrienenoic acids and hydroxyeicosatetrenoic acids, produced may have a role in hypertension.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>We aimed to develop a medium through-put method for screening samples of known and new mutations of CYP2C8 using denaturing high performance liquid chromatography (DHPLC).</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>DNA samples from 200 subjects (hypertensive patients and healthy controls) were screened for SNPs in CYP2C8 using DHPLC.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>Genotypes and allelic frequencies of CYP2C8 between the healthy controls and patients with hypertension were compared.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>RESULTS AND DISCUSSIONS: Six variants were detected and two were new; T deletion at 5063 and substitution of C to T at 33468 in exon 8.</Variant>", "label": [[79, 97, "Variant"], [118, 133, "Variant"]]}
{"id": "21054465", "text": "<Variant>Differences in variant frequencies were detected between the controls and hypertensive patients.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>The controls have significantly higher prevalence of C35322C compared to the patients.</Variant>", "label": [[62, 69, "Variant"]]}
{"id": "21054465", "text": "<Variant>The functional significance of the SNP at 35322 requires further study.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>Having homozygous C35322C could be a protective factor for hypertension.</Variant>", "label": [[27, 34, "Variant"]]}
{"id": "21054465", "text": "<Variant>WHAT IS NEW AND CONCLUSION:</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>Denaturing high performance liquid chromatography is useful for population screening to identify new and existing SNPs.</Variant>", "label": []}
{"id": "21054465", "text": "<Variant>A higher frequency of the C35322T SNP was observed among hypertensive patients than control subjects.</Variant>", "label": [[35, 42, "Variant"]]}
{"id": "21054465", "text": "<Variant>This potentially important observation requires confirmation and the clinical significance assessed.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>This study analyzed the genotype distribution and frequency of lamivudine (LAM) and tenofovir (TDF) resistance mutations in a group of patients co-infected with HIV and hepatitis B virus (HBV).</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>A cross-sectional study of 847 patients with HIV was conducted.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>Patients provided blood samples for HBsAg detection.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>The load of HBV was determined using an \"in-house\" real-time polymerase chain reaction.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>HBV genotypes/subgenotypes, antiviral resistance, basal core promoter (BCP), and precore mutations were detected by DNA sequencing.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>Twenty-eight patients with co-infection were identified.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>The distribution of HBV genotypes among these patients was A (n = 9; 50%), D (n = 4; 22.2%), G (n = 3; 16.7%), and F (n = 2; 11.1%).</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>Eighteen patients were treated with LAM and six patients were treated with LAM plus TDF.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>The length of exposure to LAM and TDF varied from 4 to 216 months.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>LAM resistance substitutions (rtL180M + rtM204V) were detected in 10 (50%) of the 20 patients with viremia.</Variant>", "label": [[41, 46, "Variant"], [51, 56, "Variant"]]}
{"id": "20648600", "text": "<Variant>This pattern and an accompanying rtV173L mutation was found in four patients.</Variant>", "label": [[44, 49, "Variant"]]}
{"id": "20648600", "text": "<Variant>Three patients with the triple polymerase substitution pattern (rtV173L + rtL180M + rtM204V) had associated changes in the envelope gene (sE164D + sI195M).</Variant>", "label": [[75, 80, "Variant"], [85, 90, "Variant"], [95, 100, "Variant"], [148, 153, "Variant"], [157, 162, "Variant"]]}
{"id": "20648600", "text": "<Variant>Mutations in the BCP region (A1762T, G1764A) and in the precore region (G1896A, G1899A) were also found.</Variant>", "label": [[38, 44, "Variant"], [46, 52, "Variant"], [81, 87, "Variant"], [89, 95, "Variant"]]}
{"id": "20648600", "text": "<Variant>No putative TDF resistance substitution was detected.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>The data suggest that prolonged LAM use is associated with the emergence of particular changes in the HBV genome, including substitutions that may elicit a vaccine escape phenotype.</Variant>", "label": []}
{"id": "20648600", "text": "<Variant>No putative TDF resistance change was detected after prolonged use of TDF.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>Analysis of a SNP linked to lactase persistence: An exercise for teaching molecular biology techniques to undergraduates.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>Recent experimental evidence indicates that the ability of adults to tolerate milk, cheese, and other lactose-containing dairy products is an autosomal dominant trait that co-evolved with dairy farming in Central Europe about 7,500 years ago.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>Among persons of European descent, this trait is strongly associated with a C to T substitution at a polymorphic site 13,910 bp upstream of the lactase gene.</Variant>", "label": [[85, 145, "Variant"]]}
{"id": "21445905", "text": "<Variant>This mutation results in the persistent expression of lactase into adulthood enabling individuals carrying a T(-13,910) allele to digest lactose as adults.</Variant>", "label": [[118, 128, "Variant"]]}
{"id": "21445905", "text": "<Variant>In this report, we describe a laboratory exercise for an undergraduate molecular biology course in which students determine their own genotype at the -13,910 polymorphic site and correlate this with their ability to tolerate dairy products.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>The exercise is used as a tool to teach basic molecular biology procedures such as agarose gel electrophoresis, PCR1, and DNA sequencing.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>Students are actively engaged in the learning process, not only by analyzing their own DNA but also by applying their knowledge and skills to answer an authentic question.</Variant>", "label": []}
{"id": "21445905", "text": "<Variant>The exercise is also integrated with lecture material on the control of gene expression at the transcriptional level, in particular, how transcription factors can influence the activity of a promoter by binding to cis-acting DNA regulatory elements located within the proximal promoter of a gene or distant enhancer regions.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>The distribution of human endogenous retrovirus K-113 in health and autoimmune diseases in Poland.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>During the evolution of the human genome, a number of retroviral integrations have occurred creating a group of human endogenous retroviruses (HERVs).</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>As of now several studies have pointed to the association of HERVs with certain autoimmune diseases such as RA, SLE, multiple sclerosis (MS) and SS as well as various neoplasms.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>In this study, we investigated the prevalence of HERV-K113 in patients with RA, SLE and in healthy subjects in the Polish population.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>Genomic DNA samples from 155 RA patients, 139 SLE patients and 261 newborns (as controls) were tested for the presence of the HERV-K113 allele using PCR.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>Each individual's DNA was genotyped for null, homozygous or heterozygous insertion of HERV-K113.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>Our data revealed statistically significant differences in the insertion frequencies of HERV-K113 between the groups of RA and SLE patients vs healthy controls (provirus DNA was found in 14.19, 15.11 and 8.05% of individuals, respectively).</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>No homozygous individuals for the K113 allele were found in each of the groups.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>There was no evidence for HERV-K113 association with clinical features in either group.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>Our study-the first such performed for the Polish population-provides a consistent observation with previous reports on the genetic association of HERV-K113 integrations in autoimmune disorders.</Variant>", "label": []}
{"id": "21343167", "text": "<Variant>Here, we found that the prevalence of insertionally polymorphic HERV-K113 was significantly increased in Polish patients with SLE and RA.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>Polymorphic deletions of GSTM1 and GSTT1 genes involved in the detoxification of potentially carcinogenic agents may be risk factors for various cancers, including head and neck cancer (HNC).</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>In the present case-control study we aimed to access possible associations of HNC with GSTM1 and GSTT1 null genotypes in a Pakistani population.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>DNA was extracted from leukocytes of 388 cancer patients and 150 healthy controls by phenol-chloroform procedure.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>GSTM1 and GSTT1 deletion variants were genotyped by multiplex PCR assay with CYP1A1 as an internal control and further analyzed by primer specific PCR assay and sequencing.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>Mean age of cases and controls was 48 ( 16.6) years with a male to female ratio of 1:1.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>Cancer of the oral cavity (57%) was most prevalent in the sampled population followed by pharynx and larynx (30% and 13% respectively).</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>A statistically significant (P<0.05) association was observed for both null genotypes in contribution to HNC as compared with the controls.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>The odds ratio (OR) for the GSTM1 null genotype was 2.3 with a 95% CI of 1.5-5.5 and for GSTT1 OR was 2.04 with 95% CI of 1.3-3.1.</Variant>", "label": []}
{"id": "21133595", "text": "<Variant>These results suggest that the GSTM1 and GSTT1 null genotypes are risk factors for HNC development among the Pakistani population.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.</Variant>", "label": [[56, 66, "Variant"]]}
{"id": "21325775", "text": "<Variant>Lipoprotein glomerulopathy (LPG) is a rare disease characterized by the presence of thrombuslike deposition in markedly dilated glomerular capillaries and is often accompanied by an increased serum apolipoprotein E (apoE) level.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>Several gene mutations of apoE have been reported to be associated with LPG.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>In the current study, we report an LPG patient with a novel apoE mutation, apoE Osaka.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>The patient was a 45-year-old man who was hospitalized due to nephrotic syndrome.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>Light and electron microscopic observations of renal biopsy clearly showed characteristic findings of LPG, including lamellate thrombi in the lumen of dilated glomerular capillaries.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>His apoE phenotype was apoE3/2 and he had mild dyslipidemia with a mid-band on polyacrylamide gel electrophoresis.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>It is intriguing that the serum apoE level was within normal limits.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>We determined the sequence of the apoE gene using direct sequencing of the polymerase chain reaction (PCR) products.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>ApoE gene analysis showed a nucleotide substitution of G to C at codon 158 of exon 4.</Variant>", "label": [[64, 83, "Variant"]]}
{"id": "21325775", "text": "<Variant>This mutation denoted an amino acid substitution of arginine residue for the proline residue at position 158 of apoE. The result of PCR associated with restriction fragment length polymorphism analysis also suggested that this mutation is heterozygous.</Variant>", "label": [[61, 117, "Variant"]]}
{"id": "21325775", "text": "<Variant>It is possible that apoE Osaka mutation causes a conformational change of apoE protein and affects the interaction between abnormal apoE-containing lipoproteins and the endothelial cells of glomerular capillaries.</Variant>", "label": []}
{"id": "21325775", "text": "<Variant>The precise mechanism of LPG related with apoE Osaka, however, remains to be elucidated.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>PAX2 gene mutations in pediatric and young adult transplant recipients: kidney and urinary tract malformations without ocular anomalies.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>Heterozygous humans for PAX2 mutations show autosomal dominant papillorenal syndrome (PRS), consisting of ocular colobomas, renal hypo/dysplasia and progressive renal failure in childhood.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>PAX2 mutations have also been identified in patients with isolated renal hypo/dysplasia.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>Twenty unrelated children and young adults with kidney and urinary tract malformations and no ocular abnormalities were retrospectively recruited for PAX2 mutational analysis.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>All patients had undergone renal transplantation after end-stage renal disease.</Variant>", "label": []}
{"id": "21108633", "text": "<Variant>We identified two new sequence variations: (i) a deletion causing a frameshift (c.69delC) and (ii) a nucleotide substitution determining a splice site mutation (c.410+5 G/A) by predictive analysis.</Variant>", "label": [[89, 97, "Variant"], [170, 181, "Variant"]]}
{"id": "21108633", "text": "<Variant>Therefore, we suggest PAX2 molecular analysis to be extended to all patients with congenital malformations of kidney and urinary tract (CAKUT).</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Clinical correlative studies have linked 1p36 deletions with worse prognosis in follicular lymphoma (FL).</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>In this study, we sought to identify the critical gene(s) in this region that is responsible for conferring inferior prognosis.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>BAC array technology applied to 141 FL specimens detected a minimum region of deletion (MRD) of 97 kb within 1p36.32 in 20% of these cases.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Frequent single-nucleotide polymorphism-detected copy-neutral loss of heterozygosity was also found in this region.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Analysis of promoter CpGs in the MRD did not reveal differential patterns of DNA methylation in samples that differed in 1p36 status.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Exon sequencing of MRD genes identified somatic alterations in the TNFRSF14 gene in 3 of 11 selected cases with matching normal DNA.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>An expanded cohort consisting of 251 specimens identified 46 cases (18.3%) with nonsynonymous mutations affecting TNFRSF14.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Overall survival (OS) and disease-specific survival (DSS) were associated with the presence of TNFRSF14 mutation in patients whose overall treatment included rituximab.</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>We further showed that inferior OS and DSS were most pronounced in patients whose lymphomas contained both TNFRSF14 mutations and 1p36 deletions after adjustment for the International Prognostic Index [hazard ratios of 3.65 (95% confidence interval, 1.35-9.878, P=0.011) and 3.19 (95% confidence interval, 1.06-9.57, P=0.039), respectively].</Variant>", "label": []}
{"id": "20884631", "text": "<Variant>Our findings identify TNFRSF14 as a candidate gene associated with a subset of FL, based on frequent occurrence of acquired mutations and their correlation with inferior clinical outcomes.</Variant>", "label": []}
{"id": "20738799", "text": "<Variant>Ankyloblepharon-ectodermal dysplasia-clefting syndrome: a novel p63 mutation associated with generalized neonatal erosions.</Variant>", "label": []}
{"id": "20738799", "text": "<Variant>Ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome is a rare disorder characterized by ankyloblepharon (congenital adhesions of the eyelids), ectodermal dysplasia, and orofacial clefts.</Variant>", "label": []}
{"id": "20738799", "text": "<Variant>Here, we report the case of an infant born with severe ectodermal dysplasia including generalized neonatal erosions with scalp involvement, facial clefting but notably without ankyloblepharon.</Variant>", "label": []}
{"id": "20738799", "text": "<Variant>Mutational analysis of the p63 gene showed a novel heterozygous T>C nucleotide substitution on exon 14 (I597T).</Variant>", "label": [[73, 76, "Variant"], [113, 118, "Variant"]]}
{"id": "20738799", "text": "<Variant>To our knowledge, this is a novel mutation that has not previously been reported in the pathogenesis of AEC, or other p63-related syndromes.</Variant>", "label": []}
{"id": "20738799", "text": "<Variant>This case further highlights the clinical and genetic heterogeneity of p63 syndromes.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Mutations in the sarcomere gene MYH7 in Ebstein anomaly.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Ebstein anomaly is a rare congenital heart malformation characterized by adherence of the septal and posterior leaflets of the tricuspid valve to the underlying myocardium.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>An association between Ebstein anomaly with left ventricular noncompaction (LVNC) and mutations in MYH7 encoding b-myosin heavy chain has been shown; in this report, we have screened for MYH7 mutations in a cohort of probands with Ebstein anomaly in a large population-based study.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>METHODS AND RESULTS: Mutational analysis in a cohort of 141 unrelated probands with Ebstein anomaly was performed by next-generation sequencing and direct DNA sequencing of MYH7.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Heterozygous mutations were identified in 8 of 141 samples (6%).</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Seven distinct mutations were found; 5 were novel and 2 were known to cause hypertrophic cardiomyopathy.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>All mutations except for 1 3-bp deletion were missense mutations; 1 was a de novo change.</Variant>", "label": [[36, 49, "Variant"]]}
{"id": "21127202", "text": "<Variant>Mutation-positive probands and family members showed various congenital heart malformations as well as LVNC.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Among 8 mutation-positive probands, 6 had LVNC, whereas among 133 mutation-negative probands, none had LVNC.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>The frequency of MYH7 mutations was significantly different between probands with and without LVNC accompanying Ebstein anomaly (P<0.0001).</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>LVNC segregated with the MYH7 mutation in the pedigrees of 3 of the probands, 1 of which also included another individual with Ebstein anomaly.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>Ebstein anomaly is a congenital heart malformation that is associated with mutations in MYH7.</Variant>", "label": []}
{"id": "21127202", "text": "<Variant>MYH7 mutations are predominantly found in Ebstein anomaly associated with LVNC and may warrant genetic testing and family evaluation in this subset of patients.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.</Variant>", "label": [[23, 30, "Variant"]]}
{"id": "21135151", "text": "<Variant>The interplay between C-C chemokine receptor type 5 (CCR5) host genetic background, disease progression, and intrahost HIV-1 evolutionary dynamics remains unclear because differences in viral evolution between hosts limit the ability to draw conclusions across hosts stratified into clinically relevant populations.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>Similar inference problems are proliferating across many measurably evolving pathogens for which intrahost sequence samples are readily available.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>To this end, we propose novel hierarchical phylogenetic models (HPMs) that incorporate fixed effects to test for differences in dynamics across host populations in a formal statistical framework employing stochastic search variable selection and model averaging.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>To clarify the role of CCR5 host genetic background and disease progression on viral evolutionary patterns, we obtain gp120 envelope sequences from clonal HIV-1 variants isolated at multiple time points in the course of infection from populations of HIV-1-infected individuals who only harbored CCR5-using HIV-1 variants at all time points.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>Presence or absence of a CCR5 wt/DD32 genotype and progressive or long-term nonprogressive course of infection stratify the clinical populations in a two-way design.</Variant>", "label": [[42, 46, "Variant"]]}
{"id": "21135151", "text": "<Variant>As compared with the standard approach of analyzing sequences from each patient independently, the HPM provides more efficient estimation of evolutionary parameters such as nucleotide substitution rates and d(N)/d(S) rate ratios, as shown by significant shrinkage of the estimator variance.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>The fixed effects also correct for nonindependence of data between populations and results in even further shrinkage of individual patient estimates.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>Model selection suggests an association between nucleotide substitution rate and disease progression, but a role for CCR5 genotype remains elusive.</Variant>", "label": []}
{"id": "21135151", "text": "<Variant>Given the absence of clear d(N)/d(S) differences between patient groups, delayed onset of AIDS symptoms appears to be solely associated with lower viral replication rates rather than with differences in selection on amino acid fixation.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>AluYb8 insertion in the MUTYH gene is related to increased 8-OHdG in genomic DNA and could be a risk factor for type 2 diabetes in a Chinese population.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>The Mutyh DNA glycosylase is involved in the repair of oxidized DNA bases.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>Because oxidative stress may contribute to increased diabetes risk, the common variant of the MUTYH gene (AluYb8MUTYH) was investigated for its possible role in type 2 diabetes mellitus (T2DM).</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>A total of 565 T2DM patients and 565 healthy subjects from China were enrolled in a case-control study.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>The distribution of AluYb8MUTYH differed in diabetic patients from controls, with a moderately increased percentage of the mutant allele (P) (44.7% versus 40.3%, P = 0.033, OR = 1.199).</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>However, this distribution was similar between the diabetic early-onset and late-onset subgroups.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>Another 66 T2DM patients were further evaluated for 8-hydroxy-2'deoxyguanosine (8-OHdG) levels in leukocytic DNA.</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>The average value of 8-OHdG/10(6) dG was 10.4 in patients with the wild-type genotype, 15.9 in heterozygotes, and 22.3 in homozygotes with the variation (P < 0.001, compared with the wild-type).</Variant>", "label": []}
{"id": "21112374", "text": "<Variant>Therefore, the AluYb8MUTYH polymorphism could be a novel genetic risk factor for T2DM, and accumulated 8-OHdG could contribute to this disease.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>BACKGROUND: Hispanic children have both a higher incidence and a poorer outcome in acute lymphoblastic leukemia (ALL).</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>Moreover, a higher incidence for therapy-related acute myeloid leukemia with 11q23 translocations after treatment with topoisomerase II (topo II) inhibitors has been observed in Hispanic children with ALL.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>We sought to determine the potential role of genetic variants within the topoisomerase IIa gene (TOP2A), within the mixed lineage leukemia gene (MLL) and two of its translocation partners, cyclin AMP response element-binding protein gene (CREBBP) and E1A binding protein gene (EP300) in the increased sensitivity of Hispanic children with ALL to topo II inhibitors.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>METHODS: Fifty-two tagged single nucleotide polymorphisms (SNP) covering the four genes were genotyped in 241 samples (66 children with ALL and 175 age matched controls) of self-identified Hispanic origin.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>RESULTS: Two SNPs within MLL (rs525549 and rs6589664) and three SNPs within EP300 (rs5758222, rs7286979, and rs20551) were significantly associated with ALL (P = 0.001-0.04).</Variant>", "label": [[39, 47, "Variant"], [52, 61, "Variant"], [92, 101, "Variant"], [103, 112, "Variant"], [118, 125, "Variant"]]}
{"id": "21493871", "text": "<Variant>A significant gene-dosage effect for increasing numbers of potential high-risk genotypes (OR = 16.66; P = 2 10(-5)) and a major haplotype significantly associated with ALL (OR = 5.68; P = 2 10(-6)) were found.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>Replication in a sample of 137 affected White children and 239 controls showed that only rs6589664 (MLL) was significantly associated in this ethnic group.</Variant>", "label": [[98, 107, "Variant"]]}
{"id": "21493871", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>Our findings indicate that the association between ALL and common genetic variants within MLL and EP300 is population specific.</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>IMPACT:</Variant>", "label": []}
{"id": "21493871", "text": "<Variant>Replication of our findings in independent Hispanic populations is warranted to elucidate the role of these variants in ALL susceptibility and define their importance in the ethnic specific differences in ALL risk.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Overall, pediatric high-grade glioma (pHGG) has a poor prognosis, in part due to the lack of understanding of the underlying biology.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>High-resolution 244 K oligo array comparative genomic hybridization (CGH) was used to analyze DNA from 38 formalin-fixed paraffin-embedded predominantly pretreatment pHGG samples, including 13 diffuse intrinsic pontine gliomas (DIPGs).</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>The patterns of gains and losses were distinct from those seen in HGG arising in adults.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>In particular, we found 1q gain in up to 27% of our cohort compared with 9% reported in adults.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>A total of 13% had a balanced genetic profile with no large-scale copy number alterations.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Homozygous loss at 8p12 was seen in 6 of 38 (16%) cases of pHGG.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>This novel deletion, which includes the ADAM3A gene, was confirmed by quantitative real-time PCR (qPCR).</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Loss of CDKN2A/CDKN2B in 4 of 38 (10%) samples by oligo array CGH was confirmed by fluorescent in situ hybridization on tissue microarrays and was restricted to supratentorial tumors.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Only 50% of supratentorial tumors were positive for CDKN2B expression by immunohistochemistry (IHC), while 75% of infratentorial tumors were positive for CDKN2B expression (P = 0.03).</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Amplification of the 4q11-13 region was detected in 8% of cases and included PDGFRA and KIT, and subsequent qPCR analysis was consistent with the amplification of PDGFRA.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>MYCN amplification was seen in 5% of samples being significantly associated with anaplastic astrocytomas (P= 0.03).</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Overall, DIPG shared similar spectrum of changes to supratentorial HGG with some notable differences, including high-frequency loss of 17p and 14q and lack of CDKN2A/CDKN2B deletion.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Informative genetic data providing insight into the underlying biology and potential therapeutic possibilities can be generated from archival tissue and typically small biopsies from DIPG.</Variant>", "label": []}
{"id": "21138945", "text": "<Variant>Our findings highlight the importance of obtaining pretreatment samples.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>BACKGROUND _#38; AIMS:</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Aceruloplasminemia is a rare autosomal recessive neurodegenerative disease associated with brain and liver iron accumulation which typically presents with movement disorders, retinal degeneration, and diabetes mellitus.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Ceruloplasmin is a multi-copper ferroxidase that is secreted into plasma and facilitates cellular iron export and iron binding to transferrin.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>A novel homozygous ceruloplasmin gene mutation, c.2554+1G>T, was identified as the cause of aceruloplasminemia in three affected siblings.</Variant>", "label": [[57, 68, "Variant"]]}
{"id": "20801540", "text": "<Variant>Two siblings presented with movement disorders and diabetes.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Complementary DNA sequencing showed that this mutation causes skipping of exon 14 and deletion of amino acids 809-852 while preserving the open reading frame.</Variant>", "label": [[95, 126, "Variant"]]}
{"id": "20801540", "text": "<Variant>Western blotting of liver extracts and sera of affected patients showed retention of the abnormal protein in the liver.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Aceruloplasminemia was associated with severe brain and liver iron overload, where hepatic mRNA expression of the iron hormone hepcidin was increased, corresponding to the degree of iron overload.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Hepatic iron concentration normalized after 3 and 5months of iron chelation therapy with deferasirox, which was also associated with reduced insulin demands.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>During short term treatment there was no clinical or imaging evidence for significant effects on brain iron overload.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Aceruloplasminemia can show an incomplete clinical penetrance but is invariably associated with iron accumulation in the liver and in the brain.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Iron accumulation in aceruloplasminemia is a result of defective cellular iron export, where hepcidin regulation is appropriate for the degree of iron overload.</Variant>", "label": []}
{"id": "20801540", "text": "<Variant>Iron chelation with deferasirox was effective in mobilizing hepatic iron but has no effect on brain iron.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>A genome-wide analysis of loss of heterozygosity and chromosomal copy number variation in Proteus syndrome using high-density SNP microarrays.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>Excessive cell proliferation and genetic changes such as loss of an allele (loss of heterozygosity (LOH)) or amplifications or deletions of parts of chromosomes (copy number variations (CNV)) are common findings in cancers.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>It is unknown whether these changes are also present in patients with overgrowth syndromes, although the presence of small-scale CNVs (such as duplication of 11p15 in Beckwith-Wiedemann syndrome), excessive cell proliferation and an increased frequency of tumors have all been reported in these patients.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>We present results of a genome-wide scan for LOH and CNV in Proteus syndrome (PS), a severely disfiguring overgrowth syndrome.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>We investigated CNV and LOH in DNA derived from affected and normal tissue samples from six PS patients using Affymetrix GeneChip Mapping 250 K Nsp high-density single-nucleotide polymorphism microarrays.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>Analysis revealed that LOH and CNVs were not common in PS.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>We attempted to validate selected CNVs detected by microarray analysis using quantitative genomic PCR, but the observed changes were not confirmed.</Variant>", "label": []}
{"id": "20555334", "text": "<Variant>These results suggest that large-scale genome-wide CNVs and LOH as seen in cancer syndromes are not characteristic findings in PS, although we cannot rule out the possibility that newer arrays with a higher number of probes could uncover smaller CNVs not detected in this study.</Variant>", "label": []}
{"id": "20538085", "text": "<Variant>A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients.</Variant>", "label": []}
{"id": "20538085", "text": "<Variant>The Fibrillin-1 gene (FBN1; chromosome 15q21.1) encodes a major glycoprotein component of the extracellular matrix.</Variant>", "label": []}
{"id": "20538085", "text": "<Variant>Mutations in FBN1, TGFBR1, TGFBR2 are known to cause Marfan syndrome (MIM 154700), a pleiotropic disorder.</Variant>", "label": []}
{"id": "20538085", "text": "<Variant>In the present study, we describe five novel missense FBN1 mutations in five Marfan patients that have the peculiarity to activate two contemporary mutational mechanisms: a missense mutation and exon skipping.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>Identification and characterization of a novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>To study the clinical, histological, in vivo confocal microscopic, and molecular profile in a family with gelatinous drop-like corneal dystrophy (GDLD) from north India.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>METHODS: Two siblings from a consanguineous family presented with clinical features analogous to GDLD.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>Detailed clinical evaluations were performed for all the available affected and unaffected members of this family.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>In vivo confocal microscopy and histology was done wherever necessary.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>DNA isolated from peripheral blood samples was subjected to polymerase chain reaction (PCR) followed by direct sequencing to detect mutations in the tumor-associated calcium signal transducer 2 (TACSTD2) gene.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>Protein modeling studies were done to asses the effect of the mutation on the protein structure.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>The diagnosis of GDLD was established in the patient and the affected sibling on slit-lamp examinations, which revealed mulberry-like opacities in the subepithelium and anterior stroma that were confirmed on histopathology.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>The findings of the in vivo confocal microscopy were consistent with those reported in previous reports.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>Sequencing TACSTD2 revealed a novel homozygous missense mutation c.356G>A, leading to amino acid substitution C119Y in the two affected siblings.</Variant>", "label": [[74, 82, "Variant"], [119, 124, "Variant"]]}
{"id": "20454699", "text": "<Variant>The mutation was found to be pathogenic on Sorting Intolerant From Tolerant (SIFT) analysis and was not found in normal controls and unaffected individuals of the family.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>A synonymous, previously reported, single nucleotide polymorphism (SNP; rs13267) was also seen in all the individuals of the family.</Variant>", "label": [[81, 88, "Variant"]]}
{"id": "20454699", "text": "<Variant>Protein modeling studies involving wild-type and mutant protein indicated an exposed cysteine residue in the mutant protein.</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20454699", "text": "<Variant>A novel TACSTD2 C119Y mutation leading to an amino acid substitution was identified in two affected siblings of a family.</Variant>", "label": [[25, 30, "Variant"]]}
{"id": "20454699", "text": "<Variant>Protein modeling studies revealed an exposed cysteine residue, which might cause interchain disulfide bond formation and protein aggregation leading to disturbed cell junctions of the corneal epithelium.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>Mutation analysis in a Chinese family with multiple endocrine neoplasia type 1.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer syndrome which is caused by germline mutations of the tumor suppressor gene MEN1.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>This study aimed to identify mutations in a Chinese pedigree with MEN1. METHODS:</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>A large Chinese family with MEN1 was collected.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>All of the coded regions and their adjacent sequences of the MEN1 gene were amplified and sequenced.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>In this family, a heterozygous cytosine insertion in exon 10 (c.1546_1547insC) inducing a frame shift mutation of MEN1 was found in the proband and the other two suffering members of his family.</Variant>", "label": [[40, 58, "Variant"], [71, 86, "Variant"]]}
{"id": "20367983", "text": "<Variant>This mutation was linked to a novel single nucleotide polymorphism (SNP) in intron 3 (IVS3 + 18C > T).</Variant>", "label": [[95, 109, "Variant"]]}
{"id": "20367983", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>The mutation in exon 10 of MEN1 gene might induce development of parathyroid hyperplasia and pituitary adenoma and cosegregate with MEN1 syndrome.</Variant>", "label": []}
{"id": "20367983", "text": "<Variant>The significance of the new found IVS3 + 18C ></Variant>", "label": [[43, 57, "Variant"]]}
{"id": "20367983", "text": "<Variant>T of MEN1 needs a further investigation.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>CONTEXT: Generalized glucocorticoid resistance syndrome is a rare familial or sporadic condition characterized by partial insensitivity to glucocorticoids, caused by mutations in the glucocorticoid receptor (GR) gene.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>Most of the reported cases are adults, demonstrating symptoms associated with mineralocorticoid and/or adrenal androgen excess caused by compensatively increased secretion of the adrenocorticotropic hormone.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>PATIENT:</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>We identified a new 2-yr-old female case of generalized glucocorticoid resistance syndrome.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>The patient (TJ) presented with a generalized seizure associated with hypoglycemia and hypokalemia.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>She also had hypertension and premature pubarche, whereas dexamethasone effectively suppressed these clinical manifestations.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>The patient's GR gene had a heterozygotic mutation (G-->A) at nucleotide position 2141 (exon 8), which resulted in substitution of arginine by glutamine at amino acid position 714 in the ligand-binding domain (LBD) of the GR alpha.</Variant>", "label": [[60, 95, "Variant"], [140, 188, "Variant"]]}
{"id": "20335448", "text": "<Variant>Molecular analysis revealed that the mutant receptor had significantly impaired transactivation activity with a 2-fold reduction in affinity to ligand.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>It showed attenuated transactivation of the activation function (AF)-2 and reduced binding to a p160 nuclear receptor coactivator.</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>Computer-based structural analysis revealed that replacement of arginine by glutamine at position 714 transmitted a conformational change to the LBD and the AF-2 transactivation surface, resulting in a decreased binding affinity to ligand and to the LXXLL coactivator motif.</Variant>", "label": [[73, 110, "Variant"]]}
{"id": "20335448", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "20335448", "text": "<Variant>Dexamethasone treatment is effective in controlling the premature pubarche, hypoglycemia, hypertension, and hypokalemia in this child case, wherein arginine 714 plays a key role in the proper formation of the ligand-binding pocket and the AF-2 surface of the GR alpha LBD.</Variant>", "label": [[157, 169, "Variant"]]}
{"id": "20300861", "text": "<Variant>Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Analysis of loss of heterozygosity (LOH) is a useful method for finding genetic alterations in tumor and precancerous lesion tissues.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>In this study, we analyzed LOH of the tumor suppressor gene Tg737</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>in side population cells of human hepatocellular carcinomas.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Side population cells were sorted and identification by flow cytometry from suspensions of hepatocarcinoma or normal liver cells generated from 95 hepatocellular carcinoma and normal tissues, respectively.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>DNA was extracted from the two groups of side population cells and peripheral blood specimens.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Five microsatellite markers on the Tg737 gene were used to analyze the frequency of loss of heterozygosity in the side population cells of the hepatocellular carcinoma.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Twenty-four (25.30%) tumor samples had a large deletion in more than three microsatellite markers.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>The highest frequency of loss of heterozygosity was observed with the G64212 marker (78.75%) and the SHGC-57879 marker (75.95%).</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Statistical analysis of the correlation between loss of heterozygosity of Tg737 and clinicopathological features indicated a strong correlation between the two markers associated with the highest frequency of loss of heterozygosity and survival.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>The results indicate that loss of heterozygosity of the tumor suppressor gene Tg737 may play an important role in the carcinogenetic mechanism of liver cancer stem cells.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>In addition, the independent association between loss of heterozygosity at the SHGC-57879 and G64212 markers and worsened short-term survival in patients could be used as a novel prognostic predictor.</Variant>", "label": []}
{"id": "20300861", "text": "<Variant>Further studies of side population cells may contribute to the establishment of novel therapeutic strategies for hepatocellular carcinoma.</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>Molecular diversity of hemoglobin H disease in India.</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>This study was undertaken to evaluate the variable clinical expression of hemoglobin (Hb) H disease in India.</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>For the study, alpha genotyping was done in 8 patients with Hb H disease using multiplex polymerase chain reaction and DNA sequencing.</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>The study revealed that 4 genotypes (- -(SEA)/ -alpha(3.7), - -(SA)/-alpha(3.7), - -(SEA)/-alpha(3.7 Sallanches), - -alpha(3.7)/-alpha(3.7 Sallanches)) were responsible for Hb H disease, the alpha+ thalassemia mutation (-alpha(3.7) deletion) being the most common defect.</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>The nondeletional mutation Hb Sallanches (alpha 2 codon 104 G --> A) was seen in 3 cases.</Variant>", "label": [[59, 76, "Variant"]]}
{"id": "20154289", "text": "<Variant>Two unique and novel genotypes leading to Hb H disease were characterized (- -(SEA)/-alpha(3.7 Sallanches) and -alpha(3.7)/-alpha(3.7 Sallanches)).</Variant>", "label": []}
{"id": "20154289", "text": "<Variant>Because a majority of patients with Hb H disease do not have severe manifestations, prenatal diagnosis is usually unwarranted in India.</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>We examined the genetic association of the promoter insertion/deletion (indel) in IRF5 gene with systemic lupus erythematosus (SLE) in distinct populations and assessed its role in gene expression.</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>Four IRF5 polymorphisms were genotyped in 1488 SLE patients and 1466 controls.</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>Gene expression was analyzed by quantitative real-time PCR using RNA from peripheral blood mononuclear cells (PBMC).</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>The promoter indel and rs2070197 had independent genetic effects, which accounted for the association of rs2004640 and rs10954213.</Variant>", "label": [[32, 41, "Variant"], [114, 123, "Variant"], [128, 138, "Variant"]]}
{"id": "20080916", "text": "<Variant>Gene expression analysis revealed that rs10954213 exerted the greatest influence on IRF5 transcript levels.</Variant>", "label": [[48, 58, "Variant"]]}
{"id": "20080916", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "20080916", "text": "<Variant>We corroborated the association of the promoter indel with SLE in 5 different populations and revealed that rs10954213 is the main single-nucleotide polymorphism responsible for altered IRF5 expression in PBMC.</Variant>", "label": [[117, 127, "Variant"]]}
{"id": "20019594", "text": "<Variant>Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by increase in low-density lipoprotein (LDL) cholesterol levels and premature coronary artery disease.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>In Venezuela, the molecular basis of FH has not been characterized, thus, the aim of this study was to investigate mutations in the exon 4 of the LDLR (LDL-receptor) gene in 225 Venezuelan mixed race individuals (65 hypercholesterolemic and 160 normolipidemic).</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>The exon 4 of the LDLR gene was screened by polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) analysis and DNA sequencing.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>Additionally, ApoB-100 gene mutations were investigated.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>Different LDLR gene mutations were identified in 5 hypercholesterolemic patients (7.7%), 3 missense mutations (4.6%), and 2 frameshift mutations (3%).</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>All mutations were heterozygous.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>The missense mutations included the amino acid substitution p.E180K, p.R194S, and p.C152G.</Variant>", "label": [[69, 76, "Variant"], [78, 85, "Variant"], [91, 98, "Variant"]]}
{"id": "20019594", "text": "<Variant>The frameshift mutations are caused by insertions resulting in the creation of stop codons: p.D157fsX158 and p.S173fsX174, which could code for truncated LDLR of 157 and 173 amino acids, respectively.</Variant>", "label": [[101, 113, "Variant"], [118, 130, "Variant"]]}
{"id": "20019594", "text": "<Variant>The apoB gene mutations were not detected in any of our patients and to our knowledge 4 mutations identified in this study have not been reported previously, this study being the first comprehensive mutation analysis of the LDLR causing FH in our region.</Variant>", "label": []}
{"id": "20019594", "text": "<Variant>The early identification of individuals at risk allows changes in lifestyle, including dietary intervention, followed by drug treatment.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>TNF receptor-associated periodic fever syndrome caused by sequence alterations in exonic splicing enhancers: comment on the article by Tr benbach et al.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), an autosomal disease belonging to human autoinflammatory syndromes, is caused by mutations in Tumor Necrosis Factor Receptor Superfamily Member 1A (TNFRSF1A) gene.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>Tr benbach and colleagues described a patient with two heterozygotic nucleotide transversions in exon 4 of TNFRSF1A gene: the first is a substitution from guanine to cytosine at position 263 of the nucleotide sequence (c.263 G>C); the second is a substitution from cytosine to adenine at position 264 (c.264 C>A); the two mutations affect the amino acid number 88 of the protein.</Variant>", "label": [[164, 199, "Variant"], [228, 237, "Variant"], [274, 309, "Variant"], [311, 320, "Variant"]]}
{"id": "19823838", "text": "<Variant>To date, this was the first report of a double monoallelic mutation in a gene related to autoinflammatory syndromes.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>Using two web interfaces (ESEfinder and RESCUE-ESE), we provide evidence that the double nucleotide change may affect an exonic splicing enhancer (ESE), a sequence element distinct from the canonical splice sites that are needed for normal splicing.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>ESEs are short and degenerate sequences found within coding exons and required for efficient splicing and splice site recognition.</Variant>", "label": []}
{"id": "19823838", "text": "<Variant>In order to verify if these changes really affect an ESE, it would be useful to analyze the described index case TNFRSF1A cDNA, because if this analysis will evidence an exon skipping in the TNFRSF1A coding sequence, it would then represent the first mutation in autoinflammatory syndromes demonstrated to be caused by ESE elements alteration.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>Mutation analysis of p63 gene in the first Chinese family with ADULT syndrome.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>BACKGROUND: ADULT syndrome (acro-dermato-ungual-lacrimal-tooth syndrome) is a rare ectodermal dysplasia disorder known as autosomal dominant inheritance.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>Recent studies have linked p63 gene mutation to the development of this disease.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>However, the genetic characteristics of ADULT syndrome were still not well understood.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>Mutation analysis of p63 gene in the first Chinese ADULT syndrome family was performed using direct DNA sequencing.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>The sequence analysis of exon 8 of p63 gene disclosed a heterozygous G>A substitution at nucleotide 893 (R298Q) in the proband.</Variant>", "label": [[78, 112, "Variant"], [114, 119, "Variant"]]}
{"id": "19781362", "text": "<Variant>In addition, a single nucleotide polymorphism (SNP) rs16864880 in the downstream flanking region (DFR) of p63 exon 8 was also identified in this family.</Variant>", "label": [[61, 71, "Variant"]]}
{"id": "19781362", "text": "<Variant>The proband and the paternal side including her father exhibited the C/G genotype at this position.</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>The C/G variant frequency in the paternal was significantly higher as compared with the maternal (6/10 vs 0/6, P = 0.034).</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "19781362", "text": "<Variant>ADULT syndrome may be caused by the p63 gene mutation, and it might have closer genetic association with the paternal side in this family.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disease.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>The disease is caused by mutations of the PKD1 (affecting roughly 85% of ADPKD patients) and PKD2 (affecting roughly 14% of ADPKD patients) genes, although in several ADPKD families, the PKD1 and/or PKD2 linkage was not found.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>Mutation analysis of the PKD1 gene is complicated by the presence of highly homologous genomic duplications of the first two thirds of the gene.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>The direct detection of mutations in the non-duplicated region of the PKD1 gene was performed in 90 unrelated individuals, consisting of 58 patients with end-stage renal failure (manifesting before their 50th year of life) and 32 individuals from families where the disease was clearly linked to the PKD1 gene.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>Mutation screening was performed using denaturing gradient gel electrophoresis (DGGE).</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>DNA fragments showing an aberrant electrophoretic banding pattern were sequenced.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>In the non-duplicated region of the PKD1 gene, 19 different likely pathogenic germline sequence changes were identified in 19 unrelated families/individuals.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>Fifteen likely pathogenic sequence changes are unique for the Czech population.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>The following probable mutations were identified: 9 nonsense mutations, 6 likely pathogenic missense mutations, 2 frameshifting mutations, one in-frame deletion and probable splice site mutation.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>In the non-duplicated region of the PKD1 gene, 16 different polymorphisms or unclassified variants were detected.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>CONCLUSION: Twenty probable mutations of the PKD1 gene in 90 Czech individuals (fifteen new probable mutations) were detected.</Variant>", "label": []}
{"id": "19686598", "text": "<Variant>The establishment of localization and the type of causal mutations and their genotype phenotype correlation in ADPKD families will improve DNA diagnosis and could help in the assessment of the clinical prognosis of ADPKD patients.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Molecular surveillance of multidrug-resistant tuberculosis (MDR TB) was implemented in Europe as case reporting in 2005.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>For all new MDR TB cases detected from January 2003 through June 2007, countries reported case-based epidemiologic data and DNA fingerprint patterns of MDR TB strains when available.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>International clusters were detected and analyzed.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>From 2003 through mid-2007 in Europe, 2,494 cases of MDR TB were reported from 24 European countries.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Epidemiologic and molecular data were linked for 593 (39%) cases, and 672 insertion sequence 6110 DNA fingerprint patterns were reported from 19 countries.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Of these patterns, 288 (43%) belonged to 18 European clusters; 7 clusters (242/288 cases, 84%) were characterized by strains of the Beijing genotype family, including the largest cluster (175/288 cases, 61%).</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Both clustering and the Beijing genotype were associated with strains originating in eastern European countries.</Variant>", "label": []}
{"id": "19624920", "text": "<Variant>Molecular cluster detection contributes to identification of transmission profile, risk factors, and control measures.</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children.</Variant>", "label": [[19, 43, "Variant"]]}
{"id": "19624485", "text": "<Variant>Human leukocyte antigen-G (HLA-G) expression is a potential factor for the pathogenesis of virus infection.</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>A 14 bp insertion/deletion polymorphism (rs16375) in the 3'-untranslated region of the HLA-G gene is involved in the stability of HLA-G mRNA and HLA-G protein expression.</Variant>", "label": [[11, 35, "Variant"], [50, 57, "Variant"]]}
{"id": "19624485", "text": "<Variant>Therefore, the HLA-G 14 bp polymorphism might be involved in human cytomegalovirus (hCMV) infection.</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>To test a possible association between the HLA-G 14 bp deletion/insertion polymorphism and the active hCMV infection, in this study, a total of 54 patients with active hCMV infection and 165 age- and sex-matched, unrelated, normal Chinese Han population were genotyped for the 14 bp insertion/deletion polymorphism.</Variant>", "label": [[58, 82, "Variant"], [286, 310, "Variant"]]}
{"id": "19624485", "text": "<Variant>Association of 14 bp polymorphism with hCMV urine DNA copies and the odds ratio (OR) of the polymorphism as a risk factor for active hCMV infection were analyzed.</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>Our results showed that the prevalence of -14 bp/ -14 bp genotype in active hCMV patients was markedly increased [P(c) = 0.00034, OR = 3.31, 95% confidence interval (CI): 1.77-6.18], and similar significance was also observed for the frequency of -14 bp allele (P c = 0.0023, OR = 2.24, 95% CI: 1.38-3.64) when compared with that of healthy controls.</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>Furthermore, urine hCMV DNA copies in patients with the -14 bp/ -14 bp genotype were significantly higher than those in patients with the +14 bp/ +14 bp genotype (P = 0.041).</Variant>", "label": []}
{"id": "19624485", "text": "<Variant>Our findings support a potential role of HLA-G 14 bp insertion/deletion polymorphism as a susceptible factor for the active hCMV infection.</Variant>", "label": [[56, 80, "Variant"]]}
{"id": "19565319", "text": "<Variant>Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder.</Variant>", "label": []}
{"id": "19565319", "text": "<Variant>Autism spectrum disorders (ASDs) are heterogeneous disorders presenting with increased rates of anxiety.</Variant>", "label": []}
{"id": "19565319", "text": "<Variant>The adenosine A(2A) receptor gene (ADORA2A) is associated with panic disorder and is located on chromosome 22q11.23.</Variant>", "label": []}
{"id": "19565319", "text": "<Variant>Its gene product, the adenosine A(2A) receptor, is strongly expressed in the caudate nucleus, which also is involved in ASD.</Variant>", "label": []}
{"id": "19565319", "text": "<Variant>As autistic symptoms are increased in individuals with 22q11.2 deletion syndrome, and large 22q11.2 deletions and duplications have been observed in ASD individuals, in this study, 98 individuals with ASD and 234 control individuals were genotyped for eight single-nucleotide polymorphisms in ADORA2A. Nominal association with the disorder was observed for rs2236624-CC, and phenotypic variability in ASD symptoms was influenced by rs3761422, rs5751876 and rs35320474.</Variant>", "label": [[366, 375, "Variant"], [441, 450, "Variant"], [452, 461, "Variant"], [466, 476, "Variant"]]}
{"id": "19565319", "text": "<Variant>In addition, association of ADORA2A variants with anxiety was replicated for individuals with ASD.</Variant>", "label": []}
{"id": "19565319", "text": "<Variant>Findings point toward a possible mediating role of ADORA2A variants on phenotypic expression in ASD that need to be replicated in a larger sample.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant disease caused by mutations in the gene encoding protein kinase C gamma (PKC gamma).</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>We report an SCA14 family with a novel deletion of a termination-codon-containing region, resulting in a missense change and a C-terminal 13-amino-acid extension with increased kinase activity.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>Notably, one patient with a severe phenotype is the first homozygote for the mutation causing SCA14.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>We show the novel molecular consequences of increased kinase activities of mutants: aprataxin (APTX), a DNA repair protein causative for autosomal recessive ataxia, was found to be a preferential substrate of mutant PKC gamma, and phosphorylation inhibited its nuclear entry.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>The phosphorylated residue was Thr111, located adjacent to the nuclear localization signal, and disturbed interactions with importin alpha, a nuclear import adaptor.</Variant>", "label": [[40, 46, "Variant"]]}
{"id": "19561170", "text": "<Variant>Decreased nuclear APTX increased oxidative stress-induced DNA damage and cell death.</Variant>", "label": []}
{"id": "19561170", "text": "<Variant>Phosphorylation-resistant APTX, kinase inhibitors, and antioxidants may be therapeutic options for SCA14.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>We have recently shown that cigarette smoking is associated with lesser responses to potent antiretroviral therapies.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>Certain Cytochrome P-450 enzymes activate compounds derived from tobacco smoke into toxic forms that may promote HIV-1 gene expression through promotion of DNA-adduct formation by the oxidation of chemical constituents of cigarette smoke, such as polyaromatic hydrocarbons and dioxins.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>To explore the association between environmental and genetic factors to viral replication in women who smoke and receive highly active anti-retroviral therapy (HAART), we assessed the impact of polymorphisms in a panel of four Cytochrome P-450 genes (CYP1A1, CYP2A6, CYP2D6, and CYP2E1) and two Glutathione S-transferase genes (GSTM1 and GSST1) in 924 participants of the Women's Interagency HIV Study (WIHS).</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>Our findings showed that GSTM1 and GSST1 deletions were not associated with HAART effectiveness.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>By contrast, homozygosity for the CYP1A1-m1 polymorphism, was associated with impaired viral response to treatment among smokers (relative hazard (RH) = 0.54; 95% confidence interval = 0.31-0.94) after adjustment for pretreament viral load, CD4 count, age, hepatitis C infection, prior HAART therapy and race, although it had no effect among nonsmokers.</Variant>", "label": []}
{"id": "19537956", "text": "<Variant>We conclude that the association of the CPY1A1-m1 variant with a reduced response to HAART therapy in HIV infected smokers is consistent with this enzyme's role in the metabolic conversion of environmental toxins to DNA adducts, which may directly promote HIV-1 gene expression.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Somatic LKB1 mutations promote cervical cancer progression.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Human Papilloma Virus (HPV) is the etiologic agent for cervical cancer.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Yet, infection with HPV is not sufficient to cause cervical cancer, because most infected women develop transient epithelial dysplasias that spontaneously regress.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Progression to invasive cancer has been attributed to diverse host factors such as immune or hormonal status, as no recurrent genetic alterations have been identified in cervical cancers.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Thus, the pressing question as to the biological basis of cervical cancer progression has remained unresolved, hampering the development of novel therapies and prognostic tests.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Here we show that at least 20% of cervical cancers harbor somatically-acquired mutations in the LKB1 tumor suppressor.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Approximately one-half of tumors with mutations harbored single nucleotide substitutions or microdeletions identifiable by exon sequencing, while the other half harbored larger monoallelic or biallelic deletions detectable by multiplex ligation probe amplification (MLPA).</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Biallelic mutations were identified in most cervical cancer cell lines; HeLa, the first human cell line, harbors a homozygous 25 kb deletion that occurred in vivo.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>LKB1 inactivation in primary tumors was associated with accelerated disease progression.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Median survival was only 13 months for patients with LKB1-deficient tumors, but >100 months for patients with LKB1-wild type tumors (P = 0.015, log rank test; hazard ratio = 0.25, 95% CI = 0.083 to 0.77).</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>LKB1 is thus a major cervical tumor suppressor, demonstrating that acquired genetic alterations drive progression of HPV-induced dysplasias to invasive, lethal cancers.</Variant>", "label": []}
{"id": "19340305", "text": "<Variant>Furthermore, LKB1 status can be exploited clinically to predict disease recurrence.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Relation between angiotensin-converting enzyme I/D gene polymorphism and pulse pressure in patients with a first anterior acute myocardial infarction.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Evidence shows that an elevated pulse pressure (PP) may lead to an increased risk of cardiovascular morbidity and mortality.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>The aim of the present study was to determine the effects of polymorphism of the angiotensin-converting enzyme (ACE) gene on the PP after a first anterior acute myocardial infarction (AMI).</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Overall 116 patients with a first anterior AMI were included in this cross-sectional study.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>DNA was isolated from peripheral leukocytes.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>The ID status was determined by polymerase chain reaction by a laboratory staff member who was unaware of the clinical details.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Based on the polymorphism of the ACE gene, they were classified into 3 groups: Deletion/Deletion (DD) genotype (Group 1, n=45), Insertion/Deletion (ID) genotype (Group 2, n=58), Insertion/Insertion (II) genotype (Group 3, n=13).</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Blood pressure measurements were performed in all patients within 10 minutes admitted to coronary care unit.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>The PP was calculated by subtraction of diastolic blood pressure (DBP) from systolic blood pressure (SBP).</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Echocardiographic examinations were performed using the parasternal longitudinal axis and apical 4-chamber windows in accordance with the recommendations of the American Echocardiography Committee.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>One-way analysis of variance (ANOVA) and Chi-square analyses were used to compare differences among subjects with different genotypes.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>There were no significant differences among clinical parameters of patients.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Pulse pressure was significantly higher in patients who have ACE DD and ID genotypes than in patients who have ACE II genotype (47+/- 16, 47+/- 14 and 39+/- 12, F=3.4, p<0.05).</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>But SBP, DBP and heart rate were not significantly different among ACE DD, ACE ID and ACE II genotypes.</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "19196567", "text": "<Variant>Our results suggested that, ACE Gene I/D polymorphism D allele may affect PP in patients with a first anterior AMI.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>Identification of microdeletions in candidate genes for cleft lip and/or palate.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>BACKGROUND: Genome-wide association studies are now used routinely to identify genes implicated in complex traits.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>The panels used for such analyses can detect single nucleotide polymorphisms and copy number variants, both of which may help to identify small deleted regions of the genome that may contribute to a particular disease.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>We performed a candidate gene analysis involving 1,221 SNPs in 333 candidate genes for orofacial clefting, using 2,823 samples from 725 two- and three-generation families with a proband having cleft lip with or without cleft palate.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>We used SNP genotyping, DNA sequencing, high-resolution DNA microarray analysis, and long-range PCR to confirm and characterize the deletion events.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>This dataset had a high duplicate reproducibility rate (99.98%), high Mendelian consistency rate (99.93%), and low missing data rate (0.55%), which provided a powerful opportunity for deletion detection.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>Apparent Mendelian inconsistencies between parents and children suggested deletion events in 15 individuals in 11 genomic regions.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>We confirmed deletions involving CYP1B1, FGF10, SP8, SUMO1, TBX1, TFAP2A, and UGT7A1, including both de novo and familial cases.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>Deletions of SUMO1, TBX1, and TFAP2A are likely to be etiologic.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>CONCLUSIONS: These deletions suggest the potential roles of genes or regulatory elements contained within deleted regions in the etiology of clefting.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>Our analysis took advantage of genotypes from a candidate-gene-based SNP survey and proved to be an efficient analytical approach to interrogate genes potentially involved in clefting.</Variant>", "label": []}
{"id": "19137569", "text": "<Variant>This can serve as a model to find genes playing a role in complex traits in general.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE.</Variant>", "label": [[9, 14, "Variant"]]}
{"id": "18945288", "text": "<Variant>This study was conducted to determine the prevalence of alkaptonuria in the UAE population and to identify the genotype of affected individuals.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>In a 3 stage sampling technique 2981 pupils from Government schools in Al Ain and private schools in Dubai were selected to take part in the study, of whom 2857 provided urine samples.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>Urine collected was analysed for homogentisic acid by gas chromatography-mass spectrometry.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>Genomic DNA was isolated from the white blood cells of all family members of the affected case following standard established protocols.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>Specific PRC primers were designed to amplify all 14 exons of the HGD gene with the flanking intronic sequences including the splice site sequences.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>2857 children returned a viable urine sample, of which one was highly positive for homogentisic acid.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>All 12 members of this girl's family were studied and one, a 22 year old brother, was found to excrete HGA.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>Another, a sister who had not provided a urine sample, was discovered by genetic testing.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>There were no complaints of joint pain or other symptoms in any member of this family.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>Parents were first cousins.</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>We found a single nucleotide deletion c.342delA, located in exon 3, which resulted in a frameshift at amino acid position 58 (p.Arg58fs or p.R58fs).</Variant>", "label": [[47, 56, "Variant"], [135, 144, "Variant"], [148, 155, "Variant"]]}
{"id": "18945288", "text": "<Variant>Alkaptonuria may be more common than it is thought to be with an allele prevalence estimated at 0.0107 (95% CI 0.000392-0.03473).</Variant>", "label": []}
{"id": "18945288", "text": "<Variant>The R58fs mutation is old, perhaps having occurred several thousand years ago, and has spread over a large geographical area.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "18759095", "text": "<Variant>Peters plus syndrome.</Variant>", "label": []}
{"id": "18759095", "text": "<Variant>A 10-year-old boy, issue of unrelated parents presented with visual impairment, short stature and mental retardation.</Variant>", "label": []}
{"id": "18759095", "text": "<Variant>The presence of a Peters' anomaly, mental retardation, disproportionate short stature, skeletal abnormalities and distinctive facial features (broad forehead, telecanthus, cupid bow shaped upper lip) established the diagnosis of Peters' plus syndrome.</Variant>", "label": []}
{"id": "18759095", "text": "<Variant>Analysis of his genomic DNA revealed a homozygous deletion in the beta1,3-galactosyltransferase-like gene (B3GALTL), a recently identified gene.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Although it has been well documented that loss of human chromosome 11q is frequently observed in primary neuroblastomas, the smallest region of overlap (SRO) has not yet been precisely identified.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Previously, we performed array-comparative genomic hybridization (array-CGH) analysis for 236 primary neuroblastomas to search for genomic aberrations with high-resolution.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>In our study, we have identified the SRO of deletion (10-Mb or less) at 11q23.</Variant>", "label": [[53, 77, "Variant"]]}
{"id": "18726896", "text": "<Variant>Within this region, there exists a TSLC1/IGSF4/CADM1 gene (Tumor suppressor in lung cancer 1/Immunoglobulin superfamily 4/Cell adhesion molecule 1), which has been identified as a putative tumor suppressor gene for lung and some other cancers.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Consistent with previous observations, we have found that 35% of primary neuroblastomas harbor loss of heterozygosity (LOH) on TSLC1 locus.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>In contrast to other cancers, we could not detect the hypermethylation in its promoter region in primary neuroblastomas as well as neuroblastoma-derived cell lines.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>The clinicopathological analysis demonstrated that TSLC1 expression levels significantly correlate with stage, Shimada's pathological classification, MYCN amplification status, TrkA expression levels and DNA index in primary neuroblastomas.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>The immunohistochemical analysis showed that TSLC1 is remarkably reduced in unfavorable neuroblastomas.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Furthermore, decreased expression levels of TSLC1 were significantly associated with a poor prognosis in 108 patients with neuroblastoma.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Additionally, TSLC1 reduced cell proliferation in human neuroblastoma SH-SY5Y cells.</Variant>", "label": []}
{"id": "18726896", "text": "<Variant>Collectively, our present findings suggest that TSLC1 acts as a candidate tumor suppressor gene for neuroblastoma.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation and several other cytogenetic aberrations, including heterozygous loss of chromosomal arms 1p, 6q, 11q and 13q and/or gains of 3q and 8q.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>The common intervals of chromosomal imbalance have been narrowed down using array-comparative genomic hybridization (CGH).</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>However, the chromosomal intervals still contain many genes potentially involved in MCL pathogeny.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Combined analysis of tiling-resolution array-CGH with gene expression profiling on 11 MCL tumours enabled the identification of genomic alterations and their corresponding gene expression profiles.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Only subsets of genes located within given cytogenetic anomaly-intervals showed a concomitant change in mRNA expression level.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>The genes that showed consistent correlation between DNA copy number and RNA expression levels are likely to be important in MCL pathology.</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Besides several 'anonymous genes', we also identified various fully annotated genes, whose gene products are involved in cyclic adenosine monophosphate-regulated pathways (PRKACB), DNA damage repair, maintenance of chromosome stability and prevention of rereplication (ATM, ERCC5, FBXO5), energy metabolism (such as genes that are involved in the synthesis of proteins encoded by the mitochondrial genome) and signal transduction (ARHGAP29).</Variant>", "label": []}
{"id": "18699851", "text": "<Variant>Deregulation of these gene products may interfere with the signalling pathways that are involved in MCL tumour development and maintenance.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>The presence of the TMPRSS2-ERG fusion gene in prostate tumors has recently been associated with an aggressive phenotype, as well as recurrence and death from prostate cancer.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>These associations suggest the hypothesis that the gene fusion may be used as a prognostic indicator for prostate cancer.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>In this study, fluorescent in situ hybridization (FISH) assays were used to assess TMPRSS2-ERG fusion status in a group of 214 prostate cancer cases from two population-based studies.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>The FISH assays were designed to detect both fusion type (deletion vs. translocation) and the number of fusion copies (single vs. multiple).</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>Genotyping of four ERG and one TMPRSS2 SNPs using germline DNA was also performed in a sample of the cases (n = 127).</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>RESULTS: Of the 214 tumors scored for the TMPRSS2-ERG fusion, 64.5% were negative and 35.5% were positive for the fusion.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>Cases with the TMPRSS2-ERG fusion did not exhibit reduced prostate cancer survival (HR = 0.92, 95% CI = 0.22-3.93), nor was there a significant difference in cause-specific survival when stratifying by translocation or deletion (HR = 0.84, 95% CI = 0.23-3.12) or by the number of retained fusion copies (HR = 1.22, 95% CI = 0.45-3.34).</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>However, evidence for reduced prostate cancer-specific survival was apparent in those cases whose tumor had multiple copies of the fusion.</Variant>", "label": []}
{"id": "18694509", "text": "<Variant>The variant T allele of the TMPRSS2 SNP, rs12329760, was positively associated with TMPRSS2-ERG fusion by translocation (p = 0.05) and with multiple copies of the gene fusion (p = 0.03).</Variant>", "label": [[50, 60, "Variant"]]}
{"id": "18694509", "text": "<Variant>CONCLUSION: If replicated, the results presented here may provide insight into the mechanism by which the TMPRSS2-ERG gene fusion arises and also contribute to diagnostic evaluations for determining the subset of men who will go on to develop metastatic prostate cancer.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>A 900-kb inversion exists within a large region of conserved linkage disequilibrium (LD) on chromosome 17.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>CRHR1 is located within the inversion region and associated with inhaled corticosteroid response in asthma.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>We hypothesized that CRHR1 variants are in LD with the inversion, supporting a potential role for natural selection in the genetic response to corticosteroids.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>We genotyped six single nucleotide polymorphisms (SNPs) spanning chromosome 17: 40,410,565-42,372,240, including four SNPs defining inversion status.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>Similar allele frequencies and strong LD were noted between the inversion and a CRHR1 SNP previously associated with lung function response to inhaled corticosteroids.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>Each inversion-defining SNP was strongly associated with inhaled corticosteroid response in adult asthma (P values 0.002-0.005).</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>The CRHR1 response to inhaled corticosteroids may thus be explained by natural selection resulting from inversion status or by long-range LD with another gene.</Variant>", "label": []}
{"id": "18622266", "text": "<Variant>Additional pharmacogenetic investigations into regions of chromosomal diversity, including copy number variation and inversions, are warranted.</Variant>", "label": []}
{"id": "18606230", "text": "<Variant>Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2.</Variant>", "label": []}
{"id": "18606230", "text": "<Variant>Premature stop codons in CACNA1A, which encodes the alpha(1A) subunit of neuronal P/Q-type (Ca(V)2.1) Ca(2+) channels, cause episodic ataxia type 2 (EA2).</Variant>", "label": []}
{"id": "18606230", "text": "<Variant>CACNA1A undergoes extensive alternative splicing, which contributes to the pharmacological and kinetic heterogeneity of Ca(V)2.1-mediated Ca(2+) currents.</Variant>", "label": []}
{"id": "18606230", "text": "<Variant>We identified three novel heterozygous stop codon mutations associated with EA2 in an alternately spliced exon (37A), which encodes part of an EF-hand motif required for Ca(2+)-dependent facilitation.</Variant>", "label": []}
{"id": "18606230", "text": "<Variant>One family had a C to G transversion (Y1854X).</Variant>", "label": [[26, 32, "Variant"], [47, 53, "Variant"]]}
{"id": "18606230", "text": "<Variant>A dinucleotide deletion results in the same premature stop codon in a second family, and a further single nucleotide change leads to a different truncation (R1858X) in a de novo case of EA2.</Variant>", "label": [[166, 172, "Variant"]]}
{"id": "18606230", "text": "<Variant>Expression studies of the Y1854X mutation revealed loss of Ca(V)2.1-mediated current.</Variant>", "label": [[35, 41, "Variant"]]}
{"id": "18606230", "text": "<Variant>Because these mutations do not affect the alternate exon 37B, these findings reveal unexpected dependence of cerebellar function on intact exon 37A-containing Ca(V)2.1 channels.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>To identify genes that modify metastatic risk in uveal melanoma, a type of cancer that is valuable for studying metastasis because of its remarkably consistent metastatic pattern and well-characterized gene expression signature associated with metastasis.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>EXPERIMENTAL DESIGN:</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>We analyzed 53 primary uveal melanomas by gene expression profiling, array-based comparative genomic hybridization, array-based global DNA methylation profiling, and single nucleotide polymorphism-based detection of loss of heterozygosity to identify modifiers of metastatic risk.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>A candidate gene, leucine zipper tumor suppressor-1 (LZTS1), was examined for its effect on proliferation, migration, and motility in cultured uveal melanoma cells.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>In metastasizing primary uveal melanomas, deletion of chromosome 8p12-22 and DNA hypermethylation of the corresponding region of the retained hemizygous 8p allele were associated with more rapid metastasis.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>Among the 11 genes located within the deleted region, LZTS1 was most strongly linked to rapid metastasis.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>LZTS1 was silenced in rapidly metastasizing and metastatic uveal melanomas but not in slowly metastasizing and nonmetastasizing uveal melanomas.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>Forced expression of LZTS1 in metastasizing uveal melanoma cells inhibited their motility and invasion, whereas depletion of LZTS1 increased their motility.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>We have described a metastatic modifier locus on chromosome 8p and identified LZTS1 as a potential metastasis suppressor within this region.</Variant>", "label": []}
{"id": "18559591", "text": "<Variant>This study shows the utility of integrative genomic methods for identifying modifiers of metastatic risk in human cancers and may suggest new therapeutic targets in metastasizing tumor cells.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>Molecular and clinical characterization in Japanese and Korean patients with Hailey-Hailey disease: six new mutations in the ATP2C1 gene.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>The autosomal dominant disorder Hailey-Hailey disease (HHD) results from mutations in the ATP2C1 gene, which encodes the human secretory pathway Ca2+/Mn2+ -ATPase protein 1.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>To date, over 90 pathological mutations scattered throughout ATP2C1 have been described with no indication of mutational hotspots or clustering of mutations.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>No paradigm for genotype-phenotype correlation has emerged.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>To determine the pathogenic ATP2C1 abnormality in additional patients with HHD in order to provide further contributions to the understanding of the molecular basis of this disorder and to add the data to the known mutation database.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>In this study, we investigated eight unrelated Japanese and Korean patients with HHD.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>We performed direct nucleotide sequencing of the ATP2C1 gene in all patients and RT-PCR analysis, using RNA extracted from a skin biopsy, in a patient with the mildest clinical features.</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>We identified seven different heterozygous mutations in seven of the eight investigated patients, including three new single nucleotide deletion/duplication mutations: c.520delC; c.681dupA; c.956delC, three new donor splice site mutations: c.360+1G>C; c.899+1G>T; c.1570+2T>C, as well as a previously described nonsense mutation: p.Arg153X. RT-PCR analysis in the mildest affected patient with a heterozygous c.360+1G>C mutation, demonstrated expression of a short in-frame mutant transcript with exon 5 skipping, which may account for the mild phenotype.</Variant>", "label": [[177, 186, "Variant"], [188, 197, "Variant"], [199, 208, "Variant"], [249, 259, "Variant"], [261, 271, "Variant"], [273, 284, "Variant"], [339, 348, "Variant"], [418, 428, "Variant"]]}
{"id": "18372165", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18372165", "text": "<Variant>The results expand the known mutation spectrum in HHD and show the importance of RNA analysis for understanding the genotype-phenotype correlations more precisely.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>BACKGROUND: To the authors' knowledge, genetic abnormalities in early-stage chronic lymphocytic leukemia (CLL) have not been examined fully.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Single nucleotide polymorphism (SNP) genomic array (SNP-chip) is a new tool that can detect copy number changes and uniparental disomy (UPD) over the entire genome with very high resolution.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>The authors performed SNP-chip analysis on 56 samples from patients with early-stage, untreated CLL.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>To validate the SNP-chip data, fluorescence in situ hybridization (FISH) analysis was performed at selected sites.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Expression levels of ZAP-70 and the mutational status of immunoglobulin heavy-chain gene also were examined.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>RESULTS: SNP-chip analysis easily detected nearly all changes that were identified by FISH, including trisomy 12, deletion of TP53 (17p13), deletion of ATM (11q22), and deletion of 13q14.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Only 10 of 56 CLL samples (18%) had no genomic abnormalities.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Excluding the 4 common abnormalities mentioned above, 25 CLL samples (45%) had a total of 45 copy number changes detected by SNP-chip analysis.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Four samples had 6q deletion at 6q21 that involved the AIM1 gene.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>UPD was detected in 4 samples;</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>2 samples involved whole chromosome 13 resulting in homozygous deletion of micro-RNA-15a (miR-15a)/miR-16-1.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>CLL samples with deletion of 13q14 and trisomy 12 were mutually exclusive.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>Genetic abnormalities, including whole chromosome 13 UPD, are very common events in early-stage CLL.</Variant>", "label": []}
{"id": "18246537", "text": "<Variant>SNP-chip analysis can detect small genetic abnormalities in CLL and may be able to support or even supplant FISH and cytogenetics.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>In the light of the established association of angiotensin-converting enzyme (ACE) with several types of cancer, the possible contribution of the insertion/deletion (I/D) polymorphism that affects ACE gene expression, in the development of colorectal cancer was investigated.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>MATERIALS AND METHODS:</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>DNA samples of 92 patients with colorectal cancer (adenocarcinomas) and 102 healthy controls were examined by allele-specific polymerase chain reaction followed by electrophoretic analysis.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>The resulting allele and genotype frequencies of the patients were compared to those of the controls by Fischer's exact test and odds ratios.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>No statistical differences were observed between healthy controls and patients with colorectal cancer regarding either genotype distribution or low expression I allele frequency.</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "18210757", "text": "<Variant>The ACE I/D polymorphism is not a genetic predisposing factor concerning the risk for colorectal cancer.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>Analysis of -1082 IL-10 gene polymorphism in Iranian patients with generalized aggressive periodontitis.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>Periodontitis is a multifactorial disease and its severe forms, such as aggressive periodontitis, are suggested to have a genetic basis.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>Among the genetic factors, polymorphisms in cytokine genes have recently been described in susceptibility to periodontitis.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>IL-10 is a multi-functional cytokine thought to play a role in the pathogenesis of periodontitis.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>A substitution G/A polymorphism in the promoter region of the IL-10 gene at position -1082 has been associated with different amounts of IL-10 production.</Variant>", "label": [[24, 27, "Variant"]]}
{"id": "17968299", "text": "<Variant>The aim of the present study was to investigate the possible links between -1082(G/A) polymorphism of the IL-10 gene and the generalized form of aggressive periodontitis.</Variant>", "label": [[84, 94, "Variant"]]}
{"id": "17968299", "text": "<Variant>MATERIAL/METHODS:</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>This study included 52 Iranian Khorasanian (north-east province of Iran) subjects suffering from generalized aggressive periodontitis referred to the Periodontology Department of Mashhad Dental School.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>They were compared to 61 age and sex-matched healthy controls of the same race.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>DNA was isolated from peripheral blood cells and genotyping was performed by means of the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>Data were analyzed using the chi-squared test.</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>There was no marked difference in genotype frequencies between the controls and generalized aggressive periodontitis patients (p=0.585).</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>Moreover, no association between patients and normal subjects was found in their allele frequency (p=0.329).</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "17968299", "text": "<Variant>We conclude that the polymorphic nucleotide A at position -1082 of the IL-10 gene is not associated with generalized aggressive periodontitis in the Iranian population.</Variant>", "label": [[53, 72, "Variant"]]}
{"id": "17961316", "text": "<Variant>In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.</Variant>", "label": [[56, 65, "Variant"]]}
{"id": "17961316", "text": "<Variant>We previously reported a case of heterozygous beta-thalassaemia with IVS1-1G > C substitution in the beta-globin gene and a non-detectable level of mutant mRNA in the patient's reticulocytes.</Variant>", "label": [[78, 89, "Variant"]]}
{"id": "17961316", "text": "<Variant>The purpose of this study was to determine whether the transcription and RNA splicing and processing of the mutant gene occurred.</Variant>", "label": []}
{"id": "17961316", "text": "<Variant>We analysed the expression of the mRNA encoded by the cloned mutant gene in COS-1 cells by reverse transcription-polymerase chain reaction followed by agarose gel electrophoresis and nucleotide sequencing.</Variant>", "label": []}
{"id": "17961316", "text": "<Variant>The G > C mutation completely inactivated the normal 5' splice site and resulted in the activation of two cryptic 5' splice sites, located 16 and 38 nt upstream of the normal site.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "17961316", "text": "<Variant>The usage of these two cryptic sites accords with the findings of reports on IVS1-1G > A or IVS1-1G > C substitution of exon 1 of the beta-globin gene.</Variant>", "label": [[86, 97, "Variant"], [101, 112, "Variant"]]}
{"id": "17961316", "text": "<Variant>Additional experiments that involved transfection of equal amounts of both normal and mutant vectors into COS-1 cells indicated the presence of mutant mRNAs.</Variant>", "label": []}
{"id": "17961316", "text": "<Variant>In conclusion, the beta-thalassaemia gene (IVS1-1G > C) was expressed in transfected cells, but showed aberrant RNA splicing.</Variant>", "label": [[52, 63, "Variant"]]}
{"id": "17961316", "text": "<Variant>Further studies will be required to clarify the molecular mechanism that results in severe reduction in the mutant mRNA level in vivo.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Somatic and gonadal mosaicism in X-linked retinitis pigmentosa.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>The g.ORF15 + 652-653delAG mutation in the RPGR gene is the most frequent mutation in X-linked retinitis pigmentosa (XLRP).</Variant>", "label": [[13, 35, "Variant"]]}
{"id": "17935240", "text": "<Variant>The objective of this study was to investigate the possibility of mosaicism in an XLRP family.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Eight subjects in the RP family were recruited.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Blood samples were collected for DNA extraction.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Haplotype analysis and mutational screening on the RPGR gene were performed.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Additionally, samples of hair follicles and buccal cells from the mother of the proband were acquired for DNA extraction and molecular analysis.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Phenotype was characterized with routine ophthalmic examination, Goldmann perimetry, electroretinography, and color fundus photography.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>A g.ORF15 + 652-653delAG mutation was identified in second- and third-generation patients/carriers.</Variant>", "label": [[11, 33, "Variant"]]}
{"id": "17935240", "text": "<Variant>A first-generation female, who was considered to be an obligate carrier, demonstrated a normal phenotype as well as a normal genotype in lymphocytic DNA, indicating the gonadal mosaicism; however, a heterozygous AG-deletion at nucleotide 652 and 653 was identified in the genomic DNA of hair follicles, hair shaft, and buccal cells, indicating that the mutation is somatic.</Variant>", "label": [[221, 258, "Variant"]]}
{"id": "17935240", "text": "<Variant>In conclusion, we reported on a family in which an asymptomatic woman with somatic-gonadal mosaicism for a RPGR gene mutation transmitted the mutation to an asymptomatic daughter and to a son with XLRP.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>Gonadal mosaicism may be responsible for a proportion of multiplex or simplex RP families, in which more than 50% of all cases of RP are found.</Variant>", "label": []}
{"id": "17935240", "text": "<Variant>(c) 2007 Wiley-Liss, Inc.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>Chemokines influence both tumor progression and anti-tumor immune response.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>A 32-bp-deletion polymorphism in the chemokine receptor 5 gene (CCR5Delta32) has been shown to result in a non-functional protein.</Variant>", "label": [[11, 25, "Variant"], [77, 84, "Variant"]]}
{"id": "17909797", "text": "<Variant>This study was aimed at evaluating the potential impact of this gene polymorphism on disease progression and treatment outcome in patients with melanoma.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>PATIENTS AND METHODS:</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>CCR5 genotyping was performed by PCR on DNA extracted from serum samples of 782 cutaneous melanoma patients with known disease history and long-term clinical follow-up.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>Genotypes were correlated with patient survival and types of treatment.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>Of 782 melanoma patients, 90 (11.5%) were heterozygous and 12 (1.5%) were homozygous for CCR5Delta32.</Variant>", "label": [[102, 109, "Variant"]]}
{"id": "17909797", "text": "<Variant>Analyzing the complete cohort, the disease-specific survival from date of primary diagnosis was not influenced by CCR5 status.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>Similarly, no significant impact could be detected on the treatment outcome of stage III patients.</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>In 139 stage IV patients receiving immunotherapy, CCR5Delta32 was associated with a decreased survival compared to patients not carrying the deletion (median 12.5 vs. 20.3 months, P = 0.029).</Variant>", "label": [[63, 70, "Variant"]]}
{"id": "17909797", "text": "<Variant>Multivariate analysis revealed the CCR5 genotype as an independent factor impacting disease-specific survival in this patient population (P = 0.002), followed by gender (P = 0.019) and pathological classification of the primary (pT; P = 0.022).</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "17909797", "text": "<Variant>The presence of the CCR5Delta32 polymorphism in patients with stage IV melanoma results in a decreased survival following immunotherapy and may help to select patients less likely to benefit from this type of treatment.</Variant>", "label": [[33, 40, "Variant"]]}
{"id": "17641158", "text": "<Variant>Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>RATIONALE:</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Familial pulmonary arterial hypertension results from heterozygous inactivating mutations of the BMPR2 gene.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Traditional mutation analysis identifies pathogenic mutations in some 70% of linked families.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>We hypothesized that the apparent shortfall is due to mutations located in the promoter region of the gene, resulting in abnormal gene regulation.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>To identify mutations in untranslated sequence regulating BMPR2 transcription.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>DNA upstream of the coding region was analyzed by direct sequencing in 16 families.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Reverse transcription-polymerase chain reaction analysis and rapid amplification of cDNA ends of normal human lung RNA were used to investigate transcription of this region.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Transcript levels were assessed by allele-specific expression analysis and inhibition of nonsense-mediated decay in lymphoblastoid cell lines.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>MEASUREMENTS AND MAIN RESULTS:</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>The wild-type transcriptional start site of BMPR2 was defined, 1,148 bp upstream of the ATG.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Within this region, we identified a double-substitution mutation, predicted to form a cryptic translational start site, in one family.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>The mutant transcript contains a premature stop codon predicted to trigger nonsense-mediated decay.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>Expression analysis in the patient's cell line indeed showed reduced expression of the mutant transcript that could be restored to normal by inhibiting nonsense-mediated decay.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>CONCLUSIONS: Activation of a cryptic translation initiation site is a novel mutational mechanism in this disorder.</Variant>", "label": []}
{"id": "17641158", "text": "<Variant>These results demonstrate that the 5'-untranslated region of BMPR2 is considerably longer than previously thought, emphasizing the need to fully characterize the BMPR2 promoter and the importance of analyzing noncoding regions in patients with pulmonary arterial hypertension who are negative for mutations within the coding region and intron-exon junctions.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>To identify genetic variants contributing to end-stage renal disease (ESRD) in type 2 diabetes, we performed a genome-wide analysis of 115,352 single nucleotide polymorphisms (SNPs) in pools of 105 unrelated case subjects with ESRD and 102 unrelated control subjects who have had type 2 diabetes for > or =10 years without macroalbuminuria.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>Using a sliding window statistic of ranked SNPs, we identified a 200-kb region on 8q24 harboring three SNPs showing substantial differences in allelic frequency between case and control pools.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>These SNPs were genotyped in individuals comprising each pool, and strong evidence for association was found with rs2720709 (P = 0.000021; odds ratio 2.57</Variant>", "label": [[123, 132, "Variant"]]}
{"id": "17395743", "text": "<Variant>[95% CI 1.66-3.96]), which is located in the plasmacytoma variant translocation gene PVT1.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>We sequenced all exons, exon-intron boundaries, and the promoter of PVT1 and identified 47 variants, 11 of which represented nonredundant markers with minor allele frequency > or =0.05.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>We subsequently genotyped these 11 variants and an additional 87 SNPs identified through public databases in 319-kb flanking rs2720709 ( approximately 1 SNP/3.5 kb); 23 markers were associated with ESRD at P < 0.01.</Variant>", "label": [[134, 143, "Variant"]]}
{"id": "17395743", "text": "<Variant>The strongest evidence for association was found for rs2648875 (P = 0.0000018; 2.97</Variant>", "label": [[62, 71, "Variant"]]}
{"id": "17395743", "text": "<Variant>[1.90-4.65]), which maps to intron 8 of PVT1.</Variant>", "label": []}
{"id": "17395743", "text": "<Variant>Together, these results suggest that PVT1 may contribute to ESRD susceptibility in diabetes.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>Semi-automated, reverse-hybridization detection of multiple mutations causing hereditary fructose intolerance.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>Hereditary fructose intolerance (HFI) is a potentially fatal nutritional disease that is caused by mutations in the liver isoenzyme of fructoaldolase (aldolase B).</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>Our aim was to evaluate a diagnostic assay capable of simultaneously analyzing three-point mutations and a small deletion in the aldolase B (ALDOB) gene.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>The test under investigation is based on multiplex DNA amplification and hybridization to membrane strips presenting a parallel array of allele-specific oligonucleotide probes.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>We used the novel reverse-hybridization (RH) protocol to analyze 54 individuals previously genotyped by direct sequencing.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>RH genotyping for ALDOB mutations Delta4E4, A149P, A174D, and N334K was in complete concordance with results obtained by DNA sequencing.</Variant>", "label": [[43, 51, "Variant"], [53, 58, "Variant"], [60, 65, "Variant"], [71, 76, "Variant"]]}
{"id": "17292585", "text": "<Variant>The procedure is rapid (<6h) and may be automated to a large extent.</Variant>", "label": []}
{"id": "17292585", "text": "<Variant>The RH assay tested in this study represents an accurate and robust screening tool to identify common ALDOB mutations.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>AIM:</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Contradictory reports exist about a correlation of angiotensin I converting enzyme (ACE) gene polymorphisms to the outcome of idiopathic nephrotic syndrome (INS) in children.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>We investigated the frequency of ACE polymorphisms and their impact on the clinical course of INS in children in a Swiss hospital.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>The ACE gene polymorphism (I, insertion; D, deletion) was assessed in 32 children - 22 with steroid-sensitive INS and 10 with steroid-resistant INS - with a median age at onset of INS of 2.9 years (range 1.1-15.0).</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Polymerase chain reaction amplification was performed on genomic DNA isolated from blood leucocytes.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Results were correlated to clinical course and renal morphology.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>The ACE genotype was I/I, I/D and D/D in two, 12 and eight patients, respectively, with steroid-sensitive INS, and in one, eight and one patient, respectively, with steroid resistance.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Renal morphology, available in 25 patients showed minimal change glomerulopathy in 17 patients (14 steroid-sensitive; three steroid-resistant) and focal segmental glomerulosclerosis in eight (one steroid-sensitive; seven steroid-resistant).</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>There was no significant correlation between ACE genotype and steroid responsiveness, histology or outcome.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>ACE genotype was I/I, I/D and D/D in none, 12 and five patients, respectively, with minimal change glomerulopathy, and in one, five and two patients, respectively, with focal segmental glomerulosclerosis.</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>Six patients with steroid-resistant nephrotic syndrome went into end stage renal disease; ACE genotype was I/I in one and I/D in five, but none were D/D. CONCLUSION:</Variant>", "label": []}
{"id": "17199794", "text": "<Variant>In contrast to previous reports, ACE gene polymorphism is irrelevant for clinical outcome, steroid responsiveness or morphology in Swiss children with INS.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Systemic sclerosis (SSc) is a connective tissue disorder characterized by early generalized microangiopathy with disturbed angiogenesis.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Endoglin gene (ENG) encodes a transmembrane glycoprotein which acts as an accessory receptor for the transforming growth factor-beta (TGF-beta) superfamily, and is crucial for maintaining vascular integrity.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>A 6-base insertion in intron 7 (6bINS) of ENG has been reported to be associated with microvascular disturbance.</Variant>", "label": [[11, 27, "Variant"], [41, 46, "Variant"]]}
{"id": "17166870", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Our objective was to investigate the relationship between 6bINS and the vascular complication pulmonary arterial hypertension (PAH) in SSc in a French Caucasian population.</Variant>", "label": [[67, 72, "Variant"]]}
{"id": "17166870", "text": "<Variant>METHODS: Two hundred eighty SSc cases containing 29/280 having PAH diagnosed by catheterism were compared with 140 patients with osteoarthritis.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Genotyping was performed by polymerase-chain-reaction-based fluorescence and direct sequencing of genomic DNA.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>The polymorphism was in Hardy-Weinberg equilibrium.</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>We observed a significant lower frequency of 6bINS allele in SSc patients with associated PAH compared with controls [10.3 vs 23.9%, P = 0.01; odds ratio (OR) 0.37, 95% confidence interval (CI) 0.15-0.89], and a trend in comparison with SSc patients without PAH (10.3 vs 20.3%, P = 0.05; OR: 0.45, 95% CI: 0.19-1.08).</Variant>", "label": [[54, 59, "Variant"]]}
{"id": "17166870", "text": "<Variant>Genotypes carrying allele 6bINS were also less frequent in SSc patients with PAH than in controls (20.7 vs 42.9%, P = 0.02).</Variant>", "label": [[35, 40, "Variant"]]}
{"id": "17166870", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "17166870", "text": "<Variant>Thus the frequency of 6bINS differs between SSc patients with or without PAH, suggesting the implication of ENG in this devastating vascular complication of SSc.</Variant>", "label": [[31, 36, "Variant"]]}
{"id": "17160997", "text": "<Variant>Severe beta(0) thalassemia/hemoglobin E disease caused by de novo 22-base pair duplication in the paternal allele of beta globin gene.</Variant>", "label": [[75, 99, "Variant"]]}
{"id": "17160997", "text": "<Variant>beta Thalassemia is a major public health concern in Southeast Asia.</Variant>", "label": []}
{"id": "17160997", "text": "<Variant>A prevention program has been implemented in Thailand comprising mass carrier screening and genetic testing.</Variant>", "label": []}
{"id": "17160997", "text": "<Variant>In this study, a Thai girl with severe beta thalassemia/hemoglobin (Hb) E disease was born from the mother with Hb E trait and the genotypically normal father.</Variant>", "label": []}
{"id": "17160997", "text": "<Variant>DNA sequencing revealed novel 22-bp tandem duplication in the paternal allele of beta globin gene, producing a severely truncated product.</Variant>", "label": [[39, 63, "Variant"]]}
{"id": "17160997", "text": "<Variant>A short recurring nucleotide at the insertion site suggested a predisposition to this mutation.</Variant>", "label": []}
{"id": "17160997", "text": "<Variant>Therefore, spontaneous beta globin mutations occasionally occur in normal population.</Variant>", "label": []}
{"id": "17160997", "text": "<Variant>Its clinical significance is noteworthy in countries with high prevalence of beta thalassemia.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>Quantitative analysis of CAPN3 transcripts in LGMD2A patients: involvement of nonsense-mediated mRNA decay.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>Limb girdle muscular dystrophy type 2A (LGMD2A) is caused by single or small nucleotide changes widespread along the CAPN3 gene, which encodes the muscle-specific proteolytic enzyme calpain-3.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>About 356 unique allelic variants of CAPN3 have been identified to date.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>We performed analysis of the CAPN3 gene in LGMD2A patients at both the mRNA level using reverse transcription-PCR, and at the DNA level using PCR and denaturing high performance liquid chromatography.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>In four patients, we detected homozygous occurrence of a missense mutation or an in-frame deletion at the mRNA level although the DNA was heterozygous for this mutation in conjunction with a frame-shift mutation.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>The relationship observed in 12 patients between the quantity of CAPN3 mRNA, determined using real-time PCR, and the genotype leads us to propose that CAPN3 mRNAs which contain frame-shift mutations are degraded by nonsense-mediated mRNA decay.</Variant>", "label": []}
{"id": "17157502", "text": "<Variant>Our results illustrate the importance of DNA analysis for reliable establishment of mutation status, and provide a new insight into the process of mRNA decay in cells of LGMD2A patients.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>Putative association of RUNX1 polymorphisms with IgE levels in a Korean population.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>RUNX1, a member of the runt domain gene family of transcription factors, encodes a heterodimeric transcription factor and regulates the expression of various genes related to hematopoiesis and myeloid differentiation.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>RUNX1 has been one of the target genes for research into various autoimmune diseases due to its properties as a transcription factor and functional distribution for chromosomal translocation.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>In an effort to identify additional gene polymorphisms in which variants have been implicated in asthma, we investigated the genetic polymorphisms in RUNX1 to evaluate it as a potential candidate gene for a host genetic study of asthma and IgE production.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>We identified 19 sequence variants by direct DNA sequencing in 24 individuals of which four common variants were selected for genotyping in our asthma cohort (1,055 asthmatic patients, 384 normal controls).</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>Using logistic regression analysis for association with the risk of asthma, while controlling for age, gender, and smoking status as covariates, no significant associations with the risk of asthma were detected.</Variant>", "label": []}
{"id": "17079875", "text": "<Variant>However, two polymorphisms in the promoter region (-2084G>C and -1282G>A) showed a marginal association with total IgE levels (0.03 and 0.03 in recessive models, respectively).</Variant>", "label": [[60, 68, "Variant"], [73, 81, "Variant"]]}
{"id": "17079875", "text": "<Variant>Our findings suggest that polymorphisms in RUNX1 might be one of the genetic factors for the regulation of IgE production.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.</Variant>", "label": [[132, 140, "Variant"]]}
{"id": "17065198", "text": "<Variant>Immunosuppressed renal transplant recipients (RTRs) are predisposed to non-melanoma skin cancers (NMSCs), predominantly squamous cell carcinomas (SCCs).</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>We have analyzed skin lesions from RTRs with aggressive tumors for p53 gene modifications, the presence of Human Papillomas Virus (HPV) DNA in relation to the p53 codon 72 genotype and polymorphisms of the XPD repair gene.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>We detected 24 p53 mutations in 15/25 (60%) NMSCs, 1 deletion and 23 base substitutions, the majority (78%) being UV-specific C to T transitions at bipyrimidine sites.</Variant>", "label": [[135, 141, "Variant"]]}
{"id": "17065198", "text": "<Variant>Importantly, 35% (6/17) are tandem mutations, including 4 UV signature CC to TT transitions possibly linked to modulated DNA repair caused by the immunosuppressive drug cyclosporin A (CsA).</Variant>", "label": [[80, 88, "Variant"]]}
{"id": "17065198", "text": "<Variant>We found 8 p53 mutations in 7/17 (41%) precancerous actinic keratosis (AK), suggesting that p53 mutations are early events in RTR skin carcinogenesis.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>Immunohistochemical analysis shows a good correlation between p53 accumulation and mutations.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>HPV DNA was detected in 78% of skin lesions (60% Basal Cell Carcinomas, 82%AK and 79% SCCs).</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>Thus, immunosuppression has increased the risk of infections by HPVs, predominantly epidermodysplasia verruciformis, speculated to play a role in skin cancer development.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>No association is found between HPV status and p53 mutation.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>Moreover, p53 codon 72 or frequencies of three XPD genotypes of RTRs are comparable with control populations.</Variant>", "label": []}
{"id": "17065198", "text": "<Variant>The p53 mutation spectrum, presenting a high level of CC to TT mutations, shows that the UV component of sunlight is the major risk factor and modulated DNA repair by immunosuppressive drug treatment may be significant in the skin carcinogenesis of RTRs.</Variant>", "label": [[63, 71, "Variant"]]}
{"id": "16780885", "text": "<Variant>16q-linked autosomal dominant cerebellar ataxia: a clinical and genetic study.</Variant>", "label": []}
{"id": "16780885", "text": "<Variant>The autosomal dominant cerebellar ataxias (ADCAs) comprise a genetically and clinically heterogenous group of neurodegenerative disorders.</Variant>", "label": []}
{"id": "16780885", "text": "<Variant>Very recently, a C-to-T single nucleotide substitution in the puratrophin-1 gene was found to be strongly associated with a form of ADCA linked to chromosome 16q22.1 (16q-linked ADCA; OMIM 600223).</Variant>", "label": [[26, 32, "Variant"]]}
{"id": "16780885", "text": "<Variant>We found the C-to-T substitution in the puratrophin-1 gene in 20 patients with ataxia (16 heterozygotes and four homozygotes) and four asymptomatic carriers in 9 of 24 families with an unknown type of ADCA.</Variant>", "label": [[22, 28, "Variant"]]}
{"id": "16780885", "text": "<Variant>We also found two cases with 16q-linked ADCA among 43 sporadic patients with late-onset cortical cerebellar atrophy (LCCA).</Variant>", "label": []}
{"id": "16780885", "text": "<Variant>The mean age at onset in the 22 patients was 61.8 years, and that of homozygous patients was lower than that of heterozygous ones in one family.</Variant>", "label": []}
{"id": "16780885", "text": "<Variant>Neurological examination revealed that the majority of our patients showed exaggerated deep tendon reflexes in addition to the cardinal symptom of cerebellar ataxia (100%), and 37.5% of them had sensorineural hearing impairment, whereas sensory axonal neuropathy was absent.</Variant>", "label": []}
{"id": "16780885", "text": "<Variant>The frequency of 16q-linked ADCA was about 1/10 of our series of 110 ADCA families, making it the third most frequent ADCA in Japan.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Both biochemical and genetic evidence have implicated the genes for TNF-alpha (TNFA) and lymphotoxin-alpha (LTA) in atopic asthma.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Here, we report for the first time the association of their genotypes and haplotypes with atopic asthma in Indian populations.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>We genotyped seven single nucleotide polymorphisms, encompassing the two genes, in patients and control subjects in two independent cohorts.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Serum TNF-alpha levels of selected individuals were measured and correlated with genotypes and haplotypes.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>The A allele of the TNFA-863C ></Variant>", "label": [[33, 42, "Variant"]]}
{"id": "16728705", "text": "<Variant>A polymorphism was associated with reduced risk of asthma (P = 0.002 and 0.007 in Cohorts A and B, respectively), reduced TsIgE levels (P = 0.0024 and P = 0.0029 in Cohorts A and B, respectively), and reduced serum TNF-alpha levels (P < 0.05).</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>A marginal association was also observed for LTA_NcoI polymorphism with asthma and TsIgE levels.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Furthermore, analysis using HAPLO.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>STATS showed significant differences in the major haplotype frequencies (> 3%) between patients and control subjects (P = 0.002 and P = 0.006 for Cohorts A and B, respectively).</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>Individually, the haplotype GATCCG was the most frequent in patients (P = 0.0029 and P = 0.0025 for Cohorts A and B, respectively), and was associated with high TsIgE and serum TNF-alpha levels, whereas AACACG was the most frequent in the control subjects (P = 0.0032 and P = 0.022 for Cohorts A and B, respectively), and was associated with low TsIgE and serum TNF-alpha levels.</Variant>", "label": []}
{"id": "16728705", "text": "<Variant>We also report here that the C > A substitution at position -863 of the TNFA influences the binding of nuclear proteins in electrophoretic mobility shift assay experiments.</Variant>", "label": [[38, 73, "Variant"]]}
{"id": "16728705", "text": "<Variant>Thus, the TNFA-863C ></Variant>", "label": [[23, 32, "Variant"]]}
{"id": "16728705", "text": "<Variant>A polymorphism in the promoter region of TNFA may influence TNF-alpha expression and affect TsIgE levels and susceptibility to asthma.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>Loss of p16 (INK4A) expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>The p16 is a tumor suppressor gene on the short arm of chromosome 9p21.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>The product of the p16 acts as a negative cell cycle regulator by inhibiting G1 cyclin-dependent kinases that phosphorylate the retinoblastoma protein.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>This study was designed to assess the frequency of genetic loss of 9p21 and to determine the role of p16 the pathogenesis of sporadic and neurofibromatosis 1 (NF1)-associated malignant peripheral nerve sheath tumors (MPNSTs).</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>The authors examined 15 cases for p16 protein expression and 10 cases for allelic imbalance (AI)/loss of heterozygosity (LOH) of chromosome 9p.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>DNA was microdissected from normal and neoplastic tissues.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>AI/LOH analysis was performed using six microsatellite markers on the 9p region.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>On immunohistochemical analysis 80% of cases showed abnormal expression of p16.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>Similarly, 8 of 10 cases revealed genetic loss with at least one microsatellite marker.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>The most frequent deletion was that within the coding sequence.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>Of p16 at me D9S974 locus.</Variant>", "label": []}
{"id": "16540739", "text": "<Variant>These findings emphasize the role of loss of p16 in the development of both sporadic and NF1-associated MPNSTs.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>BACKGROUND _#38; OBJECTIVE:</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>The infiltrating neoplastic cells within early-stage nasopharyngeal carcinoma (NPC) are consistently infected with Epstein-Barr virus (EBV).</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>The precursor lesions could often be found in paracancerous epithelium of early-stage NPC.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>This study was to investigate the role of EBV infection and the intrahost evolution of EBV genotype developed in nasopharyngeal carcinogenesis through detection of EBV harboring in precursor lesions.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>METHODS: EBV-encoded RNA (EBER) in 15 cases of early-stage NPC biopsy tissue was detected by nucleic acid in situ hybridization.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>EBV type and latent membrane protein 1 (LMP1) EBV strain in precursor lesions and carcinoma nests were detected by nested polymerase chain reaction (PCR).</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>DNA sequencing of the representative PCR products of carboxyl-terminus of LMP1 gene was analyzed by using four-colored fluorescence terminator sequencing technique.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>RESULTS: Most infiltrating carcinoma cells of all 15 cases of NPC showed EBER-positive.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>EBER-positive abnormal epithelial cells and/or infiltrating lymphocytes were found in 14 of 15 cases of precursor lesion.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>Single A-type EBV was detected in 9 of 11 available DNA samples of carcinoma nest and 9 of 10 available DNA samples of precursor lesion.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>The carboxyl-terminus of EBV LMP1 gene was detected in all 15 DNA samples of carcinoma nest, among which 14 were single 30-bp deleted LMP1 (del-LMP1) EBV infection and 1 was coinfection of wild-type LMP1 (wt-LMP1) EBV strain and del-LMP1 EBV strain.</Variant>", "label": [[129, 142, "Variant"]]}
{"id": "16480574", "text": "<Variant>Among the 11 available DNA samples of precursor lesion suitable for carboxyl-terminus amplification, 5 were coinfection of wt-LMP1 and del-LMP1 EBV, 4 were single del-LMP1 EBV infection, 1 was single wt-LMP1 EBV infection, and 1 showed negative reaction.</Variant>", "label": []}
{"id": "16480574", "text": "<Variant>The DNA sequence of the carboxyl-terminus of wt-LMP1 gene was identical with that of B95-8 cells, while that of del-LMP1 gene had a 30-bp deletion (codon: 346-355) and 4 missense point mutations (codon: 334, 335, 338, and 366).</Variant>", "label": [[141, 172, "Variant"]]}
{"id": "16480574", "text": "<Variant>CONCLUSION: EBV infection in nasopharyngeal epithelial cells is a preinvasive event of carcinogenesis of NPC, and the intrahost evolution of EBV genotype would take place during nasopharyngeal carcinogenesis.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>A juvenile hemochromatosis patient homozygous for a novel deletion of cDNA nucleotide 81 of hemojuvelin.</Variant>", "label": [[67, 97, "Variant"]]}
{"id": "16424663", "text": "<Variant>BACKGROUND: A 25-year-old woman of English/Irish background was diagnosed with hemochromatosis.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>She manifested hypogonadotrophic hypogonadism and congestive heart failure.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>Although there were abnormal liver function tests, no cirrhosis was present.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>The patient has been treated intermittently by phlebotomy for 24 years.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>The aim of this study was to investigate the genetic basis of the patient's iron overload disease.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>Genetic analysis was performed by direct sequencing of the genes for hemojuvelin, HFE, hepcidin, ferroportin and transferrin receptor 2.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>RESULTS AND CONCLUSIONS:</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>Molecular analysis showed that the patient was homozygous for a previously undescribed mutation of HJV, the gene encoding hemojuvelin.</Variant>", "label": []}
{"id": "16424663", "text": "<Variant>This mutation, nt 81G deletion, causes a frameshift encoding 23 additional irrelevant amino acids and premature termination.</Variant>", "label": [[24, 39, "Variant"]]}
{"id": "16424663", "text": "<Variant>No mutations were found in the other hemochromatosis genes, hepcidin, HFE, ferroportin or transferrin receptor 2, which might have contributed to her iron overload.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>A homozygous deletion of the DOCK8 (dedicator of cytokinesis 8) locus at chromosome 9p24 was found in a lung cancer cell line by array-CGH analysis.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>Cloning of the full-length DOCK8 cDNA led us to define that the DOCK8 gene encodes a protein consisting of 2,099 amino acids.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>DOCK8 was expressed in a variety of human organs, including the lungs, and was also expressed in type II alveolar, bronchiolar epithelial and bronchial epithelial cells, which are considered as being progenitors for lung cancer cells.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>DOCK8 expression was reduced in 62/71 (87%) primary lung cancers compared with normal lung tissue, and the reduction occurred irrespective of the histological type of lung cancer.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>5-Aza-2'-deoxy-cytidine and/or Trichostatin A treatments induced DOCK8 expression in lung cancer cell lines with reduced DOCK8 expression.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>Therefore, epigenetic mechanisms, including DNA methylation and histone deacetylation, were indicated to be involved in DOCK8 down-regulation in lung cancer cells.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>Further screening revealed homozygous deletions of the DOCK8 gene in a gastric and a breast cancer cell line.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>DOCK family proteins have been shown to play roles in regulation of migration, morphology, adhesion and growth of cells.</Variant>", "label": []}
{"id": "16391785", "text": "<Variant>Thus, the present results suggest that genetic and epigenetic inactivation of DOCK8 is involved in the development and/or progression of lung and other cancers by disturbing such regulations.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Inactivating mutations in ESCO2 cause SC phocomelia and Roberts syndrome: no phenotype-genotype correlation.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>The rare, autosomal recessive Roberts syndrome (RBS) is characterized by tetraphocomelia, profound growth deficiency of prenatal onset, craniofacial anomalies, microcephaly, and mental deficiency.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>SC phocomelia (SC) has a milder phenotype, with a lesser degree of limb reduction and with survival to adulthood.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Since heterochromatin repulsion (HR) is characteristic for both disorders and is not complemented in somatic-cell hybrids, it has been hypothesized that the disorders are allelic.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Recently, mutations in ESCO2 (establishment of cohesion 1 homolog 2) on 8p21.1 have been reported in RBS.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>To determine whether ESCO2 mutations are also responsible for SC, we studied three families with SC and two families in which variable degrees of limb and craniofacial abnormalities, detected by fetal ultrasound, led to pregnancy terminations.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>All cases were positive for HR.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>We identified seven novel mutations in exons 3-8 of ESCO2.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>In two families, affected individuals were homozygous--for a 5-nucleotide deletion in one family and a splice-site mutation in the other.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>In three nonconsanguineous families, probands were compound heterozygous for a single-nucleotide insertion or deletion, a nonsense mutation, or a splice-site mutation.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Abnormal splice products were characterized at the RNA level.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Since only protein-truncating mutations were identified, regardless of clinical severity, we conclude that genotype does not predict phenotype.</Variant>", "label": []}
{"id": "16380922", "text": "<Variant>Having established that RBS and SC are caused by mutations in the same gene, we delineated the clinical phenotype of the tetraphocomelia spectrum that is associated with HR and ESCO2 mutations and differentiated it from other types of phocomelia that are negative for HR.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>Polymerase chain reaction-based analysis using deaminated DNA of dodecamer expansions in CSTB, associated with Unverricht-Lundborg myoclonus epilepsy.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>Progressive myoclonus epilepsy of the Unverricht-Lundborg type is an autosomal recessive disorder that is characterized clinically by myoclonic seizures and ataxia.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>The majority of affected individuals carry repeat expansions of a dodecamer in the promoter region of the cystatin B gene.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>The unusually high GC content of this tract is refractory to conventional polymerase chain reaction (PCR), and, as a result, a circumventive procedure involving the deamination of DNA with sodium bisulfite has been proposed.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>This study evaluates the effectiveness of this deamination modification for the detection of dodecamer repeat variants.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>An analysis of 258 healthy Japanese individuals revealed an allele with four copies of the dodecamer repeat with a frequency of 0.01, in addition to the more commonly observed two and three copy repeat alleles.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>Homozygous repeat expansions 600 and 680 base pairs in length were detected in the analyses of two affected individuals.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>For these cases, sequencing, along with an alternative PCR-stutter formation, revealed 41 and 48 copies, respectively, of the dodecamer repeat.</Variant>", "label": []}
{"id": "16379547", "text": "<Variant>The complete conversion of C to T was observed in the expanded tracts, indicating that no methylation occurred at the CpG sites.</Variant>", "label": [[36, 42, "Variant"]]}
{"id": "16379547", "text": "<Variant>Based on these results, it was concluded that the use of deaminated DNA allows for a precise analysis of consecutive GC tracts.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>Distribution of insertion- and deletion-associated genetic polymorphisms among four Mycobacterium tuberculosis phospholipase C genes and associations with extrathoracic tuberculosis: a population-based study.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>The Mycobacterium tuberculosis genome contains four phospholipase C (PLC)-encoding genes, designated plcA, plcB, plcC, and plcD, respectively.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>Each of the four genes contributes to the overall PLC activity of M. tuberculosis.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>PLC is hypothesized to contribute to M. tuberculosis virulence.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>Infection of M. tuberculosis strains carrying a truncated plcD gene is associated with the occurrence of extrathoracic tuberculosis.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>However, whether the other three plc genes are also associated with extrathoracic tuberculosis remains to be assessed.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>We investigated the insertion- and deletion-associated genetic diversity in all four plc genes among 682 epidemiologically and clinically well-characterized M. tuberculosis clinical isolates using PCR, DNA sequencing, and Southern hybridization.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>Two hundred sixty-six (39%) of the 682 isolates had an interruption in at least one of the four plc genes, most often associated with an IS6110 insertion.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>The plcD gene interruption was the most common: it was observed in 233 (34%) of the isolates, compared to 4.7%, 4.1%, and 5.9% for plcA, plcB, and plcC gene interruption, respectively.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>The association between the plc gene genotypes and disease presentation was adjusted for clustering using generalized estimating equations for both bivariate and multivariate analyses.</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>After controlling for the genotypes of the plcABC genes and the host-related risk factors, interruption in the plcD gene remained significantly associated with extrathoracic tuberculosis (odds ratio, 3.27; 95% confidence interval, 1.32 to 8.14).</Variant>", "label": []}
{"id": "16333097", "text": "<Variant>The data suggest that the plcD gene might play a more important role in the pathogenesis of thoracic TB than it does in the pathogenesis of extrathoracic TB.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>To evaluate the clinical relevance of genomic aberrations in primary cutaneous large B-cell lymphoma (PCLBCL).</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>PATIENTS AND METHODS: Skin biopsy samples of 31 patients with a PCLBCL classified as either primary cutaneous follicle center lymphoma (PCFCL; n = 19) or PCLBCL, leg type (n = 12), according to the WHO-European Organisation for Research and Treatment of Cancer (EORTC) classification, were investigated using array-based comparative genomic hybridization, fluorescence in situ hybridization (FISH), and examination of promoter hypermethylation.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>The most recurrent alterations in PCFCL were high-level DNA amplifications at 2p16.1 (63%) and deletion of chromosome 14q32.33 (68%).</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>FISH analysis confirmed c-REL amplification in patients with gains at 2p16.1.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>In PCLBCL, leg type, most prominent aberrations were a high-level DNA amplification of 18q21.31-q21.33 (67%), including the BCL-2 and MALT1 genes as confirmed by FISH, and deletions of a small region within 9p21.3 containing the CDKN2A, CDKN2B, and NSG-x genes.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Homozygous deletion of 9p21.3 was detected in five of 12 patients with PCLBCL, leg type, but in zero of 19 patients with PCFCL.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Complete methylation of the promoter region of the CDKN2A gene was demonstrated in one PCLBCL, leg type, patient with hemizygous deletion, in one patient without deletion, but in zero of 19 patients with PCFCL.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Seven of seven PCLBCL, leg type, patients with deletion of 9p21.3 and/or complete methylation of CDKN2A died as a result of their lymphoma.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Our results demonstrate prominent differences in chromosomal alterations between PCFCL and PCLBCL, leg type, that support their classification as separate entities within the WHO-EORTC scheme.</Variant>", "label": []}
{"id": "16330669", "text": "<Variant>Inactivation of CDKN2A by either deletion or methylation of its promoter could be an important prognostic parameter for the group of PCLBCL, leg type.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>Combinations of genetic changes in the human cAMP-responsive element modulator gene: a clue towards understanding some forms of male infertility?</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>The cAMP-responsive element modulator (CREM) gene plays a pivotal role in the mouse spermatogenesis, but its role in the human infertility has not been fully established.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>We performed a mutation screening in 13 Slovenian men with round spermatid arrest and in six controls.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>Eleven genetic changes have been identified in the human CREM gene, three novel single-nucleotide polymorphisms [within the promoters P1, P3 and intervening sequence 1 (IVS1)], one insertion (IVS2) and one non-sense mutation (exon gamma).</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>Some infertile patients seem to accumulate potentially harmful genetic changes.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>We identified a patient with no CREM immunoreactive protein that was homozygous for the nucleotide changes in all promoters, IVS 1, 2, 6, and was heterozygous for the mutation in exon gamma.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>Interestingly, insertion in IVS2 (IVS2-58_55insT) results in a four-fold decrease in binding of nuclear proteins.</Variant>", "label": [[43, 57, "Variant"]]}
{"id": "16143638", "text": "<Variant>Computer predictions suggested the presence of a potential novel CREM promoter, however, random amplification of cDNA ends from the human testis cDNA library was not successful in confirming a novel transcription start site of the CREM gene.</Variant>", "label": []}
{"id": "16143638", "text": "<Variant>Screening of a larger number of patients and controls is required to elucidate whether the observed combinations of genetic changes in the CREM gene can explain some forms of male infertility.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>Autosomal dominant cerebellar ataxia (ADCA) is a group of heterogeneous neurodegenerative disorders.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>By positional cloning, we have identified the gene strongly associated with a form of degenerative ataxia (chromosome 16q22.1-linked ADCA) that clinically shows progressive pure cerebellar ataxia.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>Detailed examination by use of audiogram suggested that sensorineural hearing impairment may be associated with ataxia in our families.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>After restricting the candidate region in chromosome 16q22.1 by haplotype analysis, we found that all patients from 52 unrelated Japanese families harbor a heterozygous C-->T single-nucleotide substitution, 16 nt upstream of the putative translation initiation site of the gene for a hypothetical protein DKFZP434I216, which we have called \"puratrophin-1\" (Purkinje cell atrophy associated protein-1).</Variant>", "label": [[178, 183, "Variant"]]}
{"id": "16001362", "text": "<Variant>The full-length puratrophin-1 mRNA had an open reading frame of 3,576 nt, predicted to contain important domains, including the spectrin repeat and the guanine-nucleotide exchange factor (GEF) for Rho GTPases, followed by the Dbl-homologous domain, which indicates the role of puratrophin-1 in intracellular signaling and actin dynamics at the Golgi apparatus.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>Puratrophin-1--normally expressed in a wide range of cells, including epithelial hair cells in the cochlea--was aggregated in Purkinje cells of the chromosome 16q22.1-linked ADCA brains.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>Consistent with the protein prediction data of puratrophin-1, the Golgi-apparatus membrane protein and spectrin also formed aggregates in Purkinje cells.</Variant>", "label": []}
{"id": "16001362", "text": "<Variant>The present study highlights the importance of the 5' untranslated region (UTR) in identification of genes of human disease, suggests that a single-nucleotide substitution in the 5' UTR could be associated with protein aggregation, and indicates that the GEF protein is associated with cerebellar degeneration in humans.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>Impaired insulin secretion is a fundamental defect in type 2 diabetes.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in the genes regulating insulin secretion (SLC2A2</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>[encoding GLUT2], GCK, TCF1 [encoding HNF-1alpha], HNF4A, GIP, and GLP1R) are associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in participants of the Finnish Diabetes Prevention Study.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>With the exception of SLC2A2, other genes were not associated with the risk of type 2 diabetes.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>All four SNPs of SLC2A2 predicted the conversion to diabetes, and rs5393 (AA genotype) increased the risk of type 2 diabetes in the entire study population by threefold (odds ratio 3.04, 95% CI 1.34-6.88, P = 0.008).</Variant>", "label": [[75, 81, "Variant"]]}
{"id": "15983230", "text": "<Variant>The risk for type 2 diabetes in the AA genotype carriers was increased in the control group (5.56 [1.78-17.39], P = 0.003) but not in the intervention group.</Variant>", "label": []}
{"id": "15983230", "text": "<Variant>We conclude that the SNPs of SLC2A2 predict the conversion to diabetes in obese subjects with IGT.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>Exonic deletions in MSH2 and MLH1 are significant contributors to the mutation spectrum in HNPCC, and heterozygous changes in exon copy number are not detected by conventional mutation screening methods.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>AIMS:</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>We aimed to develop methods for screening copy number changes in all the exons of the MLH1 and MSH2 genes using a single multiplex amplifiable probe hybridisation (MAPH) assay.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>We developed a probe set consisting of probes from the 19 exons of MLH1 and 16 exons of MSH2, and 3 control probes, and applied it to screening for deletions and duplications using fluorescent detection of amplified fragments.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>We tested 73 DNA samples from controls and 50 from HNPCC patients in whom no point mutations had been found, and detected 10 copy number changes among the patient samples.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>A deletion of about 1.4 kb including exon 3 of MSH2 was confirmed by amplification of a junction fragment, and was shown to be the result of an unequal recombination between intronic Alu elements.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>MAPH can detect exonic copy number changes in MLH1 and MSH2 in DNA from HNPCC patients.</Variant>", "label": []}
{"id": "15951966", "text": "<Variant>Since finding an exonic deletion or duplication makes full sequence analysis unnecessary, it may be most cost-effective to pre-screen samples by MAPH or MLPA before screening for point mutations.</Variant>", "label": []}
{"id": "15929706", "text": "<Variant>Detection of a new 3-base pair insertion mutation in the protease gene of human immunodeficiency virus type 1 during highly active antiretroviral therapy (HAART).</Variant>", "label": [[28, 49, "Variant"]]}
{"id": "15929706", "text": "<Variant>To investigate a new insertion mutation in the protease (PR) gene of human immunodeficiency virus type 1 (HIV-1) in a patient extensively pretreated with antiretroviral drugs, genotypic analyses of plasma-derived viruses were performed by sequencing segments of 1302 nucleotides in the pol gene of HIV-1.</Variant>", "label": []}
{"id": "15929706", "text": "<Variant>Despite optimal compliance to highly active antiretroviral therapy (HAART) the patient showed poor virological success.</Variant>", "label": []}
{"id": "15929706", "text": "<Variant>Nucleotide sequences of retrospective available plasma samples exhibited a previously unknown 3-bp insertion mutation, corresponding to a leucine, between codons 31 and 32 of the PR gene.</Variant>", "label": [[103, 117, "Variant"]]}
{"id": "15929706", "text": "<Variant>This kind of mutation appears to be very rare and it does not seem to be associated with any phenotypic resistance profile known so far.</Variant>", "label": []}
{"id": "15929706", "text": "<Variant>It should be noted that the insert mutation, once it appeared, did not revert to the wild-type variant, suggesting that it seems to correspond to a better fitness of the variant viruses.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>The T-cell immunoglobulin mucin ( TIM ) proteins and their genetic variants have been suggested to play a role in regulating allergic diseases.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>Genetic association of the sequence variants for TIM-1 and TIM-3 genes with asthma in an African American population was investigated.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>METHODS: Both case-control and family-based association analyses were performed for a total of 7 polymorphisms, including 3 single nucleotide polymorphism (SNPs) and 1 insertion/deletion polymorphism in the TIM-1 and 3 SNPs in the TIM-3 genes.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>The exposure to hepatitis A virus as judged by seropositivity was also examined.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>In the case-control design, the frequencies of the TT genotype for SNP rs2277025 and the homozygous deletion variant (157delMTTTVP) in the fourth exon of the TIM-1 gene were higher among patients with patients with asthma compared with the controls (odds ratio [OR], 2.779, P = .016; and OR, 3.09, P = .022, respectively).</Variant>", "label": [[80, 89, "Variant"], [127, 139, "Variant"]]}
{"id": "15867855", "text": "<Variant>This association was substantiated by haplotype analysis of these and 2 additional SNPs (OR, 2.48; P = .004), and also by family-based tests for the allele and haplotype carrying 157delMTTTVP (P = .009 and P = .048, respectively).</Variant>", "label": [[188, 200, "Variant"]]}
{"id": "15867855", "text": "<Variant>Furthermore, this association seems to exist even in the hepatitis A virus-seronegative subjects in our data.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>None of the 3 variants in TIM-3 genes yielded significant association with either asthma or asthma-related phenotypes.</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "15867855", "text": "<Variant>Our findings suggest that the genetic variants of the TIM-1 but not the TIM-3 gene contribute to asthma susceptibility in this African-American population.</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>Nucleotide mutations associated with hepatitis B e antigen negativity.</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>One hundred and forty four patients with chronic hepatitis B were tested to identify new mutations associated with hepatitis B e antigen (HBeAg) negativity, using a full genome sequence analysis.</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>All the patients were Chinese and had hepatitis B virus infection of genotype C. Patients with none of the pre-core or core promoter mutations were significantly (P < 0.001) less common in the group with anti-HBe (13%) than in the group with HBeAg (56%).</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>The complete nucleotide sequence was determined in four anti-HBe-positive patients who had neither pre-core nor core promoter mutations and in five HBeAg-positive patients who also had neither of these mutations (the groups were matched for age and sex).</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>Six mutations were found to be significantly more common in the former group than in the latter: G529A (3/4 vs. 0/5),</Variant>", "label": [[106, 111, "Variant"]]}
{"id": "15834874", "text": "<Variant>C934A (4/4 vs. 1/5), A1053G (4/4 vs. 1/5), G1915T/</Variant>", "label": [[9, 14, "Variant"], [30, 36, "Variant"], [52, 60, "Variant"]]}
{"id": "15834874", "text": "<Variant>A (4/4 vs. 0/5), T2005C/</Variant>", "label": [[25, 33, "Variant"]]}
{"id": "15834874", "text": "<Variant>A (4/4 vs. 0/5), and C3026T (3/4 vs. 0/5).</Variant>", "label": [[28, 34, "Variant"]]}
{"id": "15834874", "text": "<Variant>Three of the six mutations were significantly more common in the four anti-HBe-positive patients who had neither pre-core nor core promoter mutations, compared to 11 HBeAg-positive patients who had pre-core and core promoter mutations, and also compared to 15 anti-HBe-positive patients who had pre-core and core promoter mutations, suggesting further the specificity of these mutations.</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>Of the six mutations, two resulted in amino acid substitution in the polymerase protein, and one is located near the enhancer I region.</Variant>", "label": []}
{"id": "15834874", "text": "<Variant>The results suggest that the six newly discovered mutations are associated with HBeAg negativity.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>No Evidence for BRAF as a melanoma/nevus susceptibility gene.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>Somatic mutations of BRAF have been identified in both melanoma tumors and benign nevi.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>Germ line mutations in BRAF have not been identified as causal in families predisposed to melanoma.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>However, a recent study suggested that a BRAF haplotype was associated with risk of sporadic melanoma in men.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>Polymorphisms or other variants in the BRAF gene may therefore act as candidate low-penetrance genes for nevus/melanoma susceptibility.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>We hypothesized that promoter variants would be the most likely candidates for determinants of risk.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>Using denaturing high-pressure liquid chromatography and sequencing, we screened peripheral blood DNA from 184 familial melanoma cases for BRAF promoter variants.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>We identified a promoter insertion/deletion in linkage disequilibrium with the previously described BRAF polymorphism in intron 11 (rs1639679) reported to be associated with melanoma susceptibility in males.</Variant>", "label": [[141, 150, "Variant"]]}
{"id": "15824163", "text": "<Variant>We therefore investigated the contribution of this BRAF polymorphism to melanoma susceptibility in 581 consecutively recruited incident cases, 258 incident cases in a study of late relapse, 673 female general practitioner controls, and the 184 familial cases.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>We found no statistically significant difference in either genotype or allele frequencies between cases and controls overall or between male and female cases for the BRAF polymorphism in the two incident case series.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>Our results therefore suggest that the BRAF polymorphism is not significantly associated with melanoma and the promoter insertion/deletion linked with the polymorphism is not a causal variant.</Variant>", "label": []}
{"id": "15824163", "text": "<Variant>In addition, we found that there was no association between the BRAF genotype and mean total number of banal or atypical nevi in either the cases or controls.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>BACKGROUND: Vitamin D-binding protein (DBP) is the main systemic transporter of 1.25(OH)2D3 and is essential for its cellular endocytosis.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>There are two known polymorphisms in exon 11 of the DBP gene resulting in amino acid variants: GAT-->GAG substitution replaces aspartic acid by glutamic acid in codon 416; and ACG-->AAG substitution in codon 420 leads to an exchange of threonine for lysine.</Variant>", "label": [[104, 179, "Variant"], [185, 220, "Variant"], [245, 265, "Variant"]]}
{"id": "15820770", "text": "<Variant>These DBP variants lead to differences in the affinity for 1.25(OH)2D3.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>Correlations between DBP alleles and type 1 diabetes have been described in different populations.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>Therefore, we investigated the polymorphism in codon 416 of the DBP gene for an association with autoimmune markers of type 1 diabetes.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>DESIGN AND METHODS:</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>The present analysis was a case control study.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>110 patients, 68 controls, and 115 first-degree relatives were genotyped for the DBP polymorphism in codon 416.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>DNA typing of DBP locus was performed by the PCR-restriction fragment length polymorphism method (RFLP).</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P < 0.01).</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>On the contrary, the DBP Glu-containing genotype was not accompanied by differences in the prevalence of GAD65 antibodies.</Variant>", "label": []}
{"id": "15820770", "text": "<Variant>These finding supports a role of the vitamin D endocrine system in the autoimmune process of type 1 diabetes.</Variant>", "label": []}
{"id": "15784611", "text": "<Variant>Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery.</Variant>", "label": [[40, 61, "Variant"]]}
{"id": "15755837", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Folate is critical for cell division, a major feature of in utero development.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Dihydrofolate reductase (DHFR) is required to convert the folic acid used in supplements and for food fortification and the dihydrofolate produced by thymidylate synthase during DNA synthesis to the reduced folate forms used by the cell.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>We aimed to determine whether a common, recently discovered deletion polymorphism in the DHFR gene is a risk factor for preterm delivery or low birth weight.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>DESIGN:</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>We studied 324 pregnant women from Camden, NJ.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Folate intake was computed from folate supplement intake plus the mean of two 24-h recalls completed during the course of pregnancy.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Genomic DNA was extracted from the women's leukocytes and genotyped.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Women with a deletion allele had a significantly greater risk of preterm delivery [adjusted odds ratio (AOR): 3.0; 95% CI: 1.0, 8.8; P < 0.05] than did those without a deletion allele.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>Women with both a DHFR deletion allele and low folate intake (<400 microg/d from diet plus supplements) had a significantly greater risk of preterm delivery (AOR: 5.5; 95% CI: 1.5, 20.4; P = 0.01) and a significantly greater risk of having an infant with a low birth weight (AOR: 8.3; 95% CI: 1.8, 38.6; P = 0.01) than did women without a deletion allele and with a folate intake >/=400 microg/d. CONCLUSIONS:</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>The DHFR 19-base pair deletion allele may be a risk factor for preterm delivery.</Variant>", "label": [[18, 39, "Variant"]]}
{"id": "15755837", "text": "<Variant>In the presence of low dietary folate, the allele may also be a risk factor for low birth weight.</Variant>", "label": []}
{"id": "15755837", "text": "<Variant>This may be a gene-environment interaction.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>Sarcoidosis (SA) is a systemic granulomatous disorder of unknown etiology characterized by T helper 1-type inflammatory responses at sites of disease with signs of B cell hyperactivity.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>Like rheumatoid arthritis and diabetes, an infectious etiology has frequently been postulated but no single infectious trigger definitively identified.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>Polymorphic alleles at SLC11A1 have previously been associated with susceptibility to both the putative infectious agents and to these autoimmune disorders.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>We therefore investigated its candidacy as a genetic determinant of SA in Poland in an association-based study comparing 86 SA patients with 85 tuberculosis (TB) patients and 93 control subjects.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>The functional promoter (GT)(n) polymorphism and four of 10 other single nucleotide or insertion/deletion polymorphisms genotyped across SLC11A1 were informative in our sample.</Variant>", "label": []}
{"id": "15702130", "text": "<Variant>Consistent with previous autoimmune disease studies, allele 3 at the functional (GT)(n) promoter region repeat polymorphism was significantly associated with SA when compared with healthy controls (odds ratio 1.68; 95% CI: 1.01-2.81; P=0.04) or with TB patients (odds ratio 1.69; 95% CI: 1.042-0.78; P=0.03).</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>We describe the development and implementation of a neurofibromatosis type 2 (NF2) mutation scanning service based on novel techniques.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>All 17 exons of the NF2 gene are amplified in four polymerase chain reaction (PCR) reactions, using the meta-PCR technique to link the NF2 exons into chimeric concatamers.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>The meta-PCR products are then scanned for point mutations by direct sequencing.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>A four-exon dosage assay is used to test for large deletion/duplication mutations.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>In certain cases when tumour studies are necessary, these techniques are also combined with loss of heterozygosity analysis with three highly polymorphic microsatellite markers located within or close to the NF2 gene.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>Over a period of 2 years, we have applied these techniques in a service setting to the analysis of 271 patient samples (245 lymphocyte DNA; 26 schwannoma DNA).</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>Meta-PCR and sequencing identified 90 point mutations in the 271 blood and tumor samples, 48 of which have not been reported previously.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>Dosage analysis identified large deletions in 12 of the lymphocyte DNA samples.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>In addition, over 84% of mutations were identified in 23 schwannoma DNA samples in which complete analysis was possible.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>Adoption of this novel strategy has increased the overall mutation detection rate in familial NF2 cases to 88% and sporadic NF2 cases to 59%.</Variant>", "label": []}
{"id": "15684865", "text": "<Variant>It has also allowed us to decrease our reporting turnaround times, and because of a low overall failure rate, permitted the running of an efficient and cost-effective service.</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>A single nucleotide A>G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnancies.</Variant>", "label": [[29, 62, "Variant"]]}
{"id": "15672026", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>The relationship between a polymorphism at position -670 in the Fas gene (TNFRSF6) and preterm premature rupture of membranes (PPROM) in multifetal pregnancies was examined.</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>METHODS: Buccal swabs from 119 mother-infant sets were analyzed for an adenine (A) to guanine (G) substitution at position -670 in the TNFRSF6 promoter.</Variant>", "label": [[80, 136, "Variant"]]}
{"id": "15672026", "text": "<Variant>Pregnancy outcome data were subsequently obtained.</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>Analysis was by Fisher exact test.</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>Maternal allele G homozygosity (TNFRSF6*G) was observed in 42.4% of 33 PPROM pregnancies as opposed to 19.5% of 77 with no spontaneous preterm birth (P = .01).</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>Similarly, TNFRSF6*G homozygosity was present in 37.5% of 32 first-born neonates from PPROM pregnancies as opposed to 18.7% of 75 uncomplicated pregnancies (P = .04).</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>PPROM occurred in 8 of 14 (57.1%) pregnancies in which mother and all neonates were TNFRSF6*G homozygotes as opposed to 25 of 105 (23.8%) cases in which uniform TNFRSF6*G homozygosity was not observed (P = .02).</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15672026", "text": "<Variant>A genetic variant in the Fas gene is associated with an increased rate of PPROM in multifetal pregnancies.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>A 3-week-old Caucasian female presented with severe unprovoked parenchymal cerebral haemorrhage.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>Her plasma factor VII (FVII) activity was <0.01 units/ml.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>FVII activities for her mother and sister were 0.65 units/ml and 0.51 units/ml, respectively, while her father's level was normal.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>These results indicated that the mother was heterozygous for a non-functional F7 gene that had also been inherited by the proband's sister.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>The proband's severe FVII deficiency was caused by a new mutation in her paternal F7 gene coupled with the inheritance of the non-functional maternal F7 gene.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>DNA sequence analysis revealed that the proband had apparent homozygosity for a novel single point mutation (g.3907G >A) changing the codon for Glu29 to Lys (E29K); neither parent had the E29K mutation.</Variant>", "label": [[118, 128, "Variant"], [153, 165, "Variant"], [167, 171, "Variant"], [197, 201, "Variant"]]}
{"id": "15667541", "text": "<Variant>Because of the unlikelihood that the proband was homozygous for two identical new point mutations, the DNA sequence abnormality was more likely to have arisen from a single mutated gene on one allele and a F7 gene deletion on the other allele.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>Real time polymerase chain reaction (PCR) analysis confirmed that the proband had inherited a gene deletion that was present in the maternal side of the family.</Variant>", "label": []}
{"id": "15667541", "text": "<Variant>Subsequent clotting assays and real time PCR revealed that the maternal deletion also included the closely linked F10 gene.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>Whereas human papillomavirus (HPV) infection is the major determinant of cervical carcinogenesis, host genetic factors may confer individual susceptibility and prognosis.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>Matrix metalloproteinase 1 (MMP-1) is an important modulator of carcinogenesis.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>A guanine insertion (2G) polymorphism at nucleotide -1607 of the MMP-1 gene promoter creates an Ets-1-binding site, which increases transcription activity.</Variant>", "label": [[11, 66, "Variant"]]}
{"id": "15661214", "text": "<Variant>The present study investigates the association between MMP-1 polymorphism and cervical neoplasia, and their prognostic significance.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>In this study, the MMP-1 polymorphism was assessed in 135 high-grade squamous intraepithelial lesions (HSILs) and 197 invasive squamous cell carcinomas (SCCs), and in age-matched controls, by capillary electrophoresis.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>The association of clinicopathological factors and HPV status with MMP-1 genotypes was tested.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>RESULTS: Frequencies of the 2G allele in HSIL and SCC were 64% and 65%, respectively, which did not differ significantly from control values (66% and 64%, respectively).</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>The 2G allele was associated with advanced stages of disease (P = 0.03), whereas the G allele was more common in patients with regional lymph node metastases (P = 0.02).</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>The survival time in patients with the heterozygous genotype G/2G (median, 55.3 months) was significantly longer than those with either the G/G (50.3 months) or 2G/2G genotype (43.9 months) (P = 0.02).</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>No significant correlation between HPV status and MMP-1 genotype was identified.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>The genetic polymorphisms of MMP-1 are not associated with the risk of HSIL and SCC, but with the invasiveness and prognosis of SCC.</Variant>", "label": []}
{"id": "15661214", "text": "<Variant>The heterozygous genotype of MMP-1 can be used as a prognostic marker in patients with invasive cervical cancer.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Treatment of MDS patients with recombinant human erythropoietin and the role of GSTs.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Glutathione S-transferases (GSTs) are a group of enzymes involved in the detoxification process of carcinogens and other substances.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>The genes encoding isoenzymes M1 and T1 have \"null\" alleles, which are polymorphic in humans.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Our purpose was to examine whether the GSTM1 and GSTT1 homozygous null genotypes have an impact on the response to recombinant human erythropoietin (rhuEpo) treatment in MDS patients.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>We analyzed lymphocyte DNA samples from 27 patients with all types of myelodysplastic syndromes (MDS) at the time of diagnosis.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>All patients were scheduled to receive rHuEpo in doses of 150 u/Kg/day for a period of 12 weeks in order to obtain and maintain stable responses.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>A multiplex polymerase chain reaction (PCR) was used to genotype both GSTM1 and GSTT1 simultaneously, in responders and non-responders to rhuEpo with respect to various pretreatment parameters: haemoglobin, white blood cell count, platelets, serum erythropoietin, transfusion requirements and bone marrow blasts.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>The data obtained were evaluated by chi2 test and odds ratio were extracted.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Twelve out of 27 evaluated patients demonstrated an erythroid response (44%).</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Nine out of the 12 patients (75%) responding after 12 weeks of treatment had GSTM1 null genotype (OR=3.4).</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>In contrast, only 1 responder (8.3%) was homozygotes of GSTT1 null genotype.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Furthermore, no statistically significant difference in the response rate of the different MDS subgroups was observed.</Variant>", "label": []}
{"id": "15595630", "text": "<Variant>Our results suggest that a treatment with rHuEpo may be effective in achieving a stable erythroid response in MDS patients who carry an homozygous deletion of the GSTM1 gene.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>Sequence variant in the intron 10 of the RET oncogene in a patient with microfollicular thyroid carcinoma with medullar differentiation: implications for newly generated chi-like sequence.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>Sequence alterations in the RET proto-oncogene are becoming increasingly important to clinical assessment of the malignant disease of the thyroid.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>A spectrum of mutations is necessary to establish comprehensive phenotype to genotype relationship relevant to diagnosis and therapy of thyroid malignancies.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>We aimed to append to the increasing database of these oncogenic lesions and, therefore, analyzed DNA from tumor tissue and constitutive DNA from a patient with thyroid carcinoma.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>Mutational screening and sequence characterization of the RET proto-oncogene was performed to include part of the intronic sequences.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>We report a germline sequence variant in DNA from the patient diagnosed with microfollicular thyroid carcinoma.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>The carcinoma presented not as fully developed medullar carcinoma (MTC) but as microfollicular carcinoma with tendency to evolve into MTC.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>We characterized the sequence variant located in the intron 10 of the RET oncogene as an A to G substitution denoted IVS10 +</Variant>", "label": [[98, 104, "Variant"], [126, 136, "Variant"]]}
{"id": "15579915", "text": "<Variant>4G.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>The described sequence alteration generates a chi-like sequence surrounded by several chi-like sequences with recombinational potential.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>Such alteration may be involved in the pathogenesis of the microfollicular carcinoma via genome destabilization through homologous recombination in the process of tumor progression.</Variant>", "label": []}
{"id": "15579915", "text": "<Variant>This result further substantiates the importance of the database correlating specific sequence variations in the RET gene with distinct disease phenotypes.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>Previous low-resolution studies of chromosome 22 in ovarian carcinoma have suggested its involvement in the development of the disease.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>We report a high-resolution analysis of DNA copy number and gene expression of 22q in 18 ovarian carcinomas using a 22q-specific genomic microarray.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>We identified aberrations in 67% of the studied tumors, which displayed 3 distinct gene copy number profiles.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>The majority of the cases (11 of 18) demonstrated heterozygous terminal deletions of various sizes, the smallest of which was 3.5 Mb.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>The second profile, detected in 3 tumors, revealed the coexistence of heterozygous deletions and different patterns of low-copy-number gain that involved the proximal half of 22q.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>The latter finding has not been reported previously in ovarian carcinoma.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>One case displayed a continuous deletion encompassing the entire 22q, consistent with monosomy 22.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>Furthermore, we compared the results with the available data on these tumors by using cDNA microarrays to define the degree of correlation between abnormalities at the DNA level and variation in mRNA expression.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>By a comparison with the expression data, we were able to identify 21 deleted genes showing low mRNA levels and 12 amplified genes displaying elevated gene expression, several of which play roles in cell cycle control and the induction of apoptosis.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>Our results indicated significant correlation between DNA copy number aberrations and variation in mRNA expression.</Variant>", "label": []}
{"id": "15578687", "text": "<Variant>We also identified several regions and candidate genes on 22q that should be studied further to determine their role in the development of ovarian cancer.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>Interleukin-12 (IL-12) governs the Th1-type immune response, affecting the spontaneous and treatment-induced recovery from HCV-infection.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>We investigated whether the IL12B polymorphisms within the promoter region (4 bp insertion/deletion) and the 3'-UTR (1188-A/C), which have been reported to influence IL-12 synthesis, are associated with the outcome of HCV infection.</Variant>", "label": [[85, 108, "Variant"], [126, 134, "Variant"]]}
{"id": "15464247", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>We analyzed 186 individuals with spontaneous HCV clearance, 501 chronically HCV infected patients, and 217 healthy controls.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>IL12B</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>3'-UTR and promoter genotyping was performed by Taqman-based assays with allele-specific oligonucleotide probes and PCR-based allele-specific DNA-amplification, respectively.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>The proportion of IL12B promoter and 3'-UTR genotypes did not differ significantly between the different cohorts.</Variant>", "label": []}
{"id": "15464247", "text": "<Variant>However, HCV genotype 1-infected patients with high baseline viremia carrying the IL12B 3'-UTR 1188-C-allele showed significantly higher sustained virologic response (SVR) rates (25.3% vs. 46% vs. 54.5% for A/A, A/C and C/C) due to reduced relapse rates (24.2% vs. 12% vs. zero % for A/A, A/C and C/C).</Variant>", "label": [[104, 110, "Variant"]]}
{"id": "15464247", "text": "<Variant>CONCLUSIONS: IL12B 3'-UTR 1188-C-allele carriers appear to be capable of responding more efficiently to antiviral combination therapy as a consequence of a reduced relapse rate.</Variant>", "label": [[35, 41, "Variant"]]}
{"id": "15464247", "text": "<Variant>No association of IL12B polymorphisms and self-limited HCV infection could be demonstrated.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>BACKGROUND: A dengue virus type 2 (DEN-2 Tonga/74) isolated from a 1974 epidemic was characterized by mild illness and belongs to the American genotype of DEN-2 viruses.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>To prepare a vaccine candidate, a previously described 30 nucleotide deletion (Delta30) in the 3' untranslated region of DEN-4 has been engineered into the DEN-2 isolate.</Variant>", "label": [[64, 86, "Variant"], [88, 95, "Variant"]]}
{"id": "15461822", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>A full-length cDNA clone was generated from the DEN-2 virus and used to produce recombinant DEN-2 (rDEN-2) and rDEN2Delta30.</Variant>", "label": [[125, 132, "Variant"]]}
{"id": "15461822", "text": "<Variant>Viruses were evaluated for replication in SCID mice transplanted with human hepatoma cells (SCID-HuH-7 mice), in mosquitoes, and in rhesus monkeys.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>Neutralizing antibody induction and protective efficacy were also assessed in rhesus monkeys.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>The rDEN2Delta30 virus was ten-fold reduced in replication in SCID-HuH-7 mice when compared to the parent virus.</Variant>", "label": [[18, 25, "Variant"]]}
{"id": "15461822", "text": "<Variant>The rDEN-2 viruses were not infectious for Aedes mosquitoes, but both readily infected Toxorynchites mosquitoes.</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>In rhesus monkeys, rDEN2Delta30 appeared to be slightly attenuated when compared to the parent virus as measured by duration and peak of viremia and neutralizing antibody induction.</Variant>", "label": [[33, 40, "Variant"]]}
{"id": "15461822", "text": "<Variant>A derivative of rDEN2Delta30, designated rDEN2Delta30-4995, was generated by incorporation of a point mutation previously identified in the NS3 gene of DEN-4 and was found to be more attenuated than rDEN2Delta30 in SCID-HuH-7 mice.</Variant>", "label": [[30, 37, "Variant"], [55, 67, "Variant"], [213, 220, "Variant"]]}
{"id": "15461822", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "15461822", "text": "<Variant>The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine.</Variant>", "label": [[18, 25, "Variant"], [35, 47, "Variant"]]}
{"id": "15455371", "text": "<Variant>Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>Estrogen has been suggested to trigger breast cancer development via an initiating mechanism involving its metabolite, catechol estrogen (CE).</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>To examine this hypothesis, we carried out a multigenic case-control study of 469 incident breast cancer patients and 740 healthy controls to define the role of important genes involved in the different metabolic steps that protect against the potentially harmful effects of CE metabolism.</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>We studied the 3 genes involved in CE detoxification by conjugation reactions involving methylation (catechol-O-methyltransferase, COMT), sulfation (sulfotransferase 1A1, SULT1A1), or glucuronidation (UDP-glucuronosyltransferase 1A1, UGT1A1), one (manganese superoxide dismutase, MnSOD) involved in protection against reactive oxidative species-mediated oxidation during the conversion of CE-semiquinone (CE-SQ) to CE-quinone (CE-Q), and 2 of the glutathione S-transferase superfamily, GSTM1 and GSTT1, involved in CE-Q metabolism.</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>Support for this hypothesis came from the observations that (i) there was a trend toward an increased risk of breast cancer in women harboring a greater number of putative high-risk genotypes of these genes (p < 0.05); (ii) this association was stronger and more significant in those women who were more susceptible to estrogen [no history of pregnancy or older (> or =26 years) at first full-term pregnancy (FFTP)]; and (iii) the risks associated with having one or more high-risk genotypes were not the same in women having experienced different menarche-to-FFTP intervals, being more significant in women having been exposed to estrogen for a longer period (> or =12 years) before FFTP.</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>Furthermore, because CE-Q can attack DNA, leading to the formation of double-strand breaks (DSB), we examined whether the relationship between cancer risk and the genotypic polymorphism of CE-metabolizing genes was modified by the genotypes of DSB repair genes, and found that a joint effect of CE-metabolizing genes and one of the two DSB repair pathways, the homologous recombination pathway, was significantly associated with breast cancer development.</Variant>", "label": []}
{"id": "15455371", "text": "<Variant>Based on comprehensive CE metabolizing gene profiles, our study provides support to the hypotheses that breast cancer can be initiated by estrogen exposure and that increased estrogen exposure confers a higher risk of breast cancer by causing DSB to DNA.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Fanconi anaemia is an autosomal recessive disease characterized by chromosome fragility, multiple congenital abnormalities, progressive bone marrow failure and a high predisposition to develop malignancies.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Most of the Fanconi anaemia patients belong to complementation group FA-A due to mutations in the FANCA gene.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>This gene contains 43 exons along a 4.3-kb coding sequence with a very heterogeneous mutational spectrum that makes the mutation screening of FANCA a difficult task.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>In addition, as the FANCA gene is rich in Alu sequences, it was reported that Alu-mediated recombination led to large intragenic deletions that cannot be detected in heterozygous state by conventional PCR, SSCP analysis, or DNA sequencing.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>To overcome this problem, a method based on quantitative fluorescent multiplex PCR was proposed to detect intragenic deletions in FANCA involving the most frequently deleted exons (exons 5, 11, 17, 21 and 31).</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Here we apply the proposed method to detect intragenic deletions in 25 Spanish FA-A patients previously assigned to complementation group FA-A by FANCA cDNA retroviral transduction.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>A total of eight heterozygous deletions involving from one to more than 26 exons were detected.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Thus, one third of the patients carried a large intragenic deletion that would have not been detected by conventional methods.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>These results are in agreement with previously published data and indicate that large intragenic deletions are one of the most frequent mutations leading to Fanconi anaemia.</Variant>", "label": []}
{"id": "15162062", "text": "<Variant>Consequently, this technology should be applied in future studies on FANCA to improve the mutation detection rate.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>Genetic variants of the extra-large stimulatory Gs protein alpha-subunit and risk of thrombotic and haemorrhagic disorders.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>A polymorphism of the gene encoding the extra-large stimulatory G-protein alpha-subunit (XLalphas), originally identified in three patients with a bleeding tendency, involved a 36-bp insertion and two missense changes.</Variant>", "label": [[186, 201, "Variant"]]}
{"id": "15147378", "text": "<Variant>A paternally-inherited insertion displayed a moderate platelet Gsalpha over-expression, which lead to platelet hypo-reactivity.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>These data prompted us to investigate the genetic, functional and clinical relevance of this polymorphism in the Mediterranean population.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>We included 414 healthy subjects and three case/control studies: 263 consecutive patients with a first episode of primary intracerebral haemorrhage, 195 patients with deep venous thrombosis, and 104 patients with cerebrovascular disease.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>Controls were selected by approximating criteria to match selected risk factors to patients.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>Moreover, we performed studies of platelet function.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>We developed a simple method to determine the methylated allele, by digestion of genomic DNA with Sma I before polymerase chain reaction amplification.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>We identified two new rare variants, resulting from the loss of repeat units 7 and 5.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>The AB genotype was present in 3.6% of healthy population and the prevalence of the B allele was similar among cases and controls.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>Accordingly, the non-methylated B allele did not modify either the expression of platelet Gsalpha or the platelet response to Gs-agonists.</Variant>", "label": []}
{"id": "15147378", "text": "<Variant>Thus, our study suggests a minor functional role of XLalphas polymorphism in thrombotic or in haemorrhagic disorders.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>Does the position of the premature termination codon in COL7A1 correlate with the clinical severity in recessive dystrophic epidermolysis bullosa?</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disease caused by mutations in the gene encoding type VII collagen (COL7A1).</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>The mutations are highly variable and this greatly complicates the study of the genotype-phenotype relationships.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>To date, three recurrent mutations, specific to Japanese RDEB patients have been reported.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>By comparing the phenotypes of RDEB patients with different recurrent mutations, the upstream positions of the premature termination codons (PTCs) showed strong correlation with the RDEB clinical disease severity.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>However, such correlations have not been supported by patients with mutations that were different from these recurrent Japanese patients mutations.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>In this study, we report a case of RDEB with a very mild clinical phenotype, who was a compound heterozygote harbouring both a recurrent Japanese mutation and a novel deletion mutation resulting in a more upstream PTC.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>The patient and his mother were shown to have a recurrent donor splice site mutation within intron 81 (6573 + 1G > C), a recurrent Japanese mutation that activates a cryptic donor splicing site and results in a downstream PTC.</Variant>", "label": [[112, 125, "Variant"]]}
{"id": "15086338", "text": "<Variant>The patient and his father shared a single-nucleotide deletion within exon 64 (5504delA), which causes a downstream frame shift in five amino acids before creating a PTC.</Variant>", "label": [[88, 96, "Variant"]]}
{"id": "15086338", "text": "<Variant>Occurrence of the PTCs in mRNA was confirmed by reverse transcription-polymerase chain reaction (RT)-PCR.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>The patient's skin showed reduced immunofluorescence staining for COL7A1 and reduced number of abnormal or short anchoring fibrils by electron microscopy.</Variant>", "label": []}
{"id": "15086338", "text": "<Variant>Although the position of the mutation 5504delA PTC was located upstream of the previous mutations reported in combination with the 6573 + 1G > C mutation, the two mutations together give an apparently milder clinical phenotype.</Variant>", "label": [[47, 55, "Variant"], [140, 153, "Variant"]]}
{"id": "15086338", "text": "<Variant>Therefore, genotype-phenotype relationships in RDEB cannot be explained purely by the position of PTC.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>The Nijmegen breakage syndrome is a rare autosomal recessive chromosomal instability disorder characterized by early growth retardation, congenital microcephaly, immunodeficiency, borderline mental development, and a high tendency to lymphoreticular malignancies.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Most Nijmegen breakage syndrome patients are of Slavonic origin, and all of them known so far carry a founder homozygous 5 nucleotide deletion in the NBS1 gene.</Variant>", "label": [[130, 151, "Variant"]]}
{"id": "15033202", "text": "<Variant>Microcephaly was present in 100% of Nijmegen breakage syndrome patients in a recent large international cooperative study.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>The frequency of Nijmegen breakage syndrome among children with primary microcephaly was not known.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Early correct diagnosis of the syndrome is crucial for appropriate preventive care and therapy.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>We tested 67 Czech patients of different ages with simple microcephaly for the presence of the most common mutation in the NBS1 gene.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Three new Nijmegen breakage syndrome cases were detected in this cohort, representing 4.5% of the cohort.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>All these newly diagnosed Nijmegen breakage syndrome patients were younger than 10 months at the time of diagnosis.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>They were all born within a 2.5-year period.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Twenty-three of the 67 children in the cohort were born within this 2.5-year period, representing a 13% incidence of Nijmegen breakage syndrome.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Frequency of Nijmegen breakage syndrome heterozygotes among infants in the Czech Republic is 1: 130-158 and the birth rate is 90,000 per year, therefore in the time span of 2.5 years, three new Nijmegen breakage syndrome homozygotes are expected to be born.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>Therefore we assume that by DNA testing of Czech primary microcephalic children it is possible to detect all Nijmegen breakage syndrome patients to be expected.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>The age at correct diagnosis was lowered from 7.1 years at the time before DNA testing, to well under 1 year of age.</Variant>", "label": []}
{"id": "15033202", "text": "<Variant>All new Nijmegen breakage syndrome patients could receive appropriate preventive care, which should significantly improve their life expectancy and prognosis.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Mutations in the leucine rich, glioma inactivated gene (LGI1) were recently described in a small number of families with autosomal dominant lateral temporal epilepsy (ADLTE).</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>ADLTE is characterized by partial seizures with symptoms suggestive of a lateral temporal onset, including frequent auditory aura.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Here we report the results of clinical and genetic analyses of two newly identified families with ADTLE.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>We identified two families whose seizure semiology was suggestive of ADLTE.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Evaluation included a detailed history and neurologic examination, as well as collection of DNA.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>The coding sequence of the LGI1 gene from affected subjects from both families was analyzed for evidence of mutation.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Each patient had a history of partial seizures, often with secondary generalization earlier in the course.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Auditory aura was reported by approximately two thirds of affected patients in each pedigree.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Novel mutations in LGI1 were detected in both families.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>A heterozygous single-nucleotide deletion at position 329 (del 329C) was detected in affected individuals from one family, whereas patients from the second family had a nonsynonymous variation, corresponding to C435G. CONCLUSIONS:</Variant>", "label": [[24, 66, "Variant"], [68, 76, "Variant"], [220, 225, "Variant"]]}
{"id": "15009222", "text": "<Variant>We identified two novel mutations in the LGI1 gene.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>The phenotype of these two families was similar to that of other kindreds with ADLTE, as auditory aura was absent in one third of affected individuals.</Variant>", "label": []}
{"id": "15009222", "text": "<Variant>Our results further support that LGI1 mutations should be considered in patients with a history of partial seizures if the semiology of seizures is consistent with the onset in the lateral temporal lobe.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>Thyroperoxidase gene mutations in congenital goitrous hypothyroidism with total and partial iodide organification defect.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>Mutations of the thyroperoxidase (TPO) gene have been reported as being the most severe and frequent abnormality in thyroid iodide organification defect (IOD) causing goitrous congenital hypothyroidism.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>The objective of this study was to screen and subsequently identify TPO gene mutations in patients with congenital hypothyroidism with evidence of total iodine organification defects (TIOD) or partial iodine organification defect (PIOD) as defined by the perchlorate discharge test.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>Seven goitrous patients with TIOD and seven patients with PIOD, from three and five unrelated families, respectively, were studied.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>We were able to detect different TPO genes mutations in patients with TIOD and PIOD.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>In TIOD families the results were as follows: (1) a homozygous GGCC insertion at exon 8, position 1277 (family 1); (2) compound heterozygosity with a GGCC insertion at exon 8 (1277) and a nucleotide substitution in exon 11 (2068G>C) (family 2); (3) compound heterozygosity with the mutation 2068G>C in exon 11 and a C insertion in exon 14 between positions 2505-2511 (family 3).</Variant>", "label": [[72, 111, "Variant"], [159, 190, "Variant"], [233, 240, "Variant"], [300, 307, "Variant"], [325, 375, "Variant"]]}
{"id": "14751036", "text": "<Variant>In patients with PIOD we have detected: (1) only one heterozygous mutation in two families (4 and 5), in exons 11 and 10 (2084G>A and 1780C>A); (2) a compound heterozygous condition in one family (family 6), with mutations, respectively in exons 8 and 10 (1242G>T and 1780C>A); (3) only polymorphisms (family VII) and (4) a heterozygous mutation in the first base of the border exon/intron 9 +1G>T (family VIII).</Variant>", "label": [[131, 138, "Variant"], [143, 150, "Variant"], [265, 272, "Variant"], [277, 284, "Variant"], [399, 406, "Variant"]]}
{"id": "14751036", "text": "<Variant>We did not detect inactivating mutations in exons 11, 16, and 21 of the THOX2 gene where mutations have been previously described.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>We concluded that homozygous and compound heterozygous mutations found in TIOD characterized the autosomal recessive mode of inheritance and will translate a nonfunctional protein or a protein that may not reach the apical membrane.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>As for PIOD, the majority of the studied kindreds had only heterozygous mutations and/or polymorphisms.</Variant>", "label": []}
{"id": "14751036", "text": "<Variant>It is conceivable that these TPO gene sequence alterations may partially affect the functional state of the translated protein or affect its transport to the apical membrane.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Fanconi anemia (FA) is an autosomal recessive chromosomal instability disorder caused by mutations in one of seven known genes (FANCA,C,D2,E,F,G and BRCA2).</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Mutations in the FANCA gene are the most prevalent, accounting for two-thirds of FA cases.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Affected individuals have greatly increased risks of acute myeloid leukemia (AML).</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>This raises the question as to whether inherited or acquired mutations in FA genes might be involved in the development of sporadic AML.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Quantitative fluorescent PCR was used to screen archival DNA from sporadic AML cases for FANCA deletions, which account for 40% of FANCA mutations in FA homozygotes.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Four heterozygous deletions were found in 101 samples screened, which is 35-fold higher than the expected population frequency for germline FANCA deletions (P<0.0001).</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>Sequencing FANCA in the AML samples with FANCA deletions did not detect mutations in the second allele and there was no evidence of epigenetic silencing by hypermethylation.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>However, real-time quantitative PCR analysis in these samples showed reduced expression of FANCA compared to nondeleted AML samples and to controls.</Variant>", "label": []}
{"id": "14749703", "text": "<Variant>These findings suggest that gene deletions and reduced expression of FANCA may be involved in the promotion of genetic instability in a subset of cases of sporadic AML.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>PURPOSE:</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>Cyclic AMP response element binding protein binding protein (CBP), a nuclear transcriptional coactivator protein, is an important component of the cAMP signal transduction pathway.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>In this study, we systematically analyzed the pattern and frequency of CBP gene alterations in esophageal squamous cell carcinoma (ESCC) samples from Linzhou (Linxian), China.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>Experimental Design: Using microsatellite markers D16S475, D16S2622, and D16S523 within the chromosome 16p13.3 locus flanking the CBP gene, we observed loss of heterozygosity (LOH), microsatellite instability (MSI), or homozygous deletion in 16 of 26 ESCC samples.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>Additional ESCC samples were analyzed using different sets of microsatellite markers (CS1-CS5) within the introns or in close proximity to the 3' end of the CBP gene.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>The data showed that CBP gene LOH or MSI occurred in 9 of 19 ESCC samples.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>A detailed genetic alteration map of the CBP gene showed that an LOH or MSI hot spot occurred within intron 2 of the CBP gene.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>Furthermore, ESCC samples were investigated for CBP gene mutation by conformation sensitive gel electrophoresis and DNA sequencing.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>These results revealed that most of the shifted fragments contained internal tandem duplication (ITD), frequently in the regions encoding the histone acetyltransferase domain and COOH-terminal transactivating domain one of the CBP gene.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>The presence of ITD within the CBP gene was additionally confirmed by Southern blot analysis and sequencing.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>CONCLUSIONS: These studies show that LOH and ITD of the CBP gene are frequent genetic events in human ESCC.</Variant>", "label": []}
{"id": "14734447", "text": "<Variant>These alterations may have functional importance in the development of human ESCC.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>Smith-Magenis syndrome (SMS) is caused by an approximately 4-Mb heterozygous interstitial deletion on chromosome 17p11.2 in approximately 80%-90% of affected patients.</Variant>", "label": [[68, 107, "Variant"]]}
{"id": "14639526", "text": "<Variant>Three large ( approximately 200 kb), complex, and highly homologous ( approximately 98%) low-copy repeats (LCRs) are located inside or flanking the SMS common deletion.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>These repeats, also known as \"SMS-REPs,\" are termed \"distal,\" \"middle,\" and \"proximal.\"</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>The directly oriented distal and proximal copies act as substrates for nonallelic homologous recombination resulting in both the deletion associated with SMS and the reciprocal duplication: dup(17)(p11.2p11.2).</Variant>", "label": [[199, 218, "Variant"]]}
{"id": "14639526", "text": "<Variant>Using restriction enzyme cis-morphism analyses and direct sequencing, we mapped the regions of strand exchange in 16 somatic-cell hybrids that harbor only the recombinant SMS-REP.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>Our studies showed that the sites of crossovers were distributed throughout the region of homology between the distal and proximal SMS-REPs.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>However, despite approximately 170 kb of high homology, 50% of the recombinant junctions occurred in a 12.0-kb region within the KER gene clusters.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>DNA sequencing of this hotspot (positional preference for strand exchange) in seven recombinant SMS-REPs narrowed the crossovers to an approximately 8-kb interval.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>Four of them occurred in a 1,655-bp region rich in polymorphic nucleotides that could potentially reflect frequent gene conversion.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>For further evaluation of the strand exchange frequency in patients with SMS, novel junction fragments from the recombinant SMS-REPs were identified.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>As predicted by the reciprocal-recombination model, junction fragments were also identified from this hotspot region in patients with dup(17)(p11.2p11.2), documenting reciprocity of the positional preference for strand exchange.</Variant>", "label": [[143, 162, "Variant"]]}
{"id": "14639526", "text": "<Variant>Several potential cis-acting recombination-promoting sequences were identified within the hotspot.</Variant>", "label": []}
{"id": "14639526", "text": "<Variant>It is interesting that we found 2.1-kb AT-rich inverted repeats flanking the proximal and middle KER gene clusters but not the distal one.</Variant>", "label": [[41, 72, "Variant"]]}
{"id": "14639526", "text": "<Variant>The role of any or all of these in stimulating double-strand breaks around this positional recombination hotspot remains to be explored.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>The promyelocytic leukemia (PML) tumor suppressor of acute promyelocytic leukemia (APL) is essential for a number of proapoptotic and growth-suppressive pathways as well as for the activity of differentiating agents such as retinoic acid (RA).</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>In human APL, the dose of PML is reduced to heterozygosity given that one allele is involved in the chromosomal translocation while the status of the remaining PML allele is unknown.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>We have therefore used single-strand conformational polymorphism (SSCP) and sequencing analysis to screen DNA from APL patients for mutations at the PML locus.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>We identified DNA sequence variations resulting in a truncated PML protein in APL cases that displayed RA resistance and a very poor prognosis.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>Mutation analysis also led to the identification of aberrant PML sequence variations in other hematopoietic malignancies.</Variant>", "label": []}
{"id": "14630830", "text": "<Variant>Complete functional loss of PML is therefore selected by the APL phenotype and associates with poor prognosis and RA unresponsiveness.</Variant>", "label": []}
{"id": "14623369", "text": "<Variant>The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia.</Variant>", "label": [[13, 18, "Variant"]]}
{"id": "14623369", "text": "<Variant>We investigated a novel polymorphism of single nucleotide substitution (C270T) of the brain-derived neurotrophic factor (BDNF) gene in schizophrenia patients (n=101) and in controls (n=68).</Variant>", "label": [[81, 86, "Variant"]]}
{"id": "14623369", "text": "<Variant>The frequency of the C/T genotype and the T allele were significantly higher in the schizophrenia patients (25.7% and 13.9%, respectively) compared with the controls (5.9% and 2.9%).</Variant>", "label": []}
{"id": "14623369", "text": "<Variant>There were no significant differences in Positive and Negative Symptom Scale (PANSS) items and Global Assessment of Functioning (GAF) scores between the patients with C/C and C/T genotypes.</Variant>", "label": []}
{"id": "14623369", "text": "<Variant>Further studies are warranted to elucidate the significance of this finding in the pathophysiology of schizophrenia.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disorder of panethnic distribution caused by a deficiency of the activity of branched-chain alpha-ketoacid dehydrogenase (BCKD) complex.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Mutations in the human BCKD genes E1alpha (BCKDHA), E1beta (BCKDHB) and E2 (DBT) are known to result in MSUD, referred to as type Ia, Ib and II mutations respectively.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>In this study 16 patients with the classic severe form of MSUD and three patients with milder variant forms of the disease were investigated for mutations in the E1alpha-, E1beta- and E2-gene by single-strand conformation polymorphism (SSCP) analysis and DNA sequencing.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>The patients' clinical and biochemical phenotypes were well characterized.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>One novel type Ia missense mutation, eight novel type Ib (three missense, two nonsense, two small deletions, one small duplication) and three novel type II (two missense, one splice site) mutations were identified in patients.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Moreover, eleven previously described mutations were detected: five type Ia (four missense, one nonsense), three type Ib mutations (two missense, one nonsense) and three type II mutations (two missense, one small deletion).</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Fourteen patients are homozygous for one single mutation, five patients are compound-heterozygous for two different mutations affecting one of the three genes.</Variant>", "label": []}
{"id": "14517957", "text": "<Variant>Thus, in all 19 patients the identified mutations can most probably be considered the molecular basis of the disease.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>BACKGROUND/AIMS:</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>Progressive familial intrahepatic cholestasis characterized by normal serum gamma-glutamyltransferase activity can be due to mutations in familial intrahepatic cholestasis type 1 (FIC1) (ATP8B1), a gene expressed in several organs.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>In some cases, it is associated with extrahepatic features.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>We searched for FIC1 mutations and analyzed the outcome of extrahepatic features after liver transplantation in two children with this form of progressive familial intrahepatic cholestasis associated with chronic unexplained diarrhea and short stature.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>FIC1 sequence was determined after polymerase chain reaction (PCR) of genomic lymphocyte DNA and/or reverse transcription-PCR of liver or lymphocyte RNA.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>A homozygous amino acid change deletion was found in one child.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>The second child harboured compound heterozygous missense and nonsense mutations.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>In both children, despite successful liver transplantation, evolution (follow-up: 9.5-11 years) was characterized by exacerbation of diarrhea and no catch-up of stature growth, and appearance of liver steatosis.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>CONCLUSIONS: Progressive familial intrahepatic cholestasis characterized by normal serum gamma-glutamyltransferase activity and extrahepatic features corresponds to progressive familial intrahepatic cholestasis type 1.</Variant>", "label": []}
{"id": "12927934", "text": "<Variant>Extrahepatic symptomatology is not corrected or may be aggravated by liver transplantation, impairing life quality.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>AIM: To refine the loss of heterozygosity on chromosome 5p15 and to identify the new tumor suppressor gene (s) in colorectal tumorigenesis.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>METHODS: Sixteen polymorphic microsatellite markers were analyzed on chromosome 5 and another 6 markers were applied on chromosome 5p15 in 83 cases of colorectal and normal DNA by PCR.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>PCR products were electrophoresed on an ABI 377 DNA sequencer.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>Genescan 3.1 and Genotype 2.1 software were used for LOH scanning and analysis.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>We observed 2 distinct regions of frequent allelic deletions on Chromosome 5, at D5S416 on 5p15 and D5S428-D5S410 on 5q.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>Another 6 polymorphric microsatellite markers were applied to 5p15 and the minimal region of frequent loss of heterozygosity was established on 5p15 spanning the D5S416 locus.</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "12918106", "text": "<Variant>Through our detailed deletion mapping studies, we have found a critical and precise location of 5p deletions, 5p15.2-5p15.3, which must contain one or more unknown tumor suppressor gene (s) of colorectal cancer.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.</Variant>", "label": [[92, 109, "Variant"]]}
{"id": "12872254", "text": "<Variant>Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations in the SMN1 (survival motor neuron) gene.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>It is classified by age of onset and maximal motor milestones achieved in type I, II, and III (severe, intermediate, and mild form, respectively).</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>Of 369 unrelated SMA patients who were investigated for homozygous deletions in the SMN1 gene, 18 patients (4.8%) revealed at least one copy of exon 7.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>A 4-bp deletion in exon 3 (c.399_402delAGAG) was detected in 15 patients from 10 families.</Variant>", "label": [[11, 24, "Variant"], [36, 52, "Variant"]]}
{"id": "12872254", "text": "<Variant>This mutation was associated with a large spectrum of phenotypes from type I to asymptomatic patients.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>Five patients from two consanguineous families were homozygous for the mutation with diverse mild phenotypes.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>Determination of the SMN2 copy number showed that the presence of two or three copies generally correlated with a better evolution.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>RT-PCR studies of SMN transcripts in control and patients with the same SMN2 copy number showed that the full-length/Delta7 ratio is influenced by the SMN1 genotype although it seems independent of the SMN2 copy number.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>Moreover, protein analysis in these patients showed a reduction in SMN protein in compound heterozygous patients (c.399_402delAGAG/deletion) when compared with homozygous c.399_402delAGAG/c.399_402delAGAG patients.</Variant>", "label": [[123, 139, "Variant"], [180, 196, "Variant"], [197, 213, "Variant"]]}
{"id": "12872254", "text": "<Variant>Microsatellite DNA markers flanking the SMA locus revealed the occurrence of the 4-bp deletion in the background of the same haplotype, suggesting that a single mutational event was involved in the 10 families.</Variant>", "label": [[90, 103, "Variant"]]}
{"id": "12872254", "text": "<Variant>The geographic origins of ancestors point to a founder effect from the south and east of Spain.</Variant>", "label": []}
{"id": "12872254", "text": "<Variant>The c.399_402delAGAG, which is to date unique to the Spanish population, constitutes the most frequently found subtle mutation in SMA.</Variant>", "label": [[13, 29, "Variant"]]}
{"id": "12872254", "text": "<Variant>Hum Mutat 22:136-143, 2003.</Variant>", "label": []}
{"id": "12829659", "text": "<Variant>Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.</Variant>", "label": [[50, 56, "Variant"], [68, 74, "Variant"]]}
{"id": "12829659", "text": "<Variant>High levels of cytokines are risk factors for type 2 diabetes.</Variant>", "label": []}
{"id": "12829659", "text": "<Variant>Therefore, we investigated whether the promoter polymorphisms of the tumor necrosis factor-alpha (TNF-alpha; G-308A) and interleukin 6 (IL-6; C-174G) genes predict the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the Finnish Diabetes Prevention Study.</Variant>", "label": [[118, 124, "Variant"], [151, 157, "Variant"]]}
{"id": "12829659", "text": "<Variant>Altogether, 490 overweight subjects with IGT whose DNA was available were randomly divided into one of the two treatment assignments: the control group and the intensive, individualized diet and exercise intervention group.</Variant>", "label": []}
{"id": "12829659", "text": "<Variant>The -308A allele of the TNF-alpha gene was associated with an approximate twofold higher risk for type 2 diabetes compared with the G-308G genotype (odds ratio 1.80, 95% CI 1.05-3.09; P = 0.034).</Variant>", "label": [[13, 18, "Variant"], [141, 147, "Variant"]]}
{"id": "12829659", "text": "<Variant>Subjects with both the A allele of the TNF-alpha gene and the C-174C genotype of the IL-6 gene had a 2.2-fold (CI 1.02-4.85, P = 0.045) higher risk of developing type 2 diabetes than subjects without the risk genotypes.</Variant>", "label": [[71, 77, "Variant"]]}
{"id": "12829659", "text": "<Variant>We conclude that the -308A allele of the promoter polymorphism (G-308A) of the TNF-alpha gene is a predictor for the conversion from IGT to type 2 diabetes.</Variant>", "label": [[30, 35, "Variant"], [73, 79, "Variant"]]}
{"id": "12829659", "text": "<Variant>Furthermore, this polymorphism seems to have a gene-gene interaction with the C-174C genotype of the IL-6 gene.</Variant>", "label": [[87, 93, "Variant"]]}
{"id": "12716337", "text": "<Variant>Polymorphism at position -174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine that mediates inflammatory tissue destruction.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>A G to C substitution at position -174 in the promoter of IL-6 gene reduces in vitro transcription of IL-6.</Variant>", "label": [[11, 47, "Variant"]]}
{"id": "12716337", "text": "<Variant>This polymorphism has been associated with inflammatory diseases like chronic arthritis.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>OBJECTIVE:</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>The aim of this study was to investigate the association between the IL-6-174 polymorphism and susceptibility to chronic periodontitis in Brazilians.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>MATERIAL AND METHODS:</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>Eighty-four nonsmoking subjects over 25 years (mean age 42.4) were divided according to the severity level of periodontal disease: 36 healthy individuals (control group), 24 subjects with moderate and 24 with severe periodontitis.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>Genomic DNA was obtained from epithelial cells through a mouthwash with 3% glucose and scraping of oral mucosa.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>The samples were analyzed for IL-6-174 polymorphism using PCR-RFLP.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>The significance of the differences in the frequencies of the polymorphism in the control and groups with periodontitis was assessed by chi2 test (p<0.05).</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>RESULTS:</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>Differences were found between control and groups with periodontitis in the genotype (p=0.0036, OR=3.0) and in the allele (p=0.0838, OR=1.9) frequencies.</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>CONCLUSION:</Variant>", "label": []}
{"id": "12716337", "text": "<Variant>We concluded that the IL-6-174 polymorphism is associated with susceptibility to chronic periodontitis in the population studied.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>BACKGROUND:</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Previous studies mapped a region at the q21 band of chromosome 13 (13q21), which is frequently deleted in various human cancers including prostate cancer, suggesting the existence of a tumor suppressor gene at 13q21.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>The target gene of deletion in prostate cancer, however, has not been identified at present.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>METHODS:</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>We examined four non-neoplastic and 18 neoplastic prostatic cell lines or xenografts.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Homozygous/hemizygous deletion was detected by assays of duplex PCR and real-time PCR.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Expression levels of genes were determined by the methods of RT-PCR, real time PCR, and northern blot analysis.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Mutations of KLF5 were detected by the approaches of single strand conformational polymorphism (SSCP) and direct sequencing.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>For the detection of promoter methylation, Southern blotting of genomic DNA and restriction digestion or SSCP analysis of methylation specific PCR products were used.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Finally, an expression plasmid of KLF5 was introduced into prostate cancer cell lines with reduced KLF5 expression to investigate colony formation for cell growth.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>RESULTS: A 2-Mb region of homozygous deletion at 13q21 was detected in the LUCaP70 xenograft of prostate cancer.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>This region of deletion was further narrowed to 142 Kb by a hemizygous deletion in the NCI-H660 cell line.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>KLF5 was identified as the only complete gene in the smallest region of deletion.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Quantitative deletion of KLF5 genome occurred in six of the 18 (33%) prostate cancer xenografts/cell lines.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Each of the six samples with deletion also showed loss of expression for KLF5, suggesting that hemizygous deletion is one mechanism for loss of KLF5 expression.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>In total, 16 of the 18 cases (89%) showed loss of KLF5 expression at different degrees.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>In contrast, mutations and promoter methylations were not detected in any of the samples.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Functionally, restoration of KLF5 in DU 145 and 22Rv1 cell lines significantly inhibited their growth in vitro.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Frequent genomic deletion and loss of expression as well as cell growth suppression indicate that KLF5 is a reasonable candidate for the tumor suppressor gene at 13q21 in prostate cancer.</Variant>", "label": []}
{"id": "12661032", "text": "<Variant>Mutation and promoter methylation are not common mechanisms for the inactivation of KLF5 in prostate cancer.</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Card15 and Crohn's disease: healthy homozygous carriers of the 3020insC frameshift mutation.</Variant>", "label": [[72, 80, "Variant"]]}
{"id": "12650796", "text": "<Variant>OBJECTIVES:</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Single nucleotide variations in the CARD15 gene have recently been shown to be associated with Crohn's disease (CD).</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Of special interest is a cytosine insertion at position 3020 of exon 11 (3020insC), which leads to a stop codon, truncation of the CARD15 protein, and an altered function of CARD15.</Variant>", "label": [[34, 69, "Variant"], [82, 90, "Variant"]]}
{"id": "12650796", "text": "<Variant>The aim of the study was to evaluate this frameshift mutation in Dutch, multiple-affected families with inflammatory bowel disease (IBD).</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>METHODS: Ninety-three Caucasian, multiple-affected families with IBD were recruited by interviewing patients attending our department.</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Sixty-one probands had CD, and 32 probands ulcerative colitis (UC).</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>The diagnosis of probands and affected family members was verified according to standard criteria.</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>In addition, 81 healthy, unrelated controls were included.</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Genomic DNA was isolated from venous blood of all participants to determine the CARD15 3020insC mutation by using an allele-specific polymerase chain reaction, followed by agarose gel electrophoresis and DNA sequencing.</Variant>", "label": [[96, 104, "Variant"]]}
{"id": "12650796", "text": "<Variant>RESULTS: Association with CARD15 3020insC was statistically significant for CD, but not for UC.</Variant>", "label": [[42, 50, "Variant"]]}
{"id": "12650796", "text": "<Variant>In one of the multiple-affected families, middle-aged and elderly homozygous carriers were identified without CD.</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>CONCLUSIONS:</Variant>", "label": []}
{"id": "12650796", "text": "<Variant>Although CARD15 3020insC appears to be etiologically important in CD, homozygous carriage does not always lead to IBD.</Variant>", "label": [[25, 33, "Variant"]]}
{"id": "12626442", "text": "<Variant>Total C4B deficiency due to gene deletion and gene conversion in a patient with severe infections.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>Deficiencies of the early components of the classical complement pathway impair the actions of innate and humoral immunity and may lead to increased susceptibility to infections.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>We have studied the genetic basis of total C4B deficiency in a Finnish patient with recurrent meningitis, chronic fistulas and abscesses.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>The maternal chromosome carried a four-gene deletion including the C4B gene, and a conversion from C4B to C4A gene was found on the paternal chromosome resulting in complete deficiency of C4B. In the converted C4A gene, mutation screening did not reveal any amino acid changes or prominent mutations, yet a large number of nucleotide variations were found.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>Further, the patient was heterozygous for structural deficiency of mannan binding lectin (MBL) associating with medium levels of serum MBL.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>Our data provides new information on the genetic instability of the C4 gene region, and on the association of homozygous C4B deficiency and variant MBL genotype with increased susceptibility to recurrent and chronic infections.</Variant>", "label": []}
{"id": "12626442", "text": "<Variant>Importantly, plasma therapy induced a prompt clinical cure with long-term effects.</Variant>", "label": []}
